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The 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)-mediated oxidative carbon–
hydrogen bond cleavage of allylic ethers has been studied. The generated α,β-unsaturated 
oxocarbenium ions can be captured by appended enol acetate nucleophiles to stereoselectively 
provide cis-2,6-disubstituted tetrahydropyrones. Alkenes with a wide assortment of substitution 
patterns undergo oxidative cyclizations efficiently, and commonly encountered functional groups 
on either side of the ether linkage are well tolerated. 
 
 
 
The scope of this method has successfully been expanded to (silyl)allylic and propargylic 
ethers. The generated vinylsilane-substituted tetrahydropyrans are versatile precursors for a wide 
range of functional group interconversions and stereocontrolled additions. The cyclization of 
(silyl)allylic ethers proceeds efficiently to generate cis-2,6-disubstituted tetrahydropyrones with 
excellent stereocontrol, and therefore is preferable for target-oriented syntheses. The cyclization 
of propargylic ethers results in a mixture of cis- and trans-2,6-disubstituted tetrahydropyrones, 
and it is applicable in diversity-oriented syntheses. 
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 iv 
 
 
Two models of the geometries of 1,1-disubstituted oxocarbenium ions (A) and the 
conformations of oxocarbenium ions that contain a tertiary stereocenter (B) have been designed. 
Both models have been applied to highly stereoselective syntheses of tetrahydropyrans 
containing tertiary ethers. 
 
 
 
DDQ-catalyzed oxidative cyclizations for tetrahydropyran synthesis have been achieved 
by using MnO2 as an inexpensive and environmentally benign terminal oxidant. This catalytic 
system is also applicable to other commonly encountered DDQ-mediated reactions, such as PMB 
ether cleavages and dehydrogenations. The products are quite easy to purify, and the yields are 
comparable with the corresponding reactions using stoichiometric DDQ. 
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1.0  CARBON‒CARBON BOND CONSTRUCTION THROUGH OXIDATIVE 
CARBON‒HYDROGEN BOND CLEAVAGE OF VINYL AND ALLYLIC ETHERS   
1.1 INTRODUCTION OF C‒H BOND ACTIVATION 
Carbon–carbon bond formation is a fundamental transformation in organic synthesis. 
Over the past few decades, much effort has been made in the development of various metal-
catalyzed coupling reactions, such as the Heck reaction, the Suzuki reaction, and olefin 
metathesis, which have greatly advanced modern organic synthesis.1 However, most methods 
require that each reactant has a pre-existing functional group (Figure 1). Moreover, incorporating 
the functional group into a carbon skeleton typically involves multiple steps, thereby lengthening 
the synthetic sequence. C–C bond formation through C–H bond activation reactions has attracted 
great attention recently.2 In such a process, a selective and direct one step formation of C‒C 
bonds from C‒H bonds allows straightforward and concise approaches to access target molecules 
with minimum intermediary functionalizations. Aside from the benefits concerning step 
economy,3 this approach is also attractive in terms of atom economy.4 Four representative types 
of C‒H functionalization strategies for C‒C bond formation and their application in complex 
molecule syntheses will be briefly discussed in this introduction. 
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Figure 1. Synthetic efficiency of traditional approach and C‒H functionalization 
 
1.1.1 C‒H activation through transition metal-catalyzed metallation 
Transition metals insert into C‒H bonds, and the resulting organometallic complex serves 
as a useful intermediate for C‒C bond formation. A suitable Lewis basic group can direct the 
transformation with high regiospecificity, which is known as coordination-directed metallation. 
Sames disclosed an sp3 C‒H bond arylation of amidine-substituted pyrrolidines through 
directed metallation (Scheme 1).5 The amidine 1.1 directs the insertion of Ru3(CO)12 into a C‒H 
bond at 150 oC to generate metal hydride 1.3, which is oxidized by pinacolone to give metal-
alkoxide 1.4. Intermediate 1.4 undergoes transmetalation with phenylboronate ester 1.2 affording 
metal-aryl 1.5. The subsequent reductive elimination results in pyrrolidine 1.6 in 62% yield with 
the trans/cis ratio of 6:1. The directing group amidine can be removed in one step from the 
sterically hindered pyrrolidine with TFA and H2NNH2. Another interesting example is the 
teleocidin B-4 synthesis by the same group (Scheme 1).6 The imine and methoxy group in 1.7 
can direct PdCl2 to insert into the C‒H bond of methyl group forming stable palladacycle 1.8, 
which undergoes transmetallation with an alkenylboronic acid to afford the alkene 1.9 in 86% 
yield. The non-traditional activation of less reactive C‒H bond of highly functionalized 
substrates opens a new synthetic strategy for modern synthesis.     
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Scheme 1. Directed sp3 C‒H activation and the application in natural product synthesis 
 
The coordination-directed metallation has also been applied to activate sp2 C‒H bonds. 
Bergman and Ellman reported a rhodium-chiral phorphoramidite-mediated enantioselective 
cyclization reaction via directed C‒H activation (Scheme 2).7 Substrate 1.10 reacts with 
[RhCl(coe)2]2 and chiral phosphoramidite 1.11 through a process involving imine-directed C‒H 
activation, asymmetric hydrometallation, and reductive elimination to give dihydropyrroloindole 
1.12 in 61% yield and 90% ee. This method is applied to the asymmetric synthesis of the potent 
protein kinase C inhibitor tricyclic indole 1.13.8 The method proved not to be applicable in the 
enantioselective total synthesis of the HIV-1 integrase inhibitor lithospermic acid; the yields and 
enantioselectivities are unsatisfactory. However, the problem is solved by using a chiral imine 
auxiliary 1.14 to direct a diastereoselective C‒H insertion into the prochiral olefin (Scheme 2).9 
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Chiral imine 1.14 reacts with [RhCl(coe)2]2 and FcPCy2 to afford dihydrobenzofuran 1.15 in 
88% yield and 73% ee, which is improved to 99% after recrystallization. Both syntheses are 
noteworthy because they provide much more efficient entries to these two inhibitors through 
C‒H activation.    
 
Scheme 2. Directed sp2 C‒H activation in natural product synthesis 
 
Transition metals can also direct insert into C‒H bonds of nitrogen heterocycles in the 
absence of directing groups, providing a powerful approach to regioselectively introducing 
various substituents onto the heterocycle scaffold. Bergman and Ellman reported a Rh-catalyzed 
intramolecular dihydroquinazoline alkylation yielding ring-fused pyrrolo[2,1-b]quinazolines, a 
common structural motif for biologically active natural products (Scheme 3).10 Exposing 
dihydroquinazoline 1.16 to [RhCl(coe)2]2 and a conformationally rigid cyclohexylphoban ligand 
at 150 oC led to tricycle 1.17 in 60% yield. The intermediate was employed in a total synthesis of 
vasicoline. The alkylation of oxazolines was also achieved in the presence of Rh-phosphine 
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catalyst to furnish a variety of alkenes with a range of functionality.11 These alkylated oxazolines 
can be converted to corresponding carboxylic acids or esters using known protocols.12  
 
 
Scheme 3. Heterocycle metalation without directing groups 
 
1.1.2 C‒H activation through metal carbenoid insertion 
Metal carbenoid insertion is a powerful strategy for C‒H functionalization.13 
Intramolecular reactions have been extensively studied. Metal carbenoids, usually generated 
from diazo compounds by the use of a transition metal, insert directly into a proximal C‒H bond 
to give cyclic ketones, lactones and lactams in one step, without the participation of the metal 
(Scheme 4).14 In most of the precedents, the regioselectivity in intramolecular metal carbenoid 
insertions occurs to form 5-membered ring structures through 1,5-C‒H insertion. Dirhodium 
complexes are efficient catalysts for the process, and good chemo-, diastereo- and 
enantioselectivity can be achieved by tuning the ligands on the metal.13 As demonstrated in 
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natural product synthesis (Scheme 4), the unique and direct strategy is attractive in terms of its 
neutral reaction conditions, good functional compatibility and high stereoselectivity.   
 
 
Scheme 4. Intramolecular metal carbenoid insertion in natural product synthesis 
 
Compared with intramolecular reactions, intermolecular transformations would be more 
efficient because multistep substrate synthesis can be avoided. However, the control of 
regioselectivity of intermolecular process proves to be much more challenging than that of 
intramolecular process mainly due to the high reactivity of metal carbenoids commonly derived 
from acceptor-only substituted diazoacetates (Figure 2).15 The major breakthroughs have been 
made to attenuate the carbenoid reactivity by incorporating a donor substituent like an aryl or 
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vinyl group into the carbenoid.13,16 This modification is beneficial to suppress carbene 
dimerization byproducts as well as increase the regioselectivity for intermolecular processes. 
 
 
Figure 2. Controlling factors of carbenoid reactivity 
 
The intermolecular donor/acceptor carbenoid C‒H insertion has been successfully 
applied to a number of complex molecule syntheses, as demonstrated in the synthesis of the 
potent monoamine re-uptake inhibitor (+)-indatraline by Davies (Scheme 5).17 The key step 
involved the allylic C‒H activation of 1,4-cyclohexadiene by the rhodium-carbenoid derived 
from 1.24, leading to 1.25 in 83% yield and 93% ee. In addition, this strategy can provide 
complementary approaches to give versatile structures such as 1.27 and 1.29, as shown in 
Scheme 5.18,19 These structures are usually synthesized by classic aldol and Mannich reactions, 
respectively.     
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Scheme 5. Intermolecular carbenoid C‒H insertions in synthesis 
 
1.1.3 C‒H activation through intramolecular hydride transfer 
Intramolecular hydride transfer is another strategy for selective activation of a variety of 
C‒H bonds. One of the most well studied examples is the “tert-amino effect” that involves the 
thermal cyclization of tertiary anilines bearing electron deficient alkenes to afford a 6-membered 
ring (Scheme 6).20 Reinhoudt reported that when aryl pyrrolidine 1.30 in BuOH was heated to 
reflux, a 1,5-hydride transfer occurred to the dicyanovinyl moiety to afford 1.32 in 82% yield in 
2 h.21 The mechanistic study shows that the first, rate limiting step comprises hydrogen migration 
in a conformation in which the vinyl group points away from the amino group to give a dipolar 
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intermediate 1.31; the migrating hydrogen atom (Ha) stays on the same face of the substrate. 
Seidel and co-workers described a first catalytic enantioselective variant of the reaction.22 
Substrate 1.33 was converted to ring-fused tetrahydroquinoline 1.35 in 80% yield with high 
enantioselectivity, though the diastereocontrol was moderate. The electrophilicity of α,β-
unsaturated acyl oxazolidinone in 1.33 was enhanced by the catalysis of chiral Lewis acid 
formed from Mg(OTf)2 and ligand 1.34. 
 
 
Scheme 6. C‒H activations through tert-amino effect 
 
Simple ethers can also undergo similar transformations to provide C‒C bonds. Sames 
developed a Lewis acid-mediated intramolecular hydride transfer to generate oxygen-containing 
heterocycles with high diastereocontrol (Scheme 7).23 The coordination of BF3•Et2O to the 
carbonyl oxygen of 1.36 activated the alkene to undergo a [1,5]-hydride transfer giving 
intermediate 1.37; the resulting enolate reacted with the oxocarbenium ion to furnish 
tetrahydropyran 1.38 in 90% yield with a diastereomeric ratio of 15:1. Enals proved to be poor 
acceptor components in such transformations, illustrated by the reaction of 1.39, in which the 
cyclization of 1.39 was very slow under similar conditions, taking four days to give 1.40 in 44% 
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yield (Scheme 7).24 The problem was addressed by converting aldehyde 1.39 to acetal 1.41, with 
a dramatic improvement in reactivity, yield and stereocontrol. 
 
 
Scheme 7. C‒H activations through intramolecular hydride transfer to alkenes 
 
1.1.4 C‒H activation through DDQ oxidation 
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) can mediate oxidative C‒H bond 
cleavage at benzylic positions.25 Benzylic substrate 1.43 reacts with DDQ through the cleavage 
of the benzylic C‒H bond to generate carbocation 1.44 (Scheme 8), which readily reacts with a 
variety of carbon nucleophiles to give 1.45.  
 
 11 
 
Scheme 8. DDQ induced oxidative transformation at the benzylic position 
 
Xu and coworkers reported the C‒H functionalization of isochroman substrates with a 
variety of carbon nucleophiles in high yields and with good stereochemical control (Scheme 9).26 
High trans-selectivity is observed for 3-substituted isochroman 1.46 especially with strong 
nucleophiles. This method was subsequently applied in a total synthesis of deoxyfrenolicin.27 As 
depicted in scheme 9, 1.48 reacted with DDQ and allyl triphenyltin smoothly to provide 1.49 in 
94% yields as a single stereoisomer. The synthesis was completed in five steps from the 
intermediate 1.49. 
 
 
Scheme 9. DDQ-mediated C‒H functionalization of isochroman substrates 
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The DDQ-mediated C‒H cleavage process was expanded to acyclic benzylic ether 
substrates (Scheme 10).28 Electron rich benzylic ethers reacted readily with DDQ to yield the 
desired products; however, no reaction was observed for the non-substituted benzylic ethers 
under the same condition. The author’s explanation was that in the non-substituted benzylic case 
the absence of the stabilizing group prevented the initial hydrogen abstraction. 
 
 
Scheme 10. DDQ-mediated oxidative C‒H functionalization of acyclic benzylic ethers 
 
DDQ can also react with allylic ethers yielding similar carbocation intermediates. In 
1987, Mukaiyama documented that the intermediate carbocations from allylic ether oxidation 
react with a variety of carbon nucleophiles to form new C‒C bonds (Table 1).29 The electron rich 
phenyl-substituted allylic ethers were excellent substrates for the process (entries 1-3, table 1), 
though reactions with simple alkyl-substituted allylic ethers did not work very well (entry 4, 
table 1). LiClO4 proved to be pivotal for the high yields, presumably because it increased the 
electrophilicity of the carbocations by counter-ion exchanges. Because the carbon nucleophiles 
that they explored were not tolerant toward DDQ, the order of reagent addition is critical: excess 
carbon nucleophiles were added 1 h after DDQ was introduced to the reaction to ensure the 
complete conversion of all the substrates to intermediate carbocations. The complicated 
procedure dictated that the intermediate carbocations should be very stable, which limited the 
substrate scope. 
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Table 1. DDQ-mediated oxidative C‒H cleavage of phenyl-substituted allylic ethers 
 
 
As mentioned above, all the previously reported carbon nucleophiles were not stable 
toward DDQ, complicating the procedure and limiting the substrate scope. During the efforts in 
developing cross dehydrogenative coupling (CDC) reactions, Li explored the DDQ mediated 
coupling of a variety of dialkyl malonates with isochroman in the presence of InCl3 and 
Cu(OTf)2 as catalysts (Scheme 11).
31 The malonates were activated by the In/Cu catalyst to serve 
as the nucleophiles, which were found to be compatible with DDQ. Furthermore, simple ketones 
can also undergo similar CDC reactions with isochroman upon treatment with DDQ, though the 
reaction conditions were very harsh (neat at 100 oC).32   
 
 
Scheme 11. DDQ-mediated CDC reactions using malonates or ketones as nucleophiles 
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Chiral nucleophiles were also employed to capture the oxidatively generated carbocations 
to functionalize the heterocyclic structures.33 Sodeoka developed a catalytic asymmetric 
functionalization of tetrahydroisoquinoline (Scheme 12). Addition of 1.50 into the reaction 
system of (Boc)2O, DDQ, diisopropyl malonate and chiral palladium catcalyst 1.51 gave 1.52 in 
97% yield and 86% ee. This transformation was proposed to begin with amine acylation, 
followed by the oxidative generation of an acyliminium ion that was captured by a chiral 
palladium enolate through a Mannich-type reaction to form the C‒C bond. Cozzi et al. reported a 
stereoselective alkylation of benzylic C‒H combining an oxidative C‒H cleavage with 
organocatalysis.34 MacMillan-type catalyst 1.55 can promote stereoselective α-alkylation of 
aldehyde 1.54 based on oxidative C‒H cleavage of substrate 1.53 to form 1.56  in 50% yield and 
78% ee. While the ee was not excellent, this method demonstrated the potential that C‒H 
activation can be coupled with stereoselective organocatalytic reactions, with the advantages of 
simple reaction conditions and absence of metal catalysts.  
 
 
Scheme 12. Catalytic asymmetric reactions through oxidative C‒H cleavage 
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While C‒C bond formations through DDQ-mediated oxidative C‒H bond cleavage of 
isochroman-related substrates have been well studied, many of them suffer from either limited 
substrate scope or poor diastereoselectivity. Our goals were to develop a diastereoselective 
tetrahydropyrone synthesis through intramolecular cyclizations initiated by DDQ-mediated 
oxidative C‒H bond cleavage process, and apply the method to complex molecule synthesis.  
Recently the Floreancig group developed a DDQ-mediated oxidative C–H bond cleavage 
of benzylic ethers leading to tetrahydropyrone synthesis through diastereoselective C–C bond 
formation (Figure 3).34 In the presence of 2,6-dichloropyridine and powdered molecular sieves, 
PMB ether 1.57 readily reacted with DDQ at room temperature to provide tetrahydropyrone 1.58 
in 77% yield as a single diastereomer. The mechanism for the C‒H bond cleavage has not been 
unambiguously understood, though a reasonable mechanism proceeds through an electron 
transfer from PMB ether 1.57 to DDQ to form the radical-ion pair 1.59 followed by hydrogen 
atom abstraction to form oxocarbenium ion 1.60. The incorporation of 2,6-dichloropyridine 
makes the reaction proceed more efficiently because it quenches the acylium ion that forms when 
the enol acetate group reacts with the oxocarbenium ion.    
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Figure 3. Diastereoselective tetrahydropyrone synthesis from PMB ether substrate 
 
Moreover, the scope of aromatic and heteroaromatic rings with different substituents was 
also examined (Scheme 13). The desired tetrahydropyrone products were obtained in good to 
very good yields as single diastereomers. The substituents on the arene have significant influence 
on the rates of the reactions. The substrate with an electron-donating group reacted faster than 
that without an electron-donating group, which was explained by the difference of the oxidation 
potential (a measure of the tendency of a chemical species to lose electrons and thereby be 
oxidized) of the substrate and the stability of the intermediate oxocarbenium ion. The oxidation 
potential of para-methyl substituted arene is lower than that of simple phenyl ring, so the 
substrate of 1.62 is oxidized more easily by DDQ than that of 1.61. The arene with 3,5-
disubstituted methoxy groups has similar oxidation potential as that with 3,4-disubstituted 
methoxy groups, however, great reactivity difference is still observed during the formation of 
1.63 and 1.64. This can be attributed to the fact that para-methoxy group in 1.64 can stabilize the 
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intermediate oxocarbenium ions better than the meta one in 1.63, facilitating the hydrogen atom 
abstraction process.       
 
 
Scheme 13. Different substituent effects on aromatic rings 
 
1.2 DEVELOPMENT OF DDQ-MEDIATED OXIDATIVE C‒H CLEAVAGE 
OF VINYL AND ALLYLIC ETHERS  
Cis-2,6-Disubstituted tetrahydropyrans occur in a wide array of biologically active 
natural products such as (+)-neopeltolide, leucascandrolide A and (+)-dactylolide (Figure 4).35  
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Figure 4. cis-2,6-Dialkyltetrahydropyran subunit in natural products 
 
Cis-2,6-Disubstituted aryl tetrahydropyrones can be prepared through DDQ-mediated 
oxidative C‒H bond cleavage reactions in moderate to good yields and with excellent 
stereocontrol. Considering the relatively low capability of the arene to be functionalized, 
however, we initiated a program directed toward broadening the scope of substrates that can be 
utilized in cyclization reactions by substituting the arene with other functional groups. After 
analyzing the structures of natural products shown in Figure 4, we believed that alkenes would 
be useful cation precursors because they can be converted to other functional groups through 
numerous transformations.  
As shown in Figure 5, tetrahydropyrone (1.67) syntheses were designed to proceed with 
vinyl ethers (1.68) or allylic ethers (1.69), respectively. Precursors 1.68 and 1.69 can react with 
DDQ to provide the corresponding radical cations 1.70 and 1.71, respectively. Following a 
hydrogen atom abstraction, both 1.70 and 1.71 will be converted to the same α,β-unsaturated 
oxocarbenium ion intermediates 1.72, which are captured by enol acetate nucleophiles to furnish 
tetrahydropyrone 1.67. In the following section, both vinyl and allylic ethers will be explored as 
substrates for the construction of vinyl tetrahydropyrones. The ability of a substrate to be 
oxidized by DDQ depends on its oxidation potential and the stability of the oxocarbenium ion 
(discussed in section 1.1). Considering that 1.68 and 1.69 should form the same oxocarbenium 
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ion intermediate (1.72), we proposed that electron rich 1.68 would react more readily with DDQ 
than 1.69. Thus we planned to test the vinyl ether substrate first.     
 
 
Figure 5. Retrosynthetic analysis of 1.67 
 
 
1.2.1 DDQ-mediated oxidative C‒H activation of vinyl ether substrates    
As an initial test of the hypothesis that α,β-unsaturated oxocarbenium ions can be 
generated through DDQ mediated C–H activation of vinyl ethers, substrate 1.73 bearing a 
primary alcohol as the nucleophile was prepared through the synthetic sequence shown in 
Scheme 14. Hydrozirconation of 1-decyne with Schwartz’s reagent, followed by the addition of 
iodine gave trans-vinyl iodide 1.74 in 94% yield.36 CuI-catalyzed cross coupling reaction37 
between 1.74 and alcohol 1.75 in the presence of 1,10-phenanthroline as a ligand, and Cs2CO3 as 
a base in toluene at 80 oC afforded the vinyl ether, which underwent desilylation with TBAF to 
provid the desired substrate 1.73 in 97% yield. 
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Scheme 14. The preparation of substrate 1.73 and its cyclization 
 
Substrate 1.73 was subjected to DDQ with 1,2-dichloroethane (DCE) as the solvent, 4 Å 
molecular sieves as the water scavenger and 2,6-dichloropyridine as the base. At ‒15 °C, the 
cyclization was complete within 5 minutes, providing 2-vinyl-1,3-dioxane products 1.76 and 
1.77 in 85% yield with an E:Z alkene ratio of 11:1. Thus, vinyl ethers are highly reactive 
substrates for DDQ-induced oxidative C‒H activation. This successful cyclization paved the way 
for our further investigations of C‒C bond construction using vinyl ethers as substrates.  
Vinyl ethers 1.78 and 1.79 were synthesized to investigate the feasibility of C‒C bond 
formations, considering that enol acetates proved to be compatible carbon nucleophiles in DDQ-
induced oxidative cyclization reactions of benzylic ethers.34 The preparation of 1.78 and 1.79 
shared the similar synthetic sequence (Scheme 15). A Barbier reaction between heptanal and 
propargyl bromide yielded homopropargylic alcohol 1.80,38 which was alkylated with allyl 
bromide or crotyl bromide (where commercial available crotyl bromide is a trans- and cis- mixed 
alkene with a ratio of 4:1) to afford allylic ethers 1.81 and 1.83, respectively. Ruthenium-
catalyzed Markovnikov addition of AcOH across the terminal alkyne generated enol acetates 
1.82 and 1.84 (where 1.84 are trans- and cis-alkene mixtures with a ratio of 4:1).39 Vinyl ether 
substrate 1.78 was obtained through iridium-catalyzed (2 mol %) olefin isomerization as 
exclusively the trans-alkene in 90% yield.40 While Ir(I) catalyzed (10 mol %) olefin 
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isomerization of 1.84 was very slow, and only 15% conversion was observed even after stirring 
at 45 °C  overnight, enough trans-alkene 1.79 was obtained to test the reaction.   
 
 
Scheme 15. The preparation of substrate 1.78 and 1.79 
 
Substrate 1.78 was examined under the same conditions as the synthesis of 1,3-dioxane 
1.76 (Scheme 16). The starting material was completely consumed in 1 minute, but no 
identifiable products were isolated. In contrast, the cyclization of substrate 1.79 proceeded 
smoothly at room temperature to provide cis-2,6-disubtituted tetrahydropyrone 1.85 in 69% yield 
as a single diastereomer.  
 
 
Scheme 16. Cyclization reactions of substrates 1.78 and 1.79 
 
Since vinyl tetrahydropyrones can be prepared through DDQ-mediated oxidative C‒H 
cleavage of vinyl ethers and good yield and high diastereoselectivity were obtained, the only 
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problem left was how to efficiently prepare the vinyl ether substrates bearing enol acetates as 
nucleophiles. This problem could be avoided, however, if allylic ethers, precursors of vinyl 
ethers, proved to be sufficiently reactive to undergo cyclization through DDQ induced C‒H 
activation. 
1.2.2 DDQ-mediated oxidative C‒H activation of allylic ether substrates  
To examine whether allylic ether substrates could undergo same oxidation process as 
vinyl ethers, allylic ether 1.84, the synthetic precursor of vinyl ether 1.79, was subjected to the 
DDQ-mediated oxidation conditions. After 2 h in DCE at room temperature, about 80% 
conversion was achieved, and the desired tetrahydropyrone 1.85 was isolated in 53% yield as a 
single diastereomer (Scheme 17). In addition, the overoxidation product 1.86 was isolated in 7% 
yield. More interestingly, the starting material recovered from the reaction was exclusively the 
cis-alkene isomer 1.87, which suggested that cis-allylic ethers reacted more slowly with DDQ 
than trans-allylic ethers.    
 
 
Scheme 17. The cyclization of substrate 1.84 
 
To improve the conversion of starting materials, all trans-crotyl bromide 1.90 was 
synthesized and allylic ether 1.88 was accessed following the same procedure of the synthesis of 
1.84 (Scheme 18).41 With isomerically pure 1.88 in hand, we optimized reaction conditions. The 
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loading of DDQ (1.5 equiv to 3.0 equiv) did not affect the yield of 1.85. When 2,6-
dichloropyridine (2 equiv) was employed as a base, the yield of 1.85 was improved from 65% to 
71%. In accord with Mukaiyama’s protocol,29 a catalytic amount of LiClO4 (10 mol %) was 
found to be quite beneficial in suppressing the overoxidation pathway. Under the optimized 
conditions (a 0.1 M solution of DDQ (2 equiv), 2,6-dichloropyridine (2 equiv), LiClO4 (10 mol 
%) and 4 Å molecule molecular sieves (2 equiv) in DCE at room temperature), 2,6-cis-
disubstituted tetrahydropyrone 1.85 was obtained in 81% yield as a single diastereomer in 1 h. 
 
 
Scheme 18. The preparation of substrate 1.88 and its cyclization 
 
 
I. Substituent effects on allylic ethers 
After optimizing the reaction conditions for DDQ-mediated oxidative cyclization of 
allylic ethers, we examined the substituent effects of alkenes on reaction rate and efficiency. 
Therefore, a series of allylic ether substrates were synthesized following the sequence that was 
used to prepare substrate 1.88 (Scheme 19).   
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Scheme 19. The preparation of substrates 1.92-1.95 
 
The optimized reaction conditions were applied to these allylic ethers and the results are 
summarized in Table 2. All the reactions proceeded smoothly to generate the corresponding cis-
2,6-disubstituted vinyl tetrahydropyrone products in very good chemical yields.     
The reaction of monosubstituted allylic ether 1.82 was very slow at room temperature, 
and even at 45 °C  it took 48 h to consume all the starting material (entry 1, table 2). Both 
disubstituted allylic ethers 1.92 and 1.88 reacted much faster than the monosubstituted alkene; 
however, a great reactivity difference between 1,1-disubstituted allylic ether 1.92 and (E)-1,2-
disubstituted allylic ether 1.88 was still observed (entries 2 and 3, table 2). The cyclization of 
1.88 went to completion in 1 h with only 2 equiv of DDQ, while complete consumption of 1.92 
required 17 h and 4 equiv of DDQ at the same temperature. The cyclizations of trisubstituted 
allylic ethers were much faster than those of monosubstituted and disubstituted allylic ethers. 
When trisubstituted alkene 1.93 was subjected to the DDQ oxidation conditions at 0 °C , the 
reaction was complete in 1.5 h (entry 4, table 2). The reactions of another two trisubstituted 
alkene substrates 1.94 and 1.95 also proceeded smoothly at 0 °C , affording 82% and 85% yields, 
respectively (entries 5 and 6, table 2). Moreover, no olefin isomerization was observed during 
the cyclization process for these two substrates. 
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Table 2. DDQ-mediated oxidative C‒H cleavage of allylic ethersa 
 
 
II. Functional group compatibility 
After examining the substituent effects on allylic ethers, we explored the tolerance of 
different functional groups to the reaction conditions to expand the range of structures that are 
accessible. Substrates 1.101-1.105 shown in Figure 6 were designed to test functional group 
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compatibility and to study the C‒C bond formation in the presence of competitive heteroatom 
nucleophiles.  
 
 
Figure 6. Substrates for the study of functional group compatibility 
 
Substrates 1.101-1.103 were prepared as shown in Scheme 20. Alcohol 1.75 was oxidized 
under Parikh-Doering conditions and the resulting aldehyde was subjected to a Barbier reaction 
with propargyl bromide and zinc to afford homopropargylic alcohol 1.106. Alkylation of 1.106 
with methallyl chloride followed by a ruthenium-catalyzed enol acetate formation provided the 
desired substrate 1.101. Desilylation of allylic ether 1.107 with TBAF, followed by an acylation 
and typical enol acetate formation gave substrate 1.102. Substrate 1.103 was synthesized from 
intermediate 1.108 through Parikh-Doering oxidation of the alcohol to the aldehyde, which was 
then converted to carboxylic acid 1.110 in the presence of NaClO2 and NaH2PO4.
42 Finally, the 
cyclization substrate 1.103 was prepared after an isopropyl ester formation and the enol acetate 
formation. 
 27 
 
Scheme 20. The preparation of substrates 1.101-1.103 
 
Substrates 1.104 and 1.105 were synthesized following the procedures shown in Scheme 
21. Protection of commercially available hydroxyacetone 1.111 as a TBS ether followed by 
Horner-Wadsworth-Emmons reaction with triethyl phosphonoacetate generated the α,β-
unsaturated ester 1.112.43 The ester was reduced by DIBAL-H to form an allylic alcohol, which 
was then converted to the allylic bromide 1.113 in the presence of MsCl and LiBr.44 Coupling 
the allylic bromide 1.113 with propargyl alcohol 1.106 yielded the allylic ether 1.114, which was 
converted to substrate 1.104 through the typical enol acetate formation protocol. Substrate 1.105 
was prepared from substrate 1.104 through desilylation of two TBS ethers with TBAF followed 
by the diacylation by Ac2O. 
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Scheme 21. The preparation of substrates 1.104 and 1.105 
 
DDQ-mediated oxidative cyclizations of substrates 1.101-1.105 were examined, and the 
results are summarized in Table 3. Substrates 1.101-1.103, bearing commonly encountered 
functional groups in the alkyl side chain, proceeded in comparable yields to those without 
functional groups in the alkyl side chain and stereocontrol remained high (entries 1-5, table 3), 
though the cyclizations proceeded somewhat more slowly than the parent model 1.92 without a 
functional group in the alkyl chain. Then we explored whether good selectivity could be obtained 
when two allylic ethers were installed in the same molecule. Under the standard DDQ oxidation 
conditions, the cyclization of 1.104 was complete in 45 minutes at room temperature, however, 
two tetrahydropyrone products (overall yield is 83%) were observed and the ratio of desired 
1.118 and undesired 1.119 was 1.2:1 (entry 6, table 3). While the cyclization of diacetate 1.105 
was much slower than that of 1.104 even at higher temperature, the desired product 1.120 was 
isolated in 80% yield with high selectivity (entry 7, table 3). 
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Table 3. Functional group compatibility with DDQ-mediated oxidative C‒H cleavagea 
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1.3 DISCUSSION 
1.3.1 Vinyl ether substrates 
Under the same reaction conditions, vinyl ether 1.79 and allylic ether 1.88 gave the same 
cis-2,6-disubstituted tetrahydropyrone product 1.85 (Figure 7). This result implies that they share 
the same α,β-unsaturated oxocarbenium ion intermediate 1.121. Although vinyl ethers are more 
stable than allylic ethers,45 the reaction of vinyl ether 1.79 is much faster than that of allylic ether 
1.88, suggesting that direct H- abstraction is an unlikely mechanism. A proposed mechanism for  
  
 
Figure 7. A comparison between vinyl ether 1.79 and allylic ether 1.88 
 
the reaction of vinyl ether with DDQ is shown in Figure 8. An electron transfer from vinyl ether 
1.79 to DDQ gives rise to a radical cation 1.122 and hydroquinone radical anion 1.123. Then a 
hydrogen atom transfer from 1.122 to 1.123 generates a α,β-unsaturated oxocarbenium ion 1.124, 
which undergoes intramolecular cyclization through a chair transition state to provide cis-2,6-
disubstituted tetrahydropyrone 1.85. The resulting acylium ion was quenched by 2,6-
dichloropyridine, facilitating the cyclization reaction. 
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Figure 8. A proposed mechanism of DDQ-mediated C‒H cleavage of vinyl ether 1.79 
 
 
Vinyl ether substrate 1.78 (Scheme 16) did not give any cyclization product under DDQ 
induced oxidation conditions, though it was consumed completely in 1 minute. I believe that the 
starting material consumption indicated the occurrence of vinyl ether oxidation by DDQ. As 
shown in Figure 9, the only difference between intermediate 1.124 generated from 1.79 and 
intermediate 1.127 from 1.78 is the presence of an extra methyl group in 1.124 that stabilizes the 
intermediate carbocation through hyperconjugation. The oxidation process was very fast, leading 
to a high concentration of highly reactive intermediate 1.127, and decomposition of 1.127 might 
be faster than the nucleophilic addition step.  
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Figure 9. A comparison between the intermediates of vinyl ethers 1.78 and 1.79 
 
1.3.2 Allylic ether substrates 
I. Proposed mechanism for allylic ether oxidation 
We did not put too much effort in improving this process because readily accessible 
allylic ethers proved to be a better option for vinyl tetrahydropyrone syntheses. Similar to the 
oxidation of vinyl ethers, the reaction of allylic ethers with DDQ was proposed to be initiated by 
a single electron transfer between the substrates and DDQ (Figure 10). The radical cation 1.128 
lose a hydrogen atom to give the α,β-unsaturated oxocarbenium ion intermediate 1.129. The 
presence of catalytic amount of LiClO4 (10 mol %) improved the yield of the reaction, though 
the origin of this curious but useful effect has not been elucidated. LiClO4 might be beneficial to 
the stability of intermediate 1.129. Intramolecular cyclization through a chair transition state 
afforded the desired product 1.85 along with the regeneration of LiClO4. 
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Figure 10. A proposed mechanism of DDQ-mediated C‒H cleavage of allylic ether 1.88 
 
II. Reaction rate analysis 
According to the analysis of kinetic isotope effects of DDQ-mediated oxidative C‒H 
cleavage of benzylic and allylic ethers,46 the rate determining step of the process was believed to 
be the hydrogen atom abstraction (Figure 11). Once the intermediate oxocarbenium ion was 
generated, the cyclization happeded readily to afford the product. A substrate with lower 
oxidation potential reacts with DDQ faster than that with higher oxidation potential, leading to a 
higher concentration of allylic ether radical cation. Moreover, a substrate with more stable 
intermediate oxocarbenium ion has a larger rate constant k2 (Figure 11). Therefore, the reaction 
rate would depend on rate constant k2, the concentration of the allylic ether radical cation and the 
concentration of hydroquinone radical anion ((eq 1), Figure 11). The equation will be useful to 
explain several interesting observations mentioned in the section 1.2.2.  
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Figure 11. Reaction rate analysis 
 
The only substrate that did not react with DDQ was the cis-allylic ether (Scheme 17). 
Considering that cis- and trans-allylic ethers should have similar oxidation potentials, the 
reactivity difference can be attributed to the stability of the respective oxocarbenium ions. DDQ-
induced oxidation processes of cis- and trans-alkenes are shown in Figure 12. Intermediate 1.134 
should be much less stable than 1.131 due to the steric interaction between methyl and hydrogen 
in 1.134. This factor inhibits the hydrogen atom abstraction of 1.133 to form 1.134, and thus 
trans-allylic ethers reacted faster than cis-isomers. 
While the same steric interaction also exists in intermediate 1.136 of trisubstituted allylic 
ether 1.93, the consumption of 1.93 is even faster than that of trans-disubstituted allylic ether 
1.88. The observation was attributed to the low oxidation potential of trisubstituted alkene that 
allows 1.93 to react with DDQ faster than disubstituted alkene 1.88, leading to a higher 
concentration of radical cation 1.135 than that of 1.130. Moreover, the extra methyl group in the 
trisubstituted alkene 1.93 stabilizes oxocarbenium ion 1.136 through the hyperconjugation, 
which offsets the destabilization of the steric interaction.  
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Figure 12. Comparisons of oxidations of 1.88, 1.132 and 1.9346 
 
The 1,1-disubstituted allylic ether substrate 1.92 reacted more slowly than (E)-1,2-
disubstituted allylic ether 1.88, which can be attributed to the stabilities of corresponding 
oxocarbenium ion intermediates (Figure 13). The vinyl methyl group in 1.137 does not directly 
stabilize the intermediate cation, while the direct stabilization by methyl group exists in 
intermediate 1.124, making 1.124 more stable than 1.137.  
 
 
Figure 13. A comparison of stabilities of oxocarbenium ions 1.137 and 1.124 
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DDQ oxidation of vinyl ether 1.78 did not afford any identifiable products (Scheme 16), 
which was attributed to the possibility that the lifetime of the intermediate cation was too short to 
be captured by the nucleophile due to the absence of stabilizing-factors. Considering that 
monosubstituted allylic ether 1.82 should have the same intermediate as 1.78, the cyclization of 
1.82 was supposed to be a challenge. Under forcing conditions, however, 77% was obtained with 
no loss of stereocontrol (entry 1, table 2). The different results between vinyl ether 1.78 and 
allylic ether 1.82 might be explained by the high reactivity of vinyl ether 1.78 that generated 
much higher concentration of highly reactive intermediate than allylic ether 1.82. Considering 
that terminal alkenes are frequently employed in organic synthesis, such as cross metathesis, 
hydroboration followed by palladium-catalyzed cross-coupling reaction, and hydroformylation, 
this protocol should have potential application in the synthesis of many complex molecules 
containing tetrahydropyrone or related structures. 
 
III. Conserved olefin geometry 
The reactions of DDQ with trisubstituted alkenes 1.94 and 1.95 proceeded smoothly to 
provide the desired products in 82% and 85% yield, respectively, and no olefin isomerization 
was observed (entries 5 and 6, Table 2). This result suggests that at the stage of radical cation 
1.138 or 1.140 (Figure 14), the hydrogen atom abstraction is faster than the rotation of C2‒C3 
bond. The potentially severe steric interaction between alkyl chain and hydrogen after the 
rotation of C2‒C3 bond may also help to suppress the olefin isomerization pathway. 
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Figure 14. DDQ-mediated oxidation processes of 1.94 and 1.95 
 
IV. Functional group compatibility 
Commonly encountered functional groups such as TBS ether, acetate and isopropyl ester 
are compatible with the DDQ oxidation process. The reactions proceeded somewhat more slowly 
than the parent model with a simple alkyl side chain (entries 1-5, Table 3), which was attributed 
to the inductive effect of the oxygen-containing groups destabilizing the intermediate 
oxocarbenium ions. Additionally, no C‒O bond forming product was observed indicating that the 
C‒C bond formation is still favored even though competitive heteroatom nucleophile exists in 
the same molecule (Figure 15).  
 
 
Figure 15. Competition between C‒C and C‒O bond formation 
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Almost no selectivity for the oxidation of two allylic ethers in 1.104 was observed (entry 
6, table 3), which was attributed to the similar oxidation potential of two allylic ethers and 
comparable stability of intermediates 1.142 and 1.143 (Figure 16). When substituting the silyl 
ether with the electron-withdrawing acetate, the oxidation potential of allylic acetate was higher 
than that of the other allylic ether in 1.105 as shown in Figure 16; the stability of the undesired 
intermediate 1.145 also decreased due to the inductive effect. Therefore the undesired pathway B 
was blocked and a high selectivity was obtained. 
 
 
Figure 16. Reactivity analysis of substrates 1.104 and 1.105 
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1.4 SUMMARY 
We have demonstrated that DDQ-mediated oxidative C–H bond cleavage of a series of 
vinyl and allylic ethers containing enol acetate nucleophiles efficiently leads to cis-2,6-
disubstituted tetrahedropyrone formation. The reaction is initiated by a single electron transfer 
from the substrate to DDQ to form a radical cation, which undergoes hydrogen atom cleavage to 
give the oxocarbenium ion intermediate. The intramolecular cyclizations occur through a chair 
transition state to afford the high diastereoselectivity. The reactivities of the substrates are 
correlated to the oxidation potential of substrates and stability of the oxocarbenium ions.  
This method is highly supplementary to acid-mediated Prins-based methods in the 
preparation of tetrahydropyrans,47 and the tolerance of acid labile functional groups on either 
side of ether linkage makes the methodology more applicable to complex molecule synthesis. 
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2.0  STRUCTURALLY AND STEREOCHEMICALLY DIVERSE 
TETRAHYDROPYRAN SYNTHESIS VIA OXIDATIVE C‒H CLEAVAGE OF 
(SILYL)ALLYLIC AND PROPARGYLIC ETHERS 
2.1 INTRODUCTION  
In Chapter 1, I reported that cis-2,6-disubstituted tetrahydropyrones could be efficiently 
prepared through DDQ-mediated oxidative C‒H cleavage of allylic ethers. The high 
stereoselectivity and good functional group compatibility suggest that the method should have 
the potential to be applied in the complex molecule synthesis. In 2009, Dr. Tu in the Floreancig 
group successfully applied this method to a total synthesis of the biologically active natural 
product (+)-neopeltolide (Scheme 22).48 Trisubstituted allylic ether 2.1 was subjected to the 
standard DDQ oxidation conditions, and the desired neopeltolide macrocycle 2.2 was isolated in 
58% yield as a single diastereomer. Consistent with predictions based on the X-ray structure of 
2.2, Pd/C catalyzed hydrogenation reaction took place with the hydrogen addition from outside 
of the macrocycle affording the desired 9S product 2.3 in 74% yields (dr > 5:1). The total 
synthesis was completed in 2 steps from 2.3. Aside from the natural product, the unsaturated 
C8‒C9 double bond afforded an excellent opportunity to prepare neopeltolide analogs. Several 
interesting analogs were achieved from 2.2 with high stereoselectivity and efficiency (Scheme 
22).48b Considering the wide range of biological activities that tetrahydropyran-containing 
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molecules possess,49 the next phase of my project was to further expand the DDQ-mediated C‒H 
cleavage method to access 2,6-disubstituted tetrahydropyrones that contain modifiable 
unsaturations. These unsaturations should be able to provide a route towards a range of 
structurally and stereochemically diverse tetrahydropyran structures through post-cyclization 
manipulations. Vinylsilanes are excellent candidates for the purpose because of their ability to 
engage in numerous transformations50 and to exist in easily-predicted conformational 
preferences.51 Besides the comparable reactivities with alkyl-substituted alkenes, vinylsilanes 
have several unique characteristics that will be briefly discussed in this introduction.  
 
Scheme 22. Total synthesis of neopeltolide and its analogues 
 
2.1.1 Vinylsilanes in palladium-catalyzed cross-coupling reactions 
Suitably functionalized vinylsilanes can participate in palladium-catalyzed cross-coupling 
reaction with organic halides to form new C‒C bonds.52 Its catalytic cycle starts from the  
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oxidative addition of an organic halide to the Pd(0)-species generating Pd(II) (Figure 17).53 In 
the presence of TBAF, vinylsilane 2.7 is converted to a pentacoordinate silicate intermediate 2.8, 
which undergoes transmetalation process with Pd(II) to provide 2.9. After trans-cis 
isomerization and reductive elimination, cross-coupling product 2.11 is obtained with the 
regeneration of Pd(0) catalyst. Examples of vinylsilanes that participate in palladium-catalyzed 
cross-coupling reactions include silacyclobutanes 2.12,54 silanols 2.13,55 silanolates 2.14,56 
siloxanes 2.15,57 benzylsilanes 2.16,58 allylsilanes 2.17,59 2-thienylsilanes 2.1858 and 2-
pyridylsilanes 2.1960 (Scheme 23). Hiyama and Hatanaka stated that the key for successful 
Hiyama coupling is the generation of reactive, pentacoordinate silicate intermediates to effect the 
rate-determining transmetalation.61 Recently, Denmark’s mechanistic studies demonstrated that 
in the presence of a fluoride activator such as TBAF and TASF, vinylsilanes are converted to 
corresponding vinylsilanols, which are the real intermediates for the cross-coupling.62 
 
 
Figure 17. Catalytic cycle of Pd-catalyzed cross-coupling of vinylsilanes 
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Scheme 23. Vinylsilanes in Pd-catalyzed cross-coupling reactions 
 
The palladium-catalyzed cross coupling of vinylsilanes with organic halides allows 
vinylsilanes to function as versatile platforms for olefin synthesis, and provides convenient and 
robust methods for library syntheses. For example, Denmark disclosed that the cross-coupling of 
N-SEM-dimethyl(2-indoly)silanolate (2.20) with a range of aryl chlorides proceeded smoothly to 
provide a library of 2-substituted indoles 2.21 in excellent yields (Scheme 24).63 
 
 
Scheme 24. Cross-coupling of 2.20 with substituted aryl chlorides 
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In addition to diversity-oriented synthesis to construct chemical libraries, cross-coupling 
has also been widely applied to the target-oriented synthesis. One of the most illustrative 
examples is the synthesis of 9-membered cyclic ether (+)-brasilenyne by Denmark (Scheme 
25).64 The key step of the synthesis was to construct the difficult-to-access 1,3-cis-cis-diene 2.24, 
which was realized through a tandem RCM/cross-coupling sequence from advanced intermediate 
2.22. The synthesis successfully illustrated the application of vinylsilanes in target-oriented 
synthesis of complex molecules, though a large scale of TBAF (10 equiv) is employed to 
consume all the siloxane 2.23. 
 
 
Scheme 25. Total synthesis of (+)-brasilenyne 
 
2.1.2 Silyl groups as masked hydroxyl groups 
The silyl group can also be replaced by a hydroxyl group to form a new C‒O bond 
(Scheme 26(a)).51 A silyl group can be introduced stereospecifically into a site of the substrate 
for a future hydroxyl group, and after a series of transformations, the silyl group is converted to a 
hydroxyl group, without having the hydroxyl group in all its attendant chemistry. Typically the 
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silyl group carrying a nucleofugal group, like a halogen, an alkoxyl group, or a hydrogen atom, 
can be oxidized by peroxides or peracids in the presence of a fluoride ion, which is known as 
Tamao oxidation (Scheme 26).65 Under Tamao oxidation conditions, vinylsilanes are oxidized to 
form enols, which then tautomerize to the corresponding ketones (Scheme 26(c)). Phenylsilanes 
can also participate in this oxidation process. In this case, the benzene ring will first be removed, 
and replaced by a nucleofugal group such as a fluoride, which is known as Fleming oxidation 
(Scheme 26(b)).66 This can be achieved by protodesilylation, mercuridesilylation or 
bromodesilylation. Aryl, heteroaryl and allyl substituents on the silicon atom also act as 
removable groups. Fleming-Tamao oxidations are stereospecific with retentions of original 
configurations (Scheme 26). 
 
 
Scheme 26. Fleming-Tamao oxidation 
 
The Fleming-Tamao oxidation conditions are sufficiently mild to tolerate a wide range of 
functional groups even in complex substrates. In West’s synthesis of dihydroxyquinolizidine, the 
dimethylphenylsilyl group served as a surrogate for one of the hydroxyl groups in the product 
(Scheme 27).67 Under Denmark’s conditions, the Fleming oxidation proceeded smoothly to 
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furnish the target molecule in 81% yield with the retention of the configuration at C2 position; 
Baeyer-Villiger oxidation of ketone 2.25 was not observed. In Marshall’s synthesis of the 
C1‒C21 subunit of tautomycin, a 5-membered siloxane 2.27 was oxidized under Tamao 
conditions to afford an enol, which tautomerized spontaneously to the corresponding β-hydroxyl 
methyl ketone in high chemical yield (Scheme 27).68  
 
 
Scheme 27. Fleming-Tamao oxidation in natural product synthesis 
 
2.1.3 Vinylsilanes as removable stereocontrol elements 
The bulky silyl group in the vinylsilane can be used to control the conformations of 
substrates, without directly participating in the chemistry.51 During stereochemistry-determining 
step, the reaction will selectively occur at one face of the molecule. Sometimes the 
stereochemistry will not exist without this conformational control element. After the silyl group 
finishes the job, it will be replaced by a proton through a desilylation process or a hydroxyl 
group through Fleming-Tamao oxidation, both of which retain the configuration of the molecule. 
The epoxidation of allylic alcohol 2.28 with mCPBA yielded epoxide 2.29 as the major 
stereoisomer in a poor 3:2 ratio (Scheme 28).69 Structures A, B and C are three possible 
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conformations of allylic alcohol 2.28. Conformation A should be more stable than B and C due 
to the steric interaction between hydrogen and methyl group in B or methylene group in C. 
However, this stability difference is small, leading to the poor selectivity. After the hydrogen on 
C2 of 2.28 is replaced with a bulky trimethylsilyl group (A = 2.4 kcal/mol)70 as shown in 2.30, 
the potential steric interaction between trimethylsilyl group and methyl group in E or methylene 
group in F increases, making conformation D much more stable than the other two (E and F). In 
the preferred conformation D, both the hydroxyl and benzyloxy groups help to direct the 
epoxidation from the lower face, leading to the epoxide 2.31 as a single diastereomer. After the 
desilylation with TBAF, the desired epoxide 2.29 was isolated with the retention of its 
stereochemistry (Scheme 28). 
 
 
Scheme 28. Vinylsilanes as stereocontrol elements in stereoselective epoxidations 
 
In addition to epoxidations, excellent stereocontrol is observed in transition-metal 
mediated hydrogenation of alkenes because of the presence of the silyl group. Saturated silanes 
2.33 and 2.35 were obtained by treating vinylsilanes 2.32 and 2.34 with rhodium catalyst 1 (5 
mol %) in DCM under a high pressure of H2 for 48 h, respectively (Scheme 29).
71 Exceptionally 
high yields and stereoselectivities were observed in both cases. The new chiral center at C3 can 
 48 
be controlled by the geometry of starting vinylsilanes. The stereochemistry of the hydrogenation 
of 2.34 was explained by the Newman projections A and B, the two most likely reactive 
conformations. The steric interaction between C6H11 group and methyl group disfavored 
conformation B; the hydrogenation proceeded through A affording the observed product. After 
Fleming oxidation under a typical bromodesilylation condition, the syn-1,3-diol 2.36 was formed 
as a single diastereomer with retention of the stereochemistry at C3 position.          
 
 
Scheme 29. Vinylsilanes as stereocontrol elements in stereoselective hydrogenations 
 
In the intramolecular Diels-Alder reaction of triene 2.37, a sterically demanding TMS 
group was employed as a removable stereocontrol element, leading to the trans ring product 2.38 
as a single diastereomer (Scheme 30).72 In the absence of the silyl group, four diastereomers 
were observed with the isomer corresponding to 2.38 only 15% of the mixture. The presence of 
the TMS group dramatically improved the stereoselectivity of the cycloaddition reaction, which 
can be attributed to the minimization of the steric interaction between TMS and hydrogen in 
2.40, making conformation 2.40 more stable than other conformations. Removal of the TMS 
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group together with the cleavage of the benzyl and methoxymethyl ethers provided 2.39 in 84% 
yield. 
 
 
Scheme 30. Vinylsilanes as stereocontrol elements in intramolecular Diels-Alder reactions 
 
2.2 DEVELOPMENT OF DDQ-MEDIATED OXIDATIVE C‒H CLEAVAGE 
OF (SILYL)ALLYLIC ETHERS 
As mentioned in the introduction section, a silyl group carrying a nucleofugal group, like 
a halogen, an alkoxyl group, or a hydrogen atom, can participate in numerous transformations. 
However, at the initial stage of the project, our concern was that these reactive nucleofugal 
groups would not be compatible with DDQ oxidation conditions. To exclude this uncertainty, 
simple (Z)- and (E)-trialkyl-substituted vinylsilanes 2.41 and 2.46 were prepared to examine 
whether (silyl)allylic ethers possess similar reactivities as simple allylic ethers towards the DDQ 
oxidation (Scheme 31). According to Trost’s protocol,73 ruthenium-mediated (5 mol %) 
hydrosilylation of propargylic alcohol 2.42 gave (silyl)allylic alcohol 2.43 in a quantitative yield 
with an E:Z alkene ratio of 9:1. In the presence of CBr4 and PPh3,
74 2.43 was converted to allyl 
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bromide 2.44, which was coupled with 3-butyn-1-ol affording (silyl)allylic ether 2.45. While the 
yield of ether formation was only 10%, the enol acetate formation reaction proceeded efficiently 
to provide us enough substrate 2.41 to test the hypothesis. The reduction of propargylic alcohol 
2.47 with Red-Al, followed by the addition of iodine gave vinyl iodide 2.48, which underwent 
copper-mediated cross-coupling with MeLi to generate (E)-(silyl)allylic alcohol 2.49 in 70% 
yields over 2 steps.75 Following the same sequence as that from 2.43 to 2.41, 2.49 was converted 
to substrate 2.46. 
 
 
Scheme 31. The preparation of substrates 2.41 and 2.46 
 
Substrate 2.41 was subjected to the standard oxidation condition using DDQ as the 
oxidant, DCE as the solvent and 4 Å molecular sieves as the water scavenger (Scheme 32). Even 
after 19 h at room temperature, the reaction did not proceed to completion (40% conversion), and 
the desired tetrahydropyrone 2.51 was obtained as the major isomer in a poor Z:E ratio of 1.7:1. 
The incorporation of 2,6-dichloropyridine proved to be beneficial in suppressing olefin 
isomerization, leading to product 2.51 in 55% yield with a Z:E ratio of 9:1 after 5 days at room 
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temperature. Reaction efficiency was enhanced by heating to 45 °C , and 2.51 was isolated in 68% 
yield with a Z:E ratio of 13:1 after 15 h. Under the optimized conditions, the cyclization of (E)-
vinylsilane 2.46 was complete in 16 h providing tetrahydropyrone 2.52 in 74% yield as a single 
diastereomer. 
 
 
Scheme 32. Cyclizations of substrates 2.41 and 2.46 
 
Since trialkyl-substituted vinylsilanes proved to be good substrates for the DDQ-induced 
oxidative C‒H activation, next we planned to investigate the feasibility of cyclization reactions 
of vinylsilanes containing reactive nucleofugal groups. In accord with the precedents mentioned 
in Section 2.1, vinylsilanes 2.53-2.56 were studied in the DDQ oxidation process for the ultimate 
purpose of post-cyclization functionalizations. 
The constructions of vinylsilanes in substrates 2.53-2.56 relied on transition-metal 
catalyzed hydrosilylation of alkynes (Scheme 33). TMSOTf-catalyzed etherification reaction of 
(silyl)allylic ether 2.57 and trichloroacetimidate 2.58 afforded the (silyl)allylic ether in 49% 
yields, which was then converted to enol acetate substrate 2.53 (Scheme 33(a)). Bromination of 
propargylic alcohol 2.42, followed by ether formation and enol acetate formation provided 
propargylic ether 2.60 (Scheme 33(b)). Ruthenium-catalyzed hydrosilylation of 2.60 with 
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phenyldimethylsilane gave substrate 2.54. 2-Thienylvinylsilane 2.55 was prepared following the 
same route as the synthesis of 2.54 (Scheme 33(c)). The preparation of vinylsiloxane 2.56 started 
from alkyne 2.63 (Scheme 33(d)). An addition of 2.63 onto paraformaldehyde followed by 
bromination gave propargylic bromide 2.64.76 After a sequence of etherification, enol acetate 
formation, desilylation and diisopropyl silyl ether formation to yield 2.66, platinum-catalyzed 
intramolecular hydrosilylation proceeded smoothly to furnish siloxane 2.56 in quantitative 
yields.57a 
 
Scheme 33. The preparation of substrates 2.53-2.56 
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The results of DDQ-mediated oxidative cyclizations of substrates 2.53-2.56 are shown in 
Scheme 34. Once benzylsilane 2.53 was treated with DDQ at room temperature, the clear 
solution turned navy blue immediately. However, no reaction was observed and starting material 
was not consumed over a prolonged time. Raising the temperature to 35 °C  led to the formation 
of olefin isomerization byproduct 2.67 (Scheme 34(a)). (Z)-3-Phenyldimethylsilane 2.54 reacted 
with DDQ smoothly to form tetrahydropyrone 2.68 in 73% yields and no olefin isomerization 
byproduct was observed (Scheme 34(b)). Hetero arylsilanes are also suitable substrates for the 
process as demonstrated by the cyclization of (Z)-3-(2-thienyl)dimethylsilane 2.55 to give 2.69 in 
82% yield (Scheme 34(c)). Consistent with previous cyclizations of simple allylic ether 
substrates, vinylsilane substrates react exclusively to generate the 2,6-cis isomers. Vinylsiloxane 
2.56 can also be oxidized by DDQ to provide the desired tetrahydropyrone 2.70 along with 
hydrated product 2.71 in over 86% yield. According to Denmark’s studies, both 2.70 and 2.71 
are expected to serve as substrates for cross-coupling and Fleming-Tamao oxidation, leading to 
same products.52b 
 
 54 
 
Scheme 34. Cyclizations of substrates 2.53-2.56 
 
Since phenyldimethylsilane, (2-thienyl)dimethylsilane and diisopropyl siloxane groups 
proved to be compatible with the DDQ oxidations, (silyl)allylic ether substrates 2.72-2.75 were 
synthesized to examine the different substituent effects of vinylsilanes on the cyclizations 
(Scheme 35). The preparation of substrates 2.72-2.74 began from 2-butyn-1-ol (1.80) through a 
similar sequence as the synthesis of substrate 2.53 (Scheme 33(a)). Chloroplatinic acid-mediated 
hydrosilylations77 of 1.80 with phenyldimethyisilane gave the corresponding (E)-3-trialkylsilyl 
allylic alcohol 2.76 and (Z)-2-trialkylsilyl allylic alcohol 2.77. The known (silyl)allylic ether 
formations under acidic or basic conditions, followed by enol acetate formations afforded 
substrates 2.72-2.73. The synthetic route to substrate 2.74 was same as that to 2.72. Pt-mediated 
reactions were not highly regioselective but were sufficiently efficient to provide suitable 
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amounts of cyclization substrates for further studies. The (Z)-2-phenyldimethylsilyl allylic ether 
2.75 was prepared through the well-known sequence from the corresponding alcohol 2.84, which 
can be accessed by hydroalumination of silylalkyne 2.83 followed by the addition to the 
paraformaldehyde.78 
 
 
Scheme 35. The preparation of substrates 2.72-2.75 
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(Silyl)allyl ethers 2.72-2.75 were studied under standard DDQ oxidation conditions and 
the results are summarized in Table 4. All the reactions proceeded smoothly to afford the desired 
tetrahydropyrone products in good yields, though alkene isomerization was observed for 2.73, 
leading to 2.86 as a 1:1 mixture of alkene isomers (entry 3, table 4).  
 
Table 4. DDQ-mediated C‒H cleavage of substituted (silyl)allylic ethersa 
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2.3 DIVERSE FUNCTIONALIZATION OF VINYLSILANE-SUBSTITUTED 
TETRAHYDROPYRONES 
With a variety of vinylsilane-substituted tetrahydropyrones in hand, we started to 
functionalize the vinylilanes to give a range of structurally and stereochemically diverse 
tetrahydropyran structures. As mentioned in Chapter 1, (Z)-allylic ether 1.84 did not react with 
DDQ to give the tetrahydropyran 1.146 containing a cis-alkene. This gap can be filled by the 
desilylation of (E)-3-phenyldimethylsilane (Scheme 36). Because the ketone moiety was not 
compatible with the succedent desilylation conditions, it was stereoselectively reduced by 
NaBH4 to give the alcohol 2.89; 2.89 can efficiently undergo desilylation process with TBAF at 
80 °C  using THF and HMPA as co-solvents to provide the (Z)-vinyl tetrahydropyran 2.90 in 
91% yield as a single diastereomer.79   
 
 
Scheme 36. (Z)-Vinyl tetrahydropyran synthesis through desilylation of (E)-vinylsilanes 
 
The Tamao oxidation of vinylsilanes was also examined (Scheme 37). After the DDQ-
mediated oxidative cyclization of vinylsiloxane 2.56, mixtures of vinylsiloxane 2.70 along with 
hydrated product 2.71 were subjected to the Tamao oxidation.80 To facilitate the separation 
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through column chromatography, the product was converted to a TBS ether to yield diketone 
2.91 in 75% yield over three steps. 
 
 
Scheme 37. Conversion of vinylsilanes to ketones through Tamao oxidations 
 
Vinylsilane tetrahydropyrans can serve as precursors to other alkenes through palladium-
catalyzed cross-coupling reactions as shown in Scheme 38. The electron-rich 2-thienyl group 
was selected as the nucleofugal group in vinylsilanes to assure that the vinylsilane was not 
cleaved during the coupling.81 Both (Z)-vinylsilane 2.69 and (E)-vinylsilane 2.75 reacted 
smoothly with iodobenzene in the presence of TBAF and Pd2(dba)3 to generate 2.92 (85%) and 
2.93 (82%), respectively. Moreover, the mixture of 2.70 and 2.71 from the oxidative cyclization 
of 2.56 can also participate in the cross-coupling reactions, giving product 2.94 in 69% yields 
over two steps from the cyclization reaction. While this study was not exhaustive, these results 
demonstrate the capacity to prepare diverse tetrahydropyran structures by combining oxidative 
cyclization of vinylsilanes with palladium-catalyzed cross-coupling reactions.   
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Scheme 38. Vinylsilanes in cross-coupling reactions 
 
As shown in Figure 18, several complex natural products share an interesting structural 
moiety that is 2-(2-hydroxyalkyl)tetrahydropyran-4-ol (2.95) containing four stereocenters.82 
Since 2.95 is frequently seen in natural products, we would like to develop a protocol to prepare 
the eight possible stereoisomers of 2.95 from vinylsilane-tetrahydropyrones. As depicted in 
Figure 19, 2.95 will be achieved from 2.96 through Fleming oxidation with the retention of the 
configuration at C2’. 2.96 will be prepared from oxidative cyclization product 2.97 through 
stereoselective hydrogenation. A1,3 strain83 dictates that 2.68 and 2.85 will strongly prefer to 
occupy conformers 2.98 and 2.99, respectively (Figure 19). These conformers present opposite 
faces of the alkene for functionalization through directed hydrogen delivery from the 
tetrahydropyranyl oxygen, thus providing an opportunity to realize the stereoselective 
hydrogenation of vinylsilanes through reagent selection. After a detailed literature search, 
Crabtree’s catalyst84 was selected for the purpose.    
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Figure 18. An interesting building block in several natural products 
 
 
Figure 19. A retrosynthetic analysis of 2.95 and conformation analysis of 2.68 and 2.85 
 
As shown in Scheme 39, exposing 2.85 to NaBH4 afforded equatorial alcohol 2.101, 
which underwent a hydrogenation mediated by Crabtree’s catalyst to yield alkyl 
phenyldimethylsilane 2.102 in 89% yield with a diastereomeric ratio of > 10:1. After oxidation 
of the silane 2.102 under Fleming’s conditions, the first dihydroxy isomer 2.103 was isolated in 
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80% yield with a diastereomeric ratio of 9:1. Tetrahydropyrone 2.85 was reduced by L-
Selectride to give axial alcohol 2.104. Changing the orientation of the hydroxyl group at C4 
position of tetrahydropyran ring did not interfere with the hydrogenation process, and 2.105 was 
obtained in 90% yield as a single diastereomer. The stereocenter at C2’ position of 2.103 and 
2.106 can be reversed by changing the geometry of the vinylsilanes from E to Z, as demonstrated 
by the efficient synthesis of another two stereoisomers 2.109 and 2.112 with excellent 
stereocontrol. The hypotheses regarding the stereochemical outcomes of these reactions were 
confirmed by single crystal diffraction studies of 2.112 (Scheme 39).  
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Scheme 39. Target-oriented synthesis of four possible stereoisomers of 2-(2-hydroxyalkyl)tetra-
hydropyran-4-ol moiety from vinylsilanes 
 
The use of alkyne hydrosilylation reactions to prepare vinylsilanes led us to study 
propargylic ethers as substrates for the oxidative cyclization reactions.  Propargylic ethers are 
worth pursing also because alkynes would provide good opportunities for late stage 
diversification. Propargylic ethers proved to be similarly reactive relative to vinylsilane 
substrates (Scheme 40), with the DDQ-mediated cyclization of alkyne 2.60 to tetrahydropyran 
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2.114 proceeding in 71% yield after 33 h at 45 °C . The oxidative cyclization of 2.62 provided a 
41% yield of cis-isomer 2.115 and a 25% yield of trans-isomer 2.116 after 18 h at the same 
temperature. While the stereocontrol (1.6:1) was moderate, the access to the rare trans-2,6-
disubstituted tetrahydropyran moiety allow us to explore the preparation of eight possible 
stereoisomers of 2.95. 
 
 
Scheme 40. Cyclizations of propargylic ether substrates 2.113 and 2.62 
 
A library that consisted of the eight possible stereoisomers of hydroxyalkyl 
tetrahydropyranyl alcohols (2.95) was prepared from propargylic ether substrate 2.62 (Scheme 
41). The approach proceeded through the non-stereoselective cyclization of 2.62 to 2.115 and 
2.116. The products are separated and subjected to ketone reduction, hydrosilylation, reduction 
and Fleming oxidation to generate the full array of stereoisomers. As shown in Scheme 41, 2,6-
cis-isomer 2.115 reacted with NaBH4 and L-Selectride in a predictable manner to form alcohol 
2.117 and 2.118, respectively. Equatorial alcohol 2.117 proceeded through hydrosilylation with 
PhMe2SiH and Cp*Ru(CH3CN)3PF6 giving (Z)-vinylsilane 2.119 in 91% yield, while 
hydrosilylation with PhMe2SiH and H2PtCl6•6H2O generating (E)-vinylsilane 2.121 in 65% 
yield. The regioselectivity of the Pt-mediated hydrosilylation was lower (~3:1) than that of the 
 64 
Ru-catalyzed reaction, but the desired product was obtained in a suitable yield to complete the 
synthesis. The vinylsilanes were reduced through the Crabtree’s catalyst mediated hydrogenation 
followed by oxidation under Fleming’s conditions to provide tetrahydropyranols 2.124 and 2.125. 
The application of the directed hydrogenation process to vinylsilanes 2.122 and 2.123 led to 
desired hydrogenated products, but poor diastereoselectivity was observed, which was attributed 
to axial hydroxyl groups as potential competitive coordination sites for Crabtree’s catalyst. This 
problem was solved by protecting the hydroxyl groups of 2.122 and 2.123 as TBDMS ethers. 
The simple functionalization allowed the sequences to proceed readily to form 2.126 and 2.127.  
Reduction of 2.116 with SmI2 and iPrOH formed equatorial alcohol 2.128 in 85% yield 
as a single isomer (Scheme 41).85 Proceeding through the sequence of stereodivergent 
hydrosilylations, vinylsilane reduction and Fleming oxidation afforded 2.135 and 2.136. 
Subjecting 2.116 to L-Selectride resulted in ketone reduction from an equatorial trajectory to 
form 2.129 with excellent stereocontrol, and the final two stereoisomers 2.137 and 2.138 were 
obtained with high selectivity following the same synthetic sequence.  
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Scheme 41. Synthesis of a stereochemically diverse library 
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At last, triethylsilyl ethers were sufficiently stable to allow the sequences to proceed with 
similar efficiencies to those employing TBS ethers. Moreover, triethylsilyl ethers were 
advantageous because desilylation can be conducted in the same flask as Fleming oxidation 
(Scheme 42), thereby saving one step in the sequence.  
 
 
Scheme 42. One step reduction using triethylsilyl ether as protecting group 
 
2.4 DISCUSSION 
2.4.1 Control of olefin geometry 
In the oxidative cyclization of (Z)-triethyl(silyl)allylic ether 2.41, stoichiometric amount 
of weak, soluble base 2,6-dichloropyridine was found to be beneficial in suppressing the olefin 
isomerization, and the Z:E ratio of 2.51 was improved from 1.7:1 to 13:1 (Scheme 32). 
Considering that the olefin isomerization was not observed in reactions of alkyl-substituted 
allylic ethers even in the absence of 2,6-dichloropyridine, it should be brought about by the 
increased interaction between bulky trialkylsilyl group and hydrogen atom on C1 carbon (Figure 
20). To alleviate this interaction, the rotation of C2‒C3 bond in 2.139 occurred ahead of 
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hydrogen atom abstraction. 2,6-Dichloropyridine would facilitate the hydrogen atom abstraction 
to give oxocarbenium ion intermediate 2.141, thereby inhibiting the olefin isomerization process. 
 
 
Figure 20. DDQ-mediated oxidation of 2.41 
 
2.4.2 Oxidation of benzylsilane substrate 
Benzylsilane 2.53 was not converted to the cyclized product (Scheme 34), though the 
clear solution turned navy blue immediately upon treating 2.53 with DDQ at room temperature. 
The color change indicates the occurrence of DDQ-mediated oxidation process. The (silyl)allylic 
ether in 2.53 is oxidized by DDQ to form radical cation 2.145 (pathway A, Figure 21), which is 
quenched by the benzylsilane to afford the radical cation intermediate 2.146; according to the 
known capacity of benzylsilanes to undergo single electron oxidation,86 the benzylsilane in 2.53 
can also be oxidized directly by DDQ to give 2.146 (pathway B, Figure 21). Either of these two 
pathways will block the hydrogen atom abstraction process.   
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Figure 21. Possible pathways for the oxidation of 2.53 
 
2.4.3 Reaction rate analysis 
Phenyl and 2-thienyl (silyl)allylic ethers proved to be good substrates for the DDQ-
induced oxidative C‒H activation (Table 4). However, these reactions were much slower than 
reactions of similarly substituted allylic ethers, requiring higher temperature and multiple hours 
for complete conversion. Trialkylsilyl groups are electron donating substituents, indicating that 
the origin of the difference should not be an electronic effect. Kochi has disclosed that sterically 
hindered arenes react with quinones much more slowly than sterically unhindered arenes with 
similar oxidation potentials because the rate of electron transfer is dependent on the ability of 
quinone to approach the arene.87 The bulky trialkylsilyl group blocks the approach of DDQ 
towards the vinylsilane, and therefore the reaction was much slower. 
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2.4.4 Stereochemically diverse library syntheses 
As shown in Scheme 39, an efficient protocol was developed to prepare the four possible 
stereoisomers of 2-(2-hydroxyalkyl)tetrahydropyran-4-ols. Each of the isomers can be accessed 
through a sequence of ketone reduction, hydrogenation and Fleming oxidation from the 
cyclization products of vinylsilane substrates. The ketone was reduced stereoselectively by 
NaBH4 or L-Selectride to provide equatorial or axial alcohol, respectively. Reduction of the 
vinylsilane with H2 and Crabtree’s catalyst resulted in the corresponding alkyl 
phenyldimethylsilane with excellent stereocontrol due to catalyst coordination by the 
tetrahydropyranyl oxygen and conformational control as defined by A1,3 strain (Figure 19). The 
orientation of the hydroxyl group at the 4-position of the tetrahydropyran did not influence the 
efficiency of the hydrogenation, and the stereocenter at C2’ was controlled by the geometry of 
the vinylsilane. Fleming oxidation proceeded smoothly with the retention of the configuration at 
C2’. 
Propargylic ethers can serve as substrates for DDQ-mediated oxidative cyclization 
reactions. Alkynes do not present the steric challenges of vinylsilanes, but are inferior cation-
stabilizing groups, so the reactivity of the propargylic ether is comparable to that of the 
vinylsilane. Different from the complete diastereocontrol observed in all previous cyclization 
reactions, the stereocontrol in the cyclization of propargylic ether 2.62 was diminished (Scheme 
40), which is attributed to the minimal energetic difference between the (E)- and (Z)-
oxocarbenium ion intermediates due to the sterically undemanding alkynyl groups. 
The access to the rare (Z)-oxocarbenium ion has been used to prepare the eight possible 
diastereomers of a 2-hydroxyalkyl-4-hydroxy-6-alkyltetrahydropyran structure through the 
established sequence (Scheme 41). Vinylsilanes 2.119 and 2.121 can be stereoselectively 
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reduced with H2 and Crabtree’s catalyst. However, the attempts to apply the same hydrogenation 
conditions to all other vinylsilanes resulted in poor stereoselectivities. We postulated that in the 
preferred conformations of stereoisomers 2.122-2.123 and 2.131-2.134 as shown in Figure 22, 
the axial hydroxyl groups served as competitive coordination sites for Crabtree’s catalyst, 
leading to the hydrogen delivery from the undesired face. Protecting these hydroxyl groups as 
silyl ethers can eliminate the undesired coordination effect to provide the hydrogenation products 
with excellent stereocontrol. 
 
 
Figure 22. Conformation analysis of eight vinylsilanes for hydrogenation processes 
 
Stereoselective reductions of trans-2,6-dialkyltetrahydropyran-4-ones are difficult when 
the alkyl substituents are sterically similar because the two possible chair conformations are 
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energetically similar.88 However, due to the significantly different A-values of alkynyl and alkyl 
groups, the preferred chair conformation of 2-alkynyl-6-alkyltetrahydropyran-4-one (2.116) 
should be 2.158B (Figure 23), in which the alkynyl group is axially oriented and the alkyl is 
equatorially oriented. L-Selectride delivered the hydride addition from an equatorial trajectory to 
give 2.129 as a single diastereomer. Reduction of 2.116 with NaBH4, however, was unselective 
due to the block of the axial trajectory by the alkynyl group. The challenge was solved finally by 
employing SmI2 and iPrOH affording 2.128 in 85% yields as a single isomer. The capacity to 
control the stereochemical outcome of the C4 carbonyl group in a tetrahydropyran-4-one in a 
completely selective and complementary manner illustrates that alkynyl-substitution should have 
broader application in the synthesis of trans-2,6-dialkyltetrahydropyrans.       
 
 
Figure 23. Stereocontrolled reduction of trans-2,6-disubstituted tetrahydropyran-4-ones 
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2.5 SUMMARY 
We have shown that vinylsilane-substituted tetrahydropyrans, readily prepared through 
oxidative cyclization on (silyl)allylic ethers or on propargylic ethers followed by transition-metal 
catalyzed hydrosilylation, provide access to a broad range of structurally and stereochemically 
diverse tetrahydropyran products. The versatility arises from the ability of vinylsilanes to engage 
in numerous transformations, such as Pd-mediated cross-coupling reactions, desilylations and 
Fleming–Tamao oxidations, as well as their well-defined conformational preferences for 
stereoselective functionalization.  
The cyclization of (silyl)allylic ethers proceeds efficiently to generate cis-2,6-
disubstituted tetrahydropyrones with excellent stereocontrol, and therefore is preferable for 
target-oriented syntheses. Pd-mediated cross-coupling reactions were useful for the synthesis of 
complex alkene structures, and desilylation process afforded us an opportunity to access (Z)-
vinyl tetrahydropyrans. Moreover, Tamao oxidations were employed to convert vinylsilanes to 
corresponding ketones. Coupling stereoselective ketone reduction, Crabtree’s catalyst mediated 
hydrogenation and Fleming oxidation led to the formation of four diastereomers of a hydroxyl 
tetrahydropyranol structure.  
The cyclization of propargylic ethers results in a mixture of cis- and trans-2,6-
disubstituted tetrahydropyrones due to the similar energies of the E- and Z-oxocarbenium ion 
intermediates. The access to the trans-2,6-disubstituted tetrahydropyrans was employed to 
prepare the eight possible stereoisomers of a 2-hydroxyalkyl-4-hydroxy-6-alkyltetrahydropyran 
structure. The approach outlined herein will have broad applications in natural product and 
libraries synthesis when coupled with the growing number of protocols that utilize vinylsilanes 
as substrates for new chemical bond forming reactions.  
 73 
3.0  STEREOSELECTIVE SYNTHESIS OF TERTIARY ETHERS THROUGH 
GEOMETRIC CONTROL OF HIGHLY SUBSTITUTED OXOCARBENIUM IONS 
3.1 INTRODUCTION OF 1,1-DISUBSTITUTED OXOCARBENIUM IONS AS 
REACTION INTERMEDIATES 
Oxocarbenium ions are important reactive intermediates in synthetic organic chemistry. 
Numerous methods for highly diastereoselective additions of carbon or heteroatom nucleophiles 
to mono-substituted oxocarbenium ions have been identified, such as Prins cyclizations,47,89 acid-
mediated additions to acetals,90 allyl group transfers,91 and additions of carbonyls to electrophiles 
(Scheme 43).92 The excellent stereoselectivities in these reactions are attributed to the strong 
preference of mono-substituted oxocarbenium ions for (E)-configurations, which are calculated 
at approximately 2 kcal/mol-1 more stable than the corresponding (Z)-isomers.93 On the other 
hand, stereoselective additions to 1,1-disubtituted oxocarbenium ions are not well developed. 
This challenge arises from the fact that the two possible chair conformations are energetically 
similar.  
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Scheme 43. Oxocarbenium ion intermediates in organic transformations 
 
 
In 1987, Olah reported that TMSI-catalyzed reductive coupling of ketone 3.1 with Et3SiH 
gave symmetrical ether 3.2 as a single diastereomer (Scheme 44).94 The stereoselectivity in the 
step of 1,1-disubstituted oxocarbenium ion 3.3 reduction with Et3SiH resulted from the 
substitution at the α-carbon of 3.1. The steric repulsion between the methyl group on C1 and the 
hydrogen atom on C3 dictated that 3.3 would strongly prefer to adopt a conformation shown in 
3.4. The bulky Et3SiH selectively attacked the oxocarbenium ion from the bottom face, since the 
top face was blocked by iPr group on C3 carbon.  
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Scheme 44. TMSI catalyzed reductive coupling of ketones with Et3SiH 
 
In 2009, Romea and Urpí disclosed a SnCl4-mediated addition of titanium enolate 3.8 
from 3.5 to dimethyl ketals 3.6 furnishing tertiary methyl ethers 3.7 with moderate to excellent 
stereoselectivity (Scheme 45).95 The stereogenic center formation step was believed to involve 
nucleophilic additions on 1,1-disubstituted oxocarbenium ions 3.9. When the substrate was the 
ketal derived from methyl isopropyl ketone, excellent stereocontrol (97:3) was observed. 
However, when the ketal with no substitution at the α-carbon was used, the stereoselectivity 
decreased to 86:14. Almost no selectivity was observed for ketal prepared from acetophenone.  
 
 
Scheme 45. Tertiary methyl ether synthesis through additions onto E-oxocarbenium ions 3.8 
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1,1-Disubstituted oxocarbenium ions also served as reactive intermediates for 
intramolecular cyclizations. Yadav realized an iodine-promoted Prins-cyclization of symmetric 
ketones affording 4-iodo-tetrahydropyrans bearing quaternary carbon centers in high yields 
(Scheme 46).96 However, when asymmetric methyl ethyl ketone was used, poor 
diastereoselectivity (2:1) was obtained, which was attributed to the small energy difference 
between the two possible chair conformations.  
 
 
Scheme 46. I2-promoted Prins-cyclization of ketones 
 
Porco documented that enantiopure spirocyclic oxindole pyrans can be efficiently 
prepared by highly stereoselective Prins-type cyclizations of homoallylic alcohols and isatin 
ketals (Scheme 47).97 The transformation was proposed to proceed through an E-1,1-
disubstituted oxocarbenium ion 3.9 in which the larger aryl substituent of the oxindole moiety 
adopted a pseudo-equatorial orientation. 
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Scheme 47. Stereoselective synthesis of spirocyclic oxindoles via Prins cyclization 
 
Despite a few precedents involving nucleophilic additions on 1,1-disubstituted 
oxocarbenium ions have been developed with moderate to high stereocontrol, there was no 
systematical study on the geometry of disubstituted oxocarbenium ions. Therefore in this project, 
our key objective is to devise a more general model that can be applied to predict the 
conformational properties of disubstituted oxocarbenium ions, and to design synthesis of natural 
products or other complex molecules containing tertiary ethers. 
 
3.2 A MODEL STUDY ON THE GEOMETRIES OF 1,1-DISUBSTITUTED 
OXOCARBENIUM IONS 
The observed 1.6:1 ratio of cis:trans isomers from the cyclization of 2.62 (Scheme 40, 
Chapter 2) can be explained by the nearly identical energies of the intermediate (E) and (Z)-
oxocarbenium ions (eq 2, Figure 24), resulting from the small steric difference between an 
alkynyl group and a hydrogen atom.98 Provided that the cyclization product distribution is 
attributed to the energetic difference between (E)- and (Z)-isomers of alkynyl-substituted 
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oxocarbenium ions (B1 and B2, Figure 24), the difference is approximately 0.3 kcal/mol-1. The 
strong preference for the (E)-dialkyl oxocarbenium ion A1 and the small energetic penalty for 
the (Z)-orientation of the alkyl and alkynyl group (B1) suggest that 1,1-disubstituted 
oxocarbenium ions containing an alkyl group and an alkynyl group on the cationic carbon will 
prefer the conformation that places the alkyl groups in an (E)-orientation (C1) (eq 3, Figure 24). 
 
 
Figure 24. Alkyl- or alkynyl-substituted oxocarbenium ions 
 
Since oxocarbenium ions can be efficiently accessed through DDQ-mediated oxidative 
C‒H activation of propargylic ethers (Scheme 40, Chapter 2),98 this protocol was employed for 
1,1-disubstituted oxocarbenium ion formation to test the hypothesis. Substrate 3.12 was prepared 
starting from alkynyl acetal 3.10 as shown in Scheme 48. The construction of the ether linkage 
between two secondary carbon atoms in 3.11 was realized by using Yamamoto’s Me3Al-
mediated acetal opening protocol99 to 3.10 with excellent stereocontrol. Parikh-Doering 
oxidation of 3.11, followed by Seyferth-Gilbert homologation100 and enol acetate formation39 
afforded the cyclization substrate 3.12. Exposing 3.12 to DDQ at room temperature provided 
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tetrahydropyran 3.14 in 72% yield as a single diastereomer after 18 h. The result validated our 
hypothesis that oxocarbenium ions containing an alkyl group and an alkynyl group exist in a 
predictable (E)-dialkyl conformation as depicted in 3.13.  
 
 
Scheme 48. The preparation of substrate 3.12 and its cyclization 
 
The result led us to design a generalized model for 1,1-disubstituted oxocarbenium ion 
geometry to guide substrate design for stereoselective cyclic tertiary ether synthesis. The model 
(model A, Figure 25) places the smaller group (RS) in a cis-relationship with the opposite ether 
linkage, and the larger group (RL) in a trans-relationship. The result in Scheme 48 showed that 
alkynyl groups act as RS substituents when compared with alkyl groups in model A. Then we 
investigated what RL should be if RS was the alkyl group. We noticed that this model was similar 
to the reactive conformation for the well-studied Corey-Bakshi-Shibata (CBS) ketone reduction 
(model C, Figure 25),101 and therefore, the substrate scope of CBS reduction can be used as 
guidance for substrate design in the project. It was reported that CBS reduction of aryl-alkyl or 
alkenyl-alkyl ketones at ‒78 °C  resulted in secondary alcohols with excellent ee, and aryl or 
alkenyl substituents served as RL groups in model C. 
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Figure 25. Models for 1,1-disubstituted oxocarbenium ion and CBS reduction 
 
Therefore, allylic ethers 3.15-3.20 and benzylic ethers 3.21-3.25 were designed for the 
stereoselective synthesis of cyclic tertiary ethers (Figure 26). The investigation began with the 
oxidation of substrate 3.15 by DDQ, on which reaction condition optimizations would be 
performed to pursue high chemical yields and stereoselectivity. 
The synthesis of substrates 3.15-3.17 and 3.19-3.21 shared the same synthetic route 
(Scheme 49). Various enals reacted with 1,3-butanediol and PPTs in refluxing benzene to afford 
the corresponding cis-acetals 3.26. Exposing 3.26 to Me3Al provided acetal opening products 
3.27, which underwent the sequence of Parikh-Doering oxidation, Seyferth-Gilbert homologation 
and enol acetate formation to furnish substrates 3.15-3.17 and 3.19-3.21. 
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Figure 26. Substrates for the study of model A 
 
 
Scheme 49. Syntheses of substrates 3.15-3.17 and 3.19-3.21 
 
Dess-Martin periodinane (DMP) oxidation of known (silyl)allyl alcohol 2.84 to 3.28, 
followed by acetal formation with 1,3-butanediol, and acetal opening with Me3Al gave alcohol 
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3.29 in 35% yield (Scheme 50). Another DMP oxidation of 3.29, followed by Seyferth-Gilbert 
homologation and enol acetate formation generated substrate 3.18. 
 
Scheme 50. The preparation of substrate 3.18 
 
p-Toluenesulfonic acid-catalyzed reaction of ketone 3.31 and 1,3-butanediol yielded ketal 
3.32 in 74% yield, which was opened by DIBAL-H102 to provide alcohol 3.33 in 70% yield as a 
single diastereomer (Scheme 51). An uneventful sequence of Parikh-Doering oxidation, 
Seyferth-Gilbert homologation and typical enol acetate formation, was executed for the 
conversion of 3.33 to substrate 3.22. The preparation of substrates 3.23-3.25 followed the same 
sequence as that of 3.22 except the ketal formation step. The transformation from 3.34 to 3.35 
was achieved in two steps. 3.34 first reacted with trimethyl orthoformate in MeOH yielding a 
dimethyl ketal derivative, which then reacted with 1,3-butanediol to provide the cyclic ketal 3.35 
in 80% yield. A one-step protocol for the synthesis of cyclic ketals 3.38 and 3.41 was employed 
by simply combining corresponding ketone 3.37 or 3.40, 1,3-butanediol, trimethyl orthoformate 
and conc. H2SO4 in the same flask.
103 Following the same sequence from 3.32 to 3.22, ketals 
3.35, 3.38 and 3.41 were converted to corresponding substrates 3.23, 3.24 and 3.25. 
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Scheme 51. The preparation of substrates 3.22-3.25 
 
Different reaction conditions for the formation of tetrahydropyran 3.43 were screened and 
the results are summarized in Table 5. Initially, 3.15 was subjected to the standard oxidation 
conditions using DDQ as the oxidant, 1,2-dichloroethane (DCE) as the solvent, 4 Å molecular 
sieves as the water scavenger and 2,6-dichloropyridine as the base. After 3 h at rt, all the starting 
material was converted to a polar compound based on TLC (entry 1, table 5). However, this 
compound decomposed during the purification through column chromatography. We believed 
that it should be 3.44 resulting from the addition of DDQH2 onto the intermediate oxocarbenium 
ion. A catalytic amount of LiClO4 (30 mol%) was found to be quite beneficial in suppressing the 
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DDQH2-adduct formation, and the desired tetrahydropyran 3.43 was isolated in 30% yield with 
the cis:trans ratio of 2:1 (entry 2, table 5). Different reaction temperatures, the LiClO4 loadings, 
and different solvents were screened to improve the yield and stereoselectivity of the reaction. 
The reaction was very slow at 0 °C , and only about 15% conversion was observed even after 24 
h (entry 3, table 5); at 45 °C  the reaction afforded lower yields and selectivities than those at 
room temperature (entries 2 and 4, table 5). The dr of 3.43 decreased from 2:1 to 1.4:1 when 
LiClO4 loadings were increased from 30 mol % to 100 mol % (entries 2 and 5, table 5). The 
reaction was strongly influenced by solvents. Et2O made the transformation sluggish, though a 
better dr was obtained (entry 6); CH3NO2 was the best solvent, affording 3.43 in 52% yield with 
a diastereomeric ratio of 3:1, though the reaction was slower than that in DCE (entry 8). 
 
Table 5. Optimizing the synthesis of tetrahydropyran 3.43 
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Substrates 3.16-3.25 were subjected to the optimized conditions using 30 mol % LiClO4 
as the additive and CH3NO2 as the solvent, and the results are summaried in Table 6. (E)-1,2-
Disubstituted allylic ether 3.16 reacted with DDQ more efficiently than trisubstituted allylic 
ether 3.15, though the diastereocontrol was still 3:1 (entry 1, table 6). However, the 
diastereomers were separable, affording the major isomer of 3.45 in good yield. Cinnamyl ethers 
were significantly more reactive than allylic ethers, allowing the reaction of 3.17 to be performed 
at ‒60 °C in nitroethane to yield 3.46 in 82% yield as a 10:1 mixture of diastereomers in 4 h 
(entry 2, table 6). No reaction was observed for (Z)-2-(silyl)allylic ether 3.18 at room 
temperature and the starting material decomposed when performed at 45 °C (entry 3, table 6). 2-
Alkyl-substituted allylic ethers 3.19 and 3.20 reacted efficiently to provide tetrahydropyrans 3.48 
and 3.49 with high stereocontrol (entries 4 and 5, table 6). Benzylic ether analogues were 
excellent substrates for quaternary center formation, with diastereomeric substrates 3.21 and 3.22 
generating the same isomer 3.50 as a single diastereomer (entries 6 and 7, table 6). Spirocyclic 
ethers 3.52, 3.53 and 3.54 were also accessible through oxidative cyclizations as shown in entries 
8, 9, and 10 of Table 6. The transformations were quite fast and extremely stereoselective. 
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Table 6. Tertiary ether synthesis from allylic and benzylic ethersa 
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3.3 A MODEL STUDY ON THE CONFORMATIONS OF OXOCARBENIUM IONS 
WITH PREEXISTING TERTIARY STEREOCENTERS 
The success of model A for the geometry of 1,1-disubstituted oxocarbenium ions led us 
to explore another model, in which preexisting tertiary stereocenters will influence the sense of 
nucleophilic addition onto oxocarbenium ions (model B, Figure 27). To minimize steric 
repulsion between the hydrogen on the cationic carbon and the substituent on the tertiary ether, 
the RS group will occupy an eclipsed orientation with the hydrogen atom on the cationic carbon.  
 
 
Figure 27. A model for oxocarbenium ions with preexisting tertiary stereocenters 
 
Substrates 3.55-3.60 were designed as shown in Figure 28 to test the generality of model 
B. Prenyl ethers were employed in theses substrates due to their high efficiency in DDQ-
mediated oxidation process. The preexisting tertiary ethers contained unsaturations, such as 
alkynes (3.55 and 3.60) and alkenes (3.56 and 3.57), as well as saturated alkyl groups (3.58 and 
3.59). 
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Figure 28. Substrates for the study of model B 
 
Substrates 3.55-3.60 were prepared as depicted in Scheme 52. Substrate 3.55 was 
synthesized from aldehyde 3.61 in 5 steps (Scheme52(a)). Propynyl magnesium bromide 
addition to 3.61, followed by Parikh-Doering oxidation afforded ketone 3.62. Propargylation of 
3.62 with propargyl magnesium bromide gave 3.63, which underwent a sequence of prenyl ether 
formation and enol acetate formation to provide substrate 3.55. A cross metathesis between 
alkene 3.64 and 3-buten-2-one yielded enone 3.65 in 78% yields, which was then converted to 
substrate 3.56 following the same synthetic route as that from 3.62 to 3.55 (Scheme 52(b)). The 
preparation of substrate 3.57 started with a methyl Grignard addition to the known enal 3.28, 
followed by a DMP oxidation to afford enone 3.67 (Scheme 52(c)). Propargylation of 3.67 
generated propargylic alcohol 3.68, followed by TMSOTf-catalyzed coupling between 3.68 and 
3.69, and enol acetate formation provided substrate 3.57. 
Propargylation of cyclohexanone 3.70, followed by prenyl ether formation and enol 
acetate formation gave substrate 3.58 (Scheme 52(d)). The preparation of substrate 3.59 started 
with the reaction of ketone 3.73 with ethylene glycol yielding a ketal, which underwent a TiCl4-
catalyzed ketal opening with allenyl(tributyl)tin 3.74 afford alcohol 3.75 (Scheme 52(e)).104 A 
sequence of DMP oxidation, Wittig olefination105 and enol acetate formation gave substrate 3.59. 
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Propynylmagnesium bromide addition to methyl ketone 3.77, followed by desilylation and acetal 
formation generated 3.78 (Scheme 52(f)). Me3Al-mediated acetal opening of 3.78 yielded 
alcohol 3.79 with excellent stereocontrol. A DMP oxidation of 3.79, followed by a Corey-Fuchs 
reaction106 afforded an alkyne, which underwent regioselective AcOH addition to the terminal 
alkyne to furnish substrate 3.60. 
 
Scheme 52. The preparation of substrates 3.55-3.60 
 90 
These substrates were applied to the DDQ oxidation process, and the results are 
summarized in Table 7. Propargylic ether 3.55 reacted smoothly with DDQ to afford 3.80 as a 
single diastereomer (entry 1, table 7). In this reaction, alkynyl group served as the RS substituent. 
Allylic ether 3.56 and (silyl)allyl ether 3.57 were oxidized by DDQ to give corresponding 
tetrahydropyrans 3.81 and 3.82 in high efficiency, respectively (entries 2 and 3, table 7). Alkenyl 
groups were also found to serve as RS substituent in both reactions. Saturated spirocyclic ethers 
can be accessed through model B, and the cyclization of 3.58 yielded spirocycle 3.83 in 88% 
yield, in which the alkyl group occupied the RS position (entry 4, table 7). Excellent 
stereocontrol was observed during the cyclization of 3.59 to 3.84 (entry 5, table 7), in which the 
unbranched group was the RS substituent and the branched group was the RL substituent. Our 
attempt to synthesize tetrahydropyrans with two tertiary ethers failed, as demonstrated by the 
oxidation of 3.60 (entry 6, table 7). No reaction was observed when performed at room 
temperature and decomposition of the starting material happened at 45 °C . We postulated that 
even the 1,3-diaxial interaction between two alkynyl groups was too significant to be overcome 
in such a transformation. 
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Table 7. Tertiary ether synthesis from prenyl ethers 3.55-3.60a 
 
 
According to the results in Tables 6 and 7, the generalized model for 1,1-disubstituted 
oxocarbenium ion geometry (model A) and the model in which preexisting tertiary stereocenters 
influence the sense of nucleophilic addition onto monosubstituted oxocarbenium ions (model B) 
are summarized in Scheme 53. The applications of models A and B to other reactions sharing 
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same oxocarbenium ion intermediates are also explored (Scheme 53). TMSI-mediated Prins 
reaction107 of acetophenone (3.85) with homoallylic alcohol 3.86, followed by radical-mediated 
removal of iodide provided tetrahydropyran 3.87 as a single diastereomer (application of model 
A). The condensation of heptanal (3.61) with tertiary alcohol 3.88 in the presence of AlCl3
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gave chlorotetrahydropyran 3.89, also as a single diastereomer (application of model B). The 
yields of these transformations were quite low due to the competitive ionization and the oxonia-
Cope rearrangement109. However, these conditions were not optimized because we are mainly 
interested in the stereoselecticities of the transformations.  
 
 
Scheme 53. Applications of models A and B to acid-mediated Prins reactions 
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3.4 DISCUSSION 
As shown in Figure 29, the reaction of secondary propargylic ether 3.12 (17 h, room 
temperature) occurred more rapidly than that of primary propargylic ether 2.62 (18 h, 45 °C ). 
This observation indicated that cation stabilization by the methyl group through 
hyperconjugation in 3.91 became a dominant factor that influences the reaction rate. Alkynes are 
inferior cation-stabilizing groups, thus the extra methyl group dramatically increased the stability 
of the cation. Compared with 3.90A, an increased steric hindrance between alkynyl and 
hydrogen atom existed in 3.91. However, this destabilization was not a big issue due to the 
sterically undemanding property of alkynes as well as the existence of a similar interaction in 
3.90B. 
 
 
Figure 29. Reaction rate comparisons between primary and secondary propargylic ethers 
 
Two possible geometric oxocarbenium ion intermediates (C and D) for the oxidation of 
secondary allylic or benzylic ethers are depicted in Figure 30. A methyl group acted as the RS 
 94 
substituent in C while an alkene group acted as the RS substituent in D. In both C and D, the 
steric repulsion between alkyl group on C1 and hydrogen on C1’ existed. However, the 
conjugation between the alkene and the oxocarbenium ion in D forced the R2 group to project 
across the ether linkage. The additional steric repulsion between R2 and hydrogen on C1’ 
disfavored D, and therefore, the subsequent cyclization proceeded through geometric 
intermediate C leading to the observed product. 
 
 
Figure 30. Stereoselectivity in oxidation of secondary allylic ethers 
 
In contrast to propargylic ether substrates, secondary allylic or benzylic ethers reacted 
with DDQ much more slowly than those of corresponding primary ethers (Figure 31). This trend 
suggested that the steric repulsion between methyl group on C1 and hydrogen on C1’ in 3.92 
should play a dominant cation-destabilization role over cation-stabilization by methyl group on 
the reaction rate. 
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Figure 31. Reaction rate comparison between primary and secondary allylic ethers 
 
The cyclization of trisubstituted allylic ether 3.15 afforded product 3.43 in 52% yield 
(Figure 32). The modest yield was attributed to the A1,3 strain between methyl groups as shown 
in 3.93. The strain destabilized 3.93, leading to a decomposition before the cyclization. 
 
 
Figure 32. The reaction of DDQ and 3.15 
 
Disubstituted allylic ether 3.16 only provided 3.45 with a modest stereocontrol (3:1) at 
room temperature (entry 1, table 6). A similar stereocontrol (4.6:1) was also observed for the 
cyclization of cinnamyl ether 3.17 at room temperature. However, the low oxidation potential of 
3.17 allowed the reaction to be conducted at ‒60 °C , and the stereoselectivity was improved to 
10:1 (entry 2, table 6). The improvement suggested that the steric difference between the alkene 
group and alkyl group could be amplified by lowering the reaction temperature, and better 
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stereocontrol should be obtained. Reactions of simple alkyl-substituted allylic and benzylic 
ethers proved to be difficult when performed at low temperature due to the issues of oxidation 
potential and intermediate stability. However, model A should have broad application in other 
temperature insensitive reactions. 
When the substituent at 2-position of the allylic ether is an alkyl group (R2 = alkyl), 
excellent stereoselectivity was achieved (entries 4 and 5, Table 6). The observation can be 
explained by the increased steric repulsion between R2 and hydrogen in intermediate D in Figure 
29. The replusion made intermediate C more favored, resulting in excellent stereocontrol. Single 
diastereomeric products were obtained for cyclizations of benzylic ether substrates (entries 6-10, 
table 6), arising from the same origin as 2-substituted allylic ethers. 
Like model A, the alkynyl group still served as the RS substituent in model B (entry 1, 
table 7). In contrast to model A, however, alkenyl groups or even bulky vinylsilane groups acted 
as the RS substituent in model B (entries 2 and 3, table 7). The twisted conformation of tertiary 
ether in model B allowed the alkenyl groups to orient their sterically undemanding flat faces 
toward the substituents across the ether linkage to minimize steric interactions (Figure 33). An 
electrostatic attraction between the π electrons and the electron deficient formyl hydrogen 
atom110 could further stabilize this conformation. The fact that alkenyl groups act as the small 
substituent in model B demonstrates that stereochemically complementary 2,2,6-trisubstituted 
tetrahydropyrans can be accessed based on models A and B. 
 
Figure 33. Explanation for oxocarbenium ion geometry in model B 
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3.5 SUMMARY 
In this project, two generalized models for oxocarbenium ion geometry have been 
extensively studied by means of our DDQ-mediated oxidative C‒H activation of secondary 
propargylic, allylic and benzylic ether substrates. Tetrahydropyrans containing tertiary ethers 
were synthesized with excellent stereocontrol. In model A, the geometry of 1,1-disubstituted 
oxocarbenium ions can be predicted based on the steric difference between two substituents. 
Oxocarbenium ions containing an alkyl group and an alkynyl group on the cationic carbon, place 
the alkynyl group (RS) in a cis-relationship with the opposite ether linkage, and the alkyl group 
(RL) in a trans-relationship. Oxocarbenium ions containing an alkyl group and an alkenyl or aryl 
group on the cationic carbon, places the alkyl group (RS) in a cis-conformation with the ether 
linkage. Model B uses the preexisting quaternary center to control the geometry of oxocarbenium 
ion, resulting in a new stereocenter with exceptionally diastereoselectivity. These two models are 
successfully applied to oxocarbenium ions derived from other processes like the acid-mediated 
Prins reactions, with excellent stereoselectivity. The generality of models A and B indicates that 
they will serve as guidance for reactions proceeding through highly substituted oxocarbenium 
ions.    
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                4.0 DDQ-CATALYZED REACTIONS USING MANGANESE DIOXIDE AS A
                                                       
                                                                   TERMINAL OXIDANT                                                                                                                                                                                                                             
4.1 INTRODUCTION OF PROTOCOLS FOR DDQ-REGENERATION FROM 
DDQH2 
In Chapters 1-3, DDQ was shown to be a powerful reagent for selective oxidation of 
various compounds with high efficiency, such as vinyl ethers, allylic ethers, and propargylic 
ethers. In addition to these transformations, DDQ is a highly effective oxidant for a wide range 
of organic transformations including protecting group removal (Scheme 54(a)), dehydrogenation 
(Scheme 54(b)), aromatization (Scheme 54(c)), and biaryl construction (Scheme 54(d)).111  
 
 
Scheme 54. DDQ in organic synthesis 
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However, the stoichiometric use of DDQ can result in difficulty in removing the reduced 
byproduct, DDQH2 (2,3-dichloro-5,6-dicyanohydroquinone). Moreover, DDQ is moderately 
expensive with a cost of $526/mol according to the 2009-2010 Aldrich catalog.112 The toxicity of 
DDQ is another problem. DDQ poses modest toxicity concerns, with an LD50 of 82 mg/kg
113 and 
the potential for HCN generation upon exposure to H2O. To address such issues, some efforts 
have been made to discover co-oxidants that regenerate DDQ from DDQH2.  
Strong acids were reported for the purpose (Scheme 55). DDQ-catalyzed allylic alcohol 
oxidations were realized by using H5IO6
114 as the terminal oxidant to afford enones in high 
yields. In addition, concentrated nitric acid115 was also a good oxidant to promote the 
transformation of DDQH2 to DDQ in large scale. However, their strong acidities are not 
compatible with functionalized organic compounds. 
 
 
Scheme 55. Strong acids as oxidants for DDQ regeneration 
 
Chandrasekhar disclosed that oxidative cleavage of PMB ethers can be achieved by the 
employment of catalytic amount of DDQ with FeCl3 serving as the stoichiometric oxidant 
(Scheme 56).116 This system is quite economical and environmentally benign because FeCl3 only 
costs $41/mol, and because FeCl3 has a higher LD50 (450 mg/kg) than DDQ. Some protecting 
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groups such as acetates, benzyl ethers, and silyl ethers, were found to be compatible with the 
process. However, the Lewis acidity makes it incompatible with many other functional groups 
like THP ethers. 
 
 
Scheme 56. FeCl3 as terminal oxidant for DDQ-catalyzed PMB ether cleavage 
 
Mn(OAc)3 proved to be an effective reagent for DDQ regeneration as demonstrated in the 
deprotection of PMB ethers.117 A proposed mechanism for the regeneration of DDQ from 
DDQH2 is shown in Scheme 57. DDQH2 reacted with Mn(OAc)3 to form Mn(III) complex A, 
the decomposition of which led to the formation of DDQ. Mn(OAc)3 does not exhibit strong 
Lewis acidity, and commonly encountered functional groups such as THP ethers, acetals, 
alkenes, and alkynes are compatible with the process. However, the price of Mn(OAc)3·2H2O 
($647/mol) is actually more expensive than DDQ. Therefore, the development of economical and 
environmentally benign oxidants that regenerate DDQ from its reduced DDQH2 is still a 
worthwhile project.  
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Scheme 57. Mn(OAc)3 as terminal oxidant for DDQ-catalyzed PMB ether cleavage 
 
4.2 RESULTS AND DISCUSSION 
The initial objective was to search for a terminal oxidant to promote our DDQ-catalyzed 
C‒H bond activation processes. Terminal oxidants (FeCl3, Mn(OAc)3) that regenerate DDQ from 
DDQH2, as well as metal oxides (PbO2,
118 MnO2,
119 Mn(acac)3
120) that are known to promote 
phenol oxidations, were applied to DDQ-catalyzed oxidative cyclization of allylic ether 4.1 
(Table 8). Substrate 4.1 was readily synthesized from known alcohol 1.106 through ether 
formation and enol acetate formation (Scheme 58). 
 
 
Scheme 58. The preparation of substrate 4.1 
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The starting material decomposed immediately upon treating 4.1 with FeCl3 or 
Mn(acac)3, most likely due to their strong Lewis acidities (entries 1 and 4, table 8). Mn(OAc)3 
and PbO2 proved to be effective terminal oxidants to promote DDQ-regeneration process, and 
70% and 72% yields were obtained after 48 h (entries 2 and 3, table 8). However, the cost 
concern for both Mn(OAc)3 ($647/mol) and PbO2 ($117/mol), combined with the toxicity issue 
of PbO2 (LD50 = 220 mg/kg) led us to explore the feasibility of MnO2 ($28/mol, LD50 = 3478 
mg/kg) as the stoichiometric oxidant.  
Exposing 4.1 to DDQ (40 mol %) and MnO2 in CH3NO2 afforded 4.3 in 66% yield after 
48 h (entry 5, tale 8). No conversion of 4.1 to 4.3 was observed when MnO2 was used in the 
absence of DDQ (entry 6, table 8), suggesting that the reaction should be mediated by DDQ. 
Moreover, DDQ regeneration was confirmed through 13C NMR spectroscopy by treating 
DDQH2
121 with MnO2 in CH3NO2.  
Different solvents were screened to improve the reaction efficiency. The starting material 
was completely consumed in 60 h and a 45% yield of 4.3 was obtained when the reaction was 
performed in DCE (entry 7, table 8); decomposition to an unidentified byproduct was the major 
side pathway. The transformation was sluggish in CH3CN (entry 8, table 8). Polar solvents, such 
as EtOAc and DMF, were not good options even for the DDQ oxidation process, and no 
reactions were observed (entries 9 and 10, table 8). Typically, oxidative cyclizations are slower 
in CH3NO2 than in less polar solvents, such as DCE. However, the regeneration of DDQ was 
faster in CH3NO2, making it the best solvent for the process.  
The yield was improved from 66% to 80% by the incorporation of NaHCO3 as a base 
(entry 11, table 8). Employing 2,6-dichloropyridine made the transformation proceed more 
efficiently (entry 12, table 8) probably because it acted as a soluble base and quenched the 
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acylium ion formed when the enol acetate nucleophile attacks the oxocarbenium ion. Increased 
temperature or sonication condition proved not to be beneficial to the reaction rate (entries 13 
and 14, table 8). Lowering DDQ loadings from 40 mol % to 15 mol % did not result in a loss of 
yield, though the reaction required an additional 12 h to go to completion (entry 15, table 8). The 
purification step was quite easy, with the removal of the excess MnO2 and metal-containing 
byproduct through a simple filtration over silica gel. 
 
Table 8. Terminal oxidant screen and reaction condition optimizationa 
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After suitable reaction conditions were identified, a variety of allylic and benzylic ethers 
that worked in stoichiometric DDQ-mediated oxidation reactions were subjected to this catalytic 
process. The results are summarized in Table 9. Cyclizations of benzylic and allylic ethers 
proceeded smoothly to provide the corresponding tetrahydropyrans (entries 1-3, table 9). 
Quaternary centers can be formed through the catalytic system by using sterically hindered 
ethers 3.21 and 3.55 as substrates (entries 4 and 5, table 9). The cyclization of substrate 3.58 
provided spirocyclic ether 4.11 in 81% yield (entry 6, table 8). Generally speaking, the yields of 
the reactions were within approximately 10% of the yields for the corresponding reactions using 
stoichiometric DDQ. The reaction rates roughly correlated with the substrate’s oxidation 
potential and the oxocarbenium ion’s stability, though the reaction time difference between the 
most and least reactive substrates was quite small (entries 1 and 3, table 8). This observation 
indicated that the hydroquinone oxidation should be the rate limiting step. No reaction was 
observed for substrate 1.92. This challenge can be attributed to the low reaction rate even when 
using stoichiometric DDQ in DCE (entry 2, table 2, Chapter 1), and the change in solvent, since 
oxidative cyclizations are slower in CH3NO2 than in DCE. 
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Table 9. DDQ-catalyzed oxidative cyclization reactionsa 
 
 
We also investigated the applicability of MnO2 as a stoichiometric oxidant in other 
commonly encountered DDQ-mediated reactions (Scheme 59). The oxidative cleavage of PMB 
ether 4.12 proceeded efficiently to afford alcohol 4.13 in 90% yield (Scheme 59(a)). H2O proved 
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to deactivate MnO2, so MeOH was employed as the nucleophile in the transformation. An 
intramolecular variant of the reaction provided cyclic acetal 4.15 in 94% yield using NaHCO3 as 
a base (Scheme 59(b)). Dehydrogenation reactions also worked pretty well, with 
dihydronaphthalene (4.16) being oxidized to naphthalene (4.17) in 96% yield (Scheme 59(c)), 
and with oxazoline 4.18 being oxidized to oxazole 4.19 in 86% yield (Scheme 59(d)). The 
protocol was also applicable to Li’s cross-dehydrogenative coupling (CDC)122 of acetophenone 
(4.20) and isochroman 4.21 forming 4.22 in 42% yield (Scheme 59(e)). While the yield was not 
satisfactory, this example demonstrated that intermolecular C‒C bond formation can be achieved 
by employing MnO2 as the terminal oxidant. When the amount of 4.16 in transformation (c) was 
scaled up from 50 mg to 4.1 g (31.5 mmol), the reaction proceeded more rapidly than that of the 
smaller scale (16 h vs 24 h) and provided a comparable yield (Scheme 60(f)). The rate 
enhancement was attributed to the increase of concentration from 0.1 M in the smaller scale 
transformation to 3 M in the larger scale. The ability to perform large-scale transformations 
indicates that this protocol might have potential application in process chemistry.   
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Scheme 59. MnO2-mediated DDQ-catalyzed reactions 
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4.3 SUMMARY 
We have demonstrated that DDQ-catalyzed oxidative C‒H functionalization of benzylic 
and allylic ethers for tetrahydropyran synthesis can be achieved by using MnO2 as an 
inexpensive and environmentally benign terminal oxidant. This catalytic system is also 
applicable to other commonly encountered DDQ-mediated reactions, such as PMB ether 
cleavages, dehydrogenations, and cross-dehydrogenative couplings. The processes are 
comparable with respect to yield and stereocontrol, though these reactions are significantly 
slower than the corresponding reactions using stoichiometric DDQ. Moreover, the products are 
quite easy to purify. Substrates with low reactivities toward DDQ oxidation are not compatible 
with this system. The success of gram-scale transformation suggests that the protocol should 
have potential application in process chemistry due to the benefits of MnO2’s low price and 
negligible toxicity. 
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APPENDIX A 
CARBON‒CARBON BOND CONSTRUCTION THROUGH OXIDATIVE 
CARBON‒HYDROGEN BOND CLEAVAGE OF VINYL AND ALLYLIC ETHERS 
General Experimental Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, 
respectively. The chemical shifts are given in parts per million (ppm) on the delta (δ) scale. The 
solvent peak was used as a reference value, for 1H NMR: CDCl3 = 7.26 ppm, for 
13C NMR: 
CDCl3 = 77.23. Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; dd 
= doublet of doublets; dt = doublet of triplets; br = broad). High resolution and low resolution 
mass spectra were recorded on a VG 7070 spectrometer. Infrared (IR) spectra were collected on 
a Mattson Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on a NaCl plate 
by dissolving the compound in CH2Cl2 and then evaporating the CH2Cl2. Analytical TLC was 
performed on E. Merck pre-coated (25 mm) silica gel 60F-254 plates. Visualization was done 
under UV light (254 nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica 
gel.  Methylene chloride was distilled under N2 from CaH2, and 1,2–dichloroethane was dried 
over 4Å molecular sieves. Reagent grade ethyl acetate, diethyl ether, pentane and hexanes were 
purchased from EM Science and used as purchased for chromatography. Tetrahydrofuran and 
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diethyl ether were dried by passage through an activated alumina column under positive N2 
pressure. Anhydrous (N,N)-dimthylformamide (DMF), methanol (MeOH), dimethyl sulfoxide 
(DMSO), acetone were purchased from Aldrich and used as it is. Activated 4 Å molecular sieves 
were obtained through drying in oven at 150 °C overnight. All reactions were performed in oven 
or flame-dried glassware under a positive pressure of N2 with magnetic stirring unless otherwise 
noted. 
 
(E)-3-(Dec-1-enyloxy)propan-1-ol (1.73) 
The mixture of vinyl iodide 1.74 (2.09 g, 7.88 mmol), alcohol 1.75 (3.00 g, 
15.8 mmol), 1,10-phenanthroline (284 mg, 1.58 mmol), Cs2CO3 (3.85 g, 11.8 mmol) and CuI 
(150 mg, 0.790 mmol) in 4 mL toluene was heated to 80 oC for 3 days.1 The reaction mixture 
was filtered through a short plug of silica gel. After concentration, the resulting residue was 
purified by flash chromatography (20% CH2Cl2 in pentane) to give desired (E)-tert-butyl(3-(dec-
1-en-1-yloxy)propoxy)dimethylsilane (951 mg, 37%). 
To (E)-tert-butyl(3-(dec-1-en-1-yloxy)propoxy)dimethylsilane (130 mg, 0.400 mmol) in 4 mL 
THF was added TBAF (414 mg, 1.60 mmol) in one portion at 0 oC. The reaction was stirred at 
that temperature for 2 h before H2O was added. The organic layer was separated and the aqueous 
layer was extracted with EtOAc. The combined organic layers were dried over MgSO4, filtered 
and concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography (20% EtOAc in hexane) to afford the desired 1.73 (84 mg, 99%). 1H NMR (300 
MHz, CDCl3)  6.19 (d, J = 12.6 Hz, 1H), 4.77 (dt, J = 7.4, 12.6, 14.6 Hz, 1H), 3.78-3.70 (m, 
4H), 2.46 (s, 1H), 1.89-1.81 (m, 4H), 1.25 (br, 12H), 0.86 (t, J =6.9 Hz, 3H); 13C (75 MHz, 
CDCl3)  145.9, 104.9, 70.0, 60.5, 32.1, 32.0, 30.8, 29.6, 29.5, 29.2, 27.9, 22.8, 14.2; IR (neat) 
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3350, 2954, 2924, 2853, 1671, 1653, 1465, 1159, 1057, 931 cm-1; HRMS (EI) calcd for 
C13H26O2 (M
+) 214.1933, found 214.1936. 
 
General procedure for the cyclization reaction:  
Substrate (1 eq), 2,6-dichloropyridine (2 eq) and 4 Å molecular sieves (2 mass eq) were 
dissolved in anhydrous 1,2-dichloroethane to give a ~0.1 M solution. The mixture was stirred at 
room temperature for 15 minutes, followed by addition of LiClO4 (0.1 eq). After 5 minutes, 
DDQ (2 eq) was added. The reaction was monitored by TLC at room temperature unless 
specified and, upon starting material consumption, was quenched by Et3N. The resulting mixture 
was loaded directly onto a short plug of silica gel and eluted with dichloromethane. The filtrate 
was concentrated and purified by flash chromatography to give the desired product. 
 
(E)-2-(Non-1-enyl)-1,3-dioxane (1.76) 
The general procedure for cyclization reaction was followed: 1.73 (109 mg, 0.509 mmol), 2,6-
dichloropyridine (301 mg, 2.03 mmol) and 4 Å molecular sieves (218 mg) were dissolved in 5.0 
mL anhydrous 1,2-dichloroethane, and the mixture was stirred at room temperature for 15 
minutes. After that, the mixture was cooled to ‒15 °C, and DDQ powder (230 mg, 1.01 mmol) 
was added in one portion. The reaction was stirred at that temperature for 1 minute and then 
quenched by Et3N. It was loaded onto a short plug of silica gel and washed off with 
dichloromethane. The filtrate was concentrated and purified by flash chromatography (50% 
CH2Cl2 in hexane) to give desired products (91.3 mg, 85%, 1.76:1.77 = 11.4:1). 
1H NMR (300 
MHz, CDCl3)  5.91 (dt, J = 6.6, 15.6 Hz, 1H), 5.50 (dd, J = 5.1, 15.6 Hz, 1H), 4.93 (d, J = 5.1 
Hz, 1H), 4.14 (dd, J = 4.9, 10.8 Hz, 2H), 3.85 (dd, J = 2.3, 12.3 Hz, 1H), 3.81 (dd, J = 2.2, 12.2 
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Hz, 1H), 2.20-2.02 (m, 3H), 1.41-1.26 (m, 11H), 0.87 (t, J = 6.9 Hz, 3H); 13C (75 MHz, CDCl3) 
 135.9, 127.1, 101.4, 67.1, 32.3, 32.0, 29.4, 29.3, 28.9, 25.9, 22.8, 14.3; IR (neat) 2958, 2927, 
2853, 1466, 1378, 1279, 1237, 1146, 1092, 997, 967 cm-1; HRMS (EI) calcd for C13H24O2 (M
+) 
212.1776, found 212.1766. 
 
(Z)-2-(Non-1-enyl)-1,3-dioxane (1.77)  
1H NMR (300 MHz, CDCl3)  5.64 (dt, J = 7.5, 11.0 Hz, 1H), 5.44 (dd, J = 6.4, 11.1 Hz, 1H), 
5.24 (d, J = 6.4 Hz, 1H), 4.14 (dd, J = 4.9, 10.7 Hz, 2H), 3.87 (dd, J = 2.3, 12.3 Hz, 1H), 3.82 
(dd, J = 2.3, 12.2 Hz, 1H), 2.21-2.02 (m, 3H), 1.38-1.28 (m, 11H), 0.89 (t, J = 6.9 Hz, 3H); 13C 
(75 MHz, CDCl3)  136.0, 127.0, 98.2, 67.1, 32.0, 29.6, 29.4, 29.3, 28.4, 25.9, 22.9, 14.3; IR 
(neat) 2956, 2925, 2853, 1465, 1238, 1139, 1118, 996, 929 cm-1; HRMS (EI) calcd for C13H24O2 
(M+) 212.1776, found 212.1775. 
 
Dec-1-yn-4-ol (1.80) 
The heptaldehyde (4.00 g, 35.5 mmol), zinc powder (11.5 g, 175 mmol), 1,2-
diiodoethane (9.87 g, 35.0 mmol) and 3-bromo-1-propyne (7.81 g, 52.5 mmol) were mixed in a 
250 mL RBF with 175 mL anhydrous THF. The reaction was sonicated for 2.5 h, and then 
quenched by adding 70 mL 2.0 M HCl (aq). The organic layer was separated and the aqueous 
layer was extracted with Et2O. The combined organic phase was washed with saturated aqueous 
Na2S2O3 to remove the iodine from the crude product. The organic layer was then dried over 
MgSO4, filtrated and concentrated. The resulting residue was purified by chromatography (10% 
EtOAc in hexane) to give 1.80 (2.97 g, 55%). The spectrum is consistent with the data reported 
by literature.2 1H NMR (300 MHz, CDCl3)  3.71-.3.79 (m, 1H), 3.44 (ddd, J = 3.0, 4.5, 16.8 Hz, 
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1H), 2.31 (ddd, J = 2.1, 6.3, 16.8 Hz, 1H), 2.06 (t, J = 2.1 Hz, 1H), 1.86 (d, J = 5.1 Hz, 1H), 
1.56-1.50 (m, 2H), 1.49-1.14 (m, 8H), 0.88 (t, J = 6.6 Hz, 3H). 
 
4-(Allyloxy)dec-1-yne (1.81) 
To 1.80 (517 mg, 3.36 mmol) in 10 mL DMF at 0 C was added NaH (60%, 
dispersed in mineral oil, 201 mg, 5.03 mmol) in one portion. The mixture was stirred at that 
temperature for 30 minutes before 3-bromo-1-propene (440 uL, 5.00 mmol) was added. The 
reaction was allowed to warm to room temperature and stirred for another 5 h. The reaction was 
quenched by H2O at 0 C, followed by excess amount of EtOAc. After the organic layer was 
washed with brine, the mixture was dried over MgSO4, filtrated and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography (10% EtOAc in hexane) to 
provide 1.81 (606 mg, 93%). 1H NMR (300 MHz, CDCl3)  5.99-5.86 (m, 1H), 5.28 (ddd, J = 
1.6, 3.2, 17.2 Hz, 1H), 5.16 (dd, J = 1.6, 10.3 Hz, 1H), 4.11 (ddt, J = 1.2, 5.4, 12.6 Hz, 1H), 3.99 
(ddt, J = 1.2, 5.7, 12.6 Hz, 1H), 3.50-3.42 (m, 1H), 2.47-2.31 (m, 2H), 1.99 (t, J = 2.7 Hz, 1H), 
1.46-1.59 (m, 2H), 1.43-1.29 (m, 8H), 0.88 (t, J = 6.9 Hz, 3H); 13C (75 MHz, CDCl3)  135.3, 
117.0, 81.5, 77.4, 70.6, 70.0, 34.2, 32.0, 29.5, 25.4, 24.0, 22.8, 14.3; IR (neat) 3311, 2859, 2360, 
2340, 1648, 1458, 1428, 1376, 1341, 1129, 1092, 995, 923 cm-1; HRMS (EI) calcd for C10H19O 
(M-C3H3)
+ 155.1436, found 155.1443. 
 
General procedure for the enol acetate preparation:3 
A mixture of Na2CO3 (15%), [(p-cymene)RuCl2]2 (0.04 eq), tri(2-furyl)phosphine (0.08 eq), 
acetic acid (2.0 eq), and 1-decyne (0.5 eq) in toluene was heated to 80 C and stirred for 1 h. 
Another portion of acetic acid (2.0 eq) and the alkyne substrate (1.0 eq) were dissolved in 
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toluene and added to the mixture (~0.15 M final substrate concentration). The reaction was 
stirred at 80 °C overnight. Then crude mixture was concentrated on a rotary evaporator and 
purified by chromatography to give the desired enol acetate product. 
 
4-(Allyloxy)dec-1-en-2-yl acetate (1.82) 
A 50 mL RBF was charged with Na2CO3 (48.9 mg, 0.461 mmol), dichloro(p-
cymene)ruthenium(II) dimer (75 mg, 0.12 mmol), tri(2-furyl)phosphine (57.1 mg, 0.246 mmol). 
Then 10 mL toluene was added into the flask, followed by acetic acid (352 uL, 6.20 mmol) and 
1-decyne (554 uL, 2.97 mmol). The mixture was then heated to 80 C and stirred for 1 h. 
Another 352 uL of acetic acid and 1.80 derived from previous step were dissolved in 10 mL 
toluene and added into the reaction through syringe. The reaction was stirred at the same 
temperature overnight. Then crude mixture was loaded onto a short plug of silica gel and washed 
off with Et2O. The residue was concentrated on a rotary evaporator and purified by 
chromatography (2% EtOAc in hexane) to give the desired product (503 mg, 65%). 1H NMR 
(300 MHz, CDCl3)  5.95-5.84 (m, 1H), 5.26 (ddd, J = 1.6, 5.1, 17.3 Hz, 1H), 5.15 (ddd, J = 1.2, 
2.8, 10.2 Hz, 1H), 4.80 (s, 2H), 4.04-3.97 (m, 2H), 3.50-3.44 (m, 1H), 2.50-2.35 (m, 2H), 2.13 (s, 
3H), 1.53-1.28 (m, 10H), 0.89 (t, J = 6.4 Hz, 3H); 13C (75 MHz, CDCl3)  169.3, 153.9, 135.5, 
116.8, 103.8, 76.7, 70.4, 38.6, 34.3, 32.0, 29.6, 25.5, 22.8, 21.3, 14.3; IR (neat) 2930, 2858, 
2360, 2340, 1758, 1717, 1666, 1459, 1429, 1370, 1195, 1130, 1081, 1020, 965, 921, 872 cm-1; 
HRMS(ESI) calcd for C15H26O3Na (M+Na)
+ 277.1780, found 277.1760. 
 
(E)-4-(Prop-1-enyloxy)dec-1-en-2-yl acetate (1.78) 
To a solution of [(cC8H14)2IrCl]2 (24 mg, 0.030 mmol) and PCy3 (44 mg, 0.16 
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mmol) in 1 mL anhydrous 1,2-dichloroethane was added to a solution of NaBPh4 (18 mg, 0.053 
mmol) in 1 mL DCE/acetone (25/1).4 The yellow mixture was stirred at room temperature for 5 
minutes, and then allylic ether 1.82 (338 mg, 1.33 mmol) was added. The mixture was stirred for 
30 minutes under N2, and purified by flash chromatography (florisil, 1% EtOAc in hexane) to 
give 1.78 (305 mg, 90%). 1H NMR (300 MHz, CDCl3)  6.03 (dd, J = 1.3, 12.3 Hz, 1H), 4.90-
4.81 (m, 1H), 4.80 (s, 1H), 4.77 (s, 1H), 3.76-3.68 (m, 1H), 2.48 (dd, J = 6.5, 15.1 Hz, 1H), 2.38 
(dd, J = 5.6, 15.0 Hz, 1H), 2.12 (s, 3H), 1.52 (dd, J = 1.3, 6.7 Hz, 3H), 1.38-1.26 (m, 10H), 0.88 
(t, J = 5.2 Hz, 3H); 13C (75 MHz, CDCl3)  169.0, 153.0, 145.6, 103.8, 100.7, 77.6, 38.3, 34.0, 
31.7, 29.2, 25.1, 22.5, 21.0, 14.0, 12.4; IR (neat) 2929, 2859, 1760, 1673, 1370, 1197, 1164, 
1019, 922, 875 cm-1; HRMS (EI) calcd for C15H26O3 (M)
+ 254.1882, found 254.1881. 
 
4-(But-2-enyloxy)dec-1-yne (1.83) 
The same procedure for the synthesis of 1.81 was followed employing 1.80 
(530 mg, 3.40 mmol), NaH (206 mg, 60% in mineral oil) and crotyl bromide (530 uL, 5.20 
mmol) in 10 mL DMF. The resulting residue was purified by chromatography (4% EtOAc in 
hexane) to give desired 1.81 (560 mg, 78%). 1H NMR (300 MHz, CDCl3)  5.72-5.53 (m, 2H), 
4.15-3.99 (m, 1H), 3.94-3.77 (m, 1H), 3.48-3.40 (m, 1H), 2.46-2.29 (m, 2H), 1.99-1.96 (m, 1H), 
1.72-1.69 (m, 3H), 1.68-1.55 (m, 2H), 1.43-1.23 (m, 8H), 0.91-0.86 (m, 3H); 13C (75 MHz, 
CDCl3)  129.4, 128.1, 81.6, 77.0, 70.4, 69.9, 34.2, 32.0, 29.5, 25.4, 24.1, 22.8, 17.9, 14.2; IR 
(neat) 3312, 3012, 2955, 2930, 2857, 2120, 1456, 1377, 1347, 1304, 1247, 1126, 1096, 1051, 
967, 907 cm-1; HRMS (EI) calcd for C14H24O (M)
+ 208.1827, found 208.1829. 
 
4-(But-2-enyloxy)dec-1-en-2-yl acetate (1.84) 
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General procedure for enol acetate preparation was followed employing Na2CO3 (42.7 mg, 0.403 
mmol), [(p-cymene)RuCl2]2 (33 mg, 0.054 mmol), tri(2-furyl)phosphine (25 mg, 0.11 mmol), 
acetic acid (310 µL, 5.40 mmol) and 1.83 (560 mg, 2.70 mmol) in 18 mL toluene at 80 C for 17 
h. Then crude mixture was concentrated on a rotary evaporator and purified by flash 
chromatography (1% EtOAc in hexane) to give 1.84 (476 mg, 66%). 1H NMR (300 MHz, 
CDCl3)  5.75-5.51 (m, 2H), 4.79 (s, 2H), 4.07-3.85 (m, 2H), 3.47-3.39 (m, 1H), 2.50-2.33 (m, 
2H), 2.14 (s, 3H), 1.71-1.64 (m, 3H), 1.51-1.47 (m, 2H), 1.44-1.20 (m, 8H), 0.88 (t, J = 6.5 Hz, 
3H); 13C (75 MHz, CDCl3)  169.3, 153.9, 129.3, 128.2, 103.7, 76.3, 70.2, 38.6, 34.3, 32.0, 29.5, 
25.4, 22.8, 21.3, 17.9, 14.3; IR (neat) 2930, 2857, 2360, 2340, 1758, 1666, 1456, 1370, 1195, 
1127, 1093, 1046, 1021, 966, 872 cm-1; HRMS (ESI) calcd for C16H28O3Na (M+Na)
+ 291.1936, 
found 291.1934. 
 
(E)-4-(But-1-enyloxy)dec-1-en-2-yl acetate (1.79) 
To a solution of [(cC8H14)2IrCl]2 (32 mg, 0.040 mmol) and PCy3 (59 mg, 0.21 
mmol) in 1 mL anhydrous 1,2-dichloroethane was added to a solution of NaBPh4 (24.3 mg, 
0.071 mmol) in 1 mL DCE/acetone (25/1). The yellow mixture was stirred at room temperature 
for 5 minutes, and then allylic ether 1.84 (475 mg, 1.77 mmol) was added. The mixture was 
stirred at 40 C overnight, and purified by chromatography (florisil, 2% EtOAc in hexane) to 
give the desired product (47 mg, 10%). 1H NMR (300 MHz, CDCl3)  6.06 (dt, J = 1.2, 12.3 Hz, 
1H), 4.95-4.80 (m, 3H), 3.79-3.69 (m, 1H), 2.51 (dd, J = 6.6, 15.1 Hz, 1H), 2.40 (dd, J = 5.6, 
15.1 Hz, 1H), 2.15 (s, 3H), 1.98-1.88 (m, 2H), 1.59-1.53 (m, 2H), 1.40-1.20 (m, 8H), 0.97 (t, J = 
7.4 Hz, 3H), 0.89 (t, J = 6.8 Hz, 3H); 13C (75 MHz, CDCl3)  169.3, 153.9, 144.8, 108.6, 104.2, 
77.8, 38.5, 34.3, 32.0, 29.4, 25.3, 22.8, 21.3, 21.2, 15.4, 14.3; IR (neat) 2958, 2929, 2857, 1759, 
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1664, 1370, 1195, 1090, 1019 cm-1; HRMS (ESI) calcd for C16H28O3Na (M+Na)
+ 291.1936, 
found 291.1933. 
 
2-Hexyl-6-((E)-prop-1-enyl)dihydro-2H-pyran-4(3H)-one (1.85) 
The general procedure for the cyclization reaction was followed: 1.79 (50 mg, 
0.19 mmol), 2,6-dichloropyridine (110 mg, 0.743 mmol) and 4 Å molecular sieves (100 mg) 
were dissolved in 1.9 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (4.0 mg, 0.037 
mmol) and DDQ (44.3 mg, 0.195 mmol). The reaction was stirred for 2 minutes at room 
temperature before quenched by Et3N. The mixture was loaded onto a short plug of silica gel and 
washed off with dichloromethane. The filtrate was concentrated and purified by flash 
chromatography (4% EtOAc in hexane) to give 1.85 (28.7 mg, 69%). 
1H NMR (300 MHz, 
CDCl3)  5.74 (ddq, J = 0.9, 12.8, 15.4 Hz, 1H), 5.54 (ddq, J = 1.5, 6.1, 15.3 Hz, 1H), 4.06-3.99 
(m, 1H), 3.58 (ddt, J = 2.7, 6.9, 14.3 Hz, 1H), 2.37-2.33 (m, 3H), 2.28-2.18 (m, 1H), 1.72-1.66 
(m, 3H), 1.54-1.27 (m, 10H), 0.87 (t, J = 6.6 Hz, 3H); 13C (75 MHz, CDCl3)  207.4, 130.7, 
128.4, 77.5, 77.2, 48.0, 47.9, 36.6, 31.9, 29.3, 25.4, 22.7, 17.9, 14.2; IR (neat) 2927, 2856, 2362, 
2342, 1719, 1458, 1408, 1377, 1349, 1320, 1280, 1247, 1154, 1112, 1053, 964, 936, 891, 841, 
724 cm-1; HRMS (EI) calcd for C14H24O2 (M)
+ 224.1776, found 224.1782. 
 
(E)-4-(But-2-enyloxy)dec-1-en-2-yl acetate (1.88) 
To a suspension of LAH (2.25 g, 58.9 mmol) in DME (60 ml) at 0 C was 
added 1.89 (3.45 g, 49.3 mmol) dropwise. The ice bath was then removed and the reaction 
mixture was stirred at room temperature for 38 h. Then the reaction was quenched by addition of 
H2O (6 mL), and washed with 6 mL 14% NaOH (aq) and 6 mL H2O. The gray precipitate was 
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filtered through Celite. The residue was washed with dry ether and the combined filtrates were 
dried over MgSO4. Evaporation of the solvent at atmospheric pressure left the crude alcohol, 
distillation of which at reduced pressure afforded (E)-2-butenol as a colourless liquid (2.15 g, 
61%), b.p. 45-48 °C, 30-40 Torr.5  
The (E)-2-butenol (1.00 g, 13.9 mmol) in dry Et2O (6 mL) at 0 °C under nitrogen was treated 
dropwise with freshly distilled phosphorus tribromide (0.67 mL, 7.1 mmol). The mixture was 
stirred for 3 h at 0 °C before it was poured onto ice (15 g). The organic phase was washed 
successively with water, saturated aqueous K2CO3, and brine, and then dried over MgSO4. Ether 
was removed by distillation at atmospheric pressure to afford the crude (E)-1-Bromo-2-butene 
(1.90) as a pale orange liquid (1.15 g, 60%), which was used as such. 
To dec-1-yn-4-ol (1.80) (848 mg, 5.5 mmol) in 15 mL DMF at 0 C was added NaH (60%, 
dispersed in mineral oil, 352 mg) in one portion. The mixture was stirred at that temperature for 
30 minutes before 1.90 (1.15 g, 8.50 mmol) was added in. The reaction was warmed to room 
temperature and stirred overnight. The reaction was then quenched by H2O at 0 C, followed by 
excess amount of EtOAc. After the organic layer was washed with brine, it was dried over 
MgSO4, filtrated and concentrated under reduced pressure. The resulting residue was purified by 
flash chromatography (10% EtOAc in hexane) to give the (E)-4-(but-2-enyloxy)dec-1-yne (896 
mg, 78%). 1H NMR (300 MHz, CDCl3)  5.77-5.65 (m, 1H), 5.62-5.53 (m, 1H), 4.03 (dd, J = 
6.1, 11.6 Hz, 1H), 3.90 (dd, J = 6.2, 11.6 Hz, 1H), 3.49-3.40 (m, 1H), 2.46-2.29 (m, 2H), 1.98 (t, 
J = 2.5 Hz, 1H), 1.70 (dd, J = 0.9, 6.0 Hz, 3H), 1.62-1.57 (m, 2H), 1.42-1.28 (m, 8H), 0.88 (t, J = 
6.3 Hz, 3H); 13C (75 MHz, CDCl3)  129.2, 127.9, 81.4, 77.4, 70.1, 69.7, 34.0, 31.8, 29.3, 25.2, 
23.8, 22.6, 17.7, 14.0; IR (neat) 3312, 3012, 2955, 2930, 2857, 2120, 1456, 1377, 1347, 1304, 
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1247, 1126, 1096, 1051, 967, 907 cm-1; HRMS (EI) calcd for C14H24O (M
+) 208.1827, found 
208.1829. 
General procedure for enol acetate preparation was followed employing Na2CO3 (68.2 mg, 0.643 
mmol), [(p-cymene)RuCl2]2 (52.5 mg, 0.0860 mmol), tri(2-furyl)phosphine (39.8 mg, 0.171 
mmol), acetic acid (490 µL, 8.56 mmol) and (E)-4-(but-2-enyloxy)dec-1-yne (893 mg, 4.29 
mmol) in 26 mL toluene at 80 C for 12 h. Then crude mixture was concentrated on a rotary 
evaporator and purified by flash chromatography (1% EtOAc in hexane) to give 1.88 (738 mg, 
65%). 1H NMR (300 MHz, CDCl3)  5.76-5.47 (m, 2H), 4.80 (s, 2H), 3.98-3.86 (m, 2H), 3.48-
3.40 (m, 1H), 2.50-2.34 (m, 2H), 2.14 (s, 3H), 1.71 (dd, J = 1.0, 6.1 Hz, 3H), 1.52-1.48 (m, 2H), 
1.44-1.29 (m, 8H), 0.89 (t, J = 6.4 Hz, 3H); 13C (75 MHz, CDCl3)  169.3, 153.9, 129.3, 128.2, 
103.7, 76.3, 70.2, 38.6, 34.3, 32.0, 29.6, 25.5, 22.8, 21.3, 17.9, 14.3; IR (neat) 2930, 2857, 2360, 
2340, 1758, 1666, 1456, 1370, 1195, 1127, 1093, 1046, 1021, 966, 872 cm-1; HRMS (EI) calcd 
for C16H28O3Na (M+Na)
+ 291.1936, found 291.1934. 
 
2-Hexyl-6-((E)-prop-1-enyl)dihydro-2H-pyran-4(3H)-one (1.85) 
The general procedure for the cyclization reaction was followed: 1.88 (130 
mg, 0.484 mmol), 2,6-dichloropyridine (288 mg, 1.95 mmol) and 4 Å molecular sieves (240 mg) 
were dissolved in 5 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (5.2 mg, 0.049 
mmol) and DDQ (221 mg, 0.974 mmol). The reaction was stirred for 17 h at room temperature 
then quenched by Et3N. The mixture was loaded onto a short plug of silica gel and washed off 
with dichloromethane. The filtrate was concentrated and purified by flash chromatography (40% 
hexane in DCM then 6% EtOAc in hexane) to furnish the desired product (88.4 mg, 82%). 
1H 
NMR (300 MHz, CDCl3)  5.74 (ddq, J = 0.9, 12.8, 15.4 Hz, 1H), 5.54 (ddq, J = 1.5, 6.1, 15.3 
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Hz, 1H), 4.06-3.99 (m, 1H), 3.58 (ddt, J = 2.7, 6.9, 14.3 Hz, 1H), 2.37-2.33 (m, 3H), 2.28-2.18 
(m, 1H), 1.72-1.66 (m, 3H), 1.54-1.27 (m, 10H), 0.87 (t, J = 6.6 Hz, 3H); 13C (75 MHz, CDCl3)  
207.4, 130.7, 128.4, 77.5, 77.2, 48.0, 47.9, 36.6, 31.9, 29.3, 25.4, 22.7, 17.9, 14.2; IR (neat) 
2927, 2856, 2362, 2342, 1719, 1458, 1408, 1377, 1349, 1320, 1280, 1247, 1154, 1112, 1053, 
964, 936, 891, 841, 724 cm-1; HRMS (EI) calcd for C14H24O2 (M
+) 224.1776, found 224.1782. 
 
2-Hexyl-6-vinyldihydro-2H-pyran-4(3H)-one (1.96) 
The general procedure for the cyclization reaction was followed: 1.82 (59 mg, 
0.23 mmol), 2,6-dichloropyridine (137 mg, 0.926 mmol) and 4 Å molecular sieves (120 mg) 
were dissolved in 2.4 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (2.5 mg, 0.024 
mmol) and DDQ (34.3 mg, 0.151 mmol). The reaction was stirred for 48 h at 45 C then 
quenched by Et3N. The mixture was loaded onto a short plug of silica gel and washed off with 
dichloromethane. The filtrate was concentrated and purified by flash chromatography (40% 
hexane in CH2Cl2 then 6% EtOAc in hexane) to give the desired product (39.1 mg, 80%). 
1H 
NMR (300 MHz, CDCl3)  5.92 (ddd, J = 5.4, 10.5, 17.2 Hz, 1H), 5.32 (dt, J = 1.3, 17.3 Hz, 
1H), 5.21 (dt, J = 1.3, 10.5 Hz, 1H), 4.13-4.07 (m, 1H), 3.67-3.59 (m, 1H), 2.43-2.22 (m, 4H), 
1.58-1.26 (m, 10H), 0.89 (t, J = 6.9 Hz, 3H); 13C (75 MHz, CDCl3)  207.3, 137.5, 116.2, 77.5, 
77.3, 48.0, 47.7, 36.6, 31.9, 29.4, 25.4, 22.8, 14.3; IR (neat) 2956, 2928, 2857, 1722, 1464, 1410, 
1327, 1255, 1221, 1157, 1060, 988, 926 cm-1; HRMS (EI) calcd for C13H22O2 (M
+) 211.1698, 
found 211.1704.  
 
4-(2-Methylallyloxy)dec-1-en-2-yl acetate (1.92) 
To dec-1-yn-4-ol (1.80) (463 mg, 300 mmol) in 8 mL DMF at 0 C was added 
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NaH (60%, dispersed in mineral oil, 216 mg) in one portion. The mixture was stirred at that 
temperature for 30 minutes before 3-chloro-2-methyl-1-propene (529 µL , 5.40 mmol) was added 
in. The reaction was warmed to room temperature and stirred overnight. The reaction was then 
quenched by H2O at 0 C, followed by excess amount of EtOAc. After the organic layer was 
washed with brine, it was dried over MgSO4, filtrated and concentrated under reduced pressure. 
The resulting residue was purified by flash chromatography (1% EtOAc in hexane) to give the 4-
((2-methylallyl)oxy)dec-1-yne (382 mg, 61%). 1H NMR (300 MHz, CDCl3)  4.99 (s, 1H), 4.89 
(s, 1H), 4.00 (d, J = 12.3 Hz, 1H), 3.89 (d, J = 12.2 Hz, 1H), 3.49-3.42 (m, 1H), 2.49-2.33 (m, 
2H), 1.99 (t, J = 2.7 Hz, 1H), 1.77 (s, 3H), 1.64-1.60 (m, 2H), 1.44-1.30 (m, 8H), 0.89 (t, J = 6.8 
Hz, 3H); 13C (75 MHz, CDCl3)  142.8, 112.5, 81.6, 77.3, 73.6, 70.0, 34.1, 32.0, 29.5, 25.5, 23.9, 
22.8, 19.8, 14.3; IR (neat) 2929, 2858, 1458, 1375, 1344, 1099, 900 cm-1; HRMS (EI) calcd for 
C11H21O (M-C3H3)
+ 169.1952, found 169.1954. 
General procedure for enol acetate preparation was followed employing Na2CO3 (29.2 mg, 0.275 
mmol), [(p-cymene)RuCl2]2 (45 mg, 0.073 mmol), tri(2-furyl)phosphine (34 mg, 0.15 mmol), 
acetic acid (420 µL, 7.34 mmol), 1-decyne (331 µL, 1.80 mmol) and 4-((2-methylallyl)oxy)dec-
1-yne (382 mg, 1.83 mmol) in 12 mL toluene at 80 C for 18 h. Then crude mixture was 
concentrated on a rotary evaporator and purified by flash chromatography (1% EtOAc in hexane) 
to give 1.92 (286 mg, 58%). 1H NMR (300 MHz, CDCl3)  4.96 (s, 1H), 4.86 (s, 1H), 4.79 (s, 
2H), 3.91 (d, J = 12.2 Hz, 1H), 3.85 (d, J = 12.2 Hz, 1H), 3.48-3.40 (m, 1H), 2.48 (dd, J = 6.3, 
14.9 Hz, 1H), 2.38 (dd, J = 5.8, 14.8 Hz, 1H), 2.13 (s, 3H), 1.74 (s, 3H), 1.54-1.49 (m, 2H), 1.40-
1.28 (m, 8H), 0.88 (t, J = 6.6 Hz, 3H); 13C (75 MHz, CDCl3)  169.3, 153.9, 142.9, 112.2, 103.7, 
76.6, 73.3, 38.4, 34.1, 32.0, 29.6, 25.4, 22.8, 21.3, 19.9, 14.3; IR (neat) 2929, 2858, 1759, 1665, 
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1457, 1370, 1195, 1092, 1020, 899, 873 cm-1; HRMS (ESI) calcd for C16H28O3Na (M+Na)
+ 
291.1936, found 291.1934. 
 
2-Hexyl-6-(prop-1-en-2-yl)dihydro-2H-pyran-4(3H)-one (1.97) 
The general procedure for the cyclization reaction was followed: 1.92 (37 mg, 
0.14 mmol), 2,6-dichloropyridine (82 mg, 0.55 mmol) and 4 Å molecular sieves (70 mg) were 
dissolved in 1.4 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (1.5 mg, 0.014 mmol) 
and DDQ (126 mg, 0.555 mmol). The reaction was stirred for 17 h at room temperature then 
quenched by Et3N. The mixture was loaded onto a short plug of silica gel and washed off with 
dichloromethane. The filtrate was concentrated and purified by flash chromatography (40% 
hexane in CH2Cl2 then 6% EtOAc in hexane) to give the desired product (24.1 mg, 77%). 
1H 
NMR (300 MHz, CDCl3)  5.03 (d, J = 0.6 Hz, 1H), 4.92 (d, J = 0.6 Hz, 1H), 3.99 (dd, J = 3.9, 
10.5 Hz, 1H), 3.67-3.58 (m, 1H), 2.50-2.36 (m, 3H), 2.31-2.22 (m, 1H), 1.80 (s, 3H), 1.61-1.38 
(m, 4H), 1.36-1.26 (m, 6H), 0.89 (t, J = 6.9 Hz, 3H); 13C (75 MHz, CDCl3)  207.9, 144.3, 111.7, 
79.7, 77.3, 48.1, 46.7, 36.6, 31.9, 29.4, 25.4, 22.8, 18.8, 14.3; IR (neat) 2929, 2857, 2360, 2340, 
1722, 1652, 1456, 1316, 1250, 1152, 1060, 902 cm-1; HRMS (EI) calcd for C14H24O2 (M
+) 
224.1776, found 224.1779. 
 
4-(3-Methylbut-2-enyloxy)dec-1-en-2-yl acetate (1.93) 
To dec-1-yn-4-ol (1.80) (617 mg, 4.00 mmol) in 11 mL DMF at 0 C was 
added NaH (60%, dispersed in mineral oil, 320 mg) in one portion. The mixture was stirred at 
that temperature for 30 minutes before 1-bromo-3-methyl-2-butene (924 µL , 7.87 mmol) was 
added in. The reaction was warmed to room temperature and stirred overnight. The reaction was 
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then quenched by H2O at 0 C, followed by excess amount of EtOAc. After the organic layer 
was washed with brine, it was dried over MgSO4, filtrated and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography (1% EtOAc in hexane) to 
give the 4-((3-methylbut-2-en-1-yl)oxy)dec-1-yne (not very pure).  
General procedure for enol acetate preparation was followed employing Na2CO3 (57.2 mg, 0.539 
mmol), [(p-cymene)RuCl2]2 (88 mg, 0.14 mmol), tri(2-furyl)phosphine (66.8 mg, 0.288 mmol), 
acetic acid (824 µL, 14.4 mmol), 1-decyne (649 µL, 3.57 mmol) and 4-((3-methylbut-2-en-1-
yl)oxy)dec-1-yne (from last step) in 24 mL toluene at 80 C for 18 h. Then crude mixture was 
concentrated on a rotary evaporator and purified by flash chromatography (1% EtOAc in hexane) 
to give 1.93 (433 mg, 38% over two steps). 1H NMR (300 MHz, CDCl3)  5.36-5.30 (m, 1H), 
4.80 (s, 2H), 4.03-3.91 (m, 2H), 3.46-3.38 (m, 1H), 2.46 (dd, J = 6.6, 15 Hz, 1H), 2.37 (dd, J = 
5.7, 15 Hz, 1H), 1.74 (s, 3H), 1.67 (s, 3H), 1.52-1.28 (m, 10H), 0.88 (t, J = 6.9 Hz, 3H); 13C (75 
MHz, CDCl3)  169.3, 154.0, 136.8, 121.7, 103.6, 76.3, 65.8, 38.7, 34.4, 32.0, 29.6, 26.0, 25.5, 
22.8, 21.3, 18.2, 14.3; IR (neat) 2928, 2857, 2360, 2340, 1758, 1666, 1455, 1370, 1196, 1063, 
1021, 871 cm-1; HRMS (ESI) calcd for C17H30O3Na (M+Na)
+ 305.2093, found 305.2089. 
 
2-Hexyl-6-(2-methylprop-1-enyl)dihydro-2H-pyran-4(3H)-one (1.98) 
The general procedure for the cyclization reaction was followed: 1.93 (66.4 
mg, 0.235 mmol), 2,6-dichloropyridine (139 mg, 0.939 mmol) and 4 Å molecular sieves (120 
mg) were dissolved in 2.5 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (2.5 mg, 0.024 
mmol) and DDQ (107 mg, 0.471 mmol). The reaction was stirred for 1.5 h at 0 C then quenched 
by Et3N. The mixture was loaded onto a short plug of silica gel and washed off with 
dichloromethane. The filtrate was concentrated and purified by flash chromatography (40% 
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hexane in CH2Cl2 then 6% EtOAc in hexane) to give the desired product (46 mg, 82%). 
1H NMR 
(300 MHz, CDCl3)  5.25 (dt, J = 1.5, 8.1 Hz, 1H), 4.36-4.23 (m, 1H), 3.62 (ddt, J = 2.7, 6.9, 
14.4 Hz, 1H), 2.43-2.33 (m, 3H), 2.29-2.20 (m, 1H), 1.76 (d, J = 0.9 Hz, 3H), 1.69 (d, J = 0.9 
Hz, 3H), 1.58-1.23 (m, 10H), 0.88 (t, J = 6.9 Hz, 3H); 13C (75 MHz, C6D6)  205.4, 135.6, 126.3, 
77.2, 74.7, 48.5, 48.3, 37.1, 32.4, 29.8, 25.9, 25.8, 23.2, 18.5, 14.6; IR (neat) 2957, 2928, 2858, 
1721, 1453, 1409, 1377, 1352, 1316, 1258, 1196, 1131, 1053 cm-1; HRMS (EI) calcd for 
C15H26O2 (M
+) 238.1933, found 238.1938. 
 
(E)-4-(3-methylhept-2-enyloxy)dec-1-en-2-yl acetate (1.94) 
To a white slurry solution of zirconocene dichloride (5.85 g, 20.0 mmol) in 
50 mL of DCE was added AlMe3 (20 mL, 2 M in hexanes, 40 mmol) at 0 °C. After stirring at 
that temperature for 45 minutes, it was warmed to room temperature for 2 h. To this lemon-
yellow solution was added 1-hexyne (2.3 mL, 20 mmol) dissolved in 10 mL of DCE at room 
temperature. The reaction was allowed to stir at room temperature for 4.5 h. The volatile 
components were evaporated under reduced pressure for 1 h (maximum 50 °C, 0.3 mm Hg). The 
remaining orange-yellow organic residue was extracted with dry hexane (4 x 30 mL), and the 
yellow extract was transferred to a 500 mL round-bottom flask via a cannula. To this was added 
nBuLi (8 mL, 2.5 M in hexane, 20 mmol) at 0 °C. This orange-yellow slurry solution was stirred 
from 0 °C to room temperature for 1.5 h, and then THF (40 mL) was added to dissolve the 
precipitate. The resulting solution (homogeneous, brown-yellow color) was cannulated to a 
suspension of paraformaldehyde (3 g, 100 mmol) in THF (60 mL) under an argon atmosphere. 
This orange-yellow suspension was allowed to stir at room temperature for 21 h before it was 
cooled to 0 °C (ice-water bath). Ice was added to dilute the reaction, and then saturated NH4Cl 
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(aq) was added. The ice bath was removed, and the reaction was further acidified with 3 M HCl 
(aq) until the reaction turned to a clear yellow (homogeneous) solution. At this time, the reaction 
pH was measured 2-3. The organic layer was separated, and the aqueous layer was extracted 
with ether. The organic extracts were combined, washed with a saturated NaHCO3 (aq), and then 
dried with MgSO4, filtered, and concentrated under reduced pressure to provide crude allylic 
alcohol. The crude product was purified by flash chromatography (10% EtOAc in hexane) to 
afford (E)-3-methylhept-2-en-1-ol (1.8 g, 70% yield) as colorless oil. 1H NMR (300 MHz, 
CDCl3)  5.41-5.37 (m, 1H), 4.16 (t, J = 5.1 Hz, 2H), 2.02 (t, J = 7.8 Hz, 2H), 1.67 (s, 3H), 1.46-
1.19 (m, 4H), 0.91 (t, J = 7.2 Hz, 3H).6 
(E)-3-Methylhept-2-en-1-ol (1.05 g, 8.2 mmol) was dissolved in Et2O, and PBr3 (386 uL, 4.10 
mmol) was added dropwise at 0 °C. The reaction was stirred at that temperature for 4 h, and 
poured into ice (10 g). The mixture was extracted three times with Et2O, and combined organic 
layers were washed with saturated aqueous NaHCO3. The organic layer was dried over MgSO4, 
filtered and concentrated under reduced pressure to afford the crude (E)-1-bromo-3-methylhept-
2-ene, which was used as such. 1H NMR (300 MHz, CDCl3)  5.54 (dt, J = 1.2, 8.4 Hz, 1H), 
4.04 (d, J = 8.4 Hz, 2H), 2.06 (t, J = 7.2 Hz, 2H), 1.73 (d, J = 0.6 Hz, 3H), 1.48-1.19 (m, 4H), 
0.91 (t, J = 7.2 Hz, 3H).7 
To 1.80 (771 mg, 5.00 mmol) in 10 mL DMF at 0 C was added NaH (60%, dispersed in mineral 
oil, 400 mg) in one portion. The mixture was stirred at the same temperature for 30 minutes, and 
then the crude (E)-1-bromo-3-methylhept-2-ene from last step was added in. The reaction was 
allowed to warm to room temperature and stirred overnight. The reaction was then quenched by 
H2O at 0 C, followed by excess amount of EtOAc. After the organic layer was washed with 
brine, it was dried over MgSO4, filtrated and concentrated. The resulting residue was purified by 
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flash chromatography (1% EtOAc in hexane) to give (E)-4-((3-methylhept-2-en-1-yl)oxy)dec-1-
yne (not very pure). 
General procedure for enol acetate preparation was followed employing Na2CO3 (50.3 mg, 0.475 
mmol), [(p-cymene)RuCl2]2 (58.2 mg, 0.0950 mmol), tri(2-furyl)phosphine (44.1 mg, 0.190 
mmol), acetic acid (363 µL, 6.34 mmol) and (E)-4-((3-methylhept-2-en-1-yl)oxy)dec-1-yne 
(from last step) in 24 mL toluene at 80 C for 18 h. Then crude mixture was concentrated on a 
rotary evaporator and purified by flash chromatography (1% EtOAc in hexane) to give 1.94 (957 
mg, 59% over two steps). 1H NMR (300 MHz, CDCl3)  5.35-5.30 (m, 1H), 4.80 (s, 2H), 4.06-
3.94 (m, 2H), 3.46-3.39 (m, 1H), 2.47 (dd, J = 6.4, 14.9 Hz, 1H), 2.37 (dd, J = 5.7, 14.9 Hz, 1H), 
2.14 (s, 3H), 2.04-1.99 (m, 2H), 1.65 (s, 3H), 1.52-1.24 (m, 14H), 0.92-0.87 (m, 6H); 13C (75 
MHz, CDCl3)  169.3, 154.0, 140.3, 121.2, 103.7, 76.3, 65.9, 39.5, 38.7, 34.4, 32.1, 30.1, 29.6, 
25.6, 22.8, 22.6, 21.3, 16.6, 14.3, 14.2; IR (neat) 2955, 2927, 1758, 1664, 1455, 1368, 1194, 
1087, 1056, 1019 cm-1; HRMS(ESI) calcd for C20H36O3Na (M+Na)
+ 347.2562, found 347.2566. 
 
2-Hexyl-6-((E)-2-methylhex-1-enyl)dihydro-2H-pyran-4(3H)-one (1.99) 
The general procedure for the cyclization reaction was followed: 1.94 (45 
mg, 0.14 mmol), 2,6-dichloropyridine (82 mg, 0.56 mmol) and 4 Å molecular sieves (90 mg) 
were dissolved in 1.5 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (1.5 mg, 0.014 
mmol) and DDQ (63 mg, 0.28 mmol). The reaction was stirred for 1 h at 0 C before quenched 
by Et3N. The mixture was loaded onto a short plug of silica gel and washed off with 
dichloromethane. The filtrate was concentrated and purified by flash chromatography (40% 
hexane in CH2Cl2 then 6% EtOAc in hexane) to give the desired product (32.1 mg, 82%). 
1H 
NMR (300 MHz, CDCl3)  5.25 (ddd, J = 1.2, 2.4, 7.6 Hz, 1H), 4.35-4.27 (m, 1H), 3.62 (ddt, J = 
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2.6, 7.0, 14.4 Hz, 1H), 2.41-2.33 (m, 3H), 2.29-2.20 (m, 1H), 1.67 (d, J = 1.2 Hz, 3H), 2.03 (t, J 
= 7.1 Hz, 2H), 1.55-1.28 (m, 14H), 0.93-0.86 (m, 6H); 13C (75 MHz, CDCl3)  207.9, 141.2, 
124.2, 74.5, 48.3, 48.1, 39.3, 36.7, 32.0, 30.0, 29.4, 25.5, 22.8, 22.6, 17.1, 14.3, 14.2; IR (neat) 
2955, 2927, 2858, 1720, 1455, 1353, 1315, 1255, 1050 cm-1; HRMS (EI) calcd for C18H32O2 
(M+) 280.2402, found 280.2403. 
 
(E)-4-(2-Methyltridec-2-enyloxy)dec-1-en-2-yl acetate (1.95) 
To 1.80 (394 mg, 2.55 mmol) in 8 mL DMF at 0 C was added NaH (60%, 
dispersed in mineral oil, 400 mg) in one portion. The mixture was stirred at the same temperature 
for 30 minutes, and then (E)-1-bromo-2-methyltridec-2-ene7 (914 mg, 3.32 mmol) was added in. 
The reaction was allowed to warm to room temperature and stirred overnight. The reaction was 
then quenched by H2O at 0 C, followed by excess amount of EtOAc. After the organic layer 
was washed with brine, it was dried over MgSO4, filtrated and concentrated. The resulting 
residue was purified by flash chromatography (20% CH2Cl2 in hexane) to give (E)-1-(dec-1-yn-
4-yloxy)-2-methyltridec-2-ene (390 mg, 44%). 1H NMR (300 MHz, CDCl3)  5.44-5.39 (m, 1H), 
3.96 (d, J = 11.2 Hz, 1H), 3.85 (d, J = 11.2 Hz, 1H), 3.46-3.38 (m, 1H), 2.47-2.31 (m, 2H), 2.06-
2.02 (m, 2H), 1.99 (t, J = 2.6 Hz, 1H), 1.67 (s, 3H), 1.62-1.59 (m, 2H), 1.29-1.27 (m, 24H), 0.91-
0.87 (m, 6H); 13C (75 MHz, CDCl3)  132.4, 129.2, 81.7, 76.5, 75.9, 69.9, 34.1, 32.1, 32.0, 31.8, 
29.9, 29.8, 29.7, 29.58, 29.56, 29.5, 27.9, 25.5, 23.9, 22.9, 22.8, 14.3 14.28; IR (neat) 3314, 
2925, 2855, 1462, 1343, 1062 cm-1; HRMS (EI) calcd for C24H44O (M
+) 348.3392, found 
348.3386. 
General procedure for enol acetate preparation was followed employing Na2CO3 (17.8 mg, 0.168 
mmol), [(p-cymene)RuCl2]2 (20.5 mg, 0.0335 mmol), tri(2-furyl)phosphine (15.6 mg, 0.0672 
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mmol), acetic acid (128 µL, 2.24 mmol) and (E)-1-(dec-1-yn-4-yloxy)-2-methyltridec-2-ene 
(390 mg, 1.12 mmol) in 12 mL toluene at 80 C for 15 h. Then crude mixture was concentrated 
on a rotary evaporator and purified by flash chromatography (2% Et2O in hexane) to give 1.95 
(234 mg, 51%). 1H NMR (300 MHz, CDCl3)  5.42-5.37 (m, 1H), 4.79 (s, 2H), 3.88 (d, J = 11.0 
Hz, 1H), 3.81 (d, J = 11.0 Hz, 1H), 3.45-3.38 (m, 1H), 2.47 (dd, J = 6.2, 14.9 Hz, 1H), 2.37 (dd, 
J = 5.8, 14.9 Hz, 1H), 2.13 (s, 3H), 2.05-1.98 (m, 2H), 1.65 (s, 3H), 1.52-1.27 (m, 26H), 0.98-
0.86 (m, 6H); 13C (75 MHz, CDCl3)  169.2, 154.0, 132.5, 128.9, 103.7, 75.9, 75.7, 38.5, 34.2, 
32.1, 32.0, 29.9, 29.8, 29.7, 29.6, 29.57, 29.55, 27.9, 25.5, 22.9, 22.8, 21.3, 14.3, 14.27; IR (neat) 
2925, 2855, 1760, 1666, 1461, 1369, 1195, 1062, 1021, 869 cm-1; HRMS (EI) calcd for 
C26H48O3 (M
+) 408.3603, found 408.3604. 
 
2-Hexyl-6-((E)-tridec-2-en-2-yl)dihydro-2H-pyran-4(3H)-one (1.100) 
The general procedure for the cyclization reaction was followed: 1.95 
(53.7 mg, 0.131 mmol), 2,6-dichloropyridine (77.8 mg, 0.526 mmol) and 4 Å molecular sieves 
(110 mg) were dissolved in 1.4 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (1.4 mg, 
0.013 mmol) and DDQ (59.7 mg, 0.263 mmol). The reaction was stirred for 1 h at 0 C and then 
quenched by Et3N. The mixture was loaded onto a short plug of silica gel and washed off with 
dichloromethane. The filtrate was concentrated and purified by flash chromatography (40% 
hexane in CH2Cl2 then 6% EtOAc in hexane) to give the desired product (40.7 mg, 85%). 
1H 
NMR (300 MHz, CDCl3)  5.45 (t, J = 7.0 Hz, 1H), 3.93 (dd, J = 2.4, 11.0 Hz, 1H), 3.60 (ddt, J 
= 2.6, 6.8, 14.1 Hz, 1H), 2.50-2.32 (m, 3H), 2.28-2.20 (m, 1H), 2.07-2.00 (m, 2H), 1.68 (s, 3H), 
1.64-1.27 (m, 26H), 0.89 (m, 6H); 13C (75 MHz, C6D6)  205.4, 134.7, 126.9, 82.0, 77.0, 48.0, 
47.0, 36.8, 32.4, 32.2, 30.1, 30.0, 29.9, 29.8, 29.79, 29.6, 27.9, 25.6, 23.2, 23.0, 14.4, 14.3, 12.3; 
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IR (neat) 2925, 2854, 1721, 1459, 1337, 1250, 1150, 1052 cm-1; HRMS (EI) calcd for C24H44O2 
(M+) 364.3341, found 364.3335. 
 
1-(tert-Butyldimethylsilyloxy)hex-5-yn-3-ol (1.106) 
The 3-(tert-butyldimethylsilyloxy)propanal (7.89 g, 41.9 mmol), zinc powder 
(13.7 g, 209 mmol), 1,2-diiodoethane (11.8 g, 41.9 mmol) and 3-bromo-1-propyne (9.35 g, 62.9 
mmol, 80% wt in toluene) were mixed in a 250 mL RBF with 130 mL anhydrous THF. The 
reaction was sonicated for 1 h, and then filtered through a short pad of celite with EtOAc, and 
concentrated. Then Et2O was added, and the mixture was filtered. The organic mixture was 
concentrated and purified by chromatography (5% to 10% EtOAc in hexane) to give 1.106 (4.7 
g, 49%). 1H NMR (300 MHz, CDCl3)  4.55-3.80 (m, 3H), 3.61 (d, J = 3.0 Hz, 1H), 2.50-2.31 
(m, 2H), 2.03 (t, J = 2.7 Hz, 1H), 1.88-1.70 (m, 2H), 0.90 (s, 9H), 0.09 (s, 6H).8 
 
tert-Butyldimethyl(3-(2-methylallyloxy)hex-5-ynyloxy)silane (1.107) 
To 1-(tert-Butyldimethylsilyloxy)hex-5-yn-3-ol (1.106) (411 mg, 1.80 mmol) 
in 6 mL DMF at 0 C was added NaH (60%, dispersed in mineral oil, 108 mg) in one portion. 
The mixture was stirred at that temperature for 30 minutes before 3-chloro-2-methyl-1-propene 
(317 µL , 3.20 mmol) was added in. The reaction was warmed to room temperature and stirred 
overnight. The reaction was then quenched by H2O at 0 C, followed by excess amount of 
EtOAc. After the organic layer was washed with brine, it was dried over MgSO4, filtrated and 
concentrated under reduced pressure. The resulting residue was purified by flash 
chromatography (4% Et2O in hexane) to give 1.107 (360 mg, 71%). 
1H NMR (300 MHz, CDCl3) 
 4.98 (s, 1H), 4.88 (s, 1H), 4.02 (d, J = 12.2 Hz, 1H), 3.89 (d, J = 12.3 Hz, 1H), 3.79-3.67 (m, 
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3H), 2.52-2.34 (m, 2H), 2.00 (t, J = 2.7 Hz, 1H), 1.88-1.79 (m, 2H), 1.77 (s, 3H), 0.90 (s, 9H), 
0.06 (s, 6H); 13C (75 MHz, CDCl3)  142.7, 112.5, 81.4, 74.2, 73.7, 70.2, 59.6, 37.4, 26.1, 24.1, 
19.8, 18.5, -5.12, -5.16; IR (neat) 3312, 2953, 2926, 2855, 1462, 1254, 1097, 835, 775 cm-1; 
HRMS (EI) calcd for C13H27O2Si (M-C3H3)
+ 243.1780, found 243.1784. 
 
6-(tert-Butyldimethylsilyloxy)-4-(2-methylallyloxy)hex-1-en-2-yl acetate 
(1.101)  
General procedure for enol acetate preparation was followed employing Na2CO3 (20.2 mg, 0.191 
mmol), [(p-cymene)RuCl2]2 (31 mg, 0.051 mmol), tri(2-furyl)phosphine (23.6 mg, 0.102 mmol), 
acetic acid (290 µL, 5.07 mmol), 1-decyne (160 µL, 0.886 mmol) and 1.107 (360 mg, 1.27 
mmol) in 12 mL toluene at 80 C for 11 h. Then crude mixture was concentrated on a rotary 
evaporator and purified by flash chromatography (2% EtOAc in hexane) to give 1.101 (274 mg, 
63%). 1H NMR (300 MHz, CDCl3)  4.95 (s, 1H), 4.86 (s, 1H), 4.81 (s, 2H), 3.95 (d, J = 12.0 
Hz, 1H), 3.85 (d, J = 12.0 Hz, 1H) 3.75-3.64 (m, 3H), 2.55-2.38 (m, 2H), 2.12 (s, 3H), 1.77-1.71 
(m, 5H), 0.89 (s, 9H), 0.05 (s, 6H); 13C (75 MHz, CDCl3)  169.3, 153.7, 142.8, 112.2, 103.9, 
73.6, 73.4, 59.6, 38.5, 37.6, 26.1, 26.0, 21.3, 19.9, 18.4, -5.1, -5.2; IR (neat) 2929, 2858, 1759, 
1650, 1254, 1200, 1095, 1019, 836, 775 cm-1; HRMS (ESI) calcd for C18H34O4SiNa (M+Na)
+ 
365.2124, found 365.2123. 
 
2-(2-(tert-Butyldimethylsilyloxy)ethyl)-6-(prop-1-en-2-yl)dihydro-2H-
pyran-4(3H)-one (1.115)  
The general procedure for the cyclization reaction was followed: 1.101 (59 mg, 0.17 mmol), 2,6-
dichloropyridine (103 mg, 0.696 mmol) and 4 Å molecular sieves (78 mg) were dissolved in 1.7 
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mL anhydrous DCE followed by LiClO4 (1.8 mg, 0.017 mmol) and DDQ (157 mg, 0.692 mmol). 
The reaction was stirred for 24 h at room temperature and then quenched by Et3N. The mixture 
was loaded onto a short plug of silica gel and washed off with dichloromethane. The filtrate was 
concentrated and purified by flash chromatography (10% EtOAc in hexane) to give the desired 
product (38.9 mg, 75%). 1H NMR (300 MHz, CDCl3)  5.01 (s, 1H), 4.92-4.91 (m, 1H), 3.99 
(dd, J = 3.3, 10.6 Hz, 1H), 3.87-3.72 (m, 3H), 2.50-2.27 (m, 4H), 1.93-1.82 (m, 1H), 1.79 (s, 
3H), 1.78-1.71 (m, 1H), 0.89 (s, 9H), 0.05 (s, 6H); 13C (75 MHz, CDCl3)  207.7, 144.2, 111.7, 
79.7, 73.8, 59.2, 48.1, 46.7, 39.5, 26.1, 18.7, 18.5, -5.1, -5.2; IR (neat) 2954, 2929, 2858, 1724, 
1469, 1388, 1362, 1325, 1254, 1145, 1096, 1027, 941, 903, 838, 777 cm-1; HRMS(EI) calcd for 
C16H30O3Si (M
+) 298.1964, found 298.1969. 
 
3-(2-Methylallyloxy)hex-5-ene-1,5-diyl diacetate (1.102) 
To 1.107 (2.0 g, 7.2 mmol) in 25 mL THF at 0 °C  under N2 was added TBAF 
(1 M in THF, 21.7 mL) dropwise. After stirring at room temperature for 4 h, the mixture was 
concentrated and purified by flash chromatography (30% EtOAc in hexane) to afford 3-((2-
methylallyl)oxy)hex-5-yn-1-ol (1.108). 
To a solution of 1.108 (300 mg, 1.78 mmol) and DMAP (10.9 mg, 0.0892 mmol) in 6.5 mL 
DCM was added Et3N (1.49 mL, 10.7 mmol) and Ac2O (2.52 mL, 26.7 mmol) at 0 °C. The 
mixture was stirred at room temperature for 3 h. Then it was poured into H2O, and extracted with 
DCM. Organic layer was washed with brine and dried over MgSO4. The crude mixture was 
concentrated and purified by flash chromatography (10% EtOAc in hexane) to give 3-(2-
methylallyloxy)hex-5-ynyl acetate (365 mg, 97%). 1H NMR (300 MHz, CDCl3)  4.97 (s, 1H), 
4.89 (s, 1H), 4.23-4.18 (m, 2H), 4.01 (d, J = 12.1 Hz, 1H), 3.87 (d, J = 12.1 Hz, 1H), 3.63-3.58 
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(m, 1H), 2.53-2.37 (m, 2H), 2.05 (s, 3H), 2.03-1.89 (m, 3H), 1.75 (s, 3H); 13C (75 MHz, CDCl3) 
 171.2, 142.3, 112.8, 80.7, 74.1, 73.7, 70.6, 61.4, 33.3, 23.9, 21.2, 19.8; IR (neat) 3294, 2919, 
1739, 1657, 1454, 1369, 1242, 1105, 1047, 903 cm-1; HRMS (EI) calcd for C9H15O3 (M-C3H3)
+ 
171.1021, found 171.1028. 
General procedure for enol acetate preparation was followed employing Na2CO3 (27.6 mg, 0.260 
mmol), [(p-cymene)RuCl2]2 (42.5 mg, 0.0694 mmol), tri(2-furyl)phosphine (32.2 mg, 0.139 
mmol), acetic acid (398 µL, 6.95 mmol), 1-decyne (219 µL, 1.15 mmol) and 3-(2-
methylallyloxy)hex-5-ynyl acetate (365 mg, 1.74 mmol) in 12 mL toluene at 80 C for 18 h. 
Then crude mixture was concentrated on a rotary evaporator and purified by flash 
chromatography (10% EtOAc in hexane) to give 1.102 (360 mg, 77%). 1H NMR (300 MHz, 
CDCl3)  4.94 (s, 1H), 4.87 (s, 1H), 4.82 (t, J = 2.0 Hz, 2H), 4.20-4.15 (m, 2H), 3.94 (d, J = 12.0 
Hz, 1H), 3.82 (d, J = 11.9 Hz, 1H) 3.61-3.57 (m, 1H), 2.54 (dd, J = 5.8, 14.9 Hz, 1H), 2.41 (dd, J 
= 6.2, 14.9 Hz, 1H), 2.13 (s, 3H), 2.04 (s, 3H), 1.95-1.81 (m, 2H), 1.73 (s, 3H); 13C (75 MHz, 
CDCl3)  171.2, 169.2, 153.1, 142.4, 112.6, 104.3, 73.5, 73.4, 61.5, 38.3, 33.3, 21.3, 21.2, 19.8; 
IR (neat) 2926, 1740, 1665, 1434, 1369, 1239, 1199, 1102, 1045, 1022, 966, 901 cm-1; HRMS 
(ESI) calcd for C14H22O5Na (M+Na)
+ 293.1365, found 293.1358. 
 
2-(4-Oxo-6-(prop-1-en-2-yl)tetrahydro-2H-pyran-2-yl)ethyl acetate 
(1.116) 
The general procedure for the cyclization reaction was followed: 1.102 (67 mg, 0.25 mmol), 2,6-
dichloropyridine (146 mg, 0.987 mmol) and 4 Å molecular sieves (100 mg) were dissolved in 2.5 
mL anhydrous 1,2-dichloroethane followed by LiClO4 (2.6 mg, 0.025 mmol) and DDQ (225 mg, 
0.991 mmol). The reaction was stirred for 30 h at room temperature and then quenched by Et3N. 
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The mixture was loaded onto a short plug of silica gel and washed off with dichloromethane. The 
filtrate was concentrated and purified by flash chromatography (2% EtOAc in hexane) to give 
the desired product (40.7 mg, 73%). 1H NMR (300 MHz, CDCl3)  5.01 (d, J = 0.81 Hz, 1H), 
4.92 (d, J = 0.63 Hz, 1H), 4.28-4.22 (m, 2H), 4.00 (dd, J = 3.3, 10.7 Hz, 1H), 3.82-3.76 (m, 1H), 
2.51-2.27 (m, 4H), 2.05 (s, 3H), 2.03-1.84 (m, 2H), 1.78 (s, 3H); 13C (75 MHz, CDCl3)  206.9, 
171.2, 143.9, 111.9, 79.8, 74.0, 61.0, 47.9, 46.6, 35.5, 21.2, 18.7; IR (neat) 2969, 2919, 2856, 
1736, 1653, 1452, 1368, 1233, 1150, 1127, 1048, 904 cm-1; HRMS (ESI) calcd for C12H18O4Na 
(M+Na)+ 249.1103, found 249.1127. 
 
Isopropyl 5-acetoxy-3-(2-methylallyloxy)hex-5-enoate (1.103)  
To a solution of alcohol 1.108 (570 mg, 3.40 mmol) in CH2Cl2 (8 mL) was 
added DMSO (4.8 mL) and Et3N (1.4 mL, 10.2 mmol) at 0 °C, followed by the addition of 
SO3•Py complex (809 mg, 5.08 mmol). The mixture was stirred at room temperature for 3.5 h, 
before it was quenched by H2O, and extracted with Et2O. The combined organic layers were 
washed with H2O and dried over MgSO4. After filtration and concentration, it was purified by 
flash chromatography (10% EtOAc in hexane) to give desired aldehyde 1.110 (>507 mg, >90%). 
1H NMR (300 MHz, CDCl3)  9.83 (t, J = 1.8 Hz, 1H), 4.97 (s, 1H), 4.90 (s, 1H), 4.07-3.89 (m, 
3H), 2.78 (dd, J = 1.8, 6.2 Hz, 2H), 2.61-2.42 (m, 2H), 2.04 (t, J = 2.7 Hz, 1H), 1.73 (s, 3H); 13C 
(75 MHz, CDCl3)  200.8, 142.0, 113.1, 80.1, 73.8, 72.5, 71.3, 48.1, 23.9, 19.7; IR (neat) 3292, 
3078, 2975, 2915, 2850, 2731, 1724, 1659, 1454, 1431, 1346, 1297, 1229, 1184, 1102, 1051, 904 
cm-1; HRMS(EI) calcd for C7H11O2 (M-C3H3)
+ 127.0759, found 127.0761. 
To a solution of 1.110 (from last step) and 2-methyl-2-butene (11.9 g, 169 mmol) in 15 mL 
tBuOH at 0 °C was added a solution of NaClO2 (2.76 g, 30.5 mmol) and NaH2PO4•H2O (3.28 g, 
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23.7 mmol) in 10 mL H2O dropwise. The mixture was warmed to room temperature for 5 h 
before acidification the reaction to PH~4. The mixture was extracted with EtOAc, and the 
combined organic layers were washed with brine and dried over MgSO4. After filtration and 
concentration, the crude acid was used as such for next step. 
To a solution of the carboxylic acid from last step, DCC (2.1 g, 10 mmol) and DMAP (83 mg, 
0.68 mmol) in DCM at room temperature was added iPrOH (519 uL, 6.80 mmol) dropwise. After 
10 minutes, the reaction was quenched by H2O and the mixture was extracted with DCM. 
Combined organic phase was washed with brine, and dried over MgSO4. The crude mixture was 
concentrated and purified by flash chromatography (3% EtOAc in hexane) to give isopropyl 3-
(2-methylallyloxy)hex-5-ynoate (410 mg, 54% over three steps). 1H NMR (300 MHz, CDCl3)  
5.06-5.00 (m, 1H), 4.96 (s, 1H), 4.87 (s, 1H), 4.02-3.90 (m, 3H), 2.71-2.56 (m, 2H), 2.55-2.40 
(m, 2H), 2.03-2.01 (m, 1H), 1.73 (s, 3H), 1.25 (s, 3H), 1.23 (s, 3H); 13C (75 MHz, CDCl3)  
171.0, 142.2, 112.8, 80.4, 74.2, 74.0, 70.8, 68.1, 39.9, 23.9, 22.0, 21.9, 19.7; IR (neat) 3296, 
2981, 2934, 2119, 1731, 1455, 1375, 1310, 1263, 1215, 1163, 1108, 968, 901 cm-1; HRMS (EI) 
calcd for C13H20O3 (M
+) 224.1412, found 224.1421. 
General procedure for enol acetate preparation was followed employing Na2CO3 (29 mg, 0.27 
mmol), [(p-cymene)RuCl2]2 (44.8 mg, 0.0732 mmol), tri(2-furyl)phosphine (34 mg, 0.15 mmol), 
acetic acid (418 µL, 7.30 mmol), 1-decyne (231 µL, 1.28 mmol) and isopropyl 3-(2-
methylallyloxy)hex-5-ynoate (410 mg, 1.83 mmol) in 12 mL toluene at 80 C for 18 h. Then 
crude mixture was concentrated on a rotary evaporator and purified by flash chromatography 
(10% EtOAc in hexane) to give the isopropyl 5-acetoxy-3-(2-methylallyloxy)hex-5-enoate (260 
mg, 50%). 1H NMR (300 MHz, CDCl3)  5.06-4.98 (m, 1H), 4.95 (s, 1H), 4.86 (s, 1H), 4.84-
4.82 (m, 2H), 3.99-3.85 (m, 3H), 2.60-2.41 (m, 4H), 2.14 (d, J = 1.7 Hz, 3H), 1.72 (s, 3H), 1.25 
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(s, 3H), 1.23 (s, 3H); 13C (75 MHz, CDCl3)  171.0, 169.2, 152.9, 142.3, 112.4, 104.5, 73.9, 
73.7, 68.1, 40.0, 38.4, 22.0, 21.9, 21.3, 19.7; IR (neat) 2981, 2936, 1758, 1731, 1666, 1454, 
1372, 1193, 1108, 1045, 1022, 967, 899 cm-1; HRMS (ESI) calcd for C15H24O5Na (M+Na)
+ 
307.1521, found 307.1516. 
 
Isopropyl 2-(4-oxo-6-(prop-1-en-2-yl)tetrahydro-2H-pyran-2-yl)acetate 
(1.117)  
The general procedure for the cyclization reaction was followed: 1.103 (54 mg, 0.19 mmol), 2,6-
dichloropyridine (113 mg, 0.764 mmol) and 4 Å molecular sieves (80 mg) were dissolved in 1.8 
mL anhydrous 1,2-dichloroethane followed by LiClO4 (2.0 mg, 0.019 mmol) and DDQ (173 mg, 
0.762 mmol). The reaction was stirred for 12 h at 45 C and then quenched by Et3N. The mixture 
was loaded onto a short plug of silica gel and washed off with dichloromethane. The filtrate was 
concentrated and purified by flash chromatography (15% EtOAc in hexane) to give the desired 
product (35.2 mg, 77%). 1H NMR (300 MHz, CDCl3)  5.11-5.02 (m, 1H), 5.00 (s, 1H), 4.91 (s, 
1H), 4.16-4.07 (m, 1H), 4.06-4.02 (m, 1H), 2.70 (dd, J = 7.4, 15.2 Hz, 1H), 2.52 (dd, J = 5.4, 
15.2 Hz, 1H), 2.47-2.31 (m, 4H), 1.77 (s, 3H), 1.25 (d, J = 1.5 Hz, 3H), 1.23 (d, J = 1.5 Hz, 3H); 
13C (75 MHz, CDCl3)  206.4, 169.9, 143.8, 112.0, 79.6, 73.6, 68.4, 47.2, 46.2, 41.8, 22.0, 21.9, 
18.7; IR (neat) 2980, 1727, 1654, 1453, 1373, 1320, 1253, 1218, 1182, 1108, 1077, 964, 903, 
828 cm-1; HRMS (EI) calcd for C13H20O4 (M
+) 240.1362, found 240.1364. 
 
(E)-Ethyl 4-(tert-butyldimethylsilyloxy)-3-methylbut-2-enoate (1.112) 
To NaH (702 mg, 17.6 mmol, 60% in mineral oil) suspended in 40 mL THF at 
0 °C was added triethyl phosphonoacetate (3.32 mL, 16.3 mmol) dropwise. After stirring at 0 °C 
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for 1 h until the end of hydrogen formation, ketone (2.45 g, 13.0 mmol) in 8 mL THF was added 
slowly. After another 1 h at room temperature, it was poured onto H2O and extracted with Et2O. 
Combined organic phase was washed with brine, and dried over MgSO4. The crude mixture was 
concentrated and purified by flash chromatography (3% Et2O in hexane) to give desired product 
(2.8 g, 85%). 1H NMR (300 MHz, CDCl3)  5.99 (s, 1H), 4.16 (q, J = 7.2 Hz, 2H), 4.11 (s, 2H), 
2.05 (s, 3H), 1.28 (t, J = 6.9 Hz, 3H), 0.92 (s, 9H), 0.08 (s, 6H).9 
 
(E)-2,2,3,3,11,14,14,15,15-Nonamethyl-7-(prop-2-ynyl)-4,8,13-trioxa-
3,14-disilahexadec-10-ene (1.114) 
To a solution of 1.112 (982 mg, 3.80 mmol) in 5 mL toluene at ‒78 °C  was added DIBAL-H (1 
M in hexane, 8.4 mL) dropwise. After stirring at room temperature for 5 h, the reaction was 
cooled to 0 °C  and quenched by saturated NH4Cl (aq). The organic layer was separated and the 
aqueous layer was extracted with CH2Cl2. Combined organic layers were dried over MgSO4. 
After filtration and concentration, crude (E)-4-((tert-butyldimethylsilyl)oxy)-3-methylbut-2-en-1-
ol was obtained which was used as such for next step. 
To a solution of (E)-4-((tert-butyldimethylsilyl)oxy)-3-methylbut-2-en-1-ol (from last step) and 
Et3N (726 µL, 5.21 mmol) in 20 mL CH2Cl2 at ‒40 °C  was added MsCl (364 µL, 4.70 mmol) 
dropwise. After 30 minutes at that temperature, LiBr (938 mg, 10.8 mmol) was added in one 
portion followed by 20 mL THF. After stirring at 0 °C  for 1.5 h, the reaction was diluted with 
hexane and washed with H2O and brine. The mixture was dried over MgSO4, filtrated and 
concentrated to afford crude (E)-((4-bromo-2-methylbut-2-en-1-yl)oxy)(tert-butyl)dimethylsilane 
for next step. 
 137 
To 1-(tert-Butyldimethylsilyloxy)hex-5-yn-3-ol (1.106) (822 mg, 3.60 mmol) in 4 mL DMF and 
10 mL THF at 0 C was added NaH (60%, dispersed in mineral oil, 259 mg) in one portion. The 
mixture was stirred at that temperature for 30 minutes before (E)-((4-bromo-2-methylbut-2-en-1-
yl)oxy)(tert-butyl)dimethylsilane from last step was added in. The reaction was warmed to room 
temperature and stirred for 27 h. The reaction was then quenched by H2O at 0 C, followed by 
excess amount of EtOAc. After the organic layer was washed with brine, it was dried over 
MgSO4, filtrated and concentrated under reduced pressure. The resulting residue was purified by 
flash chromatography (3% EtOAc in hexane) to give desired 1.114 (859 mg, 49% over three 
steps). 1H NMR (300 MHz, CDCl3)  5.62 (t, J = 6.0 Hz, 1H), 4.24-4.18 (m, 1H), 4.06-4.00 (m, 
3H), 3.77-3.61 (m, 3H), 2.46-2.42 (m, 2H), 2.00 (t, J = 2.4 Hz, 1H), 1.87-1.77 (m, 2H), 1.65 (s, 
3H), 0.92-0.86 (m, 18H), 0.10-0.05 (m, 12H); 13C (75 MHz, CDCl3)  138.8, 120.9, 81.4, 77.4, 
74.1, 70.1, 68.1, 65.9, 59.6, 37.5, 26.1, 24.2, 18.6, 18.5, 13.9, -5.1; IR (neat) 2954, 2929, 2886, 
2857, 1472, 1254, 1100, 836, 775 cm-1; HRMS (ESI) calcd for C23H46O3Si2Na (M+Na)
+ 
449.2883, found 449.2877. 
 
(E)-6-(tert-Butyldimethylsilyloxy)-4-(4-(tert-butyldimethylsilyloxy)-3-
methylbut-2-enyloxy)hex-1-en-2-yl acetate (1.104) 
General procedure for enol acetate preparation was followed employing Na2CO3 (31.6 mg, 0.298 
mmol), [(p-cymene)RuCl2]2 (48.7 mg, 0.0795 mmol), tri(2-furyl)phosphine (36.9 mg, 0.159 
mmol), acetic acid (454 µL, 7.93 mmol), 1-decyne (250 µL, 1.39 mmol) and 1.114 (848 mg, 
1.99 mmol) in 13 mL toluene at 80 C for 13 h. Then crude mixture was concentrated on a rotary 
evaporator and purified by flash chromatography (4% EtOAc in hexane) to give the desired 
product (397 mg, 41%). 1H NMR (300 MHz, CDCl3)  5.61-5.57 (m, 1H), 4.80 (s, 2H), 4.15-
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3.97 (m, 4H), 3.77-3.71 (m, 3H), 2.53-2.35 (m, 2H), 2.12 (s, 3H), 1.75-1.68 (m, 2H), 1.63 (s, 
3H), 0.91 (s, 9H), 0.89 (s, 9H), 0.06 (s, 6H), 0.05 (s, 6H); 13C (75 MHz, CDCl3)  169.3, 153.7, 
138.6, 120.9, 103.8, 73.4, 68.1, 65.8, 59.6, 38.7, 37.7, 26.1, 21.3, 18.6, 18.4, 13.8, -5.1, -5.2; IR 
(neat) 2931, 2858, 1760, 1666, 1469, 1435, 1368, 1254, 1202, 1097, 963, 940, 838, 777 cm-1; 
HRMS (ESI) calcd for C25H50O5Si2Na (M+Na)
+ 509.3095, found 509.3102. 
 
2-((E)-3-(tert-Butyldimethylsilyloxy)-2-methylprop-1-enyl)-6-(2-(tert-
butyldimethylsilyloxy)ethyl)dihydro-2H-pyran-4(3H)-one (1.118)  
The general procedure of cyclization reaction was followed: 1.104 (54.4 mg, 0.112 mmol), 2,6-
dichloropyridine (66.2 mg, 0.447 mmol) and 4 Å molecular sieves (80 mg) were dissolved in 1.1 
mL anhydrous 1,2-dichloroethane, followed by LiClO4 (1.2 mg, 0.011 mmol) and DDQ (50.7 
mg, 0.223 mmol). The reaction was stirred for 45 minutes at room temperature before quenched 
by Et3N. The mixture was loaded onto a short plug of silica gel and washed off with 
dichloromethane. The filtrate was concentrated and purified by flash chromatography (10% 
EtOAc in hexane) to give the desired product 1.118 (22.4 mg, 45%) and aldehyde 1.119 (16.2 
mg, 38%). 1H NMR (300 MHz, CDCl3)  5.52 (dd, J = 1.2, 7.8 Hz, 1H), 4.36 (dd, J = 8.4, 14.7 
Hz, 1H), 4.04 (s, 2H), 3.88-3.67 (m, 3H), 2.43-2.90 (m, 4H), 1.91-1.71 (m, 2H), 1.64 (s, 3H), 
0.89 (s, 9H), 0.92(s, 9H), 0.09 (s, 6H), 0.06 (s, 6H). 
 
(E)-3-(4-Acetoxy-3-methylbut-2-enyloxy)hex-5-ene-1,5-diyl diacetate 
(1.105) 
A solution of 1.118 (260 mg, 0.587 mmol) in 5 mL MeOH was added 3% HCl in MeOH (15 
mL) at 0 C. After 25 min at that temperature, the reaction was quenched by saturated NaHCO3 
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(aq), and extracted with EtOAc for 4 times. The combined organic layers were washed with 
brine, dried over MgSO4, filtrated and concentrated to afford crude (E)-6-hydroxy-4-((4-
hydroxy-3-methylbut-2-en-1-yl)oxy)hex-1-en-2-yl acetate for next step. 
To (E)-6-hydroxy-4-((4-hydroxy-3-methylbut-2-en-1-yl)oxy)hex-1-en-2-yl acetate from last step 
and DMAP (3.3 mg, 0.027 mmol) in 5 mL CH2Cl2 at 0 C was added pyridine (260 µL, 3.23 
mmol) and Ac2O (760 µL, 8.05 mmol). After stirring at room temperature for 3 h, the reaction 
was quenched by H2O, and the mixture was extracted with CH2Cl2 (3x). The combined organic 
layers were washed with H2O, brine, and dried over MgSO4. After filtration and concentration, 
the residue was purified by flash chromatography (30% EtOAc in hexane) to give the desired 
product (131 mg, 71% over two steps). 1H NMR (300 MHz, CDCl3)  5.62-5.57 (m, 1H), 4.84-
4.82 (m, 2H), 4.49 (s, 2H), 4.21-4.15 (m, 2H), 4.13-3.97 (m, 2H), 3.61-3.52 (m, 1H), 2.56-2.36 
(m, 2H), 2.15 (s, 3H), 2.09 (s, 3H), 2.06 (s, 3H), 1.96-1.75 (m, 2H), 1.70 (s, 3H); 13C (75 MHz, 
CDCl3)  171.2, 171.0, 169.2, 153.1, 134.2, 124.8, 104.4, 73.8, 69.1, 65.6, 61.4, 38.6, 33.5, 21.3, 
21.2, 21.1, 14.4; IR (neat) 2925, 1739, 1667, 1436, 1370, 1230, 1049 cm-1; HRMS (ESI) calcd 
for C17H26O7Na (M+Na)
+ 365.1576, found 365.1579. 
 
2-((2R,6R)-6-((E)-3-Acetoxy-2-methylprop-1-enyl)-4-oxotetrahydro-2H-
pyran-2-yl)ethyl acetate (1.120)  
The general procedure for the cyclization reaction was followed: 1.105 (31 mg, 0.091 mmol), 
2,6-dichloropyridine (53.6 mg, 0.362 mmol) and 4 Å molecular sieves (50 mg) were dissolved in 
0.9 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (1.0 mg, 0.0095 mmol) and DDQ 
(82.2 mg, 0.362 mmol). The reaction was stirred for 5.5 h at 40 C then quenched by Et3N. The 
mixture was loaded onto a short plug of silica gel and washed off with dichloromethane. The 
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filtrate was concentrated and purified by flash chromatography (30% EtOAc in hexane) to give 
the desired product (21.6 mg, 80%). 1H NMR (300 MHz, CDCl3)  5.53 (ddd, J = 1.2, 2.7, 7.5 
Hz, 1H), 4.49 (s, 2H), 4.37 (dd, J = 7.5, 14.4 Hz, 1H), 4.29-4.16 (m, 2H), 3.83-3.74 (m, 1H), 
2.44-2.31 (m, 4H), 2.10 (s, 3H), 2.05 (s, 3H),2.00-1.82 (m, 2H), 1.71 (d, J = 1.2 Hz, 3H); 13C (75 
MHz, CDCl3)  206.2, 171.2, 170.9, 134.7, 127.0, 77.4, 74.2, 73.9, 68.6, 60.9, 47.8, 47.6, 35.5, 
21.1, 14.7; IR (neat) 2922, 1737, 1370, 1320, 1232, 1148, 1055, 887 cm-1; HRMS (ESI) calcd for 
C15H22O6K (M+K)
+ 337.1053, found 337.1060. 
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APPENDIX B 
STRUCTURALLY AND STEREOCHEMICALLY DIVERSE TETRAHYDROPYRAN 
SYNTHESIS VIA OXIDATIVE C‒H CLEAVAGE OF (SILYL)ALLYLIC AND 
PROPARGYLIC ETHERS 
General Experimental Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, a Bruker 
Avance 400 spectrometer at 400 MHz and 100 MHz, a Bruker Avance 500 spectrometer at 500 
MHz and 125 MHz, a Bruker Avance 600 spectrometer at 600 MHz and 151 MHz if specified. 
The chemical shifts are given in parts per million (ppm) on the delta (δ) scale. The solvent peak 
was used as a reference value, for 1H NMR: CDCl3 = 7.26 ppm, for 
13C NMR: CDCl3 = 77.23. 
Data are reported as follows: s = singlet; d = doublet; t = triplet; q = quartet; dd = doublet of 
doublets; dt = doublet of triplets; br = broad. High resolution and low resolution mass spectra 
were recorded on a VG 7070 spectrometer. Infrared (IR) spectra were collected on a Mattson 
Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on a NaCl plate by 
dissolving the compound in CH2Cl2 and then evaporating the CH2Cl2. Analytical TLC was 
performed on E. Merck pre-coated (25 mm) silica gel 60F-254 plates. Visualization was done 
under UV light (254 nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica 
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gel.  Methylene chloride was distilled under N2 from CaH2, and 1,2–dichloroethane was dried 
over 4Å molecular sieves. Reagent grade ethyl acetate, diethyl ether, pentane and hexanes were 
purchased from EM Science and used as purchased for chromatography. Tetrahydrofuran and 
diethyl ether were dried by passage through an activated alumina column under positive N2 
pressure. Anhydrous (N,N)-dimthylformamide (DMF), methanol (MeOH), dimethyl sulfoxide 
(DMSO), acetone were purchased from Aldrich and used as it is. Activated 4 Å molecular sieves 
were obtained through drying in oven at 150 °C overnight. All reactions were performed in oven 
or flame-dried glassware under a positive pressure of N2 with magnetic stirring unless otherwise 
noted. 
 
General procedure for [Cp*Ru(MeCN)3]PF6 catalyzed alkyne hydrosilylation:
1 
Alkyne (1 eq) and silane (1.2 eq) were dissolved in acetone to give an ~0.5 M solution. 
[Cp*Ru(MeCN)3]PF6 (0.02 eq) was added to the mixture at 0 °C. The reaction was monitored by 
TLC at 0 °C and, upon starting material consumption, was concentrated and purified by flash 
chromatography to give the (Z)-vinylsilane. 
 
(Z)-3-(Triethylsilyl)oct-2-en-1-ol (2.43) 
The general procedure for [Cp*Ru(MeCN)3]PF6 catalyzed alkyne hydrosilylation 
was followed: to a solution of 2-octyn-1-ol (717 µL, 5.00 mmol) in 10 mL CH2Cl2 was added 
Et3SiH (958 µL, 6.00 mmol) and [Cp*Ru(MeCN)3]PF6 (25 mg, 0.050 mmol) at 0 °C. After 30 
minutes at that temperature, the reaction was concentrated and the resulting residue was purified 
by flash chromatography (8% EtOAc in hexane) to give 2.43 (1.2 g, 99%). 1H NMR (400 MHz, 
CDCl3)  6.17 (tt, J = 1.1, 6.8 Hz, 1H), 4.15 (d, J = 6.8 Hz, 2H), 2.03 (t, J = 6.7 Hz, 2H), 1.84 
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(br, 1H), 1.37-1.23 (m, 6H), 0.98-0.86 (m, 12H), 0.67-0.61 (m, 6H); 13C (100 MHz, CDCl3)  
141.4, 62.4, 38.2, 32.0, 30.4, 22.7, 14.2, 7.7, 4.5; IR (neat) 3301, 2954, 1461, 1416, 1378, 1236, 
1074, 1004, 849, 731 cm-1; HRMS (EI) calcd for C14H30O2Si (M
+) 242.2066, found 242.2071. 
 
(Z)-(1-Bromooct-2-en-3-yl)triethylsilane (2.44) 
To a solution of 2.43 (1.2 g, 4.95 mmol) in 50 mL CH2Cl2 at 0 C was added CBr4 
(1.8 g, 5.5 mmol) and PPh3 (1.8 g, 6.9 mmol). After stirring at that temperature for 5 minutes, the 
reaction was concentrated, and the resulting residue was purified by flash chromatography 
(pentane) to afford 2.44 (1.53 g, 99%). 1H NMR (400 MHz, CDCl3)  6.24 (t, J = 11.4 Hz, 1H), 
4.06 (d, J = 11.3 Hz, 2H), 2.07 (t, J = 8.7 Hz, 2H), 1.40-1.27 (m, 6H), 0.99-0.88 (m, 12H), 0.75-
0.67 (m, 6H); 13C (100 MHz, CDCl3)  144.8, 137.8, 38.0, 32.9, 31.9, 30.1, 22.8, 14.3, 7.8, 4.4; 
IR (neat) 2956, 1461, 1416, 1378, 1237, 1199, 1074, 1004, 972, 890, 731 cm-1. 
 
(Z)-(1-(But-3-yn-1-yloxy)oct-2-en-3-yl)triethylsilane (2.45) 
To a solution of 3-butyn-1-ol (381 µL, 5.03 mmol) in 10 mL THF at 0 C was 
added NaH (60%, dispersed in mineral oil, 231 mg, 5.78 mmol) in one portion. The mixture was 
stirred at that temperature for 30 minutes before 2.44 (1.69 g, 5.53 mmol) was added. The 
reaction was allowed to warm to room temperature and stirred for another 2 h. The reaction was 
quenched by H2O at 0 C, followed by excess amount of EtOAc. After the organic layer was 
washed with brine, the mixture was dried over MgSO4, filtrated and concentrated under reduced 
pressure. The resulting residue was purified by flash chromatography (5% EtOAc in hexane) to 
provide 2.45 (147 mg, 10%). 1H NMR (400 MHz, CDCl3)  6.15 (tt, J = 1.1, 6.5 Hz, 1H), 4.06 
(d, J = 6.6 Hz, 2H), 3.57 (t, J = 7.0 Hz, 2H), 2.48 (dt, J = 2.7, 7.0 Hz, 2H), 2.05 (t, J = 6.9 Hz, 
 144
2H), 1.98 (t, J = 2.7 Hz, 1H), 1.39-1.22 (m, 6H), 0.96-0.87 (m, 12H), 0.69-0.63 (m, 6H); 13C 
(100 MHz, CDCl3)  141.9, 139.1, 81.5, 70.5, 69.4, 68.5, 38.3, 32.0, 30.3, 22.8, 20.1, 14.3, 7.7, 
4.4; IR (neat) 3313, 2955, 2928, 2874, 1462, 1418, 1377, 1358, 1237, 1108, 1058, 1005, 971, 
732 cm-1; HRMS (EI) calcd for C18H34OSi (M
+) 294.2379, found 294.2383. 
 
General procedure for the enol acetate preparation:2 
A mixture of Na2CO3 (15%), [(p-cymene)RuCl2]2 (0.04 eq), tri(2-furyl)phosphine (0.08 eq), 
acetic acid (2.0 eq), and 1-decyne (0.5 eq) in toluene was heated to 80 C and stirred for 1 h. 
Another portion of acetic acid (2.0 eq) and the alkyne substrate (1.0 eq) were dissolved in 
toluene and added to the mixture (~0.15 M final substrate concentration). The reaction was 
stirred at 80 °C overnight. Then crude mixture was concentrated on a rotary evaporator and 
purified by flash chromatography to give the desired enol acetate product. 
 
(Z)-4-((3-(Triethylsilyl)oct-2-en-1-yl)oxy)but-1-en-2-yl acetate (2.41)  
The general procedure for the preparation of enol acetate was followed: A 50 
mL RBF was charged with Na2CO3 (8.7 mg, 0.082 mmol), dichloro(p-cymene)ruthenium(II) 
dimer (13.4 mg, 0.0219 mmol), tri(2-furyl)phosphine (10.1 mg, 0.0435 mmol). Then 3.0 mL 
toluene was added into the flask, followed by acetic acid (125 uL, 2.18 mmol) and 1-decyne (49 
uL, 0.27 mmol). The mixture was then heated to 80 C and stirred for 1 h. Then 2.45 (160 mg, 
0.550 mmol) in 1 mL toluene was added into the reaction through syringe. The reaction was 
stirred at the same temperature overnight. Then crude mixture was loaded onto a short plug of 
silica gel and washed off with Et2O. The residue was concentrated on a rotary evaporator and 
purified by chromatography (3% EtOAc in hexane) to give the desired product (125 mg, 65%). 
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1H NMR (300 MHz, CDCl3)  6.14 (tt, J = 1.2, 6.5 Hz, 1H), 4.82-4.80 (m, 2H), 4.03 (d, J = 6.5 
Hz, 2H), 3.56 (t, J = 6.6 Hz, 2H), 2.53 (t, J = 6.7 Hz, 2H), 2.15 (s, 3H), 2.05 (t, J = 6.5 Hz, 2H), 
1.41-1.25 (m, 6H), 0.97-0.87 (m, 12H), 0.70-0.62 (m, 6H); 13C (75 MHz, CDCl3)  169.4, 153.7, 
141.7, 139.3, 103.1, 70.5, 67.3, 38.3, 34.3, 32.0, 30.4, 22.8, 21.3, 14.3, 7.8, 4.4; IR (neat) 2954, 
2927, 2874, 1759, 1669, 1458, 1367, 1212, 1184, 1105, 1017 cm-1; HRMS (EI) calcd for 
C20H38O3Si (M
+) 354.2590, found 354.2605. 
 
General procedure for the cyclization reactions: 
Substrate (1 eq), 2,6-dichloropyridine (2 eq) and 4 Å molecular sieves (2 mass eq) were 
dissolved in anhydrous 1,2-dichloroethane to give a ~0.1 M solution. The mixture was stirred at 
room temperature for 15 minutes, followed by addition of LiClO4 (0.2 eq). After 5 minutes, 
DDQ (4 eq) was added. The reaction was monitored by TLC at 45 °C unless specified and, upon 
starting material consumption, was quenched by 5% aqueous NaHCO3. The mixture was 
extracted with CH2Cl2 three times, and combined organic layers were dried over MgSO4. The 
filtrate was concentrated and purified by flash chromatography to give the desired product. 
 
(Z)-2-(2-(Triethylsilyl)hept-1-en-1-yl)dihydro-2H-pyran-4(3H)-one (2.51)  
The general procedure for the cyclization reaction was followed: 2.41 (35 mg, 
0.10 mmol), 2,6-dichloropyridine (29 mg, 0.20 mmol) and 4 Å molecular sieves (70 mg) were 
dissolved in 1.0 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (3.2 mg, 0.030 mmol) 
and DDQ (91 mg, 0.40 mmol). The reaction was stirred at 45 °C for 15 h and then quenched by 
5% aqueous NaHCO3. The crude mixture was extracted with CH2Cl2, concentrated, and purified 
by flash chromatography (6% EtOAc in hexane) to give the desired product (21 mg, 68%, Z:E = 
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13:1). 1H NMR (500 MHz, CDCl3)  6.00 (dd, J = 1.1, 9.1 Hz, 1H), 4.31 (dd, J = 7.5, 11.5 Hz, 
1H), 5.25-4.20 (m, 1H), 3.71-3.65 (m, 1H), 2.65-2.59 (m, 1H), 2.45-2.32 (m, 3H), 2.07-2.04 (m, 
2H), 1.43-1.25 (m, 5H), 0.99-0.92 (m, 9H), 0.90-0.87 (m, 3H), 0.69-0.59 (m, 7H); 13C (75 MHz, 
CDCl3)  206.8, 144.0, 140.6, 77.6, 66.5, 48.9, 42.4, 38.1, 31.9, 30.1, 22.7, 14.3, 7.7, 4.6; IR 
(neat) 2954, 1722, 1249, 1160, 1083, 1016, 838, 751 cm-1; HRMS (EI) calcd for C18H34O2Si 
(M+) 310.2128, found 310.2119. 
 
(E)-3-(Trimethylsilyl)but-2-en-1-ol (2.49) 
To a solution of Red-Al (70% wt in toluene, 8.9 mL, 32 mmol) in 12 mL Et2O at 0 °C was added 
2.47 (2.6 g, 20 mmol) in 12 mL Et2O dropwise over 20 minutes. After another 10 minutes, the 
reaction was warmed to room temperature for 2.5 h. Then the solution was recooled to 0 °C, and 
EtOAc (3.9 mL, 40 mmol) was added. 10 minutes later, the reaction was cooled to ‒78 °C and I2 
(15.2 g, 59.9 mmol) was added in several portions. After that, the reaction was warmed to room 
temperature for 2 h before it was quenched with H2O and saturated Na-K tartrate, and it stirred 
vigorously for 1 h. The organic layer was washed with Na2S2O3, and dried over MgSO4. After 
filtration and concentration, the resulting residue was purified by flash chromatography (20% 
Et2O in hexane) to give 2.48.
3 
To a solution of CuCN (3.9 g, 44 mmol) in 15 mL Et2O was added CH3Li (3 M in hexane, 29 
mL) dropwise at 0 °C. After 2 h at that temperature, 2.48 from last step in 20 mL Et2O was 
added and the mixture was allowed to warm to room temperature for 8 h. It was quenched by 
saturated NH4Cl (aq), and extracted with Et2O. The organic layer was washed with H2O, K2CO3 
(aq) and then dried over MgSO4. After filtration and concentration, the resulting residue was 
purified by flash chromatography ((20% Et2O in hexane) to afford 2.49 (2 g, 70% over two 
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steps). 1H NMR (300 MHz, CDCl3)  5.95-5.84 (m, 1H), 4.26 (d, J = 5.7 Hz, 2H), 1.69 (d, J = 
0.9 Hz, 3H), 1.60 (br, 1H), 0.06 (s, 9H).3 
 
(E)-4-((3-(Trimethylsilyl)but-2-en-1-yl)oxy)but-1-en-2-yl acetate (2.46)  
Compound 2.46 was prepared from 2.49 following the same protocol for 
converting 2.43 to 2.41. 1H NMR (300 MHz, CDCl3)  5.86-5.81 (m, 1H), 4.82-4.81 (m, 2H), 
4.10 (dd, J = 0.6, 5.8 Hz, 2H), 3.58 (t, J = 6.7 Hz, 2H), 2.54 (t, J = 6.6 Hz, 2H), 2.15 (s, 3H), 
1.70 (s, 3H), 0.07 (s, 9H); 13C (75 MHz, CDCl3)  169.3, 153.7, 140.1, 135.2, 103.1, 67.9, 67.5, 
34.1, 21.2, 15.0, 2.1; IR (neat) 2955, 2859, 1758, 1369, 1248, 1213, 1185, 1108, 1019, 838 cm-1; 
HRMS (EI) calcd for C13H24O3Si (M
+) 256.1495, found 256.1489. 
 
(E)-2-(2-(Trimethylsilyl)prop-1-en-1-yl)dihydro-2H-pyran-4(3H)-one (2.52) 
The general cyclization reaction procedure was followed with 2.46 (36 mg, 0.14 
mmol), 2,6-dichloropyridine (41 mg, 0.28 mmol), 4 Å molecular sieves (72 mg), 1,2-
dichloroethane (1.4 mL), LiClO4 (4.5 mg, 0.042 mmol), and DDQ (63 mg, 0.28 mmol). The 
reaction was stirred at 45 °C for 16 h and then quenched by 5% aqueous NaHCO3. The crude 
mixture was extracted with CH2Cl2, concentrated, and purified by flash chromatography (10% 
EtOAc in hexane) to give the desired product (22 mg, 74%, Z:E > 20:1). 1H NMR (500 MHz, 
CDCl3)  5.74 (dd, J = 1.5, 7.3 Hz, 1H), 4.48 (ddd, J = 4.2, 7.4, 10.7 Hz, 1H), 4.33 (dd, J = 7.3, 
11.5 Hz, 1H), 3.75 (dt, J = 2.8, 12.3 Hz, 1H), 2.64 (ddd, J = 7.5, 12.5, 14.5 Hz, 1H), 2.41-2.33 
(m, 3H), 1.73 (d, J = 1.5 Hz, 3H), 0.08 (s, 9H); 13C (75 MHz, CDCl3)  206.8, 141.4, 136.9, 75.0, 
66.8, 48.1, 42.5, 15.3, -2.2; IR (neat) 2956, 1721, 1248, 1159, 1084, 1016, 838, 751 cm-1; HRMS 
(EI) calcd for C11H20O2Si (M
+) 212.1233, found 212.1240. 
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(Z)-4-((3-(Benzyldimethylsilyl)oct-2-en-1-yl)oxy)but-1-en-2-yl acetate 
(2.53) 
The general procedure for [Cp*Ru(MeCN)3]PF6 catalyzed alkyne hydrosilylation was followed 
with 2-octyn-1-ol (288 µL, 2.00 mmol), dimethylbenzylsilane (380 µL, 2.40 mmol), 
[Cp*Ru(MeCN)3]PF6 (10 mg, 0.040 mmol) and acetone (4 mL). The reaction was stirred at 0 °C 
for 10 minutes and then concentrated under reduced pressure. The resulting residue was purified 
by flash chromatography (10% EtOAc in hexane) to give the (Z)-3-(benzyldimethylsilyl)oct-2-
en-1-ol (555 mg, >99%).  
To a solution of (Z)-3-(benzyldimethylsilyl)oct-2-en-1-ol (555 mg, 2.00 mmol) and 2.58 (343 
mg, 1.60 mmol) in 25 mL cyclohexane was added TMSOTf (18 µL, 0.10 mmol) dropwise at 0 
°C. After 1 h at that temperature, the mixture went through a short pad of Celit with hexane, and 
the filtrate was concentrated. The residue was purified by flash chromatography (30% CH2Cl2 in 
hexane to 3% Et2O in hexane) to afford (Z)-benzyl(1-(but-3-yn-1-yloxy)oct-2-en-3-
yl)dimethylsilane (324 mg, 49%). 
The general procedure for enol acetate formation was followed with alkyne (135 mg, 0.410 
mmol), Na2CO3 (6.5 mg, 0.061 mmol), dichloro(p-cymene)ruthenium(II) dimer (10 mg, 0.016 
mmol), tri(2-furyl)phosphine (7.6 mg, 0.033 mmol), toluene (10 mL), acetic acid (70 uL, 1.2 
mmol) and 1-decyne (35 uL, 0.21 mmol). The mixture was stirred at 80 C overnight. Then 
crude mixture was loaded onto a short plug of silica gel and washed off with Et2O. The residue 
was concentrated on a rotary evaporator and purified by chromatography (4% EtOAc in hexane) 
to give the desired product (110 mg, 69%). 1H NMR (600 MHz, CDCl3) δ 7.21 (t, J = 7.4 Hz, 
2H), 7.1 (t, J = 7.3 Hz, 1H), 7.00 (d, J = 7.5 Hz, 2H), 6.11 (t, J = 6.5 Hz, 1H), 4.82 (s, 1H), 4.80 
(s, 1H), 3.88 (d, J = 6.5 Hz, 2H), 3.50 (t, J = 6.6 Hz, 2H), 2.51 (t, J = 6.5 Hz, 2H), 2.20 (s, 2H), 
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2.14 (s, 3H), 2.06-2.02 (m, 2H), 1.33-1.22 (m, 6H), 0.88 (t, J = 7.1 Hz, 3H), 0.12 (s, 6H); 13C 
NMR (151 MHz, CDCl3) δ 169.4, 153.6, 142.8, 139.9, 139.2, 128.5, 128.4, 124.3, 103.1, 70.3, 
67.4, 38.5, 34.2, 32.0, 30.2, 26.8, 22.8, 21.3, 14.3, -1.6; IR (neat) 2957, 2859, 1756, 1667, 1429, 
1370, 1213, 1186 cm-1; HRMS (EI) calcd for C23H36O3Si (M
+) 388.2434, found 388.2429. 
 
4-(Oct-2-yn-1-yloxy)but-1-en-2-yl acetate (2.60) 
Compound 2.60 was prepared from 2.42 following the same protocol for 
converting 2.43 to 2.41. 1H NMR (600 MHz, CDCl3) δ 4.84 (d, J = 1.2 Hz, 1H), 4.81 (d, J = 1.4 
Hz, 1H), 4.15 (t, J = 2.1 Hz, 2H), 3.64 (t, J = 6.5 Hz, 2H), 2.54 (t, J = 6.5 Hz, 2H), 2.22 (tt, J = 
2.1, 7.1 Hz, 2H), 2.15 (s, 3H), 1.52 (p, J = 7.0 Hz, 2H), 1.39-1.29 (m, 4H), 0.90 (t, J = 7.1 Hz, 
3H); 13C NMR (151 MHz, CDCl3) δ 169.2, 153.3, 103.0, 87.3, 75.7, 66.4, 58.7, 33.7, 31.1, 28.3, 
22.2, 21.1, 18.7, 14.0; IR (neat) 2956, 2931, 2858, 1758, 1367, 1193, 1066, 1019 cm-1; HRMS 
(ESI) calcd for C14H22O3Na (M+Na)
+ 261.1467, found 261.1460. 
 
2-(Hept-1-ynyl)dihydro-2H-pyran-4(3H)-one (2.114) 
The general procedure of cyclization reaction was followed: 2.60 (75 mg, 0.31 
mmol), 2,6-dichloropyridine (93 mg, 0.62 mmol) and 4 Å molecular sieves (150 mg) were 
dissolved in 3.2 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (10 mg, 0.094 mmol) 
and DDQ (285 mg, 1.26 mmol). The reaction was stirred at 45 °C for 33 h and then quenched by 
5% aqueous NaHCO3. The crude mixture was extracted with CH2Cl2. After concentration, it was 
purified by flash chromatography (9% EtOAc in hexane) to give the desired product (43 mg, 
71%). 1H NMR (300 MHz, CDCl3)  4.72-4.67 (m, 1H), 4.30 (dt, J = 5.9, 11.7 Hz, 1H), 3.88 (dt, 
J = 6.1, 12.0 Hz, 1H), 2.71 (dd, J = 4.8, 15.1 Hz, 1H), 2.57 (dd, J = 6.8, 14.3 Hz, 1H), 2.51-2.46 
 150
(m, 2H), 2.23 (dt, J = 2.0, 7.1 Hz, 2H), 1.54-1.47 (m, 2H), 1.38-1.26 (m, 4H), 0.90 (t, J = 7.0 Hz, 
3H); 13C (75 MHz, CDCl3)  205.0, 89.1, 76.6, 67.4, 64.2, 48.4, 42.1, 31.0, 28.1, 22.1, 18.6, 
13.9; IR (neat) 2957, 2931, 2860, 1797, 1723, 1416, 1365, 1223, 1168, 1152, 1081, 1017 cm-1; 
HRMS(EI) calcd for C12H18O2 (M
+) 194.1307, found 194.1306. 
 
(Z)-4-((3-(Dimethyl(phenyl)silyl)oct-2-en-1-yl)oxy)but-1-en-2-yl acetate 
(2.54) 
The general procedure for [Cp*Ru(MeCN)3]PF6 catalyzed alkyne hydrosilylation was followed 
with 2.60 (72 mg, 0.30 mmol), HSiMe2Ph (56 µL, 0.36 mmol), [Cp*Ru(MeCN)3]PF6 (1.5 mg, 
0.0030 mmol) and acetone (0.6 mL). After stirring for 2 h, the mixture was concentrated, and 
purified by flash chromatography (3% EtOAc in hexane) to give 2.54 (90 mg, 80%). 1H NMR 
(600 MHz, CDCl3) δ 7.53-7.51 (m, 2H), 7.35-7.34 (m, 3H), 6.17 (dt, J = 0.8, 6.7 Hz, 1H), 4.76 
(d, J = 1.3 Hz, 1H), 4.73 (s, 1H), 3.82 (d, J = 6.6 Hz, 2H), 3.29 (t, J = 6.7 Hz, 2H), 2.38 (t, J = 
6.7 Hz, 2H), 2.16 (t, J = 7.5 Hz, 2H), 2.12 (s, 3H), 1.37 (p, J = 7.8 Hz, 2H), 1.32-1.21 (m, 4H), 
0.87 (t, J = 6.7 Hz, 3H), 0.40 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 169.1, 153.4, 142.2, 139.6, 
139.2, 133.7, 128.9, 127.8, 102.7, 70.1, 66.9, 38.3, 33.9, 31.7, 30.1, 22.5, 21.0, 14.1, -1.0; IR 
(neat) 2957, 2927, 2857, 1758,1250, 1213, 1185, 1109, 833, 817 cm-1; HRMS (EI) calcd for 
C22H34O3Si (M
+) 374.2277, found 374.2277. 
 
(Z)-2-(2-(Dimethyl(phenyl)silyl)hept-1-en-1-yl)dihydro-2H-pyran-4(3H)-one 
(2.68) 
The general cyclization reaction procedure was followed with 2.54 (65 mg, 0.17 mmol), 2,6-
dichloropyridine (51 mg, 0.35 mmol), 4 Å molecular sieves (130 mg), 1,2-dichloroethane (1.7 
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mL), LiClO4 (5.5 mg, 0.052 mmol), and DDQ (158 mg, 0.696 mmol). The reaction was stirred at 
45 °C for 10 h and then quenched by 5% aqueous NaHCO3. The crude mixture was extracted 
with CH2Cl2, concentrated, and purified by flash chromatography (9% EtOAc in hexane) to give 
the desired product (38 mg, 73%). 1H NMR (600 MHz, CDCl3) δ 7.52-7.51 (m, 2H), 7.37-7.34 
(m, 3H), 6.02 (d, J = 8.8 Hz, 1H), 4.09 (ddd, J = 0.9, 6.7, 11.7 Hz, 1H), 3.97 (ddd, J = 2.6, 8.8, 
11.3 Hz, 1H), 3.13 (dt, J = 2.6, 12.1 Hz, 1H), 2.48 (ddd, J = 7.4, 12.5, 14.6 Hz, 1H), 2.30 (dd, J = 
11.0, 14.3 Hz, 1H), 2.19-2.13 (m, 4H), 1.45-1.34 (m, 2H), 1.33-1.23 (m, 4H), 0.88 (t, J = 6.9 Hz, 
3H), 0.41 (s, 3H), 0.39 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 206.6, 144.6, 140.9, 139.0, 133.9, 
129.4, 128.1, 66.1, 48.2, 42.1, 38.4, 31.9, 30.1, 22.7, 14.3, -0.6, -0.9; IR (neat) 2957, 2927, 2856, 
1719, 1248, 1153, 1110, 1080, 815 cm-1; HRMS (EI) calcd for C20H30O2Si (M
+) 330.2015, found 
330.2015. 
 
4-(Oct-2-yn-1-yloxy)dec-1-en-2-yl acetate (2.62) 
Compound 2.62 was prepared from 1.71 following the same protocol for 
converting 2.42 to 2.60. 1H NMR (500 MHz, CDCl3) δ 4.82 (s, 1H), 4.81 (s, 1H), 4.19-4.12 (m, 
2H), 3.62 (p, J = 5.9 Hz, 1H), 2.47 (dd, J = 6.3, 15.0 Hz, 1H), 2.39 (dd, J = 5.6, 15.0 Hz, 1H), 
2.22-2.19 (m, 2H), 2.15 (s, 3H), 1.55-1.49 (m, 4H), 1.41-1.29 (m, 12H), 0.90 (t, J = 7.2 Hz, 3H), 
0.89 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 169.1, 153.5, 103.6, 86.5, 76.3, 75.8, 
57.0, 38.1, 33.9, 31.8, 31.1, 29.4, 28.3, 25.2, 22.6, 22.2, 21.1, 18.8, 14.1, 14.0; IR (neat) 2956, 
2930, 2858, 1758, 1369, 1194, 1067, 1020 cm-1; HRMS (ESI) calcd for C20H34O3Na (M+Na)
+ 
345.2406, found 345.2428. 
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(2R,6R)-2-(Hept-1-ynyl)-6-hexyldihydro-2H-pyran-4(3H)-one (2.115) 
The general cyclization reaction procedure was followed with 2.62 (75 
mg, 0.23 mmol), 2,6-dichloropyridine (69 mg, 0.47 mmol), 4 Å molecular sieves (150 mg), 1,2-
dichloroethane (2.4 mL), LiClO4 (7 mg, 0.07 mmol), and DDQ (185 mg, 0.815 mmol). The 
reaction was stirred at 40 °C for 18 h and then quenched by 5% aqueous NaHCO3. The crude 
mixture was extracted with CH2Cl2. After concentration, it was purified by flash chromatography 
(30% CH2Cl2 in hexane to 8% Et2O in hexane) to give the desired products 2.115 and 2.116 
(2.115, 27 mg, 41%; 2.116, 16 mg, 25%). 1H NMR (300 MHz, CD2Cl2) δ 4.34 (tdd, J = 1.9, 4.0, 
10.4 Hz, 1H), 3.61-3.52 (m, 1H), 2.67-2.52 (m, 2H), 2.39 (ddd, J = 1.6, 2.7, 14.6 Hz, 1H), 2.31-
2.21 (m, 3H), 1.79-1.68 (m, 1H), 1.54-1.44 (m, 3H), 1.41-1.20 (m, 12H), 0.93-0.87 (m, 6H); 13C 
NMR (75 MHz, CDCl3) δ 206.0, 87.6, 77.8, 77.4, 67.5, 48.6, 47.8, 36.6, 31.9, 31.3, 29.3, 28.3, 
25.4, 22.8, 22.4, 19.0, 14.3, 14.2; IR (neat) 2956, 2930, 2858, 1723, 1464, 1346, 1056 cm-1; 
HRMS (EI) calcd for C18H30O2 (M
+) 278.2246, found 278.2242. 
 
(2R,6S)-2-(Hept-1-ynyl)-6-hexyldihydro-2H-pyran-4(3H)-one (2.116) 
1H NMR (300 MHz, CD2Cl2)  5.06 (qd, J = 1.8, 6.9 Hz, 1H), 4.27-4.19 
(m, 1H), 2.75 (ddd, J = 1.0, 6.9, 14.6 Hz, 1H), 2.46-2.37 (m, 2H), 2.27-2.16 (m, 3H), 1.73-1.63 
(m, 1H), 1.57-1.44 (m, 3H), 1.43-1.30 (m, 12H), 0.92-0.87 (m, 6H); 13C (75 MHz, CDCl3)  
205.9, 90.1, 72.1, 65.6, 48.3, 47.6, 36.2, 31.9, 31.2, 29.2, 28.4, 25.3, 22.8, 22.3, 18.8, 14.3, 14.2; 
IR (neat) 2956, 2929, 2858, 1723 cm-1; HRMS(EI) calcd for C18H30O2 (M
+) 278.2246, found 
278.2256. 
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(Z)-4-(3-(Dimethyl(thiophen-2-yl)silyl)oct-2-enyloxy)dec-1-en-2-yl 
acetate (2.55) 
The general procedure for [Cp*Ru(MeCN)3]PF6 catalyzed alkyne hydrosilylation was followed 
with 2.62 (105 mg, 0.330 mmol), HSiMe2Ph (70 µL, 0.39 mmol), [Cp*Ru(MeCN)3]PF6 (3 mg, 
0.006 mmol) and acetone (0.7 mL). After stirring for 30 minutes, the mixture was concentrated, 
and purified by flash chromatography (3% EtOAc in hexane) to give 2.54 (160 mg, 99%). 1H 
NMR (300 MHz, CD2Cl2)  7.61 (dd, J = 0.8, 4.7 Hz, 1H), 7.28 (dd, J = 0.9, 3.4 Hz, 1H), 7.18 
(dd, J = 3.4, 4.6 Hz, 1H), 6.14 (t, J = 6.5 Hz, 1H), 4.72 (d, J = 1.3 Hz, 1H), 4.70 (s, 1H), 3.93-
3.90 (m, 2H), 3.29 (p, J = 5.8 Hz, 1H), 2.28 (dd, J = 3.9, 5.8 Hz, 2H), 2.17-2.12 (m, 2H), 2.07 (s, 
3H), 1.41-1.26 (m, 16H), 0.91-0.85 (m, 6H), 0.44 (s, 6H); 13C (75 MHz, CD2Cl2)  169.4, 154.6, 
141.8, 140.9, 135.5, 131.4, 128.7, 103.5, 77.2, 69.1, 38.8, 38.7, 34.5, 32.4, 32.3, 30.9, 30.0, 25.7, 
23.2, 23.1, 21.5, 14.5, 14.4, 0.5; IR (neat) 2956, 2927, 2856, 1758, 1212, 1194, 1086, 832, 810 
cm-1; HRMS(ESI) calcd for C26H44O3SiSNa (M+Na)
+ 487.2678, found 487.2656. 
 
(2R,6R)-2-((Z)-2-(Dimethyl(thiophen-2-yl)silyl)hept-1-enyl)-6-
hexyldihydro-2H-pyran-4(3H)-one (2.69) 
The general procedure of cyclization reaction was followed: 2.55 (50 mg, 0.11 mmol), 2,6-
dichloropyridine (32 mg, 0.21 mmol) and 4 Å molecular sieves (100 mg) were dissolved in 1.1 
mL anhydrous 1,2-dichloroethane, followed by LiClO4 (4 mg, 0.03 mmol) and DDQ (97 mg, 
0.43 mmol). The reaction was stirred at 45 °C for 18 h and then quenched by 5% aqueous 
NaHCO3. The crude mixture was extracted with CH2Cl2. After concentration, it was purified by 
flash chromatography (5% Et2O in hexane to 7% EtOAc in hexane) to give the desired product 
(37 mg, 82%). 1H NMR (500 MHz, CD2Cl2)  7.62 (d, J = 4.5 Hz, 1H), 7.28 (dd, J = 0.6, 3.4 Hz, 
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1H), 7.17 (dd, J = 3.4, 4.6 Hz, 1H), 6.01 (dd, J = 9.2 Hz, 1H), 4.11 (ddd, J = 2.7, 9.2, 11.5 Hz, 
1H), 3.29-3.24 (m, 1H), 2.34-2.09 (m, 6H), 1.47-1.35 (m, 4H), 1.34-1.16 (m, 12H), 0.89 (t, J = 
6.8 Hz, 3H), 0.88 (t, J = 7.1 Hz, 3H), 0.46 (s, 3H), 0.43 (s, 3H); 13C (125 MHz, CDCl3)  206.9, 
143.6, 142.5, 139.0, 135.7, 131.6, 128.7, 77.3, 76.5, 48.1, 48.0, 38.5, 37.0, 32.4, 32.1, 30.5, 29.8, 
25.9, 23.2, 23.1, 14.5, 14.4, 0.7, 0.5; IR (neat) 2956, 2927, 2856, 1721, 1409, 1349, 1252, 1049, 
992, 810 cm-1; HRMS(ESI) calcd for C24H40O2SiSNa (M+Na)
+ 443.2416, found 443.2436. 
 
(E)-4-(2-(2,2-Diisopropyl-1,2-oxasilolan-3-ylidene)ethoxy)but-1-en-2-yl 
acetate (2.56)4,5 
1H NMR (300 MHz, CDCl3)  5.96 (tt, J = 2.7, 5.4 Hz, 1H), 4.82-4.81 (m, 2H), 
4.11 (d, J = 5.2 Hz, 2H), 4.01 (t, J = 6.5 Hz, 2H), 3.58 (t, J = 6.5 Hz, 2H), 2.53 (t, J = 6.5 Hz, 
2H), 2.48 (t, J = 6.6 Hz, 2H), 2.14 (s, 3H), 1.09-0.93 (m, 14H); 13C (75 MHz, CDCl3)  169.3, 
153.6, 139.1, 135.2, 103.2, 69.6, 67.4, 67.2, 34.2, 32.9, 21.3, 17.3, 17.2, 12.5; IR (neat) 2940, 
2865, 1758, 1213, 1184, 1105, 1020, 783 cm-1; HRMS(EI) calcd for C14H23O4Si (M
+-C3H7) 
283.1366, found 283.1364. 
 
(E)-2-((2,2-Diisopropyl-1,2-oxasilolan-3-ylidene)methyl)dihydro-2H-pyran-
4(3H)-one (2.70) 
The general procedure of cyclization reaction was followed: 2.56 (37 mg, 0.11 
mmol), 2,6-dichloropyridine (28 mg, 0.19 mmol) and 4 Å molecular sieves (70 mg) were 
dissolved in 1.3 mL anhydrous 1,2-dichloroethane, followed by LiClO4 (3 mg, 0.03 mmol) and 
DDQ (85 mg, 0.38 mmol). The reaction was stirred at 45 °C for 33 h and then quenched by 5% 
aqueous NaHCO3. The crude mixture was extracted with CH2Cl2. After concentration, it was 
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purified by flash chromatography (20% to 30% to 60% EtOAc in hexane) to give the desired 
products 2.70 and 2.71 (29 mg, > 86%). 1H NMR (600 MHz, CDCl3)  5.91 (td, J = 2.6, 6.7 Hz, 
1H), 4.39 (q, J = 7.1 Hz, 1H), 4.36-4.33 (m, 1H), 4.05 (ddd, J = 5.2, 7.4, 9.3 Hz, 1H), 3.98 (td, J 
= 7.0, 9.1 Hz, 1H), 3.75 (dt, J = 2.8, 12.1 Hz, 1H), 2.65 (ddd, J = 7.3, 12.3, 14.4 Hz, 1H), 2.61-
2.56 (m, 1H), 2.46-2.41 (m, 3H), 2.39-2.36 (m, 1H), 1.07-0.98 (m, 14H); 13C (151 MHz, CDCl3) 
 206.5, 139.8, 136.7, 77.1, 67.1, 66.8, 47.8, 42.5, 33.1, 17.3, 17.3, 17.3, 17.2, 12.6, 12.5; IR 
(neat) 2941, 2865, 1720, 1463, 1247, 1154, 1061, 1023, 783 cm-1; HRMS(EI) calcd for 
C15H26O3Si (M
+) 282.1651, found 282.1655. 
 
(E)-2-(4-Hydroxy-2-(hydroxydiisopropylsilyl)but-1-enyl)dihydro-2H-pyran-
4(3H)-one (2.71)  
1H NMR (600 MHz, CDCl3)  5.90 (d, J = 7.6 Hz, 1H), 4.50 (ddd, J = 3.1, 7.6, 
10.7 Hz, 1H), 4.33 (dd, J = 6.5, 10.7 Hz, 1H), 3.79-3.73 (m, 2H), 3.71-3.66 (m, 1H), 2.88 (br, 
1H), 2.64 (ddd, J = 7.4, 12.5, 14.5 Hz, 1H), 2.54-2.36 (m, 6H), 1.06-0.98 (m, 14H); IR (neat) 
3385, 2927, 2864, 1716, 1460, 1247, 1058, 1020, 881 cm-1; HRMS(ESI) calcd for C12H19O3Si 
(M+-C3H7-H2O)
 239.1103, found 239.1100. 
 
General procedure for H2PtCl6•6H2O catalyzed hydrosilylation of alkyne:
6 
To a stirred solution of alkyne (1 eq) in THF was added dimethylphenylsilane (1.1 eq) and a 
0.001 M solution of H2PtCl6•6H2O (0.001 eq) in THF (~0.53 M final substrate concentration). 
The mixture was heated at 50 °C for 5 h unless specified, cooled and filtered through Celite with 
Et2O. The solvent was removed under vacuum and purified by flash chromatography to give the 
(E)-vinyl silane. 
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(E)-4-(3-(Dimethyl(phenyl)silyl)but-2-enyloxy)but-1-en-2-yl acetate (2.72) 
The general procedure for H2PtCl6•6H2O catalyzed hydrosilylation of alkyne 
was followed with 1.80 (76 µL, 1.0 mmol), HSiMe2Ph (311 µL, 2.00 mmol), H2PtCl6•6H2O 
(0.001 M THF solution, 0.5 mL) and THF (0.95 mL). After 4 h at 50 °C, the mixture was cooled 
to 0 °C, and 0.5 mL HCl (1% solution in methol) was added dropwise. After 5 minutes, the 
reaction was quenched with saturated NaHCO3 (aq), and extracted with EtOAc. The organic 
layer was dried over MgSO4, and filtered. After concentration, it was purified by flash 
chromatography (10% EtOAc in hexane) to give 2.76 (115 mg, 56%) and 2.77 (59 mg, 29%). 
Compound 2.72 was prepared following the same synthetic route to 2.53. 1H NMR (600 MHz, 
CDCl3)  7.51-7.50 (m, 2H), 7.37-7.34 (m, 3H), 5.94 (qt, J = 1.7, 5.7 Hz, 1H), 4.82 (s, 1H), 4.81 
(d, J = 1.4 Hz, 1H), 4.13 (d, J = 5.7 Hz, 2H), 3.58 (t, J = 6.6 Hz, 2H), 2.54 (t, J = 6.5 Hz, 2H), 
2.13 (s, 3H), 1.69 (t, J = 0.7 Hz, 3H), 0.36 (s, 6H); 13C (151 MHz, CDCl3)  169.4, 153.7, 138.1, 
138.1, 137.5, 134.2, 129.2, 128.0, 103.2, 68.1, 67.6, 34.1, 21.3, 15.4, -3.4; IR (neat) 2956, 2857, 
1755, 1667, 1427, 1368, 1212, 1183, 1109, 1018 cm-1; HRMS(EI) calcd for C18H26O3Si (M
+) 
318.1651, found 318.1649. 
 
(E)-2-(2-(Dimethyl(phenyl)silyl)prop-1-enyl)dihydro-2H-pyran-4(3H)-one 
(2.85)  
The general procedure of cyclization reaction was followed: 2.72 (72 mg, 0.23 mmol), 2,6-
dichloropyridine (67 mg, 0.46 mmol) and 4 Å molecular sieves (140 mg) were dissolved in 2.3 
mL anhydrous 1,2-dichloroethane, followed by LiClO4 (7.2 mg, 0.068 mmol) and DDQ (154 
mg, 0.678 mmol). The reaction was stirred at 45 °C for 17 h and then quenched by 5% aqueous 
NaHCO3. The crude mixture was extracted with CH2Cl2. After concentration, it was purified by 
 157
flash chromatography (10%-15% EtOAc in hexane) to give the desired product (58 mg, 94%). 
1H 
NMR (300 MHz, CDCl3)  7.51-7.48 (m, 2H), 7.38-7.35 (m, 3H), 5.84 (qd, J = 1.7, 7.2 Hz, 1H), 
4.55-4.48 (m, 1H), 4.33 (ddd, J = 1.4, 7.3, 11.4 Hz, 1H), 3.75 (dt, J = 2.7, 12.1 Hz, 1H), 2.64 
(ddd, J = 7.3, 12.2, 14.5 Hz, 1H), 2.42-2.32 (m, 3H), 1.72 (d, J = 1.7 Hz, 3H), 0.38 (s, 6H); 13C 
(75 MHz, CDCl3)  206.7, 139.3, 139.0, 137.5, 134.2, 129.4, 128.1, 75.2, 66.8, 48.0, 42.5, 15.6, -
3.5, -3.6; IR (neat) 2956, 2918, 2850, 1717, 1247, 1157, 1111, 1082 cm-1; HRMS(EI) calcd for 
C16H22O2Si (M
+) 274.1389, found 274.1388. 
 
(E)-4-(2-(Dimethyl(phenyl)silyl)but-2-enyloxy)but-1-en-2-yl acetate (2.73) 
Compound 2.73 was prepared following the same synthetic route to 2.72. 
1H NMR (600 MHz, CDCl3)  7.53-7.52 (m, 2H), 7.35-7.33 (m, 3H), 5.99 (tq, J = 1.3, 6.7 Hz, 
1H), 4.76 (s, 1H), 4.73 (s, 1H), 4.12 (s, 2H), 3.41 (t, J = 6.8 Hz, 2H), 2.40 (t, J = 6.7 Hz, 2H), 
2.13 (s, 3H), 1.74 (d, J = 6.8 Hz, 3H), 0.38 (s, 6H); 13C (151 MHz, CDCl3)  169.4, 153.7, 139.2, 
139.1, 138.0, 134.3, 128.9, 127.8, 103.1, 69.3, 67.5, 34.1, 21.3, 15.2, -2.2; IR (neat) 2956, 2858, 
1756, 1427, 1368, 1212, 1182, 1108 cm-1; HRMS(ESI) calcd for C18H26O3SiNa (M+Na)
+ 
341.1549, found 341.1556. 
 
(E)-2-(1-(Dimethyl(phenyl)silyl)prop-1-enyl)dihydro-2H-pyran-4(3H)-one 
(E-2.86) 
The general procedure of cyclization reaction was followed: 2.73 (49 mg, 0.15 mmol), 2,6-
dichloropyridine (46 mg, 0.31 mmol) and 4 Å molecular sieves (100 mg) were dissolved in 1.5 
mL anhydrous 1,2-dichloroethane, followed by LiClO4 (5 mg, 0.05 mmol) and DDQ (140 mg, 
0.617 mmol). The reaction was stirred at 45 °C for 24 h and then quenched by 5% aqueous 
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NaHCO3. The crude mixture was extracted with CH2Cl2. After concentration, it was purified by 
flash chromatography (30% CH2Cl2 in hexane then 5% EtOAc in hexane) to give the desired 
product (29 mg, 69%, E:Z = 1.1:1). 1H NMR (500 MHz, CDCl3)  7.59-7.57 (m, 2H), 7.35-7.33 
(m, 3H), 5.85 (dq, J = 1.3, 6.8 Hz, 1H), 4.60 (dd, J = 2.1, 11.4 Hz, 1H), 4.30 (dd, J = 7.3, 11.4 
Hz, 1H), 3.63 (dt, J = 2.4, 12.4 Hz, 1H), 2.41 (ddd, J = 7.4, 13.7, 13.7 Hz, 1H), 2.25-2.12 (m, 
3H), 1.67 (d, J = 6.8 Hz, 3H), 0.47 (s, 3H), 0.44 (s, 3H); 13C (75 MHz, CDCl3)  207.0, 141.8, 
139.4, 136.3, 134.3, 128.8, 127.5, 79.4, 66.4, 47.7, 42.3, 15.2, -1.0, -1.5; IR (neat) 2959, 2920, 
2852, 1719, 1247, 1157, 1108, 817 cm-1; HRMS(EI) calcd for C15H19O2Si (M
+-CH3) 259.1154, 
found 259.1146. 
 
(Z)-2-(1-(Dimethyl(phenyl)silyl)prop-1-enyl)dihydro-2H-pyran-4(3H)-one  
(Z-2.86) 
1H NMR (600 MHz, CDCl3)  7.56-7.54 (m, 2H), 7.36-7.35 (m, 3H), 6.44 (dq, J = 1.0, 7.0 Hz, 
1H), 4.25 (ddd, J = 1.4, 7.4, 11.4 Hz, 1H), 4.10-4.08 (m, 1H), 3,53 (dt, J = 2.9, 11.8 Hz, 1H), 
2.58-2.52 (m, 2H), 2.43 (td, J = 2.3, 14.2 Hz, 1H), 2.32-2.28 (m, 1H), 1.69 (d, J = 6.7, 3H), 0.48 
(s, 3H), 0.46 (s, 3H); 13C (75 MHz, CDCl3)  207.6, 139.7, 138.9, 138.1, 133.8, 128.9, 127.8, 
81.6, 66.2, 48.2, 42.2, 18.0, -0.8, -0.9; IR (neat) 2958, 2919, 2852, 1719, 1243, 1156, 1110, 816 
cm-1; HRMS(EI) calcd for C15H19O2Si (M
+-CH3) 259.1154, found 259.1151. 
 
(E)-4-(3-(Dimethyl(thiophen-2-yl)silyl)but-2-enyloxy)but-1-en-2-yl acetate 
(2.74)  
Compound 2.74 was prepared from 1.80 following the same synthetic route to substrate 2.72.  
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1H NMR (300 MHz, CDCl3)  7.61 (dd, J = 0.8, 4.6 Hz, 1H), 7.27-7.26 (m, 1H), 7.19 (dd, J = 
3.3, 4.6 Hz, 1H), 5.97 (qt, J = 1.7, 5.6 Hz, 1H), 4.82 (s, 1H), 4.81 (d, J = 1.5 Hz, 1H), 4.13 (dd, J 
= 0.9, 5.6 Hz, 2H), 3.58 (t, J = 6.6 Hz, 2H), 2.53 (t, J = 6.5 Hz, 2H), 2.13 (s, 3H), 1.73-1.72 (m, 
3H), 0.41 (s, 6H); 13C (75 MHz, CDCl3)  169.4, 153.7, 137.7, 135.1, 131.1, 128.4, 103.2, 68.1, 
67.6, 34.1, 21.3, 15.3, -2.3; IR (neat) 2957, 2917, 2853, 1756, 1666, 1368, 1250, 1213, 1183, 
1107, 991 cm-1; HRMS(EI) calcd for C16H24O3SiS (M
+) 324.1219, found 324.1215. 
 
(E)-2-(2-(Dimethyl(thiophen-2-yl)silyl)prop-1-enyl)dihydro-2H-pyran-
4(3H)-one (2.87)  
The general procedure of cyclization reaction was followed: 2.74 (38 mg, 0.12 mmol), 2,6-
dichloropyridine (35 mg, 0.24 mmol) and 4 Å molecular sieves (75 mg) were dissolved in 1.2 
mL anhydrous 1,2-dichloroethane, followed by LiClO4 (4 mg, 0.04 mmol) and DDQ (107 mg, 
0.471 mmol). The reaction was stirred at 45 °C for 8 h and then quenched by 5% aqueous 
NaHCO3. The crude mixture was extracted with CH2Cl2. After concentration, it was purified by 
flash chromatography (15% EtOAc in hexane) to give the desired product (28 mg, 86%). 
1H 
NMR (600 MHz, CDCl3)  7.63 (d, J = 4.7 Hz, 1H), 7.27 (d, J = 3.2 Hz, 1H), 7.20 (dd, J = 3.4, 
4.5 Hz, 1H), 5.87 (qd, J = 1.6, 7.2 Hz, 1H), 4.50 (ddd, J = 5.2, 7.3, 8.7 Hz, 1H), 4.33 (ddd, J = 
1.0, 7.4, 11.5 Hz, 1H), 3.75 (dt, J = 2.7, 12.1 Hz, 1H), 2.64 (ddd, J = 7.4, 12.5, 14.4 Hz, 1H), 
2.42-2.40 (m, 2H), 2.37-2.34 (m, 1H), 1.76 (d, J = 1.6 Hz, 3H), 0.42 (s, 6H); 13C (151 MHz, 
CDCl3)  206.7, 139.1, 138.8, 137.0, 135.3, 131.3, 128.4, 75.1, 66.8, 47.8, 42.5, 15.5, -2.3, -2.4; 
IR (neat) 2959, 2920, 2852, 1718, 1249, 990, 807 cm-1; HRMS(EI) calcd for C14H20O2SiS (M
+) 
280.0953, found 280.0948. 
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(Z)-4-(2-(Dimethyl(phenyl)silyl)hept-2-enyloxy)but-1-en-2-yl acetate (2.75) 
To a solution of 2.82 (1.2 mL, 10 mmol) in THF (20 mL) was added nBuLi (1.6 
M, 6.9 mL) dropwise at ‒78 °C. After 1 h at that temperature, PhMe2SiCl (1.7 mL, 10 mmol) 
was added and the mixture was stirred from ‒78 °C to room temperature for 3 h. The reaction 
was quenched with saturated NH4Cl (aq), and extracted with Et2O. The organic layer was dried 
over MgSO4 and filtered. After concentration, the residue was purified by flash chromatography 
(3% EtOAc in hexane) to give 2.83 (2.3 g, >99%). 
To a solution of DIBAL-H (1 M solution in hexane, 11.7 mL) in Et2O (4 mL) was added 2.83 
(2.30 g, 10.6 mmol) in Et2O (4 mL) dropwise at 0 °C. After stirring at room temperature for 3 h, 
it was cooled to 0 °C, and MeLi (1.6 M in hexane, 7.3 mL) was added. After another 1 h, the 
solution was transferred via cannula to para-formaldehyde in Et2O (6 mL) at 0 °C, and the 
mixture was stirred at room temperature overnight. The mixture was quenched by 1 M HCl at 0 
°C, and extracted with Et2O. The organic layer was dried over MgSO4, and filtrated. After 
concentration, it was purified by flash chromatography (8% EtOAc in hexane) to afford 2.84 
(2.18 g, 83%). 
Compound 2.75 was prepared from 2.84 following the same synthetic route to substrate 2.72.  
1H NMR (500 MHz, CDCl3)  7.56-7.54 (m, 2H), 7.34-7.32 (m, 3H), 6.27 (t, J = 7.5 Hz, 1H), 
4.78 (s, 2H), 3.99 (s, 2H), 3.44 (t, J = 6.9 Hz, 2H), 2.48 (t, J = 6.8 Hz, 2H), 2.13 (s, 3H), 1.98 (q, 
J = 7.3 Hz, 2H), 1.23-1.12 (m, 4H), 0.77 (t, J = 7.2 Hz, 3H), 0.42 (s, 6H); 13C (125 MHz, CDCl3) 
 169.4, 153.8, 148.2, 139.7, 134.2, 134.0, 128.9, 127.8, 103.1, 77.9, 66.8, 34.2, 32.0, 31.8, 22.6, 
21.3, 14.1, -1.2; IR (neat) 2956, 2927, 2856, 1757, 1368, 1211, 1183, 1106, 817 cm-1; 
HRMS(ESI) calcd for C21H32O3SiNa (M+Na)
+ 383.2018, found 383.20175. 
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(Z)-2-(1-(Dimethyl(phenyl)silyl)hex-1-enyl)dihydro-2H-pyran-4(3H)-one 
(2.88)  
The general procedure of cyclization reaction was followed: 2.75 (40 mg, 0.11 mmol), 2,6-
dichloropyridine (33 mg, 0.22 mmol) and 4 Å molecular sieves (80 mg) were dissolved in 1.1 
mL anhydrous 1,2-dichloroethane, followed by LiClO4 (3.5 mg, 0.033 mmol) and DDQ (100 
mg, 0.44 mmol). The reaction was stirred at 40 °C for 5.5 h and then quenched by 5% aqueous 
NaHCO3. The crude mixture was extracted with CH2Cl2. After concentration, it was purified by 
flash chromatography (10% EtOAc in hexane) to give the desired product (29 mg, 82%). 
1H 
NMR (600 MHz, CDCl3)  7.55-7.54 (m, 2H), 7.35-7.34 (m, 3H), 6.30 (t, J = 7.4 Hz, 1H), 4.26 
(ddd, J = 1.1, 7.6, 11.3 Hz, 1H), 4.08 (d, J = 9.9 Hz, 1H), 3.54 (dt, J = 2.9, 11.8 Hz, 1H), 2.58-
2.52 (m, 2H), 2.44 (td, J = 2.2, 14.2 Hz, 1H), 2.32-2.29 (m, 1H), 2.01 (q, J = 7.4 Hz, 2H), 1.26-
1.14 (m, 4H), 0.78 (t, J = 7.3 Hz, 3H), 0.46 (s, 3H), 0.45 (s, 3H); 13C (151 MHz, CDCl3)  207.8, 
145.7, 139.4, 137.0, 134.0, 129.1, 127.9, 81.8, 66.4, 48.5, 42.4, 32.0, 31.7, 22.5, 14.1, -0.4, -0.6; 
IR (neat) 2958, 2926, 2854, 1720, 1246, 1110, 816 cm-1; HRMS(EI) calcd for C19H28O2Si (M
+) 
316.1859, found 316.1852. 
 
2-((Z)-Prop-1-en-1-yl)tetrahydro-2H-pyran-4-ol (2.90) 
To 2.85 (40 mg, 0.15 mmol) in 1.4 mL MeOH at ‒10 °C was added NaBH4 (4.0 mg, 
0.11 mmol) in one portion. The mixture was stirred at that temperature for 10 minutes before it 
was quenched with 3 drops of H2O. After concentration, it was purified by flash chromatography 
(30% EtOAc in hexane) to give 2.89 (35 mg, 87%). 
To 2.89 (15 mg, 0.054 mmol) in 0.9 mL THF and 3 mL HMPA was added TBAF (1 M in THF, 
271 µL), and the mixture was heated to 80 °C for 1.5 h.8 Then the reaction was diluted with 
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EtOAc, and washed with H2O. The organic layer was concentrated and the residue was purified 
by flash chromatography (10% hexane in Et2O) to give the desired product (7 mg, 91%). 
1H 
NMR (300 MHz, CDCl3)  5.60 (dq, J = 1.1, 11.0 Hz, 1H), 5.43 (qdd, J = 1.6, 7.8, 11.1 Hz, 1H), 
4.17-4.11 (m, 1H), 4.06 (ddd, J = 1.7, 4.9, 11.8 Hz, 1H), 3.84 (tt, J = 4.7, 11.0 Hz, 1H), 3.48 (dt, 
J = 2.1, 12.3 Hz, 1H), 1.97-1.87 (m, 2H), 1.69 (dd, J = 1.7, 6.8 Hz, 3H), 1.56-1.47 (m, 1H), 1.41-
1.29 (m, 1H); 13C (125 MHz, CDCl3)  131.0, 127.0, 72.4, 68.3, 66.0, 41.7, 35.7, 13.7; IR (neat) 
3383, 2922, 2852, 1073 cm-1; HRMS(EI) calcd for C8H14O2 (M
+) 142.0994, found 142.0989. 
 
2-(4-(tert-Butyldimethylsilyloxy)-2-oxobutyl)dihydro-2H-pyran-4(3H)-
one (2.91)  
To the mixture of 2.70 and 2.71 (9 mg) in 0.2 mL THF under a N2 atmosphere, 0.06 mL of 
TBAF in THF (1 M, 0.06 mmol) was added. The resulting mixture was stirred for 15 minutes 
before KHCO3 (15 mg, 0.15 mmol), KF (9.0 mg, 0.15 mmol), 0.3 mL MeOH and H2O2 (30-
32 wt. % in H2O, 0.15 mL) were added.
9 After 31 h, the mixture was quenched with saturated 
Na2S2O3 (aq), and extracted with EtOAc. After concentration, the alcohol was obtained and used 
as such. To the alcohol in 1 mL CH2Cl2 was added imidazole (3 mg, 0.04 mmol) and TBSCl (5.4 
mg, 0.040 mmol). After 30 minutes, the mixture was concentrated and the residue was purified 
by flash chromatography (20% EtOAc in CH2Cl2) to give the desired product (7.9 mg, 75% over 
three steps). 1H NMR (300 MHz, CDCl3)  4.26 (dd, J = 7.4, 11.5 Hz, 1H), 4.16-4.07 (m, 1H), 
3.90 (t, J = 6.2 Hz, 2H), 3.70 (dt, J = 2.9, 12.0 Hz, 1H), 2.89 (dd, J = 7.4, 16.5 Hz, 1H), 2.68-
2.52 (m, 4H), 2.48 (td, J = 2.3, 14.6 Hz, 1H), 2.37-2.26 (m, 2H), 0.88 (s, 9H), 0.06 (s, 6H); 13C 
(125 MHz, CDCl3)  206.8, 206.1, 73.9, 66.7, 58.8, 49.8, 48.0, 46.8, 42.1, 29.9, 26.1, -5.2; IR 
 163
(neat) 2955, 2929, 2857, 1717, 1472, 1375, 1254, 1089, 836 cm-1; HRMS(EI) calcd for 
C11H19O4Si (M
+-C4H9) 243.1053, found 243.1056. 
 
(2R,6R)-2-Hexyl-6-((Z)-2-phenylhept-1-enyl)dihydro-2H-pyran-4(3H)-
one (2.92) 
To the vinyl silane 2.69 (18 mg, 0.040 mmol) in 0.4 mL THF under a N2 atmosphere, 0.09 mL of 
TBAF in THF (1 M, 0.09 mmol) was added. The resulting mixture was stirred for 15 minutes 
before PhI (6 µL, 0.05 mmol) and Pd2(dba)3 were added.
10 After another 30 minutes, the mixture 
was filtered through a short silica gel pad with CH2Cl2 and Et2O. After concentration, it was 
purified by flash chromatography (8% Et2O in hexane) to give the desired product (12 mg, 82%). 
1H NMR (600 MHz, CDCl3)  7.33 (dd, J = 7.1, 7.4 Hz, 2H), 7.29 (d, J = 7.3 Hz, 1H), 7.18 (d, J 
= 6.9 Hz, 2H), 5.50 (d, J = 8.8 Hz, 1H), 3.94 (ddd, J = 2.5, 8.9, 11.3 Hz, 1H), 3.44-3.40 (m, 1H), 
2.42-2.33 (m, 3H), 2.31-2.28 (m, 2H), 2.21 (dd, J = 11.5, 14.3 Hz, 1H), 1.71-1.67 (m, 1H), 1.50-
1.45 (m, 2H), 1.36-1.27 (m, 13H), 0.90 (t, J = 6.6 Hz, 3H), 0.85 (t, J = 6.8 Hz, 3H); 13C (151 
MHz, CDCl3)  207.3, 146.9, 140.2, 128.2, 127.9, 127.3, 125.5, 76.5, 74.5, 48.1, 47.8, 39.0, 
36.5, 31.8, 31.5, 29.1, 27.4, 25.4, 22.6, 22.5, 14.1, 14.0; IR (neat) 2954, 2926, 2856, 1719, 1045 
cm-1; HRMS(ESI) calcd for C24H36O2K (M+K)
+ 395.2352, found 395.2388. 
 
(E)-2-(2-Phenylprop-1-enyl)dihydro-2H-pyran-4(3H)-one (2.93) 
To the vinyl silane 2.75 (15 mg, 0.050 mmol) in 0.4 mL THF under a N2 
atmosphere, 0.11 mL of TBAF in THF (1 M, 0.11 mmol) was added. The resulting mixture was 
stirred for 10 minutes before PhI (7 µL, 0.06 mmol) and Pd2(dba)3 were added. After another 20 
minutes, the mixture was filtered through a short silica gel pad with CH2Cl2 and Et2O. After 
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concentration, it was purified by flash chromatography (15% EtOAc in hexane) to give the 
desired product (9.7 mg, 85%). 1H NMR (500 MHz, CDCl3)  7.42 (d, J = 7.6 Hz, 2H), 7.34 (t, J 
= 7.2 Hz, 2H), 7.29 (t, J = 7.2 Hz, 1H), 5.81 (dd, J = 0.9, 7.7 Hz, 1H), 4.54 (dt, J = 5.4, 8.2 Hz, 
1H), 4.37 (ddd, J = 0.9, 7.2, 11.4 Hz, 1H), 3.81 (dt, J = 2.8, 11.8 Hz, 1H), 2.67 (ddd, J = 7.3, 
12.2, 14.6 Hz, 1H), 2.52-2.50 (m, 2H), 2.41-2.38 (m, 1H), 2.11 (d, J = 0.7 Hz, 3H); 13C (151 
MHz, CDCl3)  206.7, 142.6, 139.3, 128.5, 127.9, 126.7, 126.1, 75.7, 66.7, 48.4, 42.5, 16.8; IR 
(neat) 2964, 2920, 2852, 1717, 1367, 1249, 1153, 1080, 757 cm-1; HRMS(EI) calcd for C14H16O2 
(M+) 216.1150, found 216.1144. 
 
(E)-2-(4-Hydroxy-2-phenylbut-1-enyl)dihydro-2H-pyran-4(3H)-one (2.94) 
To the mixture of 2.70 and 2.71 (15 mg) in 0.55 mL THF under a N2 
atmosphere, 0.1 mL of TBAF in THF (1 M, 0.1 mmol) was added. The resulting mixture was 
stirred for 25 minutes before PhI (12 µL, 0.1 mmol) and Pd2(dba)3 were added. After 5 h, the 
reaction was quenched by H2O, and the crude mixture was extracted with EtOAc. After 
concentration, it was purified by flash chromatography (70% EtOAc in hexane) to give the 
desired product (10 mg, 69% over two steps). 1H NMR (600 MHz, CDCl3)  7.39-7.32 (m, 5H), 
5.83 (d, J = 7.8 Hz, 1H), 4.55 (q, J = 7.4 Hz, 1H), 4.36 (dd, J = 7.3, 11.4 Hz, 1H), 3.84 (dt, J = 
2.8, 11.9 Hz, 1H), 3.70-3.65 (m, 1H), 3.62-3.56 (m, 1H), 2.89-2.81 (m, 2H), 2.67 (ddd, J = 7.3, 
12.2, 14.7 Hz, 1H), 2.57-2.56 (m, 2H), 2.42-2.40 (m, 1H), 2.07 (t, J = 5.4 Hz, 1H); 13C (151 
MHz, CDCl3)  206.2, 142.6, 141.1, 129.4, 128.8, 128.2, 126.9, 74.8, 66.6, 60.6, 48.5, 42.3, 
34.3; IR (neat) 3359, 2922, 2854, 1714, 1650, 1367, 1246, 1041, 761 cm-1; HRMS(EI) calcd for 
C15H18O3 (M
+) 246.1256, found 246.1249. 
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(2R,4S)-2-((E)-2-(Dimethyl(phenyl)silyl)prop-1-enyl)tetrahydro-2H-
pyran-4-ol (2.101) 
To a solution of 2.85 (40 mg, 0.15 mmol) in MeOH (1.4 mL) at ‒10 °C was added NaBH4 (4 mg, 
0.1 mmol) in one portion. After stirring at that temperature for 10 minutes, the reaction was 
quenched with H2O. After concentration, it was purified by flash chromatography (30% EtOAc 
in hexane) to give the desired alcohol (35 mg, 87%). 1H NMR (300 MHz, CDCl3)  7.51-7.48(m, 
2H), 7.37-7.34 (m, 3H), 5.81 (qd, J = 1.5, 7.2 Hz, 1H), 4.21 (ddd, J = 1.8, 7.3, 11.1 Hz, 1H), 4.06 
(dd, J = 1.6, 5.0, 11.8 Hz, 1H), 3.84 (tt, J = 4.7, 11.0 Hz, 1H), 3.48 (dt, J = 2.1, 12.4 Hz, 1H), 
1.99-1.87 (m, 2H), 1.71 (d, 1.7 Hz, 3H), 1.66-1.50 (m, 2H), 0.36 (s, 6H); 13C (125 MHz, CDCl3) 
 140.6, 138.0, 137.4, 134.2, 129.2, 128.0, 73.5, 68.2, 66.0, 41.1, 35.7, 15.5, -3.4, -3.5; IR (neat) 
3371, 2950, 2850, 1427, 1361, 1247, 1110, 1077, 832, 813 cm-1; HRMS(EI) calcd for 
C16H24O2Si (M
+) 276.1546, found 276.1537. 
 
General procedure for Crabtree’s catalyst catalyzed hydrogenation of vinyl silane:11 
A mixture of vinyl silane (1 eq) and Crabtree’s catalyst (0.02 eq) in CH2Cl2 (0.02-0.04 M final 
substrate concentration) was evacuated and back-filled with H2 three times. The mixture was 
stirred under H2 atmosphere for 10 minutes, before another portion of Crabtree’s catalyst (0.02 
eq) was added, and the mixture was evacuated and back-filled with H2 three times. More 
Crabtree’s catalyst was added every 10 minutes until the reaction was complete monitored by 
TLC. The mixture was concentrated and the residue was purified by flash chromatography to 
give the desired product. 
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(2R,4S)-2-((S)-2-(Dimethyl(phenyl)silyl)propyl)tetrahydro-2H-pyran-4-ol 
(2.102)  
The general procedure of Crabtree’ catalyst catalyzed hydrogenation reaction was followed: A 
mixture of 2.101 (30 mg, 0.11 mmol) and Crabtree’s catalyst (1.7 mg, 0.002 mmol) in CH2Cl2 (3 
mL) was evacuated and back-filled with H2 three times. The mixture was stirred under H2 
atmosphere for 5 h, before another portion of Crabtree’s catalyst (1.7 mg, 0.0021 mmol) was 
added, and the mixture was evacuated and back-filled with H2 three times. After 1 h, more 
Crabtree’s catalyst (1.7 mg, 0.0021 mmol) was added, and 1.5 h later, the mixture was 
concentrated and the residue was purified by flash chromatography (25% EtOAc in hexane) to 
give the desired product (27 mg, 89%). 1H NMR (600 MHz, CDCl3)  7.52-7.50 (m, 2H), 7.36-
7.35 (m, 3H), 4.01 (dd, J = 4.4, 11.8 Hz, 1H), 3.76-3.70 (m, 1H), 3.36-3.30 (m, 2H), 1.88-1.82 
(m, 2H), 1.69 (ddd, J = 2.7, 9.5, 13.0 Hz, 1H), 1.51-1.44 (m, 2H), 1.22-1.15 (m, 2H), 0.92 (d, J = 
7.1 Hz, 3H), 0.27 (s, 3H), 0.26 (s, 3H); 13C (75 MHz, CDCl3)  138.5, 134.2, 129.0, 127.9, 73.5, 
68.6, 66.1, 42.6, 38.1, 36.0, 14.8, 13.9, -4.7, -4.9; IR (neat) 3364, 2943, 2847, 1247, 1081, 1027, 
813 cm-1; HRMS(EI) calcd for C15H23O2Si (M
+-CH3) 263.1467, found 263.1461. 
 
General procedure for Fleming oxidation reactions:12 
Potassium bromide (1.2 eq) and anhydrous sodium acetate (3.1 eq) were added to a stirred 
solution of the dimethylphenylsilane (1 eq) in glacial acetic acid (~0.17 M substrate 
concentration). Then peracetic acid (10 eq, 32 wt. % in dilute acetic acid) was added dropwise to 
the mixture at 0 °C. More sodium acetate (9.3 eq) and peracetic acid (30 eq) were added to the 
mixture and the mixture was stirred at room temperature for specified time. After the addition of 
ether and powdered Na2S2O3 to the mixture, it was stirred vigorously for 30 minutes, filtered 
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through Celit with Et2O, and the filtrate was washed with aqueous NaHCO3. After concentration, 
the residue was purified by flash chromatography to give the desired alcohol. 
 
(2S,4S)-2-((S)-2-Hydroxypropyl)tetrahydro-2H-pyran-4-ol (2.103) 
The general procedure of Fleming oxidation reaction was followed: KBr (4 mg, 0.03 
mmol) and NaOAc (6.5 mg, 0.079 mmol) were added to a stirred solution of the 2.102 (7 mg, 
0.02 mmol) in glacial acetic acid (120 µL). Then peracetic acid (32 µL) was added dropwise to 
the mixture at 0 °C. 1.5 h later, ether and powdered Na2S2O3 were added to the mixture. The 
mixture was stirred vigorously for 30 minutes, filtered through Celit with Et2O, and the filtrate 
was washed with aqueous NaHCO3. After concentration, the residue was purified by flash 
chromatography (90% EtOAc in hexane) to give the desired product (3.2 mg, 80%, dr = 9:1). 1H 
NMR (600 MHz, CDCl3)  4.07-3.99 (m, 2H), 3.80 (tt, J = 4.7, 10.7 Hz, 1H), 3.75 (s, 1H), 3.57-
3.53 (m, 1H), 3.44 (dt, J = 1.4, 12.1 Hz, 1H), 1.95-1.90 (m, 2H), 1.67 (dt, J = 4.7, 9.9 Hz, 2H), 
1.55-1.49 (m, 1H), 1.32-1.28 (m, 1H), 1.18 (d, J = 6.1 Hz, 3H); 13C (151 MHz, CDCl3)  77.7, 
68.3, 67.9, 66.2, 44.6, 42.1, 35.6, 23.6; IR (neat) 3417, 2956, 2848, 1643 cm-1; HRMS(EI) calcd 
for C8H14O2 (M
+-H2O) 142.0994, found 142.0989. 
 
(2R,4R)-2-((E)-2-(Dimethyl(phenyl)silyl)prop-1-en-1-yl)tetrahydro-2H-
pyran-4-ol (2.104) 
To a solution of 2.85 (33 mg, 0.12 mmol) in THF (6 mL) at ‒90 °C was added L-Selectride (180 
µL, 0.180 mmol, 1 M in THF) dropwise over 5 minutes. After stirring at that temperature for 45 
minutes, the reaction was quenched with saturated potassium sodium tartrate (aq). The mixture 
was diluted with Et2O, and stirred at room temperature for 1 h. Then the mixture was extracted 
with EtOAc. After concentration, it was purified by flash chromatography (20% EtOAc in 
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hexane) to give the desired alcohol (25 mg, 75%). 1H NMR (500 MHz, CDCl3)  7.50-7.48 (m, 
2H), 7.35-7.34 (m, 3H), 5.78 (dd, J = 1.5, 7.3 Hz, 1H), 4.72-4.68 (m, 1H), 4.29-4.23 (m, 1H), 
3.96 (dt, J = 2.1, 12.3 Hz, 1H), 3.82 (dd, J = 3.9, 11.5 Hz, 1H), 1.94-1.87 (m, 1H), 1.74 (d, J = 
1.4 Hz, 3H), 1.70-1.66 (m, 2H), 0.99-0.91 (m, 1H), 0.35 (s, 6H); 13C (125 MHz, CDCl3)  141.2, 
138.1, 137.4, 134.2, 129.2, 128.0, 69.0, 64.3, 62.3, 38.6, 33.1, 15.6, -3.3, -3.5; IR (neat) 3416, 
2952, 2920, 2867, 1427, 1248, 1110, 1059, 832, 813 cm-1; HRMS(EI) calcd for C16H24O2Si (M
+) 
276.1546, found 276.1555. 
 
(2R,4R)-2-((S)-2-(Dimethyl(phenyl)silyl)propyl)tetrahydro-2H-pyran-4-ol 
(2.105)  
The general Crabtree’ catalyst mediated hydrogenation reaction procedure was followed with a 
mixture of 2.104 (21 mg, 0.076 mmol) and Crabtree’s catalyst (1.4 mg, 0.0017 mmol) in CH2Cl2 
(1.7 mL). The mixture was stirred under H2 for 1 h and another portion of Crabtree’s catalyst 
(1.4 mg, 0.0017 mmol) was added. After 30 minutes the mixture was concentrated and the 
residue was purified by flash chromatography (30% EtOAc in hexane) to give the desired 
product (19 mg, 90%). 1H NMR (600 MHz, CDCl3)  7.52-7.51(m, 2H), 7.36-7.35 (m, 3H), 4.20 
(t, J = 3.0 Hz, 1H), 3.84-3.70 (m, 3H), 1.82 (ddt, J = 2.7, 5.6, 14.2 Hz, 1H), 1.62 (ddd, J = 3.5, 
9.7, 13.4 Hz, 1H), 1.52-1.44 (m, 3H), 1.22 (m, 1H), 1.09 (ddd, J = 3.2, 11.8, 14.1 Hz, 1H), 0.95 
(d, J = 7.3 Hz, 3H), 0.27 (s, 3H), 0.26 (s, 3H); 13C (125 MHz, CDCl3)  138.7, 134.3, 129.0, 
127.9, 68.7, 64.5, 62.5, 39.9, 38.0, 33.4, 14.7, 13.9, -4.7, -4.8; IR (neat) 3419, 2921, 2863, 1248, 
1110, 1069, 814 cm-1; HRMS(EI) calcd for C15H23O2Si (M
+-CH3) 263.1467, found 263.1459. 
 
 
 169
(2S,4R)-2-((S)-2-Hydroxypropyl)tetrahydro-2H-pyran-4-ol (2.106) 
The general Fleming oxidation reaction procedure was followed with 2.105 (14 mg, 
0.050 mmol), KBr (8 mg, 0.07 mmol), NaOAc (13 mg, 0.16 mmol), glacial acetic acid (200 μL), 
and peracetic acid (64 μL). The reaction was stirred at room temperature for 0.5 h and purified 
by flash chromatography (10% hexane in EtOAc) to give the desired product (6.3 mg, 79%). 1H 
NMR (600 MHz, CDCl3)  4.24 (br, 1H), 4.06-4.01 (m, 2H), 3.92 (t, J = 12.7 Hz, 1H), 3.82 (dd, 
J = 5.3, 11.4 Hz, 1H), 3.79 (br, 1H), 1.88 (ddt, J = 3.2, 5.2, 15.6 Hz, 1H), 1.60-1.56 (m, 3H), 
1.49-1.46 (m, 2H), 1.17 (d, J = 6.2 Hz, 3H); 13C (151 MHz, CDCl3)  73.2, 68.3, 63.6, 62.2, 
44.4, 39.2, 32.8, 23.4; IR (neat) 3384, 2924, 1650, 1423, 1113, 1058 cm-1; HRMS(EI) calcd for 
C8H14O2 (M
+-H2O) 142.0994, found 142.0987. 
 
(2R,4S)-2-((Z)-2-(Dimethyl(phenyl)silyl)hept-1-enyl)tetrahydro-2H-pyran-4-
ol (2.107) 
To a solution of 2.68 (28 mg, 0.080 mmol) in MeOH (0.9 mL) at ‒10 °C was added NaBH4 (2 
mg, 0.05 mmol) in one portion. After stirring at that temperature for 15 minutes, the reaction was 
quenched with H2O. After concentration, it was purified by flash chromatography (15% EtOAc 
in hexane) to give the desired alcohol (24 mg, 85%). 1H NMR (600 MHz, CDCl3)  7.55-7.53(m, 
2H), 7.36-7.35 (m, 3H), 5.99 (d, J = 8.8 Hz, 1H), 3.87 (ddd, J = 1.1, 4.7, 11.7 Hz, 1H), 3.68 (dt, J 
= 1.8, 10.8 Hz, 1H), 3.43-3.39 (m, 1H), 3.02 (dt, J = 1.9, 12.3 Hz, 1H), 2.14 (t, J = 7.7 Hz, 2H), 
1.73 (qd, J = 1.9, 12.4 Hz, 1H), 1.60 (pd, J = 2.3, 12.4 Hz, 1H), 1.37-1.31 (m, 4H), 1.30-1.24 (m, 
4H), 0.87 (t, J = 6.7 Hz, 3H), 0.43 (s, 3H), 0.38 (s, 3H); 13C (151 MHz, CDCl3)  142.5, 142.4, 
139.7, 134.0, 129.1, 128.0, 75.6,  68.1, 65.6, 41.5, 38.2, 35.4, 31.9, 30.2, 22.7, 14.3, -0.6, -0.9; IR 
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(neat) 3379, 2955, 2926, 2854, 1427, 1364, 1250, 1110, 1076, 833, 815 cm-1; HRMS(EI) calcd 
for C20H32O2Si (M
+) 332.2172, found 332.2170. 
 
(2S,4S)-2-((R)-2-Hydroxyheptyl)tetrahydro-2H-pyran-4-ol (2.109) 
The general Crabtree’ catalyst mediated hydrogenation reaction procedure was 
followed with a mixture of 2.107 (10 mg, 0.030 mmol) and Crabtree’s catalyst (0.5 mg, 0.0006 
mmol) in CH2Cl2 (1 mL). The mixture was stirred under H2 for 10 minutes and another portion 
of Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was added. The mixture was stirred under H2 for 
another 15 minutes and the other portion of Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was 
added. After 10 minutes the mixture was concentrated and the residue was purified by flash 
chromatography (20% EtOAc in hexane) to give 2.108. The general Fleming oxidation reaction 
procedure was followed with 2.108 from last step, KBr (3.4 mg, 0.029 mmol), NaOAc (6 mg, 
0.07 mmol), glacial acetic acid (110 μL), and peracetic acid (30 μL). The reaction was stirred at 
room temperature for 1 h and purified by flash chromatography (25% hexane in EtOAc) to give 
the desired product (4 mg, 65% over two steps). 1H NMR (500 MHz, CDCl3)  4.03 (dd, J = 3.9, 
11.8 Hz, 1H), 3.88 (br, 1H), 3.82 (tt, J = 4.7, 10.9 Hz, 1H), 3.65-3.61 (m, 1H), 3.41 (dt, J = 1.6, 
12.4 Hz, 1H), 2.50 (br, 1H), 1.91-1.88 (m, 2H), 1.69 (ddd, J = 2.5, 8.1, 14.6 Hz, 1H), 1.56-1.36 
(m, 6H), 1.35-1.28 (m, 5H), 0.90 (t, J = 6.6 Hz, 3H); 13C (125 MHz, CDCl3)  73.8, 68.7, 68.1, 
66.0, 42.3, 41.4, 37.5, 35.6, 31.9, 25.5, 22.7, 14.1; IR (neat) 3385, 2923, 1651, 1427, 1110, 1059 
cm-1; HRMS(EI) calcd for C12H24O3Na (M+Na)
+ 239.1623, found 239.1618. 
 
(2S,4R)-2-((R)-2-Hydroxyheptyl)tetrahydro-2H-pyran-4-ol (2.112) 
To a solution of 2.68 (79 mg, 0.24 mmol) in THF (12 mL) at -90 °C was added 
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L-selectride (260 µL, 0.360 mmol, 1 M in THF) dropwise over 5 minutes. After stirring at that 
temperature for 40 minutes, the reaction was quenched with saturated potassium sodium tartrate 
(aq). The mixture was diluted with Et2O, and stirred at room temperature for 0.5 h. Then the 
mixture was extracted with EtOAc. After concentration, it was purified by flash chromatography 
(20% EtOAc in hexane) to give 2.110 (73 mg, 92%). The general Crabtree’ catalyst mediated 
hydrogenation reaction procedure was followed with a mixture of 2.110 (10 mg, 0.03 mmol) and 
Crabtree’s catalyst (0.5 mg, 0.0006 mmol) in CH2Cl2 (1 mL). The mixture was stirred under H2 
for 10 minutes and another portion of Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was added. The 
mixture was stirred under H2 for another 10 minutes and the other portion of Crabtree’s catalyst 
(0.5 mg, 0.0006 mmol) was added. After 10 minutes the mixture was concentrated and the 
residue was purified by flash chromatography (20% EtOAc in hexane) to give 2.111. The general 
Fleming oxidation reaction procedure was followed with 2.111 from last step, KBr (4.3 mg, 
0.036 mmol), NaOAc (9.7 mg, 0.12 mmol), glacial acetic acid (140 μL), and peracetic acid (40 
μL). The reaction was stirred at room temperature for 30 minutes and purified by flash 
chromatography (25% hexane in EtOAc) to give the desired product (5.6 mg, 86% over two 
steps). 1H NMR (600 MHz, CDCl3)  4.27-4.25 (m, 1H), 4.10 (tdd, J = 2.5, 8.2, 11.0 Hz, 1H), 
3.91-3.85 (m, 2H), 3.80 (dd, J = 5.0, 11.5 Hz, 1H), 2.78 (br,1H), 1.86 (ddt, J = 2.6, 5.2, 14.1 Hz, 
1H), 1.70 (ddd, J = 2.5, 11.7, 14.0 Hz, 1H), 1.66-1.63 (m, 1H), 1.61-1.59 (m, 1H), 1.58-1.49 (m, 
3H), 1.43-1.39 (m, 2H), 1.35-1.28 (m, 5H), 0.89 (t, J = 6.4 Hz, 3H); 13C (125 MHz, CDCl3)  
69.6, 69.1, 64.1, 62.6, 42.1, 38.8, 37.6, 33.1, 32.1, 25.8, 22.9, 14.3; IR (neat) 3383, 2927, 1649, 
1430, 1111, 1061 cm-1; HRMS(ESI) calcd for C12H24O3Na (M+Na)
+ 239.1623, found 239.1611. 
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(2R,4S,6S)-2-Hexyl-6-((R)-2-hydroxyheptyl)tetrahydro-2H-pyran-4-ol 
(2.124) 
To a solution of 2.115 (40 mg, 0.14 mmol) in MeOH (1.5 mL) at –10 °C was added NaBH4 (2.8 
mg, 0.074 mmol) in one portion. After stirring at that temperature for 15 minutes, the reaction 
was quenched with H2O. After concentration, it was purified by flash chromatography (15% 
EtOAc in hexane) to give the 2.117 (34 mg, 85%). To 2.117 (from last step) and 
dimethylphenylsilane (6 µL, 0.04 mmol) in acetone (0.25 mL) was added [Cp*Ru(MeCN)3]PF6 
(0.5 mg, 0.001 mmol) at 0 °C. After 10 minutes at 0 °C, the mixture was concentrated and 
purified by flash chromatography to give 2.119 (14 mg, 91%). The general Crabtree’ catalyst 
mediated hydrogenation reaction procedure was followed with a mixture of 2.119 (14 mg) and 
Crabtree’s catalyst (0.5 mg, 0.0006 mmol) in CH2Cl2 (1 mL). The mixture was stirred under H2 
for 10 minutes and another portion of Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was added. 
After 10 minutes the mixture was concentrated and the residue was purified by flash 
chromatography (15% EtOAc in hexane) to give (2R,4S,6R)-2-((R)-2-(dimethyl(phenyl)silyl)-
heptyl)-6-hexyltetrahydro-2H-pyran-4-ol. The general Fleming oxidation reaction procedure was 
followed with (2R,4S,6R)-2-((R)-2-(dimethyl(phenyl)silyl)heptyl)-6-hexyltetrahydro-2H-pyran-
4-ol (from last step), KBr (5 mg, 0.04 mmol), NaOAc (16 mg, 0.20 mmol), glacial acetic acid 
(150 μL), and peracetic acid (80 μL). The reaction was stirred at room temperature for 1.5 h and 
purified by flash chromatography (30% hexane in EtOAc) to give the desired product (2.5 mg, 
53% over two steps). 1H NMR (600 MHz, CDCl3)  3.92-3.86 (m, 1H), 3.83 (ddd, J = 4.6, 10.8, 
15.6 Hz, 1H), 3.68-3.64 (m, 1H), 3.32-3.29 (m, 1H), 2.89 (br, 1H), 1.97-1.94 (m, 1H), 1.88-1.85 
(m, 1H), 1.73-1.64 (m, 2H), 1.57-1.11 (m, 20H), 0.91-0.87 (m, 6H); 13C (151 MHz, CDCl3)  
76.0, 73.4, 68.9, 68.2, 41.6, 41.2, 40.9, 37.3, 36.0, 31.9, 31.8, 29.2, 25.6, 25.5, 22.7, 22.6, 14.1, 
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14.0; IR (neat) 3379, 2924, 2853, 1716, 1457 cm-1; HRMS(EI) calcd for C18H36O3 (M
+) 
300.2664, found 300.2650. 
 
(2R,4S,6R)-2-((E)-2-(Dimethyl(phenyl)silyl)hept-1-enyl)-6-hexyl-
tetrahydro-2H-pyran-4-ol (2.121) 
To a stirred solution of 2.117 (32 mg, 0.11 mmol) in 0.1 mL THF was added 
dimethylphenylsilane (20 µL, 0.13 mmol) and a solution of H2PtCl6•6H2O (0.001 M in THF, 114 
µL). The mixture was heated at 50 °C for 5 h, cooled and filtered through Celite with Et2O. The 
solvent was removed under vacuum and purified by flash chromatography (12% EtOAc in 
hexane) to give the desired product (31 mg, 65%). 1H NMR (300 MHz, CDCl3)  7.52-7.49 (m, 
2H), 7.35-7.32 (m, 3H), 5.82 (d, J = 7.8 Hz, 1H), 4.17 (ddd, J = 1.8, 8.9, 13.0 Hz, 1H), 3.85 (tdd, 
J = 4.6, 10.8, 15.6 Hz, 1H), 3.35-3.29 (m, 1H), 2.11 (t, J = 7.2 Hz, 2H), 2.00-1.89 (m, 2H), 1.70-
1.60 (m, 1H), 1.48-1.33 (m, 4H), 1.33-1.29 (m, 7H), 1.22-1.11 (m, 6H), 0.89 (t, J = 7.1 Hz, 3H), 
0.81 (t, J = 5.9 Hz, 3H), 0.37 (s, 3H), 0.36 (s, 3H); 13C (151 MHz, CDCl3)  142.6, 141.1, 138.8, 
134.2, 129.1, 127.9, 76.0, 72.6, 68.5, 41.7, 41.2, 36.3, 32.4, 32.0, 30.8, 30.3, 29.5, 25.8, 22.8, 
22.6, 14.3, 14.2, –2.4, –2.7; IR (neat) 3363, 2954, 2928, 2857, 1459, 1427, 1363, 1249, 1111, 
1063, 831, 814 cm-1; HRMS(ESI) calcd for C26H44O2SiNa (M+Na)
+ 439.3008, found 439.3014. 
 
(2R,4S,6S)-2-Hexyl-6-((R)-2-hydroxyheptyl)tetrahydro-2H-pyran-4-ol 
(2.125) 
The general Crabtree’s catalyst mediated hydrogenation reaction procedure was followed with a 
mixture of 2.121 (10 mg, 0.024 mmol) and Crabtree’s catalyst (0.5 mg, 0.0006 mmol) in CH2Cl2 
(1 mL). The mixture was stirred under H2 atmosphere for 10 minutes and another portion of 
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Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was added. After 10 minutes, the mixture was 
concentrated and the residue was purified by flash chromatography (18% EtOAc in hexane) to 
give the desired product. The general Fleming oxidation reaction procedure was followed with 
the silane, KBr (3 mg, 0.02 mmol), NaOAc (20 mg, 0.24 mmol), glacial acetic acid (110 μL) and 
peracetic acid (120 μL). The reaction was stirred at room temperature for 5 h and purified by 
flash chromatography (30% EtOAc in hexane) to give the desired product (4.8 mg, 67% over 
two steps). 1H NMR (600 MHz, CDCl3)  3.88 (br, 1H), 3.86-3.77 (m, 2H), 3.61-3.57 (m, 1H), 
3.39-3.35 (m, 1H), 1.97-1.91 (m, 2H), 1.67-1.57 (m, 2H), 1.52-1.36 (m, 6H), 1.35-1.27 (m, 10H), 
1.24-1.15 (m, 4H), 0.90 (t, J = 6.8 Hz, 3H), 0.88 (t, J = 7.1 Hz, 3H); 13C (151 MHz, CDCl3)  
77.3, 76.3, 72.5, 68.0, 42.6, 41.9, 41.2, 37.8, 36.1, 32.2, 31.9, 29.5, 25.8, 25.4, 22.9, 22.8, 14.3; 
IR (neat) 3379, 2924, 2853, 1716, 1457, 1374, 1034 cm-1; HRMS(EI) calcd for C18H36O3 (M
+) 
300.2664, found 300.2660. 
 
(2R,4R,6S)-2-Hexyl-6-((R)-2-hydroxyheptyl)tetrahydro-2H-pyran-4-ol 
(2.126) 
To a solution of 2.115 (102 mg, 0.37 mmol) in THF (15 mL) at –90 °C was added L-Selectride 
(550 μL, 0.550 mmol, 1 M in THF) dropwise over 5 minutes. After stirring at –90 °C for 20 
minutes, the reaction was quenched with saturated potassium sodium tartrate (aq). The mixture 
was diluted with Et2O, and stirred at room temperature for 1 h. The mixture was extracted with 
Et2O, concentrated, and purified by flash chromatography (20% EtOAc in hexane) to give the 
desired alcohol (67 mg, 65%). To the alcohol (15 mg, 0.050 mmol) and dimethylphenylsilane 
(9.2 μL, 0.060 mmol) in acetone (0.4 mL) was added [Cp*Ru(MeCN)3]PF6 (0.5 mg, 0.001 
mmol) at 0 °C. After 30 minutes at 0 °C, the mixture was concentrated and purified by flash 
chromatography to give 2.122 (20 mg, 92%). To 2.122 (34 mg, 0.080 mmol) in DMF (0.15 mL) 
 175
was added imidazole (23 mg, 0.34 mmol), TBSCl (32 mg, 0.21 mmol) and DMAP (10 mg, 0.08 
mmol) successively at room temperature. After stirring for 24 h, it was quenched with H2O, and 
the mixture was extracted with Et2O. After concentration, it was purified by flash 
chromatography (5% Et2O in hexane) to give the tert-butyl(((2R,4R,6R)-2-((Z)-2-
(dimethyl(phenyl)silyl)hept-1-en-1-yl)-6-hexyltetrahydro-2H-pyran-4-yl)oxy)dimethylsilane (42 
mg, 97%). 1H NMR (600 MHz, CDCl3)  7.56-7.55 (m, 2H), 7.32-7.31 (m, 3H), 6.00 (d, J = 9.5 
Hz, 1H), 4.37 (td, J = 7.0, 9.3 Hz, 1H), 4.12 (t, J = 2.6 Hz, 1H), 3.37 (p, J = 5.6 Hz, 1H), 2.13-
2.04 (m, 2H), 1.49 (dd, J = 2.6, 7.3 Hz, 2H), 1.43-1.19 (m, 18H), 0.90 (t, J = 7.2 Hz, 3H), 0.85-
0.83 (m, 12H), 0.43 (s, 3H), 0.40 (s, 3H), 0.00 (s, 3H), -0.01 (s, 3H); 13C (151 MHz, CDCl3)  
143.8, 141.9, 140.0, 134.1, 128.9, 127.8, 71.4, 71.2, 65.4, 39.8, 39.1, 38.6, 36.5, 32.1, 31.9, 30.1, 
29.6, 26.1, 25.8, 22.9, 22.7, 18.2, 14.4, 14.3, –0.2, –0.5, –4.6, –4.8; IR (neat) 2925, 2848, 1716, 
1457, 1374, 1014 cm-1; HRMS(ESI) calcd for C32H58O2Si2Na (M+Na)
+ 553.3873, found 
553.3837. 
The general Crabtree’s catalyst catalyzed hydrogenation reaction procedure was followed with a 
mixture of the vinylsilane (10 mg, 0.020 mmol) and Crabtree’s catalyst (0.5 mg, 0.0006 mmol) 
in CH2Cl2 (1.0 mL). The mixture was stirred under H2 for 10 minutes, and another portion of 
Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was added. After 10 minutes the mixture was 
concentrated and the residue was purified by flash chromatography (2% Et2O in hexane) to give 
the desired product. The general Fleming oxidation reaction procedure was followed with the 
silane, KBr (3 mg, 0.02 mmol), NaOAc (21 mg, 0.24 mmol), glacial acetic acid (120 μL), and 
peracetic acid (200 μL). The reaction was stirred at room temperature for 18 h and purified by 
flash chromatography (10% Et2O in hexane) to give the desired product (4.8 mg, 56% over two 
steps). 1H NMR (600 MHz, CDCl3)  4.19-4.18 (m, 1H), 4.16-4.12 (m, 1H), 3.89-3.86 (m, 1H), 
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3.80-3.75 (m, 1H), 3.35 (d, J = 4.5 Hz, 1H), 1.64-1.61 (m, 2H), 1.55-1.50 (m, 2H), 1.48-1.41 (m, 
4H), 1.40-1.36 (m, 2H), 1.34-1.27 (m, 14H), 0.90-0.87 (m, 15H), 0.05 (s, 3H), 0.04 (s, 3H); 13C 
(151 MHz, CDCl3)  72.3, 70.1, 69.4, 65.3, 41.4, 39.5, 39.1, 37.4, 36.4, 32.2, 32.0, 29.5, 26.0, 
25.8, 25.7, 22.9, 22.8, 18.3, 14.3, 14.2, –4.6, –4.7; IR (neat) 3381, 2921, 2854, 1715, 1459, 1374, 
1030 cm-1; HRMS(EI) calcd for C23H47O3Si (M
+-CH3) 399.3294, found 399.3280. 
To the silyl ether (1.5 mg, 0.0050 mmol) in 0.5 mL THF was added Bu4NF (17 μL, 1 M in THF). 
The reaction was stirred at rt for 5 h, then was concentrated and purified by flash 
chromatography (50% EtOAc in hexane) to give 2.126 (1.0 mg, 92%). 1H NMR (600 MHz, 
CDCl3)  4.28 (br, 1H), 4.15-4.12 (m, 1H), 3.90-3.85 (m, 1H), 3.79-3.75 (m, 1H), 3.12 (d, J = 
4.9 Hz, 1H),1.69-1.62 (m, 4H), 1.61-1.58 (m, 1H), 1.54-1.36 (m, 8H), 1.36-1.27 (m, 11H), 0.90 
(t, J = 6.7 Hz, 3H), 0.88 (t, J = 7.2 Hz, 3H); 13C (151 MHz, CDCl3)  72.1, 69.9, 69.4, 65.0, 41.7, 
38.8, 38.5, 37.5, 36.4, 32.2, 32.0, 29.5, 25.9, 25.7, 22.9, 22.8, 14.3, 14.2; IR (neat) 3379, 2925, 
2853, 1717, 1460, 1374, 1032 cm-1; HRMS(ESI) calcd for C23H47O3SiNa (M+Na)
+ 323.2562, 
found 323.2541. 
 
(2R,4R,6S)-2-Hexyl-6-((S)-2-hydroxyheptyl)tetrahydro-2H-pyran-4-ol 
(2.127) 
To a stirred solution of 2.118 (46 mg, 0.16 mmol) in 0.15 mL THF was added 
dimethylphenylsilane (30 μL, 0.19 mmol) and a solution of H2PtCl6•6H2O (0.001 M in THF, 164 
μL). The mixture was heated at 50 °C for 6 h, cooled and filtered through Celite with Et2O. The 
solvent was removed under vacuum and purified by flash chromatography (5% to 10% EtOAc in 
hexane) to give 2.123 (46 mg, 67%). To 2.123 (45 mg, 0.11 mmol) in DMF (0.2 mL) was added 
imidazole (30 mg, 0.43 mmol), TBSCl (41 mg, 0.27 mmol) and DMAP (10 mg, 0.080 mmol) 
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successively at room temperature. After stirring for 23 h, it was quenched with H2O, and the 
mixture was extracted with Et2O. After concentration, it was purified by flash chromatography 
(2% Et2O in hexane) to give the desired product (55 mg, 96%). 
1H NMR (500 MHz, CDCl3)  
7.51-7.50 (m, 2H), 7.34-7.33 (m, 3H), 5.81 (d, J = 7.9 Hz, 1H), 4.71 (dt, J = 4.2, 8.7 Hz, 1H), 
4.19 (br, 1H), 3.82-3.78 (m, 1H), 2.15-2.06 (m, 2H), 1.60-1.57 (m, 1H), 1.53-1.51 (m, 2H), 1.40-
1.34 (m, 3H), 1.32-1.29 (m, 8H), 1.24-1.18 (m, 6H), 0.91 (s, 9H), 0.89 (t, J = 6.6 Hz, 3H), 0.81 
(t, J = 6.5 Hz, 3H), 0.36 (s, 3H), 0.35 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H); 13C (151 MHz, CDCl3)  
142.5, 141.2, 139.1, 134.2, 129.0, 127.8, 71.9, 69.3, 65.4, 40.0, 39.2, 36.5, 32.5, 32.0, 30.8, 30.4, 
29.5, 26.0, 25.7, 22.9, 22.7, 18.2, 14.3, 14.2, –2.3, –2.6, –4.6, –4.7; IR (neat) 2953, 2928, 2857, 
1251, 1095, 1055, 832, 814, 772 cm-1; HRMS(EI) calcd for C32H58O2Si2 (M
+) 530.3975, found 
530.3970. 
The general Crabtree’s catalyst mediated hydrogenation reaction procedure was followed with a 
mixture of the silane (12 mg, 0.020 mmol) and Crabtree’s catalyst (0.5 mg, 0.0006 mmol) in 
CH2Cl2 (1 mL). The mixture was stirred under H2 for 10 minutes and another portion of 
Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was added. After 10 minutes the mixture was 
concentrated and the residue was purified by flash chromatography (3% Et2O in hexane) to give 
the desired product. The general Fleming oxidation reaction procedure was followed with the 
silane, KBr (3.2 mg, 0.030 mmol), NaOAc (23 mg, 0.28 mmol), glacial acetic acid (130 μL) and 
peracetic acid (180 μL). The reaction was stirred at room temperature for 8 h and purified by 
flash chromatography (4% EtOAc in hexane) to give the desired product (6.6 mg, 71% over two 
steps). 1H NMR (600 MHz, CDCl3)  4.22 (br, 1H), 4.15-4.14 (m, 1H), 4.05 (tt, J = 2.8, 10.0 Hz, 
1H), 3.90-3.86 (m, 1H), 3.84-3.80 (m, 1H), 1.55-1.44 (m, 8H), 1.43-1.28 (m, 16H), 0.90 (s, 9H), 
0.89-0.86 (m, 6H), 0.05 (s, 6H); 13C (151 MHz, CDCl3)  73.9, 72.8, 72.2, 65.0, 42.6, 40.2, 39.4, 
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37.9, 36.3, 32.3, 31.9, 29.6, 26.0, 25.8, 25.4, 22.9, 22.8, 18.3, 14.3, –4.7; IR (neat) 3505, 2928, 
2856, 1726, 1463, 1254, 1076, 837 cm-1; HRMS(ESI) calcd for C24H50O3SiNa (M+Na)
+ 
437.3427, found 437.3465. 
To the alcohol (1.5 mg, 0.0050 mmol) in THF (0.5 mL) was added Bu4NF (17 μL, 1 M in THF). 
The reaction was stirred at room temperature for 5 h, then was concentrated and purified by flash 
chromatography (40% EtOAc in hexane) to give the desired product (1.0 mg, 92%). 1H NMR 
(600 MHz, CDCl3)  4.26-4.22 (m, 1H), 4.08-4.04 (m, 2H), 3.89-3.85 (m, 1H), 3.84-3.81 (m, 
1H), 1.67-1.61 (m, 2H), 1.55-1.47 (m, 6H), 1.44-1.36 (m, 5H), 1.35-1.29 (m, 11H), 0.90 (t, J = 
6.8 Hz, 3H), 0.88 (t, J = 7.1 Hz, 3H); 13C (151 MHz, CDCl3)  73.7, 72.7, 72.1, 64.7, 42.6, 39.4, 
38.8, 37.8, 36.3, 32.2, 31.9, 29.5, 25.8, 25.4, 22.9, 22.8, 14.3; IR (neat) 3376, 2924, 2850, 1465, 
1379, 1021 cm-1; HRMS(ESI) calcd for C18H36O3Na (M+Na)
+ 323.2562, found 323.2548. 
 
(2R,4S,6R)-2-Hexyl-6-((S)-2-hydroxyheptyl)tetrahydro-2H-pyran-4-ol 
(2.135) 
To a freshly prepared SmI2 solution
8 (8.0 mL, 0.06 M in THF, 0.48 mmol) was added a solution 
of 2.116 (65 mg, 0.23 mmol) and iPrOH (20 μL, 0.23 mmol) in THF (1 mL) dropwise. The 
reaction was stirred under argon for 6 h, and then was quenched with aq. NaHCO3 at 0 °C. The 
crude mixture was extracted with EtOAc and the combined organic layer was dried over MgSO4, 
concentrated, and purified by flash chromatography (15% EtOAc in hexane) to give 2.128 (55 
mg, 85%). 1H NMR (600 MHz, CDCl3)  4.84-4.82 (m, 1H), 4.14 (m, 1H), 3.89-3.86 (m, 1H), 
2.21 (dt, J = 2.1, 7.1 Hz, 2H), 2.02 (td, J = 2.1, 12.1 Hz, 1H), 1.97 (td, J = 2.3, 12.2 Hz, 1H), 
1.65-1.60 (m, 1H), 1.54-1.49 (m, 3H), 1.48-1.14 (m, 14H), 0.92-0.88 (m, 6H); 13C (75 MHz, 
CDCl3)  87.6, 77.4, 70.5, 65.6, 64.8, 41.7, 40.3, 36.1, 32.0, 31.3, 29.4, 28.6, 25.5, 22.8, 22.4, 
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18.9, 14.3, 14.2; IR (neat) 3583, 3417, 2927, 2857, 1459, 1337, 1064 cm-1; HRMS(ESI) calcd for 
C18H36O3K (M+K)
+ 319.2039, found 319.2029. 
To the alcohol (18 mg, 0.06 mmol) and dimethylphenylsilane (12 μL, 0.080 mmol) in acetone 
(0.4 mL) was added [Cp*Ru(MeCN)3]PF6 (0.5 mg, 0.001 mmol) at 0 °C. After 2 h at 0 °C, the 
mixture was concentrated and purified by flash chromatography to give 2.131 (23 mg, 86%). To 
2.131 (16 mg, 0.04 mmol) in DMF (0.25 mL) was added imidazole (11 mg, 0.16 mmol), TBSCl 
(15 mg, 0.1 mmol) and DMAP (10 mg, 0.08 mmol) successively at room temperature. After 
stirring for 8 h, the reaction was quenched with H2O, and the mixture was extracted with Et2O. 
After concentration, the mixture was purified by flash chromatography (3% Et2O in hexane) to 
give the tert-butyl(((2S,4S,6R)-2-((Z)-2-(dimethyl(phenyl)silyl)hept-1-en-1-yl)-6-hexyltetra-
hydro-2H-pyran-4-yl)oxy)dimethylsilane (17 mg, 84%). 1H NMR (600 MHz, CDCl3)  7.53-
7.51 (m, 2H), 7.33-7.32 (m, 3H), 6.30 (d, J = 9.4 Hz, 1H), 4.55 (p, J = 4.6 Hz, 1H), 4.05-4.02 (m, 
1H), 3.70-3.67 (m, 1H), 2.11 (t, J = 7.6 Hz, 2H), 1.79 (td, J = 3.0, 12.4 Hz, 1H), 1.53-1.46 (m, 
2H), 1.36-1.22 (m, 17H), 0.90-0.85 (m, 15H), 0.44 (s, 3H), 0.42 (s, 3H), 0.04 (s, 3H), 0.03 (s, 
3H); 13C (151 MHz, CDCl3)  142.4, 141.7, 139.4, 134.0, 129.1, 128.0, 70.5, 69.2, 65.4, 40.0, 
39.5, 38.7, 35.6, 32.1, 31.8, 30.3, 29.5, 26.2, 26.1, 22.9, 22.7, 18.4, 14.3, 14.2, –0.4, –0.5, –4.4, –
4.5; IR (neat) 2927, 2846, 1715, 1459, 1373, 1011 cm-1; HRMS(ESI) calcd for C32H58O2Si2Na 
(M+Na)+ 553.3873, found 553.3822. 
The general Crabtree’ catalyst mediated hydrogenation reaction procedure was followed with a 
mixture of the vinylsilane (7.5 mg, 0.010 mmol) and Crabtree’s catalyst (0.5 mg, 0.0006 mmol) 
in CH2Cl2 (0.8 mL). The mixture was stirred under H2 for 15 minutes and another portion of 
Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was added. After 15 minutes the mixture was 
concentrated and the residue was purified by flash chromatography (4% Et2O in hexane) to give 
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the desired product. The general Fleming oxidation reaction procedure was followed with the 
silane, KBr (3 mg, 0.03 mmol), NaOAc (14 mg, 0.17 mmol), glacial acetic acid (100 μL), and 
peracetic acid (130 μL). The reaction was stirred at room temperature for 5 h and purified by 
flash chromatography (10% EtOAc in hexane) to give the (S)-1-((2R,4S,6R)-4-((tert-
butyldimethylsilyl)oxy)-6-hexyltetrahydro-2H-pyran-2-yl)heptan-2-ol (3.7 mg, 65% over two 
steps). 1H NMR (600 MHz, CDCl3)  4.35-4.31 (m, 1H), 4.01 (tt, J = 4.9, 9.7 Hz, 1H), 3.79 (br, 
1H), 3.64 (tt, J = 4.9, 9.5 Hz, 1H), 2.48 (br, 1H), 1.91 (ddd, J = 3.5, 12.3, 16.4 Hz, 1H), 1.81 (td, 
J = 4.1, 15.7 Hz, 1H), 1.78-1.68 (m, 1H), 1.67-1.60 (m, 2H), 1.54-1.38 (m, 6H), 1.37-1.26 (m, 
13H), 0.92-0.88 (m, 15H), 0.06 (s, 3H), 0.05 (s, 3H); 13C (151 MHz, CDCl3)  70.6, 69.2, 67.1, 
65.4, 39.7, 39.4, 39.2, 37.5, 35.5, 32.1, 32.0, 29.6, 26.3, 26.0, 25.8, 22.9, 18.3, 14.3, 14.2, –4.4, –
4.5; IR (neat) 3510, 2918, 2859, 1726, 1466, 1251, 1079, 837 cm-1; HRMS(ESI) calcd for 
C24H50O3SiNa (M+Na)
+ 437.3427, found 437.3432. 
To the alcohol (3 mg, 0.01 mmol) in THF (0.6 mL) was added Bu4NF (30 μL, 1 M in THF). The 
reaction was stirred at room temperature for 24 h, then was concentrated and purified by flash 
chromatography (30% hexane in EtOAc) to give 2.135 (2.1 mg, 97%). 1H NMR (600 MHz, 
CDCl3)  4.40-4.37 (m, 1H), 4.02 (tt, J = 5.3, 9.7 Hz, 1H), 3.77 (br, 1H), 3.60-3.56 (m, 1H), 2.17 
(br, 1H), 2.00 (ddd, J = 2.9, 11.0, 14.2 Hz, 1H), 1.96-1.94 (m, 1H), 1.83-1.81 (m, 1H), 1.68-1.62 
(m, 2H), 1.55-1.50 (m, 1H), 1.45-1.39 (m, 5H), 1.36-1.28 (m, 13H), 0.90 (t, J = 6.8 Hz, 3H), 
0.89 (t, J = 7.1 Hz, 3H); 13C (151 MHz, CDCl3)  69.4, 68.9, 68.7, 65.0, 40.9, 39.0, 38.4, 37.7, 
36.1, 32.1, 32.0, 29.6, 26.0, 25.8, 22.9, 14.3, 14.2; IR (neat) 3375, 2927, 2851, 1465, 1381, 1026 
cm-1; HRMS(ESI) calcd for C18H36O3Na (M+Na)
+ 323.2562, found 323.2574. 
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(2R,4S,6R)-2-Hexyl-6-((R)-2-hydroxyheptyl)tetrahydro-2H-pyran-4-ol 
(2.136) 
To a stirred solution of 2.128 (54 mg, 0.19 mmol) in THF (0.18 mL) was added 
dimethylphenylsilane (35 μL, 0.22 mmol) and a solution of H2PtCl6•6H2O (0.001 M in THF, 193 
μL). The mixture was heated at 50 °C for 3.5 h, cooled and filtered through Celite with Et2O. 
The solvent was removed under vacuum and purified by flash chromatography (15% EtOAc in 
hexane) to give 2.132 (65 mg, 62%). To 2.132 (22 mg, 0.05 mmol) in CH2Cl2 (2 mL) was added 
imidazole (6 mg, 0.09 mmol), TBSCl (10 mg, 0.068 mmol) and DMAP (5 mg, 0.04 mmol) 
successively at room temperature. After stirring for 8 h, the mixture was concentrated and 
purified by flash chromatography (4% Et2O in hexane) to give the tert-Butyl((2S,4S,6R)-2-((E)-
2-(dimethyl(phenyl)silyl)hept-1-enyl)-6-hexyltetrahydro-2H-pyran-4-yloxy)dimethylsilane (28 
mg, 99%). 1H NMR (600 MHz, CDCl3)  7.51-7.50 (m, 2H), 7.35-7.34 (m, 3H), 5.95 (d, J = 7.5 
Hz, 1H), 4.85 (td, J = 4.3, 8.0 Hz, 1H), 3.96 (ddd, J = 3.7, 7.4, 12.6 Hz, 1H), 3.65-3.61 (m, 1H), 
2.27-2.22 (m, 1H), 2.16-2.11 (m, 1H), 1.82-1.80 (m, 1H), 1.72 (td, J = 4.0, 12.8 Hz, 1H), 1.69-
1.64 (m, 2H), 1.51-1.35 (m, 3H), 1.34-1.27 (m, 8H), 1.24-1.17 (m, 5H), 0.90-0.88 (m, 12H), 0.82 
(t, J = 6.2 Hz, 3H), 0.38 (s, 6H), 0.05 (s, 3H), 0.04 (s, 3H); 13C (151 MHz, CDCl3)  144.0, 
140.4, 138.9, 134.2, 129.1, 127.9, 70.5, 67.5, 65.7, 40.5, 40.3, 35.8, 32.5, 32.1, 30.5, 29.9, 29.5, 
26.1, 26.0, 22.9, 22.7, 18.4, 14.3, 14.2, –2.3, –2.4, –4.4, –4.5; IR (neat) 2955, 2929, 2856, 1250, 
1096, 1048 cm-1; HRMS(ESI) calcd for C32H58O2Si2Na (M+Na)
+ 553.3873, found 553.3916. 
The general Crabtree’s catalyst mediated hydrogenation reaction procedure was followed with a 
mixture of the silane (9 mg, 0.02 mmol) and Crabtree’s catalyst (0.5 mg, 0.0006 mmol) in 
CH2Cl2 (1 mL). The mixture was stirred under H2 for 15 minutes, then another portion of 
Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was added. After 20 minutes the mixture was 
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concentrated and the residue was purified by flash chromatography (5% Et2O in hexane) to give 
the desired product. The general Fleming oxidation reaction procedure was followed with the 
silane, KBr (2.4 mg, 0.020 mmol), NaOAc (13 mg, 0.16 mmol), glacial acetic acid (100 μL), and 
peracetic acid (120 μL). The reaction was stirred at room temperature for 3.5 h and purified by 
flash chromatography (10% EtOAc in hexane) to give the desired product (4.2 mg, 60% over 
two steps). 1H NMR (500 MHz, CDCl3)  4.24-4.22 (m, 1H), 4.02-3.97 (m, 1H), 3.84-3.80 (m, 
1H), 3.79-3.75 (m, 1H), 3.72 (s, 1H), 1.86-1.76 (m, 3H), 1.63-1.61 (m, 2H), 1.50-1.34 (m, 8H), 
1.31-1.28 (m, 11H), 0.91-0.87 (m, 15H), 0.06 (s, 3H), 0.05 (s, 3H); 13C (125 MHz, CDCl3)  
72.9, 71.3, 70.9, 65.1, 40.2, 39.7, 39.2, 37.7, 35.3, 32.2, 31.9, 29.6, 26.1, 26.0, 25.4, 22.9, 22.8, 
18.3, 14.3, –4.4, –4.5; IR (neat) 3515, 2916, 2855, 1726, 1460, 1249, 1081, 837 cm-1; 
HRMS(ESI) calcd for C24H50O3SiNa (M+Na)
+ 437.3427, found 437.3428. 
To the alcohol (3.5 mg, 0.0080 mmol) in THF (0.6 mL) was added Bu4NF (30 μL, 1 M in THF). 
The reaction was stirred at room temperature for 8 h, then was concentrated and purified by flash 
chromatography (45% hexane in EtOAc) to give 2.136 (2.5 mg, 97%). 1H NMR (600 MHz, 
CDCl3)  4.32-4.30 (m, 1H), 4.02 (ddd, J = 4.0, 9.0, 13.5 Hz, 1H), 3.86-3.80 (m, 1H), 3.78-3.74 
(m, 1H), 3.48 (br, 1H), 1.99-1.97 (m, 1H), 1.91 (td, J = 9.9, 14.6 Hz, 1H), 1.81-1.78 (m, 1H), 
1.68-1.64 (m, 2H), 1.50-1.37 (m, 7H), 1.34-1.27 (m, 12H), 0.90 (t, J = 6.8 Hz, 3H), 0.88 (t, J = 
7.0 Hz, 3H); 13C (151 MHz, CDCl3)  73.1, 72.9, 69.9, 64.7, 40.4, 39.6, 38.5, 37.6, 36.0, 32.1, 
31.9, 29.6, 25.8, 25.4, 22.9, 22.8, 14.3; IR (neat) 3378, 2921, 2852, 1464, 1380, 1069 cm-1; 
HRMS(ESI) calcd for C18H36O3Na (M+Na)
+ 323.2562, found 323.2582. 
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(2R,4R,6R)-2-Hexyl-6-((S)-2-hydroxyheptyl)tetrahydro-2H-pyran-4-ol 
(2.137) 
To a solution of 2.116 (47 mg, 0.17 mmol) in THF (7 mL) at ‒90 °C was added L-Selectride 
(252 µL, 0.252 mmol, 1 M in THF) dropwise over 10 minutes. After stirring at that temperature 
for 15 minutes, the reaction was quenched with saturated potassium sodium tartrate (aq). The 
mixture was diluted with Et2O, and stirred at room temperature for 1 h. Then the mixture was 
extracted with Et2O. After concentration, it was purified by flash chromatography (15% EtOAc 
in hexane) to give 2.129 (42 mg, 89%). 1H NMR (600 MHz, CDCl3)  4.71 (dd, J = 2.0, 5.3 Hz, 
1H), 4.20-4.16 (m, 1H), 4.13 (qd, J = 3.4, 12.4 Hz, 1H), 3.11 (d, J = 9.1 Hz, 1H), 2.25 (dt, J = 
2.0, 7.1 Hz, 2H), 2.03 (ddd, J = 3.6, 5.6, 14.0 Hz, 1H), 1.90-1.88 (m, 1H), 1.81-1.78 (m, 1H), 
1.54-1.49 (m, 4H), 1.43-1.29 (m, 13H), 0.91 (t, J = 7.2 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C 
(125 MHz, CDCl3)  88.5, 80.0, 66.5, 65.5, 61.9, 38.9, 37.0, 35.8, 32.0, 31.3, 29.4, 28.4, 25.5, 
22.9, 22.4, 18.9, 14.3, 14.2; IR (neat) 3356, 2926, 2856, 1457, 1366, 1334, 1045 cm-1; 
HRMS(EI) calcd for C18H30O (M
+) 262.2297, found 262.2289. 
To 2.129 (10 mg, 0.038 mmol) and dimethylphenylsilane (8 µL, 0.04 mmol) in acetone (0.2 mL) 
was added [Cp*Ru(MeCN)3]PF6 (0.5 mg, 0.001 mmol) at 0 °C. After 1 h at 0 °C, the mixture 
was concentrated and purified by flash chromatography to give 2.133 (15 mg, 99%). 1H NMR 
(600 MHz, CDCl3)  7.54-7.52 (m, 2H), 7.37-7.36 (m, 3H), 6.00 (d, J = 8.9 Hz, 1H), 4.01-3.98 
(m, 1H), 3.92 (q, J = 5.9 Hz, 1H), 3.53 (ddd, J = 4.6, 10.7, 15.3 Hz, 1H), 2.14 (t, J = 7.7 Hz, 2H), 
1.73-1.70 (m, 1H), 1.48-1.44 (m, 2H), 1.43-1.35 (m, 2H), 1.30-1.24 (m, 12H), 1.16-1.14 (m, 2H), 
1.12-1.06 (m, 1H), 0.90 (t, J = 7.1 Hz, 3H), 0.88 (t, J = 7.1 Hz, 3H), 0.42 (s, 3H), 0.39 (s, 3H); 
13C (151 MHz, CDCl3)  143.5, 140.5, 140.0, 133.9, 129.2, 128.1, 73.4, 68.7, 64.4, 41.5, 38.3, 
37.7, 32.0, 31.9, 31.7, 30.2, 29.4, 26.6, 22.9, 22.7, 14.4, 14.3, –0.6, –1.1; IR (neat) 3382, 2926, 
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2854, 1650, 1540, 1457, 1366, 1252, 1110 cm-1; HRMS(EI) calcd for C26H44O2Si (M
+) 
416.3111, found 416.3107. 
To 2.133 (30 mg, 0.072 mmol) in CH2Cl2 (1.5 mL) was added imidazole (7 mg, 0.1 mmol), 
TBSCl (13 mg, 0.086 mmol) and DMAP (3 mg, 0.02 mmol) successively at room temperature. 
After stirring for 3 h, the mixture was concentrated and purified by flash chromatography (4% 
Et2O in hexane) to give the desired product (36 mg, 94%). The general Crabtree’s catalyst 
mediated hydrogenation reaction procedure was followed with the vinylsilane (10 mg, 0.020 
mmol) and Crabtree’s catalyst (0.5 mg, 0.0006 mmol) in CH2Cl2 (1 mL). The mixture was stirred 
under H2 for 10 minutes and another portion of Crabtree’s catalyst (0.5 mg, 0.0006 mmol) was 
added. After 10 minutes the mixture was concentrated and the residue was purified by flash 
chromatography (5% EtOAc in hexane) to give the desired product. The general Fleming 
oxidation reaction procedure was followed with the silane, KBr (3.2 mg, 0.027 mmol), NaOAc 
(8.2 mg, 0.10 mmol), glacial acetic acid (120 μL), and peracetic acid (45 μL). The reaction was 
stirred at room temperature for 2 h and purified by flash chromatography (25% Et2O in hexane) 
to give the (S)-1-((2R,4R,6R)-4-(tert-Butyldimethylsilyloxy)-6-hexyltetrahydro-2H-pyran-2-
yl)heptan-2-ol (5.6 mg, 74% over two steps). 1H NMR (600 MHz, CDCl3) , 4.02-3.94 (m, 3H), 
3.88-3.83 (m, 1H), 2.68 (d, J = 4.2 Hz, 1H), 1.86 (ddd, J = 2.4, 8.8, 14.6 Hz, 1H), 1.77-1.75 (m, 
1H), 1.73-1.66 (m, 2H), 1.64-1.60 (m, 1H), 1.53-1.48 (m, 2H), 1.43-1.36 (m, 4H), 1.36-1.29 (m, 
13H), 0.90-0.85 (m, 15H), 0.06 (s, 6H); 13C (151 MHz, CDCl3)  71.8, 69.1, 66.9, 65.3, 41.8, 
41.0, 38.9, 37.7, 32.3, 32.2, 32.0, 29.4, 26.4, 26.1, 25.7, 22.9, 22.8, 18.3, 14.3, 14.2, –4.4, –4.5; 
IR (neat) 3508, 2929, 2856, 1463, 1253, 1105, 1045, 835 cm-1; HRMS(ESI) calcd for 
C24H50O3SiNa (M+Na)
+ 437.3427, found 437.3422. 
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To the alcohol (1.7 mg, 0.0039 mmol) in THF (0.4 mL) was added Bu4NF (20 μL, 1 M in THF). 
The reaction was stirred at room temperature for 5 h then was concentrated and purified by flash 
chromatography (30% hexane in EtOAc) to give 2.137 (1.2 mg, 97%). 1H NMR (600 MHz, 
CDCl3)  4.06-4.00 (m, 2H), 3.93 (tdd, J = 2.6, 8.1, 10.7 Hz, 1H), 3.86 (br, 1H), 2.66 (s, 1H), 
1.90-1.83 (m, 2H), 1.77-1.73 (m, 2H), 1.63-1.58 (m, 2H), 1.53-1.46 (m, 1H), 1.43-1.29 (m, 17H), 
0.90 (t, J = 6.8 Hz, 3H), 0.89 (t, J = 7.0 Hz, 3H); 13C (151 MHz, CDCl3)  72.9, 69.1, 66.5, 64.8, 
42.2, 41.2, 38.4, 37.8, 32.1, 32.0, 31.8, 29.3, 26.4, 25.7, 22.9, 22.8, 14.3, 14.2; IR (neat) 3383, 
2927, 2850, 1462, 1381, 1076 cm-1; HRMS(ESI) calcd for C18H36O3Na (M+Na)
+ 323.2562, 
found 323.2567. 
 
(2R,4R,6R)-2-Hexyl-6-((R)-2-hydroxyheptyl)tetrahydro-2H-pyran-4-ol 
(2.138) 
To a stirred solution of 2.129 (37 mg, 0.13 mmol) in 0.12 mL THF was added 
dimethylphenylsilane (25 µL, 0.15 mmol) and a solution of H2PtCl6•6H2O (0.001 M in THF, 130 
µL). The mixture was heated at 50 °C for 5 h, cooled and filtered through Celite with Et2O. The 
solvent was removed under vacuum and purified by flash chromatography (15% EtOAc in 
hexane) to give 2.134 (35 mg, 64%). 1H NMR (500 MHz, CDCl3)  7.51-7.49 (m, 2H), 7.35-7.32 
(m, 3H), 5.86 (d, J = 7.8 Hz, 1H), 4.49 (ddd, J = 2.7, 8.0, 10.5 Hz, 1H), 4.08-4.03 (m, 2H), 2.11 
(t, J = 7.2 Hz, 2H), 1.95-1.91 (m, 1H), 1.87-1.84 (m, 1H), 1.78-1.70 (m, 1H), 1.63 (ddd, J = 5.6, 
10.6, 12.6 Hz, 1H), 1.46-1.39 (m, 2H), 1.37-1.27 (m, 9H), 1.25-1.18 (m, 5H), 0.89 (t, J = 6.7 Hz, 
3H), 0.82 (t, J = 6.7 Hz, 3H), 0.38 (s, 3H), 0.37 (s, 3H); 13C (151 MHz, CDCl3)  142.3, 141.5, 
138.7, 134.2, 129.1, 127.9, 73.0, 65.5, 64.7, 41.4, 38.1, 32.4, 32.1, 32.0, 30.5, 30.3, 29.5, 26.5, 
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22.9, 22.6, 14.3, 14.2, –2.4, –2.7; IR (neat) 3375, 2928, 2856, 1456, 1427, 1372, 1249, 1111, 
1054, 814 cm-1; HRMS(EI) calcd for C26H44O2Si (M
+) 416.3111, found 416.3118. 
To 2.134 (27 mg, 0.065 mmol) in CH2Cl2 (2 mL) were added imidazole (7 mg, 0.1 mmol), 
TBSCl (12 mg, 0.080 mmol) and DMAP (5 mg, 0.04 mmol) successively at room temperature. 
After stirring for 8 h, the mixture was concentrated and purified by flash chromatography (3% 
Et2O in hexane) to give the tert-butyl((2S,4R,6R)-2-((E)-2-(dimethyl(phenyl)silyl)hept-1-enyl)-6-
hexyltetrahydro-2H-pyran-4-yloxy)dimethylsilane (34 mg, 99%). 1H NMR (600 MHz, CDCl3)  
7.52-7.50 (m, 2H), 7.34-7.33 (m, 3H), 5.93 (d, J = 7.9 Hz, 1H), 4.49 (td, J = 2.9, 8.7 Hz, 1H), 
4.02 (ddd, J = 4.5, 9.4, 13.9 Hz, 1H), 2.15-2.08 (m, 2H), 1.81-1.79 (m, 1H), 1.75-1.69 (m, 2H), 
1.64 (ddd, J = 5.2, 9.6, 14.7 Hz, 1H), 1.44-1.39 (m, 3H), 1.34-1.25 (m, 8H), 1.23-1.17 (m, 5H), 
0.90-0.88 (m, 12H), 0.82 (t, J = 6.7 Hz, 3H), 0.37 (s, 3H), 0.36 (s, 3H), 0.07 (s, 6H); 13C (151 
MHz, CDCl3)  141.9, 139.9, 134.3, 129.0, 127.9, 72.4, 65.8, 65.3, 41.3, 38.7, 32.4, 32.3, 32.0, 
30.5, 30.4, 29.5, 26.5, 26.1, 22.9, 22.6, 18.4, 14.3, 14.2, –2.4, –2.6, –4.4; IR (neat) 2959, 2927, 
2856, 1248, 1087, 1043 cm-1; HRMS(ESI) calcd for C32H58O2Si2Na (M+Na)
+ 553.3873, found 
553.3880. 
The general Crabtree’s catalyst mediated hydrogenation reaction procedure was followed with 
the vinylsilane (12 mg, 0.022 mmol) and Crabtree’s catalyst (0.5 mg, 0.0006 mmol) in CH2Cl2 (1 
mL). The mixture was stirred under H2 for 15 minutes, and another portion of Crabtree’s catalyst 
(0.5 mg, 0.0006 mmol) was added. After 15 minutes more Crabtree’s catalyst (0.5 mg, 0.0006 
mmol) was added. This was repeated three more times, then after 1.5 h at room temperature the 
mixture was concentrated and the residue was purified by flash chromatography (3% Et2O in 
hexane) to give the desired product. The general Fleming oxidation reaction procedure was 
followed with the silane, KBr (3.2 mg, 0.027 mmol), NaOAc (23 mg, 0.28 mmol), glacial acetic 
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acid (130 μL), and peracetic acid (180 μL). The reaction was stirred at room temperature for 6 h 
and purified by flash chromatography (5% EtOAc in hexane) to give the desired product (5.8 
mg, 62% over two steps). 1H NMR (600 MHz, CDCl3) , 4.03 (qd, J = 4.7, 8.8 Hz, 1H), 3.98 
(ddd, J = 4.4, 9.2, 13.7 Hz, 1H), 3.86 (td, J = 2.6, 9.9 Hz, 1H), 3.85 (s, 1H), 3.79-3.76 (m, 1H), 
1.82-1.79 (m, 1H), 1.77-1.72 (m, 2H), 1.67-1.60 (m, 2H), 1.52-1.47 (m, 2H), 1.39-1.36 (m, 4H), 
1.35-1.29 (m, 13H), 0.90-0.88 (m, 15H), 0.06 (s, 6H); 13C (151 MHz, CDCl3)  72.6, 71.8, 70.9, 
64.7, 42.1, 41.4, 38.5, 37.5, 32.1, 32.0, 31.7, 29.2, 25.9, 25.8, 25.2, 22.7, 22.6, 18.1, 14.1, –4.6; 
IR (neat) 3505, 2928, 2856, 1726, 1463, 1254, 1117, 1076, 837 cm-1; HRMS(ESI) calcd for 
C24H50O3SiNa (M+Na)
+ 437.3427, found 437.3425. 
To the alcohol (2.7 mg, 0.0065 mmol) in THF (0.7 mL) was added Bu4NF (30 μL, 1 M in THF). 
The reaction was stirred at room temperature for 8 h, then was concentrated and purified by flash 
chromatography (30% hexane in EtOAc) to give 2.138 (1.8 mg, 92%). 1H NMR (600 MHz, 
CDCl3)  4.09-4.06 (m, 1H), 4.00 (ddd, J = 4.7, 10.6, 15.2 Hz, 1H), 3.84-3.78 (m, 2H), 3.77 (s, 
1H), 1.94 (td, J = 2.2, 12.4 Hz, 1H), 1.85 (td, J = 2.3, 12.7 Hz, 1H), 1.80-1.75 (m, 1H), 1.69-1.60 
(m, 3H), 1.51-1.47 (m, 1H), 1.43-1.36 (m, 5H), 1.34-1.28 (m, 12H), 0.90 (t, J = 6.7 Hz, 3H), 
0.89 (t, J = 7.0 Hz, 3H); 13C (151 MHz, CDCl3)  73.0, 72.2, 70.1, 64.2, 42.6, 41.7, 38.0, 37.5, 
32.0, 31.7, 31.4, 29.1, 26.0, 25.2, 22.7, 22.6, 14.1; IR (neat) 3381, 2925, 2852, 1461, 1380, 1074 
cm-1; HRMS(ESI) calcd for C18H36O3Na (M+Na)
+ 323.2562, found 323.2535. 
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APPENDIX C 
STEREOSELECTIVE SYNTHESIS OF TERTIARY ETHERS THROUGH 
GEOMETRIC CONTROL OF HIGHLY SUBSTITUTED OXOCARBENIUM IONS 
General Experimental Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, a Bruker 
Avance 400 spectrometer at 400 MHz and 100 MHz, a Bruker Avance 500 spectrometer at 500 
MHz and 125 MHz, a Bruker Avance 600 spectrometer at 600 MHz and 151 MHz if specified. 
The chemical shifts are given in parts per million (ppm) on the delta (δ) scale. The solvent peak 
was used as a reference value, for 1H NMR: CDCl3 = 7.26 ppm, for 
13C NMR: CDCl3 = 77.23. 
Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; dd = doublet of 
doublets; dt = doublet of triplets; br = broad). High resolution and low resolution mass spectra 
were recorded on a VG 7070 spectrometer. Infrared (IR) spectra were collected on a Mattson 
Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on a NaCl plate by 
dissolving the compound in CH2Cl2 and then evaporating the CH2Cl2. Analytical TLC was 
performed on E. Merck pre-coated (25 mm) silica gel 60F-254 plates. Visualization was done 
under UV light (254 nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica 
gel.  Methylene chloride was distilled under N2 from CaH2, and 1,2–dichloroethane was dried 
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over 4Å molecular sieves. Reagent grade ethyl acetate, diethyl ether, pentane and hexanes were 
purchased from EM Science and used as purchased for chromatography. Tetrahydrofuran and 
diethyl ether were dried by passage through an activated alumina column under positive N2 
pressure. Anhydrous (N,N)-dimthylformamide (DMF), methanol (MeOH), dimethyl sulfoxide 
(DMSO), acetone were purchased from Aldrich and used as it is. Activated 4 Å molecular sieves 
were obtained through drying in oven at 150 °C overnight. All reactions were performed in oven 
or flame-dried glassware under a positive pressure of N2 with magnetic stirring unless otherwise 
noted.  
 
(2S,4R)-2-(Hept-1-yn-1-yl)-4-methyl-1,3-dioxane (3.10) 
The mixture of oct-2-ynal (3.43 g, 27.6 mmol), 1,3-butanediol (2.50 mL, 27.6 
mmol) and PPTs (30 mg, 0.12 mmol) in 30 mL benzene was heated at reflux with azeotropic 
removal of water overnight. Then the reaction mixture was concentrated and purified by flash 
chromatography (5% EtOAc in pentane) to give the desired product (3.3 g, 61%). 1H NMR (300 
MHz, CDCl3)  5.21 (s, 1H), 4.11 (dd, J = 4.9, 11.6 Hz, 1H), 3.85-3.72 (m, 2H), 2.22 (dt, J = 
1.3, 7.1 Hz, 2H), 1.80-1.63 (m, 1H), 1.56-1.29 (m, 7H), 1.26 (d, J = 6.2 Hz, 3H), 0.86 (t, J = 6.9 
Hz, 3H); 13C (75 MHz, CDCl3)  91.8, 86.4, 75.8, 73.7, 67.1, 32.8, 31.2, 28.0, 22.3, 21.8, 18.7, 
14.0; IR (neat) 2933, 2859, 2253, 1462, 1430, 1399, 1375, 1356, 1222, 1248, 1166, 1145, 1103, 
1053, 1021, 994, 964, 951, 933 cm-1; HRMS (EI) calcd for C12H20O2 (M
+) 196.1463, found 
196.1458. 
 
(R)-3-((R)-Non-3-yn-2-yloxy)butan-1-ol (3.11) 
To 3.10 (196 mg, 1.00 mmol) in 20 mL toluene at 0 °C  was added AlMe3 
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(2 M in toluene, 6 mL) dropwise.1 After stirring at rt for 30 minutes, the mixture was poured into 
40 mL 2 N NaOH (aq), and the organic layer was separated. After concentration, the resulting 
residue was purified by flash chromatography (20% EtOAc in pentane) to give the desired 
product (160 mg, 75%). 1H NMR (400 MHz, CDCl3)  4.24 (tq, J = 1.9, 6.5 Hz, 1H), 3.89 (qd, J 
= 6.4, 12.8 Hz, 1H), 3.79-3.71 (m, 2H), 2.44 (br, 1H), 2.18 (dt, J = 1.9, 7.1 Hz, 2H), 1.77-1.65 
(m, 2H), 1.53-1.46 (m, 2H), 1.38 (d, J = 6.5 Hz, 3H), 1.36-1.29 (m, 4H), 1.27 (d, J = 6.3 Hz, 
3H), 0.88 (t, J = 7.0 Hz, 3H); 13C (100 MHz, CDCl3)  85.1, 81.1, 73.8, 64.6, 60.5, 38.5, 31.2, 
28.5, 23.2, 22.3, 21.0, 18.8, 14.1; IR (neat) 3405, 2960, 2933, 2863, 1458, 1372, 1328, 1166, 
1136, 1080, 1058 cm-1; HRMS (EI) calcd for C13H24O2 (M
+) 212.1776, found 212.1769. 
 
General procedure for the enol acetate preparation:2 
A mixture of Na2CO3 (15%), [(p-cymene)RuCl2]2 (0.04 eq), tri(2-furyl)phosphine (0.08 eq), 
acetic acid (2.0 eq), and 1-decyne (0.5 eq) in toluene was heated to 80 C and stirred for 1 h. 
Another portion of acetic acid (2.0 eq) and the alkyne substrate (1.0 eq) were dissolved in 
toluene and added to the mixture (~0.15 M final substrate concentration). The reaction was 
stirred at 80 °C overnight. Then crude mixture was concentrated on a rotary evaporator and 
purified by flash chromatography to give the desired enol acetate product. 
 
(R)-4-((R)-Non-3-yn-2-yloxy)pent-1-en-2-yl acetate (3.12) 
To a solution of 3.11 (680 mg, 3.20 mmol), Et3N (1.43 mL, 10.2 mmol) and 
DMSO (26.8 mmol, 1.90 mL) in 12 mL CH2Cl2 at 0 °C  was added Py•SO3 (816 mg, 5.13 mmol) 
in one portion. The mixture was allowed to warm to rt for 5 h before it was quenched by H2O. 
The aqueous layer was extracted with Et2O and the combined organic layers were dried over 
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MgSO4. After filtration and concentration, the residue was purifier by flash chromatography (7% 
EtOAc in pentane) to give (R)-3-((R)-non-3-yn-2-yloxy)butanal (620 mg, 92%). 1H NMR (400 
MHz, CDCl3)  9.76 (s, 1H), 4.25-4.15 (m, 2H), 2.63 (ddd, J = 2.3, 6.6, 16.3, Hz, 1H), 2.46 (dd, 
J = 2.0, 5.4, 16.3 Hz, 1H), 2.16 (dt, J = 1.9, 7.1 Hz, 2H), 1.47 (p, J = 7.1 Hz, 2H), 1.37-1.22 (m, 
10H), 0.86 (t, J = 7.0 Hz, 3H); 13C (100 MHz, CDCl3)  201.5, 85.4, 80.6, 69.4, 64.4, 50.3, 31.2, 
28.5, 23.0, 22.3, 21.6, 18.7, 14.1; IR (neat) 2959, 2933, 2862, 1727, 1458, 1373, 1328, 1168, 
1102, 1081 cm-1. 
To a solution of (R)-3-((R)-non-3-yn-2-yloxy)butanal (446 mg, 2.12 mmol) and 
(MeO)2P(O)C(N2)C(O)CH3
3 (570 mg, 3.00 mmol) in 10 mL dry MeOH was added K2CO3 (586 
mg, 4.24 mmol) in one portion at 0 ° .     C      After stirring at the same temperature for 30 minutes, the 
reaction was quenched with saturated NH4Cl (aq), and the aqueous layer was extracted with 
Et2O. The combined organic layers were dried over MgSO4, filtrated and concentrated. The 
resulting residue was purified by flash chromatography (5% EtOAc in pentane) to give (R)-2-
((R)-pent-4-yn-2-yloxy)non-3-yne (100 mg, 23%). 1H NMR (600 MHz, CDCl3)  4.32 (tq, J = 
1.9, 6.5 Hz, 1H), 3.94 (qd, J = 6.3, 11.2 Hz, 1H), 2.43 (ddd, J = 2.7, 4.8, 16.7 Hz, 1H), 2.32 (ddd, 
J = 2.7, 6.9, 16.7 Hz, 1H), 2.20 (dt, J = 1.9, 7.1 Hz, 2H), 1.99 (t, J = 2.7 Hz, 1H), 1.52 (p, J = 7.0 
Hz, 2H), 1.40 (d, J = 6.6 Hz, 3H), 1.39-1.33 (m, 4H), 1.32 (d, J = 6.2 Hz, 3H), 0.91 (t, J = 7.1 
Hz, 3H). 
The general procedure for the preparation of enol acetate was followed: A 50 mL RBF was 
charged with Na2CO3 (8.0 mg, 0.075 mmol), dichloro(p-cymene)ruthenium(II) dimer (12 mg, 
0.019 mmol), tri(2-furyl)phosphine (9.0 mg, 0.039 mmol). Then 4.0 mL toluene was added into 
the flask, followed by acetic acid (42 uL, 0.73 mmol) and 1-decyne (18 uL, 0.10 mmol). The 
mixture was then heated to 80 C and stirred for 1 h. Then (R)-2-((R)-pent-4-yn-2-yloxy)non-3-
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yne (100 mg, 0.485 mmol) in 2.0 mL toluene was added into the reaction through syringe. The 
reaction was stirred at the same temperature overnight. Then crude mixture was loaded onto a 
short plug of silica gel and washed off with Et2O. The residue was concentrated on a rotary 
evaporator and purified by chromatography (6% Et2O in hexane) to give the desired product (84 
mg, 65%). 1H NMR (600 MHz, CDCl3)  4.80 (s, 2H), 4.23 (tq, J = 1.8, 6.5 Hz, 1H), 3.88 (qd, J 
= 6.3, 12.4 Hz, 1H), 2.48 (dd, J = 6.1, 14.8 Hz, 1H), 2.30 (dd, J = 6.1, 14.8 Hz, 1H), 2.20 (dt, J = 
1.7, 7.1 Hz, 2H), 2.16 (s, 3H), 1.51 (q, J = 7.1 Hz, 2H), 1.41-1.29 (m, 7H), 1.26 (d, J = 6.2 Hz, 
3H), 0.91 (t, J = 7.2 Hz, 3H); 13C (151 MHz, CDCl3)  169.1, 153.4, 103.7, 84.8, 80.8, 71.3, 
64.0, 40.3, 31.0, 28.4, 22.9, 22.2, 21.2, 21.0, 18.7, 14.0; IR (neat) 2958, 2932, 2861, 1758, 1665, 
1369, 1327, 1218, 1190, 1129, 1082, 1019 cm-1; HRMS(EI) calcd for C16H26O3 (M
+) 266.1882, 
found 266.1880. 
 
General procedure for the cyclization reaction: 
Substrate (1 eq), 2,6-dichloropyridine (2 eq) and 4 Å molecular sieves (2 mass eq) were 
dissolved in anhydrous 1,2-dichloroethane to give a ~0.1 M solution. The mixture was stirred at 
room temperature for 15 minutes, followed by addition of LiClO4 (0.3 eq). After 5 minutes, 
DDQ (2 eq) was added. The reaction was monitored by TLC at room temperature unless 
specified and, upon starting material consumption, was quenched by 5% aqueous NaHCO3. The 
mixture was extracted with CH2Cl2 three times, and combined organic layers were dried over 
MgSO4. The filtrate was concentrated and purified by flash chromatography to give the desired 
product. 
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(2S,6R)-2-(Hept-1-ynyl)-2,6-dimethyldihydro-2H-pyran-4(3H)-one (3.14) 
The general procedure of cyclization reaction was followed: 3.12 (23 mg, 0.086 
mmol), 2,6-dichloropyridine (26 mg, 0.18 mmol) and 4 Å molecular sieves (45 mg) 
were dissolved in 0.9 mL anhydrous 1,2-dichloroethane, followed by DDQ (79 mg, 0.35 mmol). 
The reaction was stirred at room temperature for 18 h and then quenched by 5% aqueous 
NaHCO3. The crude mixture was extracted with CH2Cl2 (3x). After concentration, it was purified 
by flash chromatography (5% EtOAc in hexane) to give the desired product (14 mg, 72%). 
1H 
NMR (600 MHz, CDCl3)  4.33 (ddq, J = 2.8, 6.2, 12.3 Hz, 1H), 2.51 (dd, J = 1.7, 13.7 Hz, 1H), 
2.44 (d, J = 13.7 Hz, 1H), 2.38-2.35 (m, 1H), 2.18-2.13 (m, 3H), 1.60 (s, 3H), 1.50-1.45 (m, 2H), 
1.34 (d, J = 6.2 Hz, 3H), 1.33-1.30 (m, 4H), 0.90 (t, J = 7.0 Hz, 3H); 13C (151 MHz, CDCl3)  
205.9, 88.7, 79.2, 72.1, 68.9, 53.9, 48.7, 31.0, 30.3, 28.2, 22.1, 22.0, 18.5, 14.0 ; IR (neat) 2959, 
2931, 2859, 1726, 1300, 1257, 1195, 1176, 1156, 1092 cm-1; HRMS(EI) calcd for C14H22O2 (M
+) 
222.1620, found 222.1614. 
 
(R)-4-(((R)-4-Methylpent-3-en-2-yl)oxy)pent-1-en-2-yl acetate (3.15) 
Substrate 3.15 was prepared following the same synthetic route to substrate 
3.12. 1H NMR (500 MHz, CDCl3)  5.08 (pd, J = 1.3, 7.7 Hz, 1H), 4.80 (s, 2H), 4.25 (qd, J = 
6.3, 9.0 Hz, 1H), 3.59 (qd, J = 6.3, 12.6 Hz, 1H), 2.49 (dd, J = 6.1, 14.6 Hz, 1H), 2.28 (dd, J = 
6.4, 14.6 Hz, 1H), 2.14 (s, 3H), 1.73 (d, J = 1.0 Hz, 3H), 1.67 (d, J = 1.1 Hz, 3H), 1.16 (s, 3H), 
1.14 (s, 3H); 13C NMR (75 MHz, CDCl3)  169.3, 153.9, 133.8, 128.5, 103.8, 70.3, 69.7, 41.0, 
26.0, 21.8, 21.4, 21.3, 18.3; IR (neat) 2970, 2965, 2850, 1758, 1564, 1370, 1190, 1021 cm-1; 
HRMS (EI) calcd for C13H22O3 (M
+) 226.1569, found 226.1566. 
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(2R,6R)-2,6-Dimethyl-2-(2-methylprop-1-en-1-yl)dihydro-2H-pyran-4(3H)-
one (3.43) 
The general cyclization reaction procedure was followed with 3.15 (50 mg, 0.22 mmol), 2,6-
dichloropyridine (49 mg, 0.33 mmol), 4 Å molecular sieves (100 mg), nitromethane (2.2 mL), 
LiClO4 (7 mg, 0.07 mmol), and DDQ (125 mg, 0.551 mmol). The reaction was stirred at room 
temperature for 10 h and then quenched by Et3N. The crude was purified by flash 
chromatography (10% to 15% Et2O in pentane) to give the desired product (21 mg, 52%, dr = 
3:1). Data for the cis-3.43: 1H NMR (600 MHz, CDCl3)  5.29 (d, J = 1.0 Hz, 1H), 4.08-4.02 (m, 
1H), 2.61 (d, J = 13.9 Hz, 1H), 2.37-2.35 (m, 2H), 2.28-2.22 (m, 1H), 1.88 (s, 3H), 1.74 (s, 3H), 
1.35 (d, J = 6.0 Hz, 3H), 1.32 (s, 3H); 13C NMR (151 MHz, CDCl3)  208.3, 135.8, 130.4, 78.0, 
67.1, 52.8, 49.7, 27.5, 24.2, 22.7, 19.4; Data for the trans-3.43: 1H NMR (600 MHz, CDCl3)  
5.00 (s, 1H), 3.94-3.89 (m, 1H), 2.35-2.32 (m, 3H), 2.20-2.16 (m, 1H), 1.80 (s, 3H), 1.69 (s, 3H), 
1.46 (s, 3H), 1.30 (d, J = 6.1 Hz, 3H); 13C NMR (151 MHz, CDCl3)  208.3, 138.3, 125.3, 78.0, 
67.6, 55.2, 49.3, 29.7, 26.9, 22.6, 18.4; Data for the mixture of isomers: IR (neat) 2960, 2928, 
2870, 1725, 1379, 1278, 1176, 1085, 975 cm-1; HRMS (EI) calcd for C11H18O2 (M
+) 182.1307, 
found 182.1302. 
 
(R)-4-((R,E)-Oct-3-en-2-yloxy)pent-1-en-2-yl acetate (3.16) 
Substrate 3.16 was prepared following the same synthetic route to substrate 
3.12. 1H NMR (500 MHz, CDCl3)  5.56 (td, J = 6.7, 15.3 Hz, 1H), 5.34 (tdd, J = 1.4, 7.8, 15.4 
Hz, 1H), 4.79 (s, 2H), 3.88 (p, J = 6.4 Hz, 1H), 3.64 (qd, J = 6.3, 12.5 Hz, 1H), 2.49 (dd, J = 6.1, 
14.7 Hz, 1H), 2.28 (dd, J = 6.4, 14.7 Hz, 1H), 2.15 (s, 3H), 2.04 (q, J = 6.8 Hz, 2H), 1.40-1.29 
(m, 4H), 1.19 (d, J = 6.4 Hz, 3H), 1.15 (d, J = 6.3 Hz, 3H), 0.91 (t, J = 7.1 Hz, 3H); 13C NMR 
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(125 MHz, CDCl3)  169.3, 153.9, 132.9, 132.6, 103.8, 75.1, 69.8, 40.7, 32.0, 31.6, 22.4, 22.2, 
21.4, 21.3, 14.1; IR (neat) 2966, 2915, 2872, 1759, 1666, 1370, 1212, 1120, 1109, 1018, 971 cm-
1; HRMS (EI) calcd for C15H26O3 (M
+) 254.1882, found 254.1879. 
 
(2R,6R)-2-((E)-Hex-1-en-1-yl)-2,6-dimethyldihydro-2H-pyran-4(3H)-one 
(cis-3.45)  
The general cyclization reaction procedure was followed with 3.16 (44 mg, 0.17 mmol), 2,6-
dichloropyridine (38 mg, 0.26 mmol), 4 Å molecular sieves (90 mg), nitromethane (1.7 mL), 
LiClO4 (5.5 mg, 0.052 mmol), and DDQ (98 mg, 0.43 mmol). The reaction was stirred at room 
temperature for 5.5 h and then quenched by Et3N. The crude mixture was purified by flash 
chromatography (9%-20% Et2O in hexane) to give the desired product (31 mg, 85%, dr = 3:1).  
1H NMR (600 MHz, CDCl3)  5.67 (td, J = 6.5, 15.5 Hz, 1H), 5.59 (d, J = 15.7 Hz, 1H), 4.09-
4.04 (m, 1H), 2.48 (d, J = 13.6 Hz, 1H), 2.34 (td, J = 2.2, 14.0 Hz, 1H), 2.30 (dd, J = 1.9, 13.6 
Hz, 1H), 2.22 (dd, J = 11.8, 14.3 Hz, 1H), 2.04 (q, J = 6.7 Hz, 2H), 1.37-1.34 (m, 3H), 1.32 (d, J 
= 6.1 Hz, 3H), 1.30-1.29 (m, 1H), 1.26 (s, 3H), 0.89 (t, J = 7.3 Hz, 3H); 13C NMR (151 MHz, 
CDCl3)  208.2, 135.7, 129.2, 76.8, 67.2, 52.0, 49.4, 32.1, 31.4, 23.2, 22.7, 22.5, 14.2; IR (neat) 
2962, 2928, 2872, 1724, 1379, 1278, 1176, 1085, 975 cm-1; HRMS (EI) calcd for C13H22O2 (M
+) 
210.1620, found 210.1617. 
 
(2S,6R)-2-((E)-Hex-1-en-1-yl)-2,6-dimethyldihydro-2H-pyran-4(3H)-one 
(trans-3.45) 
1H NMR (600 MHz, CDCl3)  5.50 (td, J = 6.7, 16.0 Hz, 1H), 5.33 (d, J = 16.1 Hz, 1H), 3.97-
3.91 (m, 1H), 2.67 (dd, J = 1.8, 14.5 Hz, 1H), 2.38 (d, J = 14.4 Hz, 1H), 2.27 (td, J = 2.2, 14.4 
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Hz, 1H), 2.13 (dd, J = 11.2, 14.3 Hz, 1H), 2.01 (q, J = 7.0 Hz, 2H), 1.37 (s, 3H), 1.34-1.30 (m, 
3H), 1.28 (d, J = 6.1 Hz, 3H), 1.27-1.26 (m, 1H), 0.88 (t, J = 7.2 Hz, 3H); 13C NMR (151 MHz, 
CDCl3)  208.0, 133.9, 133.4, 77.1, 67.4, 49.8, 49.0, 32.4, 31.4, 30.7, 22.4, 14.1; IR (neat) 2961, 
2929, 2871, 1725, 1379, 1278, 1176, 1085, 977 cm-1; HRMS (EI) calcd for C13H22O2 (M
+) 
210.1620, found 210.1610. 
 
(R)-4-(((R,E)-4-Phenylbut-3-en-2-yl)oxy)pent-1-en-2-yl acetate (3.17) 
Substrate 3.17 was prepared following the same synthetic route to substrate 
3.12. 1H NMR (300 MHz, CDCl3)  7.42-7.28 (m, 4H), 7.26-7.22 (m, 1H), 6.51 (d, J = 16.0 Hz, 
1H), 6.12 (dd, J = 7.7, 16.0 Hz, 1H), 4.82 (s, 2H), 4.13 (p, J = 6.5 Hz, 1H), 3.71 (qd, J = 6.3, 
12.5 Hz, 1H), 2.55 (dd, J = 6.1, 14.6 Hz, 1H), 2.31 (dd, J = 6.1, 14.5 Hz, 1H), 2.13 (s, 3H), 1.31 
(d, J = 6.4 Hz, 3H), 1.19 (d, J = 6.2 Hz, 3H); 13C NMR (125 MHz, CDCl3)  169.2, 153.7, 136.8, 
132.5, 130.7, 128.7, 127.8, 126.6, 103.8, 75.0, 70.2, 40.6, 22.1, 21.3, 21.2; IR (neat) 2974, 2929, 
1756, 1666, 1494, 1447, 1370, 1192, 1130, 1067, 1021, 968, 875, 750, 694 cm-1; HRMS (ESI) 
calcd for C17H22O3Na (M+Na)
+ 297.1467, found 297.1486. 
 
(2R,6R)-2,6-Dimethyl-2-((E)-styryl)dihydro-2H-pyran-4(3H)-one (cis-3.46) 
The general cyclization reaction procedure was followed with 3.17 (30 mg, 0.11 
mmol), 2,6-dichloropyridine (24 mg, 0.16 mmol), 4 Å molecular sieves (60 mg), nitroethane (1.1 
mL), LiClO4 (3.5 mg, 0.033 mmol), and DDQ (38 mg, 0.16 mmol). The reaction was stirred at – 
60 °C for 4 h and then quenched by Et3N. The crude mixture was purified by flash 
chromatography (15% Et2O in hexane to 10% EtOAc in hexane) to give the desired product (21 
mg, 82%). 1H NMR (300 MHz, CDCl3)  7.43-7.40 (m, 2H), 7.35-7.30 (m, 2H), 7.25-7.22 (m, 
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1H), 6.65 (d, J = 16.1 Hz, 1H), 6.32 (d, J = 16.1 Hz, 1H), 4.20-4.10 (m, 1H), 2.59 (d, J = 13.7 
Hz, 1H), 2.46-2.36 (m, 2H), 2.28 (dd, J = 11.0, 13.9 Hz, 1H), 1.40-1.38 (m, 6H); 13C NMR (75 
MHz, CDCl3)  207.6, 136.7, 135.2, 128.8, 127.9, 127.8, 126.8, 76.8, 67.4, 51.9, 49.4, 23.5, 
22.7; IR (neat) 2974, 1720, 1494, 1415, 1380, 1302, 1175, 1083, 1018, 970, 749, 694 cm-1; 
HRMS (ESI) calcd for C15H18O2Na (M+Na)
+ 253.1204, found 253.1229. 
 
(2S,6R)-2,6-Dimethyl-2-((E)-styryl)dihydro-2H-pyran-4(3H)-one (trans-3.46) 
1H NMR (300 MHz, CDCl3)  7.40-7.28 (m, 4H), 7.27-7.25 (m, 1H), 6.44 (d, J = 16.6 
Hz, 1H), 6.12 (d, J = 16.6 Hz, 1H), 4.05-3.95 (m, 1H), 2.84 (dd, J = 1.6, 14.5 Hz, 1H), 
2.51 (d, J = 14.6 Hz, 1H), 2.34-2.28 (m, 1H), 2.20 (dd, J = 11.0, 14.4 Hz, 1H), 1.49 (s, 3H), 1.31 
(d, J = 6.1 Hz, 3H); 13C NMR (75 MHz, CDCl3)  207.5, 136.2, 133.1, 132.1, 128.8, 128.3, 
126.7, 77.4, 67.9, 49.8, 49.0, 30.6, 22.4; IR (neat) 2974, 1720, 1494, 1413, 1380, 1301, 1175, 
1082, 1018, 970, 749, 696 cm-1; HRMS (ESI) calcd for C15H18O2Na (M+Na)
+ 253.1204, found 
253.1228. 
 
(R)-4-(((R,Z)-3-(Dimethyl(phenyl)silyl)oct-3-en-2-yl)oxy)pent-1-en-2-yl 
acetate (3.18) 
Substrate 3.18 was prepared following the similar synthetic route to substrate 3.12. 1H NMR 
(600 MHz, CDCl3)  7.47-7.45 (m, 2H), 7.28-7.27 (m, 3H), 6.26 (t, J = 7.4 Hz, 1H), 4.73-4.72 
(m, 2H), 4.00 (q, J = 6.4 Hz, 1H), 3.56 (qd, J = 6.3, 12.6 Hz, 1H), 2.45 (dd, J = 5.3, 14.5 Hz, 
1H), 2.21 (dd, J = 6.8, 14.5 Hz, 1H), 2.05 (s, 3H), 1.91-1.85 (m, 2H), 1.44 (d, J = 6.4 Hz, 3H), 
1.11 (d, J = 6.2 Hz, 3H), 1.10-1.02 (m, 4H), 0.69 (t, J = 7.1 Hz, 3H), 0.36 (s, 6H); 13C NMR (151 
MHz, CDCl3)  169.3, 153.9, 145.2, 140.1, 139.5, 133.9, 128.9, 127.9, 103.9, 79.0, 70.0, 40.5, 
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32.0, 31.9, 23.8, 22.5, 21.3, 21.0, 14.1, 0.1, -0.3; IR (neat) 2975, 2928, 1756, 1667, 1490, 1371, 
1190, 1067, 1022, 969, 876, cm-1; HRMS (EI) calcd for C23H36O3Si (M
+) 388.2434, found 
388.2441. 
 
(R)-4-(((R,E)-3-Methyltetradec-3-en-2-yl)oxy)pent-1-en-2-yl acetate 
(3.19)4 
Substrate 3.19 was prepared following the same synthetic route to substrate 3.12. 1H NMR (500 
MHz, CDCl3)  5.32 (t, J = 6.5 Hz, 1H), 4.79 (d, J = 1.3 Hz, 1H), 4.78 (s, 1H), 3.85 (q, J = 6.4 
Hz, 1H), 3.54 (qd, J = 6.3, 12.5 Hz, 1H), 2.48 (dd, J = 5.6, 14.6 Hz, 1H), 2.26 (dd, J = 6.6, 14.6 
Hz, 1H), 2.14 (s, 3H), 2.08-1.95 (m, 2H), 1.56 (s, 3H), 1.41-1.27 (m, 16H), 1.18 (d, 6.5 Hz, 3H), 
1.13 (d, J = 6.3 Hz, 3H), 0.89 (t, 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3)  169.3, 154.0, 
136.5, 127.9, 103.8, 79.6, 69.5, 40.4, 32.1, 29.9, 29.8, 29.8, 29.7, 29.6, 29.5, 27.8, 22.9, 21.4, 
21.2, 20.5, 14.3, 10.8; IR (neat) 2925, 2855, 1760, 1666, 1369, 1192, 1080, 1020 cm-1; HRMS 
(EI) calcd for C22H40O3 (M
+) 352.2977, found 352.2987. 
 
(2R,6R)-2,6-Dimethyl-2-((E)-tridec-2-en-2-yl)dihydro-2H-pyran-4(3H)-
one (3.48) 
The general cyclization reaction procedure was followed with 3.19 (52 mg, 0.15 mmol), 2,6-
dichloropyridine (44 mg, 0.30 mmol), 4 Å molecular sieves (100 mg), nitromethane (1.5 mL), 
LiClO4 (4.7 mg, 0.044 mmol), and DDQ (110 mg, 0.485 mmol). The reaction was stirred at 
room temperature for 13 h and then quenched by Et3N. The crude mixture was purified by flash 
chromatography (6% Et2O in hexane) to give the desired product (38 mg, 84%, dr = 26:1). 
1H 
NMR (500 MHz, CDCl3)  5.51 (dt, J = 1.1, 6.9 Hz, 1H), 4.11-4.04 (m, 1H), 2.53 (d, J = 13.5 
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Hz, 1H), 2.40-2.33 (m, 2H), 2.22 (dd, J = 11.1, 13.7 Hz, 1H), 2.03 (q, J = 7.1 Hz, 2H), 1.70 (d, J 
= 0.4 Hz, 3H), 1.38-1.35 (m, 2H), 1.33 (d, J = 6.0 Hz, 3H), 1.27-1.26 (m, 17H), 0.89 (t, J = 6.8 
Hz, 3H); 13C NMR (151 MHz, CDCl3)  208.8, 139.1, 124.4, 79.2, 67.0, 50.9, 49.4, 32.1, 29.9, 
29.8, 29.7, 29.7, 29.6, 28.1, 22.9, 22.7, 22.6, 14.3, 12.3; IR (neat) 2957, 2923, 2853, 1722, 1457, 
1444, 1379, 1299, 1278, 1018 cm-1; HRMS (EI) calcd for C20H36O2 (M
+) 308.2715, found 
308.2729. 
 
(R)-4-((R)-1-(Cyclohex-1-en-1-yl)ethoxy)pent-1-en-2-yl acetate (3.20) 
Substrate 3.20 was prepared following the same synthetic route to substrate 
3.12. 1H NMR (600 MHz, CDCl3)  5.59 (br, 1H), 4.79 (s, 2H), 3.84 (q, J = 6.4 Hz, 1H), 3.56 
(qd, J = 6.2, 12.5 Hz, 1H), 2.50 (dd, J = 5.7, 14.5 Hz, 1H), 2.26 (dd, J = 6.5, 14.5 Hz, 1H), 2.15 
(s, 3H), 2.06-2.00 (m, 2H), 1.97-1.92 (m, 2H), 1.69-1.62 (m, 2H), 1.58-1.50 (m, 2H), 1.19 (d, J = 
6.5 Hz, 3H), 1.14 (d, J = 6.2 Hz, 3H); 13C NMR (151 MHz, CDCl3)  169.3, 154.0, 139.4, 124.1, 
103.8, 78.5, 69.6, 40.4, 25.3, 23.0, 22.8, 21.4, 21.2, 20.3; IR (neat) 2975, 2930, 1758, 1666, 
1439, 1370, 1290, 1218, 1193, 1139, 1070, 1019, 975, 921, 873 cm-1; HRMS (ESI) calcd for 
C15H24O3Na (M+Na)
+ 275.1623, found 275.1596. 
 
(2R,6R)-2-(Cyclohex-1-en-1-yl)-2,6-dimethyldihydro-2H-pyran-4(3H)-one 
(3.49) 
The general cyclization reaction procedure was followed with 3.20 (70 mg, 0.28 mmol), 2,6-
dichloropyridine (82 mg, 0.55 mmol), 4 Å molecular sieves (140 mg), nitromethane (2.7 mL), 
LiClO4 (9 mg, 0.08 mmol), and DDQ (220 mg, 0.969 mmol). The reaction was stirred at room 
temperature for 2.5 hours and then quenched by Et3N. The crude mixture was purified by flash 
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chromatography (30% CH2Cl2 in hexane to 10% Et2O in hexane) to give the desired product (50 
mg, 86%). 1H NMR (600 MHz, CDCl3)  5.79 (br, 1H), 4.09-4.04 (m, 1H), 2.50 (d, 13.6 Hz, 
1H), 2.37-2.32 (m, 2H), 2.21 (dd, J = 11.8, 14.3 Hz, 1H), 2.11-2.02 (m, 4H), 1.66-1.54 (m, 4H), 
1.31 (d, J = 6.0 Hz, 3H), 1.24 (s, 3H); 13C NMR (151 MHz, CDCl3)  208.8, 141.9, 120.7, 78.8, 
66.9, 50.7, 49.4, 25.2, 23.9, 23.1, 22.6, 22.5, 22.4; IR (neat) 2973, 2930, 2858, 2839, 1722, 1444, 
1381, 1341, 1297, 1277, 1231, 1180, 1151, 1107, 1076, 1036, 1013, 966 cm-1; HRMS (EI) calcd 
for C13H20O2 (M
+) 208.1463, found 208.1468. 
 
(R)-4-((R)-1-(4-Methoxyphenyl)ethoxy)pent-1-en-2-yl acetate (3.21) 
Substrate 3.21 was prepared following the same synthetic route to substrate 
3.12. 1H NMR (300 MHz, CDCl3)  7.27-7.23 (m, 2H), 6.91-6.86 (m, 2H), 
4.80 (s, 2H), 4.50 (q, J = 6.5 Hz, 1H), 3.82 (s, 3H), 3.56-3.43 (m, 1H), 2.56 (dd, J = 5.7, 14.6 Hz, 
1H), 2.32 (dd, J = 6.4, 14.7 Hz, 1H), 2.11 (s, 3H), 1.39 (d, J = 6.5 Hz, 3H), 1.07 (d, J = 6.3 Hz, 
3H); 13C NMR (75 MHz, CDCl3)  169.3, 159.2, 153.8, 136.8, 127.7, 114.0, 103.9, 75.6, 70.2, 
55.5, 40.5, 24.5, 21.4, 21.1; IR (neat) 2973, 1755, 1612, 1512, 1370, 1288, 1245, 1191, 1088, 
1036, 833 cm-1; HRMS (EI) calcd for C16H22O4 (M
+) 278.1518, found 278.1525. 
 
(2R,6R)-2-(4-Methoxyphenyl)-2,6-dimethyldihydro-2H-pyran-4(3H)-one 
(3.50) 
The general cyclization reaction procedure was followed with 3.21 (43 mg, 
0.15 mmol), 2,6-dichloropyridine (46 mg, 0.31 mmol), 4 Å molecular sieves (90 mg), 
nitromethane (1.5 mL), LiClO4 (5 mg, 0.05 mmol), and DDQ (70 mg, 0.31 mmol). The reaction 
was stirred at room temperature for 2 h and then quenched by Et3N. The crude mixture was 
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purified by flash chromatography (40% CH2Cl2 in hexane to 10% EtOAc in hexane) to give the 
desired product (29 mg, 78%). 1H NMR (300 MHz, CDCl3)  7.42 (d, J = 8.9 Hz, 2H), 6.90 (d, J 
= 8.9 Hz, 2H), 4.27-4.17 (m, 1H), 3.81 (s, 3H), 2.72-2.61 (m, 2H), 2.46-2.40 (m, 1H), 2.29 (dd, J 
= 11.0, 14.1 Hz, 1H), 1.48 (s, 3H), 1.42 (d, J = 6.0 Hz, 3H); 13C NMR (151 MHz, CDCl3)  
207.9, 158.8, 139.6, 125.5, 113.8, 77.9, 67.2, 55.5, 53.4, 49.4, 25.5, 22.8; IR (neat) 2972, 2931, 
1713, 1608, 1515, 1450, 1412, 1384, 1310, 1280, 1252, 1182, 1111, 1029, 843 cm-1; HRMS (EI) 
calcd for C14H18O3 (M
+) 234.1256, found 234.1245. 
 
(R)-4-((S)-1-(4-Methoxyphenyl)ethoxy)pent-1-en-2-yl acetate (3.22)5 
1H NMR (500 MHz, CDCl3)  7.25-7.23 (m, 2H), 6.88-6.86 (m, 2H), 4.75 
(d, J = 1.3 Hz, 1H), 4.70 (s, 1H), 4.50 (q, J = 6.5 Hz, 1H), 3.81 (s, 3H), 
3.49-3.43 (m, 1H), 2.41 (dd, J = 6.6, 14.7 Hz, 1H), 2.28 (dd, J = 6.3, 14.5 Hz, 1H), 1.95 (s, 3H), 
1.39 (d, J = 6.5 Hz, 3H), 1.17 (d, J = 6.1 Hz, 3H); 13C NMR (75 MHz, CDCl3)  169.2, 159.1, 
153.5, 136.2, 127.8, 113.8, 103.6, 74.5, 69.2, 55.4, 41.9, 24.7, 21.2, 19.2; IR (neat) 2973, 1755, 
1612, 1512, 1370, 1288, 1245, 1191, 1088, 1036, 833 cm-1; HRMS (EI) calcd for C16H22O4 (M
+) 
278.1518, found 278.1523. 
 
(2R,6R)-2-(4-Methoxyphenyl)-2,6-dimethyldihydro-2H-pyran-4(3H)-one 
(3.50) 
The general cyclization reaction procedure was followed with 3.22 (39 mg, 
0.14 mmol), 2,6-dichloropyridine (42 mg, 0.28 mmol), 4 Å molecular sieves (80 mg), 
nitromethane (1.4 mL), LiClO4 (4.5 mg, 0.042 mmol), and DDQ (63 mg, 0.28 mmol). The 
reaction was stirred at room temperature for 2 h and then quenched by Et3N. The crude mixture 
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was purified by flash chromatography (40% CH2Cl2 in hexane to 10% EtOAc in hexane) to give 
the desired product (25 mg, 74%). 1H NMR (300 MHz, CDCl3)  7.42 (d, J = 8.9 Hz, 2H), 6.90 
(d, J = 8.9 Hz, 2H), 4.27-4.17 (m, 1H), 3.81 (s, 3H), 2.72-2.61 (m, 2H), 2.46-2.40 (m, 1H), 2.29 
(dd, J = 11.0, 14.1 Hz, 1H), 1.48 (s, 3H), 1.42 (d, J = 6.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) 
 207.9, 158.8, 139.6, 125.5, 113.8, 77.9, 67.2, 55.5, 53.4, 49.4, 25.5, 22.8; IR (neat) 2972, 2931, 
1713, 1608, 1515, 1450, 1412, 1384, 1310, 1280, 1252, 1182, 1111, 1029, 843 cm-1; HRMS (EI) 
calcd for C14H18O3 (M
+) 234.1256, found 234.1245. 
 
(R)-4-(((S)-6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)oxy)pent-1-en-
2-yl acetate (3.23) 
1H NMR (600 MHz, CDCl3)  7.29 (d, J = 8.5 Hz, 1H), 6.73 (dd, J = 2.6, 8.5 
Hz, 1H), 6.61 (d, J = 2.3 Hz, 1H), 4.84 (d, J = 1.2 Hz, 1H), 4.82 (s, 1H), 4.46 (t, J = 4.4 Hz, 1H), 
3.83-3.78 (m, 1H), 3.78 (s, 3H), 2.81 (td, J = 5.3, 16.6 Hz, 1H), 2.71-2.66 (m, 1H), 2.59 (dd, J = 
6.7, 14.6 Hz, 1H), 2.38 (dd, J = 6.1, 14.7 Hz, 1H), 2.12 (s, 3H), 2.06-1.96 (m, 2H), 1.86-1.80 (m, 
1H), 1.74-1.68 (m, 1H), 1.26 (d, J = 6.2 Hz, 3H); 13C NMR (151 MHz, CDCl3)  169.4, 159.0, 
153.8, 139.2, 131.0, 129.6, 113.5, 112.3, 104.0, 73.9, 70.7, 55.4, 41.8, 29.7, 29.3, 21.7, 21.4, 
18.6; IR (neat) 2933, 1754, 1665, 1608, 1501, 1450, 1369, 1316, 1254, 1189, 1123, 1064, 1038, 
1015, 985 cm-1; HRMS (EI) calcd for C18H24O4 (M
+) 304.1675, found 304.1671. 
 
(1S,6'S)-6-Methoxy-6'-methyl-3,4,5',6'-tetrahydro-2H-spiro[naphthalene-
1,2'-pyran]-4'(3'H)-one (3.52) 
The general cyclization reaction procedure was followed with 3.23 (60 mg, 0.20 mmol), 2,6-
dichloropyridine (44 mg, 0.30 mmol), 4 Å molecular sieves (120 mg), nitromethane (2 mL), 
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LiClO4 (6.3 mg, 0.059 mmol), and DDQ (89 mg, 0.39 mmol). The reaction was stirred at 0 °C 
for 40 minutes and then quenched by Et3N. The crude mixture was purified by flash 
chromatography (10% EtOAc in hexane) to give the desired product (42 mg, 82%). 1H NMR 
(600 MHz, CDCl3)  7.57 (d, J = 8.7 Hz, 1H), 6.83 (dd, J = 2.7, 8.7 Hz, 1H), 6.59 (d, J = 2.6 Hz, 
1H), 4.18-4.13 (m, 1H), 3.79 (s, 3H), 2.83-2.72 (m, 3H), 2.59 (dd, J = 1.9, 14.0 Hz, 1H), 2.45-
2.42 (m, 1H), 2.37 (dd, J = 11.0, 13.8 Hz, 1H), 2.01-1.92 (m, 2H), 1.87-1.83 (m, 1H), 1.74-1.68 
(m, 1H), 1.36 (d, J = 6.0 Hz, 3H); 13C NMR (151 MHz, CDCl3)  208.4, 159.0, 138.4, 132.6, 
128.5, 113.4, 113.0, 77.4, 67.0, 55.5, 53.1, 49.6, 32.4, 29.9, 23.0, 20.0; IR (neat) 2930, 1754, 
1714, 1674, 1605, 1500, 1450, 1345, 1250, 1179, 1017 cm-1; HRMS (EI) calcd for C16H20O3 
(M+) 260.1412, found 260.1410. 
 
(R)-4-(((S)-5-Methoxy-2,3-dihydro-1H-inden-1-yl)oxy)pent-1-en-2-yl 
acetate (3.24)6 
1H NMR (600 MHz, CDCl3)  7.29 (d, J = 8.2 Hz, 1H), 6.77-6.75 (m, 2H), 
4.94 (dd, J = 4.5, 6.1 Hz, 1H), 4.82 (s, 1H), 4.81 (s, 1H), 3.84-3.80 (m, 1H), 3.79 (s, 3H), 3.04 
(ddd, J = 5.7, 8.2, 15.2 Hz, 1H), 2.76 (ddd, J = 5.9, 8.0, 14.5 Hz, 1H), 2.52 (dd, J = 7.0, 14.8 Hz, 
1H), 2.39-2.34 (m, 2H), 2.12 (s, 3H), 2.07-2.01 (m, 1H), 1.26 (d, J = 6.1 Hz, 3H); 13C NMR (151 
MHz, CDCl3)  169.4, 160.3, 153.7, 145.7, 135.8, 125.9, 112.8, 109.9, 103.9, 81.8, 71.7, 55.6, 
41.6, 34.4, 30.5, 21.4, 21.3; IR (neat) 2934, 1755, 1666, 1609, 1492, 1454, 1370, 1329, 1255, 
1191, 1140, 1099, 1026, 983, 872, 814 cm-1; HRMS (ESI) calcd for C17H22O4Na (M+Na)
+ 
313.1416, found 313.1421. 
 
 205
(1S,6'S)-5-Methoxy-6'-methyl-2,3,5',6'-tetrahydrospiro[indene-1,2'-
pyran]-4'(3'H)-one (3.53) 
The general cyclization reaction procedure was followed with 3.24 (37 mg, 0.13 mmol), 2,6-
dichloropyridine (28 mg, 0.19 mmol), 4 Å molecular sieves (74 mg), nitromethane (1.3 mL), 
LiClO4 (4.1 mg, 0.039 mmol), and DDQ (57 mg, 0.25 mmol). The reaction was stirred at 0 °C 
for 30 minutes and then quenched by Et3N. The crude mixture was purified by flash 
chromatography (10% EtOAc in hexane) to give the desired product (26 mg, 84%). 1H NMR 
(600 MHz, CDCl3)  7.34 (d, J = 8.3 Hz, 1H), 6.84 (dd, J = 2.2, 8.3 Hz, 1H), 6.77 (s, 1H), 4.07-
4.01 (m, 1H), 3.80 (s, 3H), 2.98 (td, J = 5.9, 16.1 Hz, 1H), 2.83 (td, J = 8.2, 16.2 Hz, 1H), 2.69 
(d, J = 13.6 Hz, 1H), 2.43-2.37 (m, 3H), 2.16 (dd, J = 5.9, 7.9 Hz, 2H), 1.37 (d, J = 6.1 Hz, 3H); 
13C NMR (151 MHz, CDCl3)  207.7, 160.7, 143.7, 138.1, 124.0, 113.8, 109.8, 87.5, 69.2, 55.7, 
51.5, 49.7, 36.0, 29.8, 22.7; IR (neat) 2925, 1718, 1608, 1493, 1455, 1326, 1247, 1143, 1078, 
1022 cm-1; HRMS (EI) calcd for C15H18O3 (M
+) 246.1256, found 246.1250. 
 
(R)-4-(((S)-1,2,3,4-Tetrahydronaphthalen-1-yl)oxy)pent-1-en-2-yl acetate 
(3.25) 
1H NMR (600 MHz, CDCl3)  7.39-7.38 (m, 1H), 7.18-7.16 (m, 2H), 7.09-7.08 
(m, 1H), 4.84 (d, J = 1.3 Hz, 1H), 4.83 (s, 1H), 4.50 (t, J = 4.7 Hz, 1H), 3.83 (qd, J = 6.3, 12.6 
Hz, 1H), 2.84 (td, J = 5.8, 16.7 Hz, 1H), 2.74-2.69 (m, 1H), 2.61 (dd, J = 6.6, 14.6 Hz, 1H), 2.39 
(dd, J = 6.2, 14.7 Hz, 1H), 2.12 (s, 3H), 2.06-1.96 (m, 2H), 1.91-1.86 (m, 1H), 1.76-1.71 (m, 
1H), 1.28 (d, J = 6.2 Hz, 3H); 13C NMR (151 MHz, CDCl3)  169.4, 153.7, 137.7, 137.2, 129.6, 
129.1, 127.7, 125.9, 104.1, 74.4, 71.0, 41.8, 29.3, 29.2, 21.7, 21.4, 18.8; IR (neat) 2933, 1754, 
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1665, 1490, 1453, 1369, 1189, 1126, 1066, 1015, 985, 871, 763, 739 cm-1; HRMS (ESI) calcd 
for C17H22O3Na (M+Na)
+ 297.1467, found 297.1461. 
 
(1S,6'S)-6'-Methyl-3,4,5',6'-tetrahydro-2H-spiro[naphthalene-1,2'-pyran]-
4'(3'H)-one (3.54) 
The general cyclization reaction procedure was followed with 3.25 (32 mg, 0.12 mmol), 2,6-
dichloropyridine (26 mg, 0.17 mmol), 4 Å molecular sieves (65 mg), nitromethane (1.1 mL), 
LiClO4 (3.8 mg, 0.036 mmol), and DDQ (79 mg, 0.35 mmol). The reaction was stirred at room 
temperature for 7 hours and then quenched by Et3N. The crude mixture was purified by flash 
chromatography (7% EtOAc in hexane) to give the desired product (18 mg, 67%). 1H NMR (600 
MHz, CDCl3)  7.67 (dd, J = 0.8, 7.9 Hz, 1H), 7.28-7.26 (m, 1H), 7.20 (dt, J = 1.3, 7.6 Hz, 1H), 
7.08 (d, J = 7.6 Hz, 1H), 4.22-4.16 (m, 1H), 22.85-2.76 (m, 2H), 2.73 (d, J = 14.0 Hz, 1H), 2.63 
(dd, J = 1.9, 14.0 Hz, 1H), 2.47-2.44 (m, 1H), 2.39 (ddd, J = 0.5, 10.7, 13.9 Hz, 1H), 2.05 (ddd, J 
= 2.5, 6.1, 12.7 Hz, 1H), 1.99-1.94 (m, 1H), 1.89-1.84 (m, 1H), 1.77-1.69 (m, 1H), 1.38 (d, J = 
6.0 Hz, 3H); 13C NMR (151 MHz, CDCl3)  208.2, 140.1, 136.7, 129.1, 127.8, 127.1, 126.9, 
77.5, 67.1, 53.1, 49.6, 32.3, 29.5, 23.0, 20.0; IR (neat) 2933, 1717, 1450, 1314, 1274, 1172, 
1022, 759 cm-1; HRMS (EI) calcd for C15H18O2 (M
+) 230.1307, found 230.1306. 
 
4-((3-Methylbut-2-en-1-yl)oxy)-4-(prop-1-yn-1-yl)dec-1-en-2-yl acetate 
(3.55) 
1H NMR (600 MHz, CDCl3)  5.33 (t, J = 6.7 Hz, 1H), 4.87 (s, 2H), 4.06 (p, J 
= 10.7 Hz, 2H), 2.67-2.62 (m, 2H), 2.12 (s, 3H), 1.88 (s, 3H), 1.74 (s, 3H), 1.72-1.69 (m, 2H), 
1.70 (s, 3H), 1.48-1.29 (m, 8H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3)  169.4, 
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152.4, 136.1, 121.9, 105.7, 82.8, 79.7, 75.3, 61.0, 42.4, 39.3, 32.1, 29.7, 26.1, 24.2, 22.9, 21.4, 
18.3, 14.3, 3.8; IR (neat) 2926, 2858, 1758, 1663, 1442, 1369, 1196, 1056, 873 cm-1; HRMS 
(ESI) calcd for C20H32O3Na (M+Na)
+ 343.2249, found 343.2216. 
 
(2R,6R)-2-Hexyl-6-(2-methylprop-1-en-1-yl)-2-(prop-1-yn-1-yl)dihydro-
2H-pyran-4(3H)-one (3.80) 
The general cyclization reaction procedure was followed with 3.55 (40 mg, 
0.12 mmol), 2,6-dichloropyridine (37 mg, 0.25 mmol), 4 Å molecular sieves (80 mg), 1,2-
dichloroethane (1.2 mL), LiClO4 (4 mg, 0.04 mmol), and DDQ (62 mg, 0.27 mmol). The 
reaction was stirred at 0 °C for 2.3 hours and then quenched by Et3N. The crude mixture was 
purified by flash chromatography (40% CH2Cl2 in hexane to 8% EtOAc in hexane) to give the 
desired product (27 mg, 79%). 1H NMR (600 MHz, CDCl3)  5.24 (d, J = 6.8 Hz, 1H), 4.92 
(ddd, J = 3.1, 7.9, 11.0 Hz, 1H), 2.49 (dd, J = 1.6, 13.7 Hz, 1H), 2.41 (d, J = 13.7 Hz, 1H), 2.35-
2.32 (m, 1H), 2.28 (dd, J = 11.0, 14.2 Hz, 1H), 1.85 (s, 3H), 1.75 (s, 3H), 1.71 (d, J = 0.8 Hz, 
3H), 1.58-1.29 (m, 10H), 0.88 (t, J = 6.6 Hz, 3H); 13C NMR (151 MHz, CDCl3)  206.5, 138.2, 
124.6, 85.2, 77.7, 75.6, 69.8, 52.9, 47.8, 43.1, 32.0, 29.5, 25.9, 24.1, 22.8, 18.8, 14.3, 3.7; IR 
(neat) 2924, 2857, 1724, 1448, 1377, 1319, 1291, 1261, 1207, 1118, 1046 cm-1; HRMS (ESI) 
calcd for C18H28O2Na (M+Na)
+ 299.1987, found 299.1979. 
 
(E)-4-Methyl-4-((3-methylbut-2-en-1-yl)oxy)hexadeca-1,5-dien-2-yl 
acetate (3.56) 
1H NMR (600 MHz, CDCl3)  5.57 (td, J = 6.7, 15.8 Hz, 1H), 5.43 (d, J = 15.8 Hz, 1H), 5.28 (t, 
J = 6.7 Hz, 1H), 4.82 (s, 1H), 4.80 (s, 1H), 3.81-3.79 (m, 2H), 2.54 (d, J = 14.5 Hz, 1H), 2.47 (d, 
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J = 14.5 Hz, 1H), 2.09 (s, 3H), 2.06 (q, J = 7.0 Hz, 2H), 1.72 (s, 3H), 1.63 (s, 3H), 1.39-1.36 (m, 
2H), 1.32 (s, 3H), 1.3-1.24 (m, 14H), 0.89 (t, J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3)  
169.3, 153.0, 135.6, 134.2, 131.7, 122.4, 105.5, 76.3, 59.3, 44.8, 32.8, 32.1, 29.9, 29.7, 29.6, 
29.4, 26.1, 22.9, 22.5, 21.5, 18.2, 14.4; IR (neat) 2925, 2854, 1759, 1662, 1454, 1369, 1200, 
1027, 978 cm-1; HRMS (ESI) calcd for C24H42O3Na (M+Na)
+ 401.3032, found 401.3020. 
 
(2R,6R)-2-((E)-Dodec-1-en-1-yl)-2-methyl-6-(2-methylprop-1-en-1-
yl)dihydro-2H-pyran-4(3H)-one (3.81) 
The general cyclization reaction procedure was followed with 3.56 (45 mg, 0.12 mmol), 2,6-
dichloropyridine (35 mg, 0.24 mmol), 4 Å molecular sieves (90 mg), 1,2-dichloroethane (1.2 
mL), LiClO4 (3.8 mg, 0.036 mmol), and DDQ (54 mg, 0.24 mmol). The reaction was stirred at 0 
°C for 2 h and then quenched by Et3N. The crude mixture was purified by flash chromatography 
(35% CH2Cl2 in hexane to 5% EtOAc in hexane) to give the desired products (38 mg, 95%, dr = 
15.7:1). 1H NMR (500 MHz, CDCl3)  5.56 (td, J = 6.7, 16.1 Hz, 1H), 5.38 (d, J = 16.1 Hz, 1H), 
5.25 (d, J = 8.1 Hz, 1H), 4.58-4.52 (m, 1H), 2.68 (d, J = 14.4 Hz, 1H), 2.41 (d, J = 14.4 Hz, 1H), 
2.29-2.21 (m, 2H), 2.04 (q, J = 6.9 Hz, 2H), 1.75 (s, 3H), 1.65 (s, 3H), 1.39 (s, 3H), 1.36-1.34 
(m, 2H),1.30-1.25 (m, 14H), 0.88 (t, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3)  207.7, 
137.5, 134.3, 133.2, 124.9, 77.2, 68.4, 50.0, 47.6, 32.7, 32.1, 30.7, 29.9, 29.8, 29.7, 29.6, 29.3, 
29.2, 26.0, 22.9, 18.6, 14.3; IR (neat) 25, 2854, 1759, 1723, 1444, 1371, 1206, 1115, 1046, 981 
cm-1; HRMS (EI) calcd for C22H38O2 (M
+) 334.2872, found 334.2879. 
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(2S,6R)-2-((E)-Dodec-1-en-1-yl)-2-methyl-6-(2-methylprop-1-en-1-
yl)dihydro-2H-pyran-4(3H)-one (3.81-minor) 
1H NMR (600 MHz, CDCl3)  5.66 (td, J = 6.2, 15.6 Hz, 1H), 5.62 (d, J = 15.7 Hz, 1H), 5.28-
5.26 (m, 1H), 4.66 (ddd, J = 3.3, 8.1, 11.2 Hz, 1H), 2.55 (d, J = 13.6 Hz, 1H), 2.38-2.28 (m, 3H), 
2.03 (q, J = 6.4 Hz, 2H), 1.75 (s, 3H), 1.69 (s, 3H), 1.44 (s, 3H), 1.38-1.35 (m, 2H),1.29-1.26 (m, 
14H), 0.89 (t, J = 6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3)  208.0, 137.0, 135.8, 129.4, 125.1, 
76.9, 68.3, 52.1, 48.0, 32.5, 32.1, 30.5, 29.9, 29.8, 29.6, 29.5, 29.3, 26.0, 23.1, 22.9, 18.6, 14.4; 
IR (neat) 2925, 2854, 1759, 1723, 1444, 1371, 1206, 1115, 1046, 981 cm-1; HRMS (EI) calcd for 
C22H38O2 (M
+) 334.2872, found 334.2885. 
 
(Z)-5-(Dimethyl(phenyl)silyl)-4-methyl-4-((3-methylbut-2-en-1-
yl)oxy)deca-1,5-dien-2-yl acetate (3.57) 
1H NMR (600 MHz, CDCl3)  7.55-7.53 (m, 2H), 7.32-7.31 (m, 3H), 6.17 (t, J = 7.5 Hz, 1H), 
5.27 (t, J = 6.3 Hz, 1H), 4.83 (s, 1H), 4.81 (s, 1H), 3.92-3.78 (m, 2H), 2.87 (d, J = 14.8 Hz, 1H), 
2.42 (d, J = 14.8 Hz, 1H), 2.09 (s, 3H), 1.94-1.90 (m, 2H), 1.71 (s, 3H), 1.60 (s, 3H), 1.45 (s, 
3H), 1.22-1.07 (m, 4H), 0.73 (t, J = 7.2 Hz, 3H), 0.47 (s, 3H), 0.46 (s, 3H); 13C NMR (151 MHz, 
CDCl3)  169.5, 153.5, 144.9, 142.1, 141.3, 134.4, 133.9, 128.6, 127.8, 122.6, 105.4, 81.0, 59.7, 
44.2, 32.2, 31.9, 26.0, 23.8, 22.6, 21.5, 18.3, 14.1, 2.1, 1.6; IR (neat) 2959, 2927, 2858, 1758, 
1453, 1428, 1370, 1250, 1199, 1108, 1089, 1036, 836, 818, 773, 731, 701, 660 cm-1; HRMS 
(ESI) calcd for C26H40O3SiNa (M+Na)
+ 451.2644, found 451.2622. 
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(2R,6R)-2-((Z)-1-(Dimethyl(phenyl)silyl)hex-1-en-1-yl)-2-methyl-6-(2-
methylprop-1-en-1-yl)dihydro-2H-pyran-4(3H)-one (3.82) 
The general cyclization reaction procedure was followed with 3.57 (14 mg, 0.031 mmol), 2,6-
dichloropyridine (10 mg, 0.068 mmol), 4 Å molecular sieves (30 mg), 1,2-dichloroethane (0.04 
mL), LiClO4 (1 mg, 0.010 mmol), and DDQ (15 mg, 0.066 mmol). The reaction was stirred at 0 
°C for 0.5 h and then quenched by Et3N. The crude mixture was purified by flash 
chromatography (30% CH2Cl2 in hexane to 5% EtOAc in hexane) to give the desired products 
(9.4 mg, 76%). 1H NMR (600 MHz, CDCl3)  7.52-7.50 (m, 2H), 7.33-7.31 (m, 3H), 6.20 (t, J = 
7.5 Hz, 1H), 5.29-5.28 (m, 1H), 4.57-4.54 (m, 1H), 3.04 (d, J = 14.2 Hz, 1H), 2.47 (d, J = 14.2 
Hz, 1H), 2.24-2.22 (m, 2H), 1.98-1.83 (m, 2H), 1.73 (s, 3H), 1.54 (s, 3H), 1.53 (s, 3H), 1.17-1.05 
(m, 4H), 0.72 (t, J = 7.2 Hz, 3H), 0.46 (s, 3H), 0.44 (s, 3H); 13C NMR (151 MHz, CDCl3)  
207.7, 147.6, 140.3, 140.2, 134.0, 133.9, 128.9, 127.9, 125.6, 82.5, 69.6, 51.6, 47.8, 32.6, 31.7, 
31.6, 25.9, 22.5, 18.7, 14.1, 2.3, 1.3; IR (neat) 2925, 2855, 1723, 1428, 1293, 1249, 1108, 1045, 
810, 775, 730, 700 cm-1; HRMS (EI) calcd for C24H36O2Si (M
+) 384.2485, found 384.2489. 
 
3-(1-((3-Methylbut-2-en-1-yl)oxy)cyclohexyl)prop-1-en-2-yl acetate (3.58) 
1H NMR (500 MHz, CDCl3)  5.33-5.31 (m, 1H), 4.84 (d, J = 0.9 Hz, 1H), 4.80 
(s, 1H), 3.85-3.84 (m, 2H), 2.43 (s, 2H), 2.12 (s, 3H), 1.82-1.79 (m, 2H), 1.73 (s, 
3H), 1.66 (s, 3H), 1.61-1.20 (m, 8H); 13C NMR (125 MHz, CDCl3)  169.5, 153.1, 135.4, 122.2, 
105.3, 75.0, 57.5, 34.7, 26.1, 25.9, 22.1, 21.4, 18.3; IR (neat) 2931, 2857, 1756, 1663, 1449, 
1369, 1201, 1057, 1024, 961, 872 cm-1; HRMS (ESI) calcd for C16H26O3Na (M+Na)
+ 289.1780, 
found 289.1786. 
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2-(2-Methylprop-1-en-1-yl)-1-oxaspiro[5.5]undecan-4-one (3.83) 
The general cyclization reaction procedure was followed with 3.58 (45 mg, 0.17 
mmol), 2,6-dichloropyridine (50 mg, 0.34 mmol), 4 Å molecular sieves (90 mg), 1,2-
dichloroethane (1.7 mL), LiClO4 (5.4 mg, 0.051 mmol), and DDQ (77 mg, 0.34 mmol). The 
reaction was stirred at room temperature for 20 minutes and then quenched by Et3N. The crude 
mixture was purified by flash chromatography (15% Et2O in hexane) to give the desired product 
(33 mg, 88%). 1H NMR (500 MHz, CDCl3)  5.26 (d, J = 8.0 Hz, 1H), 4.56 (dt, J = 4.4, 9.2 Hz, 
1H), 2.33-2.29 (m, 4H), 1.82-1.72 (m, 5H), 1.70 (s, 3H), 1.57-1.29 (m, 8H); 13C NMR (151 
MHz, CDCl3)  208.5, 137.0, 125.4, 76.6, 67.1, 52.4, 48.1, 39.8, 32.2, 26.1, 25.7, 22.0, 21.6, 
18.6; IR (neat) 2931, 2858, 1719, 1449, 1375, 1307, 1262, 1235, 1204, 1156, 1121, 1048, 978 
cm-1; HRMS (EI) calcd for C14H22O2 (M
+) 222.1620, found 222.1613. 
 
3-((1S,2S)-2-Methyl-1-((3-methylbut-2-en-1-yl)oxy)cyclohexyl)prop-1-en-2-
yl acetate (3.59)7-8 
1H NMR (300 MHz, CDCl3)  5.30-5.25 (m, 1H), 4.84 (s, 2H), 3.85-3.83 (m, 2H), 2.61-2.49 (m, 
2H), 2.14 (s, 3H), 1.85-1.77 (m, 1H), 1.73 (d, J = 0.8 Hz, 3H), 1.64 (s, 3H), 1.61-1.22 (m, 8H), 
0.93 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3)  169.4, 153.8, 134.5, 122.7, 105.5, 77.4, 
57.4, 39.3, 37.7, 31.5, 30.5, 26.0, 25.2, 22.3, 21.4, 18.4, 15.4; IR (neat) 2966, 2931, 2857, 1759, 
1661, 1446, 1370, 1209, 1186, 1147, 1081, 1058, 1040, 1022, 875 cm-1; HRMS (ESI) calcd for 
C17H28O3Na (M+Na)
+ 303.1936, found 303.1922. 
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(2S,6R,7R)-7-Methyl-2-(2-methylprop-1-en-1-yl)-1-oxaspiro[5.5]undecan-4-
one (3.84) 
The general cyclization reaction procedure was followed with 3.59 (30 mg, 0.11 mmol), 2,6-
dichloropyridine (32 mg, 0.22 mmol), 4 Å molecular sieves (60 mg), 1,2-dichloroethane (1.1 
mL), LiClO4 (4 mg, 0.03 mmol), and DDQ (49 mg, 0.21 mmol). The reaction was stirred at – 30 
°C for 5 h and then quenched by Et3N. The crude mixture was purified by flash chromatography 
(30% CH2Cl2 in hexane to 5% EtOAc in hexane) to give the desired product (21 mg, 81%). 
1H 
NMR (500 MHz, CDCl3)  5.24 (d, J = 7.8 Hz, 1H), 4.52-4.48 (m, 1H), 2.68 (d, J = 13.6 Hz, 
1H), 2.26-2.19 (m, 2H), 2.02-1.95 (m, 2H), 1.75 (s, 3H), 1.67 (s, 3H), 1.61-1.52 (m, 1H), 1.45-
1.38 (m, 4H), 1.31-1.22 (m, 2H), 1.14-1.08 (m, 1H), 0.98 (d, J = 6.5 Hz, 3H); 13C NMR (125 
MHz, CDCl3)  209.7, 135.5, 125.8, 77.5, 67.0, 50.4, 48.0, 40.8, 32.9, 30.3, 26.1, 21.0, 18.5, 
15.3; IR (neat) 2966, 2930, 2857, 1718, 1448, 1377, 1308, 1297, 1262, 1164, 1049, 975 cm-1; 
HRMS (EI) calcd for C15H24O2 (M
+) 236.1776, found 236.1777. 
 
(R)-4-Methyl-4-((R)-non-3-yn-2-yloxy)hept-1-en-5-yn-2-yl acetate (3.60) 
1H NMR (600 MHz, CDCl3)  4.87 (s, 1H), 4.86 (d, J = 1.0 Hz, 1H), 4.61 
(tq, J = 2.0, 6.6 Hz, 1H), 2.67 (d, J = 14.5 Hz, 1H), 2.54 (d, J = 14.5 Hz, 
1H), 2.18 (dt, J = 1.9, 7.1 Hz, 2H), 2.13 (s, 3H), 1.87 (s, 3H), 1.56 (s, 3H), 1.52-1.48 (m, 2H), 
1.37 (d, J = 6.6 Hz, 3H), 1.36-1.28 (m, 4H), 0.90 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, 
CDCl3)  169.4, 152.4, 105.8, 84.4, 83.0, 82.2, 79.9, 77.5, 77.2, 77.0, 73.7, 60.7, 46.6, 31.2, 28.6, 
27.7, 24.3, 22.4, 21.5, 19.0, 14.2, 3.9; IR (neat) 2964, 2929, 2853, 1756, 1659, 1443, 1371, 1203, 
1183, 1148, 1085, 1052, 1043, 1026, 877 cm-1; HRMS (EI) calcd for C19H28O3 (M
+) 304.2038, 
found 304.2029. 
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(2R,6R)-6-Hexyl-2-methyl-2-phenyltetrahydro-2H-pyran (3.87) 
To a mixture of homoallylic alcohol 3.86 (157 mg, 1.00 mmol), acetophenone 
(118 µL, 1.00 mmol) and NaI (150 mg, 1.00 mmol) in 1.2 mL dry acetonitrile was added 
anhydrous TMSCl (124 µL, 1.00 mmol) dropwise and the resulting mixture stirred at room 
temperature.9 After 4 h later, the reaction was quenched by the addition of H2O, and the mixture 
was extracted with EtOAc. The organic layer was washed with Na2S2O3 solution, and dried over 
MgSO4. The solvent was removed under reduced pressure and the crude mixture was purified by 
flash chromatography (20% CH2Cl2 in hexane) to give the desired product (51 mg, 13%). To the 
4-iodotetrahydropyran (48 mg, 0.12 mmol) and AIBN (4.1 mg, 0.020 mmol) in 1.3 mL toluene 
was added nBu3SnH, and the mixture was heated to 80 °C for 1 h. After concentration, the crude 
mixture was purified by flash chromatography (hexane to 5% to 10% CH2Cl2 in hexane) to give 
the desired product (29 mg, 90%). 1H NMR (600 MHz, CDCl3)  7.50-7.49 (m, 2H), 7.33 (t, J = 
7.9 Hz, 2H), 7.23-7.21 (m, 1H), 3.76-3.72 (m, 1H), 1.95-1.92 (m, 1H), 1.84-1.76 (m, 2H), 1.65-
1.56 (m, 3H), 1.53-1.51 (m, 1H), 1.49 (s, 3H), 1.47-1.44 (m, 1H), 1.42-1.37 (m, 1H), 1.36-1.29 
(m, 6H), 1.23-1.16 (m, 1H), 0.91 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3)  150.8, 
128.2, 126.4, 124.4, 74.6, 70.3, 37.1, 36.4, 32.1, 31.8, 29.6, 25.8, 23.4, 22.9, 20.5, 14.4; IR (neat) 
2930, 2856, 1493, 1446, 1371, 1257, 1204, 1071, 761 cm-1; HRMS (EI) calcd for C18H28O (M
+) 
260.2140, found 260.2128. 
 
(2S,4R,6S,7S)-4-Chloro-2-hexyl-7-methyl-1-oxaspiro[5.5]undecane (3.89) 
To AlCl3 in 0.5 mL CH2Cl2 at 0 °C was added alcohol 3.88 (155 mg, 1.00 mmol) 
and heptanal (147 µL, 1.00 mmol) in 2 mL CH2Cl2.
10 After striring at room temperature for 2.5 
h, the reaction was quenched with a buffer solution (PH = 7.5). The mixture was extracted with 
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Et2O for two times, and the organic layer was dried over MgSO4. The solvent was removed 
under reduced pressure and the crude mixture was purified by flash chromatography (5% CH2Cl2 
in hexane) to give the desired product (60 mg, 21%). 1H NMR (600 MHz, CDCl3)  4.27 (tt, J = 
4.4, 12.1 Hz, 1H), 3.46-3.42 (m, 1H), 2.15-2.13 (m, 1H), 2.07 (pd, J = 1.9, 12.4 Hz, 1H), 1.89 (t, 
J = 12.4 Hz, 1H), 1.75 (ddd, J = 1.6, 4.4, 12.5 Hz, 1H), 1.66-1.63 (m, 1H), 1.53-1.44 (m, 3H), 
1.41-1.33 (m, 6H), 1.32-1.24 (m, 8H), 1.02-0.97 (m, 1H), 0.91 (t, J = 6.4 Hz, 3H), 0.89 (t, J = 7.1 
Hz, 3H); 13C NMR (151 MHz, CDCl3)  75.3, 68.7, 55.5, 43.4, 43.3, 40.8, 36.7, 32.1, 31.1, 30.6, 
29.6, 26.2, 25.8, 22.9, 21.1, 15.2, 14.4; IR (neat) 2930, 2856, 1457, 1377, 1335, 1257, 1218, 
1141, 1064, 998, 871, 798, 706 cm-1; HRMS (EI) calcd for C17H31OCl (M
+) 286.2063, found 
286.2060. 
 
References in experimental of Chapter 3: 
1.AlMe3-mediated acetal opening: Ishihara, K.; Hanaki, N.; Yamamoto, H. J. Am. Chem. Soc. 
1993, 115, 10695. 
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3.Ohira-Bestmann reagent: a) Ohira, S. Synth. Commun. 1989, 19, 561-564. b) Müller, S.; 
Liepold, B.; Roth, G. J.; Bestmann, H. J. Synlett 1996, 521. 
4.Xiao, Y.; Araldi, G. L.; Zhao, Z.; Brugger, N.; Karra, S.; Fischer, D.; Palmer, E. Bioorg. Med. 
Chem. Lett.2007, 17, 4323. 
5.DIBAL-H-mediated ketal opening: Mori, A.; Fujiwara, J.; Maruoka, K.; Yamamoto, H. 
Tetrahedron Lett. 1983, 24, 4581. 
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APPENDIX D 
DDQ-CATALYZED REACTIONS USING MANGANESE DIOXIDE AS A TERMINAL 
OXIDANT 
General Experimental Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, a Bruker 
Avance 400 spectrometer at 400 MHz and 101 MHz, a Bruker Avance 500 spectrometer at 500 
MHz and 125 MHz, a Bruker Avance 600 spectrometer at 600 MHz and 151 MHz if specified. 
The chemical shifts are given in parts per million (ppm) on the delta (δ) scale. The solvent peak 
was used as a reference value, for 1H NMR: CDCl3 = 7.26 ppm, for 
13C NMR: CDCl3 = 77.23. 
Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; dd = doublet of 
doublets; dt = doublet of triplets; br = broad). High resolution and low resolution mass spectra 
were recorded on a VG 7070 spectrometer. Infrared (IR) spectra were collected on a Mattson 
Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on a NaCl plate by 
dissolving the compound in CH2Cl2 and then evaporating the CH2Cl2. Analytical TLC was 
performed on E. Merck pre-coated (25 mm) silica gel 60F-254 plates. Visualization was done 
under UV light (254 nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica 
gel.  Methylene chloride was distilled under N2 from CaH2, and 1,2–dichloroethane was dried 
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over 4Å molecular sieves. Reagent grade ethyl acetate, diethyl ether, pentane and hexanes were 
purchased from EM Science and used as purchased for chromatography. Tetrahydrofuran and 
diethyl ether were dried by passage through an activated alumina column under positive N2 
pressure. Anhydrous (N,N)-dimthylformamide (DMF), methanol (MeOH), dimethyl sulfoxide 
(DMSO), acetone were purchased from Aldrich and used as it is. Activated 4 Å molecular sieves 
were obtained through drying in oven at 150 °C overnight. All reactions were performed in oven 
or flame-dried glassware under a positive pressure of N2 with magnetic stirring unless otherwise 
noted.  
 
General procedure for the cyclization reactions:  
Substrate (1 eq), 2,6-dichloropyridine (2 eq), MnO2 (6 eq) and 4 Å molecular sieves (2 mass eq) 
were suspended in anhydrous nitromethane to give a ~0.1 M solution (substrate concentration). 
The mixture was stirred at room temperature for 15 minutes, followed by the addition of DDQ 
(0.05 eq). The mixture was stirred at rt for 10 h and a second portion of DDQ (0.05 eq) was 
added. After an additional 14 h, the last portion of DDQ (0.05 eq) was added. The reaction was 
monitored by TLC and, upon starting material consumption, was quenched by Et3N. The mixture 
was filtrated through a short pad of Celit with Et2O. The filtration was concentrated and purified 
by flash chromatography to give the desired product. 
 
6-((tert-Butyldimethylsilyl)oxy)-4-((3-methylbut-2-en-1-yl)oxy)hex-1-
en-2-yl acetate (4.1) 
Substrate 4.1 was prepared following the same synthetic route to substrate 1.93. 1H NMR (400 
MHz, CDCl3)  5.36-5.32 (m, 1H), 4.82 (s, 2H), 4.04 (dd, J = 7.0, 11.0 Hz, 1H), 3.96-3.92 (m, 
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1H), 3.77-3.62 (m, 3H), 2.50 (dd, J = 6.4, 10.9 Hz, 1H), 2.41 (dd, J = 5.8, 14.7 Hz, 1H), 2.14 (s, 
3H), 1.74 (s, 3H), 1.73-1.70 (m, 2H), 1.68 (s, 3H), 0.90 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 13C 
(100 MHz, CDCl3)  169.3, 153.8, 136.9, 121.5, 103.8, 73.1, 66.2, 59.6, 38.8, 37.8, 26.1, 26.0, 
21.3, 18.5, 18.2, -5.1, -5.2; IR (neat) 2927, 2859, 1759, 1651, 1254, 1200, 1094, 1020, 835, 773 
cm-1; HRMS(EI) calcd for C19H36O4Si (M
+) 356.2383, found 356.2376. 
 
(2R,6R)-2-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-6-(2-methylprop-1-en-
1-yl)dihydro-2H-pyran-4(3H)-one (4.3) 
The general procedure of cyclization reaction was followed: 4.1 (42 mg, 0.12 mmol), 2,6-
dichloropyridine (35 mg, 0.23 mmol), MnO2 (61 mg, 0.70 mmol) and 4 Å molecular sieves (60 
mg) were dissolved in 1.1 mL anhydrous nitromethane, followed by DDQ (3 x 1.4 mg, 15% eq). 
The reaction was stirred at room temperature for 48 h and then quenched by Et3N. The mixture 
was filtrated through a short pad of Celit with Et2O. The filtration was concentrated and purified 
by flash chromatography (30% CH2Cl2 in hexane to 5% EtOAc in hexane) to give the desired 
product (29 mg, 79%). 1H NMR (400 MHz, CDCl3)  5.23-5.21 (m, 1H), 4.34-4.25 (m, 1H), 
3.86-3.75 (m, 2H), 3.72-3.67 (m, 1H), 2.39-2.25 (m, 4H), 1.89-1.79 (m, 1H), 1.74 (s, 3H), 1.72-
1.69 (m, 1H), 1.67 (s, 3H), 0.87 (s, 9H), 0.03 (s, 6H); 13C (100 MHz, CDCl3)  207.6, 137.4, 
124.7, 74.3, 73.8, 59.0, 48.2, 48.1, 39.5, 26.1, 25.9, 18.6, 18.4, -5.2, -5.3; IR (neat) 2953, 2927, 
2859, 1724, 1469, 1385, 1361, 1325, 1253, 1146, 1098, 1025, 940, 901, 835, 777 cm-1; 
HRMS(EI) calcd for C17H32O3Si (M
+) 312.2121, found 312.2124. 
 
2-(4-Methoxyphenyl)dihydro-2H-pyran-4(3H)-one (4.5) 
The general procedure of cyclization reaction was followed: 4.41 (35 mg, 0.14 
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mmol), 2,6-dichloropyridine (41 mg, 0.28 mmol), MnO2 (75 mg, 0.84 mmol) and 4 Å molecular 
sieves (40 mg) were dissolved in 1.4 mL anhydrous nitromethane, followed by DDQ (3 x 1.6 
mg, 15% eq). The reaction was stirred at room temperature for 41 h and then quenched by Et3N. 
The mixture was filtrated through a short pad of Celit with Et2O. The filtration was concentrated 
and purified by flash chromatography (15% EtOAc in hexane) to give the desired product (22 
mg, 76%). 1H NMR (400 MHz, CDCl3)  7.31-7.29 (m, 2H), 6.93-6.90 (m, 2H), 4.60 (dd, J = 
3.9, 10.1 Hz, 1H), 4.41 (ddd, J = 1.5, 7.3, 11.5 Hz, 1H), 3.87-3.83 (m, 1H), 3.81 (s, 3H), 2.76-
2.69 (m, 1H), 2.67-2.63 (m, 2H), 2.43 (dm, J = 14.6 Hz, 1H); 13C (100 MHz, CDCl3)  206.8, 
159.7, 132.9, 127.3, 114.2, 79.7, 66.9, 55.5, 50.1, 42.4. These data are consistent with reported 
literature values.1 
 
2-p-Tolyldihydro-2H-pyran-4(3H)-one (4.7) 
The general procedure of cyclization reaction was followed: 4.61 (49 mg, 0.21 
mmol), 2,6-dichloropyridine (46 mg, 0.31 mmol), MnO2 (109 mg, 1.25 mmol) and 
4 Å molecular sieves (80 mg) were dissolved in 2 mL anhydrous nitromethane, followed by 
DDQ (3 x 2.4 mg, 15% eq). The reaction was stirred at room temperature for 44 h and then 
quenched by Et3N. The mixture was filtrated through a short pad of Celit with Et2O. The 
filtration was concentrated and purified by flash chromatography (30% CH2Cl2 in hexane to 7% 
EtOAc in hexane) to give the desired product (33 mg, 83%). 
1H NMR (400 MHz, CDCl3)  7.27 
(d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 4.64 (dd, J = 5.4, 8.7 Hz, 1H), 4.43 (ddd, J = 1.5, 
7.4, 11.5 Hz, 1H), 3.89 (td, J = 2.9, 12.0 Hz, 1H), 2.73 (ddd, J = 7.4, 12.3, 14.6 Hz, 1H), 2.66-
2.64 (m, 2H), 2.44 (dm, J = 14.4 Hz, 1H), 2.36 (s, 3H); 13C (100 MHz, CDCl3)  206.8, 138.2, 
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137.8, 129.6, 125.9, 80.0, 66.9, 50.2, 42.4, 21.4. These data are consistent with reported literature 
values.1 
 
(2R,6R)-2-Hexyl-6-((E)-prop-1-en-1-yl)dihydro-2H-pyran-4(3H)-one (4.8) 
The general procedure of cyclization reaction was followed: 1.88 (26 mg, 
0.097 mmol), 2,6-dichloropyridine (22 mg, 0.15 mmol), MnO2 (51 mg, 0.58 mmol) and 4 Å 
molecular sieves (40 mg) were dissolved in 1.0 mL anhydrous nitromethane, followed by DDQ 
(3 x 1.1 mg, 15% eq). The reaction was stirred at room temperature for 40 h and then quenched 
by Et3N. The mixture was filtrated through a short pad of Celit with Et2O. The filtration was 
concentrated and purified by flash chromatography (30% CH2Cl2 in Hexane to 5% EtOAc in 
hexane) to give the desired product (20 mg, 92%). 1H NMR (300 MHz, CDCl3)  5.73 (ddq, J = 
0.9, 12.5, 15.2 Hz, 1H), 5.53 (ddq, J = 1.5, 6.1, 15.2 Hz, 1H), 4.05-4.00 (m, 1H), 3.59 (ddt, J = 
2.7, 7.0, 14.3 Hz, 1H), 2.38-2.32 (m, 3H), 2.28-2.18 (m, 1H), 1.71-1.64 (m, 3H), 1.55-1.26 (m, 
10H), 0.87 (t, J = 6.6 Hz, 3H); 13C (75 MHz, CDCl3)  207.4, 130.7, 128.4, 77.5, 77.2, 48.0, 
47.9, 36.6, 31.9, 29.3, 25.4, 22.7, 17.9, 14.2. These data are consistent with reported literature 
values.2 
 
(2R,6R)-2-(4-Methoxyphenyl)-2,6-dimethyl-tetrahydropyran-4-one (4.9) 
The general procedure of cyclization reaction was followed: 3.21 (46 mg, 
0.17 mmol), 2,6-dichloropyridine (49 mg, 0.33 mmol), MnO2 (86 mg, 0.99 
mmol) and 4 Å molecular sieves (80 mg) were dissolved in 1.6 mL anhydrous nitromethane, 
followed by DDQ (4 x 1.9 mg, 20% eq). The reaction was stirred at room temperature for 48 h 
and then quenched by Et3N. The mixture was filtrated through a short pad of Celit with Et2O. 
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The filtration was concentrated and purified by flash chromatography (30% CH2Cl2 in hexane to 
7% EtOAc in hexane) to give the desired product (29 mg, 75%). 
1H NMR (300 MHz, CDCl3)  
7.42 (d, J = 8.9 Hz, 2H), 6.90 (d, J = 8.9 Hz, 2H), 4.27-4.17 (m, 1H), 3.81 (s, 3H), 2.72-2.61 (m, 
2H), 2.46-2.40 (m, 1H), 2.29 (dd, J = 11.0, 14.1 Hz, 1H), 1.48 (s, 3H), 1.42 (d, J = 6.0 Hz, 3H); 
13C (75 MHz, CDCl3)  207.9, 158.8, 139.6, 125.5, 113.8, 77.9, 67.2, 55.5, 53.4, 49.4, 25.5, 22.8. 
These data are consistent with reported literature values.3 
 
(2R,6R)-2-Hexyl-6-(2-methylprop-1-enyl)-2-(prop-1-ynyl)dihydro-2H-
pyran-4(3H)-one (4.10) 
The general procedure of cyclization reaction was followed: 3.55 (35 mg, 0.11 
mmol), 2,6-dichloropyridine (24 mg, 0.16 mmol), MnO2 (57 mg, 0.66 mmol) and 4 Å molecular 
sieves (70 mg) were dissolved in 1.1 mL anhydrous nitromethane, followed by DDQ (3 x 1.4 
mg, 15% eq). The reaction was stirred at room temperature for 40 h and then quenched by Et3N. 
The mixture was filtrated through a short pad of Celit with Et2O. The filtration was concentrated 
and purified by flash chromatography (30% CH2Cl2 in hexane to 5% EtOAc in hexane) to give 
the desired product (21 mg, 70%). 1H NMR (600 MHz, CDCl3)  5.24 (d, J = 6.8 Hz, 1H), 4.92 
(ddd, J = 3.1, 7.9, 11.0 Hz, 1H), 2.49 (dd, J = 1.6, 13.7 Hz, 1H), 2.41 (d, J = 13.7 Hz, 1H), 2.36-
2.31 (m, 1H), 2.28 (dd, J = 11.0, 14.2 Hz, 1H), 1.85 (s, 3H), 1.75 (s, 3H), 1.71 (d, J = 0.8 Hz, 
3H), 1.57-1.28 (m, 10H), 0.88 (t, J = 6.6 Hz, 3H); 13C (100 MHz, CDCl3)  206.5, 138.2, 124.6, 
85.2, 77.7, 75.6, 69.8, 52.9, 47.8, 43.1, 32.0, 29.5, 25.9, 24.1, 22.8, 18.8, 14.3, 3.7. These data 
are consistent with reported literature values.3 
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2-(2-Methylprop-1-enyl)-1-oxaspiro[5.5]undecan-4-one (4.11) 
The general procedure of cyclization reaction was followed: 3.58 (38 mg, 0.14 
mmol), 2,6-dichloropyridine (31 mg, 0.21 mmol), MnO2 (74 mg, 0.85 mmol) 
and 4 Å molecular sieves (60 mg) were dissolved in 1.4 mL anhydrous nitromethane, followed 
by DDQ (3 x 1.7 mg, 15% eq). The reaction was stirred at room temperature for 30 h and then 
quenched by Et3N. The mixture was filtrated through a short pad of Celit with Et2O. The 
filtration was concentrated and purified by flash chromatography (30% CH2Cl2 in hexane to 15% 
Et2O in hexane) to give the desired product (26 mg, 81%). 
1H NMR (500 MHz, CDCl3)  5.26 
(d, J = 8.0 Hz, 1H), 4.56 (dt, J = 4.4, 9.2 Hz, 1H), 2.33-2.29 (m, 4H), 1.76-1.70 (m, 5H), 1.70 (s, 
3H), 1.57-1.31 (m, 8H); 13C (100 MHz, CDCl3)  208.5, 137.0, 125.4, 76.6, 67.1, 52.4, 48.1, 
39.8, 32.2, 26.1, 25.7, 22.0, 21.6, 18.6. These data are consistent with reported literature values.3 
 
2-Phenylethanol (4.13) 
To 4.12 (60 mg, 0.25 mmol) and MnO2 (129 mg, 1.48 mmol) in anhydrous 
nitromethane (1.3 mL) was added MeOH (60 µL) and DDQ (2.8 mg, 0.012 mmol). The mixture 
was stirred at 60 °C for 10 h and a second portion of DDQ (2.8 mg, 0.012 mmol) was added. 
After an additional 18 h the last portion of DDQ (2.8 mg, 0.012 mmol) was added. After another 
20 h, the reaction was quenched by Et3N. The mixture was filtrated through a short pad of Celit 
with Et2O. The filtration was concentrated and purified by flash chromatography (10% to 15% 
EtOAc in hexane) to give the desired alcohol (27 mg, 90%). 1H NMR (400 MHz, CDCl3)  7.38-
7.26 (m, 4H), 3.86-3.85 (m, 2H), 2.89 (t, J = 6.7 Hz, 2H), 2.07 (br, 1H); 13C (100 MHz, CDCl3)  
138.7, 129.2, 128.7, 126.6, 63.7, 39.3. 
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2-(4-Methoxyphenyl)-1,3-dioxane (4.15) 
4.14 (45 mg, 0.23 mmol), MnO2 (120 mg, 1.38 mmol), NaHCO3 (39 mg, 0.46 
mmol) and 4 Å molecular sieves (80 mg) were dissolved in 1.5 mL anhydrous nitromethane, 
followed by DDQ (3 x 2.6 mg, 15% eq). The reaction was stirred at room temperature for 40 h 
and then quenched by Et3N. The mixture was filtrated through a short pad of Celit with Et2O. 
The filtration was concentrated and purified by flash chromatography (10% EtOAc in hexane) to 
give the desired product (42 mg, 94%). 1H NMR (400 MHz, CDCl3)  7.44-7.40 (m, 2H), 6.92-
6.88 (m, 2H), 5.47 (s, 1H), 4.26 (ddd, J = 1.2, 4.9, 11.8 Hz, 2H), 4.18 (dt, J = 2.5, 12.3 Hz, 2H),  
3.81 (s, 3H), 2.29-2.16 (m, 1H), 1.46-1.43 (m, 1H); 13C (100 MHz, CDCl3)  160.1, 131.5, 
127.5, 113.8, 101.7, 67.6, 55.5, 25.9. These data are consistent with reported literature values.4 
 
Naphthalene (4.17) 
4.16 (46 mg, 0.35 mmol) and MnO2 (185 mg, 2.13 mmol) were dissolved in 2.5 mL 
anhydrous nitromethane, followed by DDQ (2 x 4 mg, 10% eq). The reaction was stirred at room 
temperature for 24 h. The mixture was filtrated through a short pad of Celit with Et2O. The 
filtration was concentrated and purified by flash chromatography (hexane) to give the desired 
product (43 mg, 96%). 1H NMR (400 MHz, CDCl3)  8.00-7.97 (m, 4H), 7.63-7.61 (m, 4H); 
13C 
(100 MHz, CDCl3)  133.7, 128.1, 126.0. 
 
 
2-Phenyloxazole (4.19) 
4.18 (60 mg, 0.41 mmol) and MnO2 (213 mg, 2.45 mmol) were dissolved in 4.0 mL 
anhydrous benzene, followed by DDQ (4 x 4.7 mg, 20% eq). The reaction was stirred at 80 C 
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for 48 h. The mixture was filtrated through a short pad of Celit with Et2O. The filtration was 
concentrated and purified by flash chromatography (20% EtOAc in hexane) to give the desired 
product (51 mg, 86%). 1H NMR (300 MHz, CDCl3)  8.08-8.05 (m, 2H), 7.72 (s, 1H), 7.49-7.44 
(m, 3H), 7.25 (s, 1H); 13C (75 MHz, CDCl3)  138.8, 130.5, 129.0, 128.6, 127.7, 126.6. These 
data are consistent with reported literature values.5 
 
2-(Isochroman-1-yl)-1-phenylethanone (4.22) 
Isochroman (27 mg, 0.20 mmol), acetophenone (72 mg, 0.60 mmol) and MnO2 (105 
mg, 1.21 mmol) were dissolved in 0.25 mL anhydrous nitromethane, followed by 
DDQ (4 x 2.3 mg, 20% eq). The reaction was stirred at 100 C for 48 h. The mixture was 
filtrated through a short pad of Celit with Et2O. The filtration was concentrated and purified by 
flash chromatography (40% CH2Cl2 in hexane to 10% EtOAc in hexane) to give the desired 
product (21 mg, 42%). 1H NMR (300 MHz, CDCl3)  8.05-8.01 (m, 2H), 7.59 (tt, J = 1.4, 8.6 
Hz, 1H), 7.51-7.45 (m, 2H), 7.23-7.10 (m, 4H), 5.52 (dd, J = 3.4, 8.5 Hz, 1H), 4.13 (ddd, J = 3.7, 
5.4, 11.3 Hz, 1H), 3.82 (ddd, J = 3.8, 9.5, 13.4 Hz, 1H), 3.63 (dd, J = 8.7, 16.2 Hz, 1H), 3.33 (dd, 
J = 3.6, 16.2 Hz, 1H), 3.03 (ddd, J = 6.0, 10.0, 16.2 Hz, 1H), 2.73 (td, J = 3.2, 15.8 Hz, 1H); 13C 
(100 MHz, CDCl3)  198.4, 137.8, 137.5, 134.3, 133.4, 129.3, 128.8, 128.6, 126.8, 126.5, 124.8, 
72.9, 63.7, 45.7, 29.2. These data are consistent with reported literature values.6 
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